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Abstract 
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Doctor of Philosophy 
Calcium sensor proteins in hearing and sight. 
Biochemical investigation of disease-associated variants. 
by Giuditta DAL CORTIVO 
Calcium is a cation which plays a pivotal role as second messenger, thus its 
concentration in cells needs to be finely regulated. Many systems work for that 
purpose, including Ca2+ sensor proteins, which undergo conformational changes 
upon Ca2+ coordination via EF-hands. Ca2+ sensors can be ubiquitous or tissue 
specific. Examples in this sense are represented by Guanylate Cyclase Activating 
Protein 1 (GCAP1) and Calcium- and Integrin-Binding Protein 2 (CIB2), involved 
in sight and hearing respectively. Missense point mutations in GCAP1 and CIB2 
were found to be associated with genetic diseases characterized by retinal 
dystrophies and/or deafness. During my PhD, I focused my attention on the 
characterization of two point mutations namely p.Glu111Val (E111V) in GCAP1, 
leading to Cone/Rod dystrophy in an Italian family, and p.Glu64Asp (E64D) in 
CIB2, linked to Usher syndrome type 1J (USH1J), a rare disease characterized by 
the copresence of blindness and deafness. In particular, I spent the first part of the 
PhD investigating the role of CIB2 which is still under debate, finding that it is per 
se uncapable to work as a Ca2+ sensor under physiological conditions and that the 
conservative mutation linked to USH1J perturbs an allosteric communication 
between pseudo-EF1 and EF3, thus blocking the protein in an unfunctional 
conformation. Then, I characterized E111V GCAP1, finding that it is incapable of 
regulating its molecular target (Guanylate Cyclase), leading to a constitutive active 
enzyme and thus a progressively high concentrations of Ca2+ and cGMP in cells, 
which may explain the pathological phenotype. Looking for a potential therapeutic 
approach for Cone-Rod dystrophies, we found that the well-established Ca2+-relay 
model, explaining the gradual activation of Guanylate Cyclase by multiple GCAP 
molecules following gradual changes in intracellular Ca2+ concentrations, seems to 
be species-specific, since it apparently does not work in the same way in humans 
as in mouse and bovine photoreceptors. Finally, we identified a general method for 
the characterization of the interaction between a ubiquitous Ca2+ sensor protein 
(calmodulin) and inorganic CaF2 nanoparticles, suggesting their suitability as 
devices for nanomedicine applications.  
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Figure 1: Representation of EF-hand motif.  
 
EF-hand motif and Ca2+ binding proteins 
The EF-hand motif is a super secondary structure element composed by two 10-
residues α-helices separated by a 12-residues loop (Figure 1) able to coordinate 
divalent cations, especially Ca2+. The negative charges required for Ca2+ coordina-
tion in a pentagonal bi-pyramidal geometry are given by the side chains of residues 
1, 3, 5, and 9, the C=O of residue 7 and a water molecule. Furthermore, EF-hand 
motifs can also coordinate other divalent cations such as Zn2+, Cu2+, Fe2+ e Mg2+1; 
2. This latter is particularly interesting in a physiological context; thanks to its in-
volvement in a broad variety of processes (i.e. cofactor for many enzymes) its con-
centration is kept around 1 mM 3. Nevertheless, EF-hands display a lower affinity 
for Mg2+, preferring the Ca2+, due to a very strict Mg2+-coordination geometry con-
sisting in six ligands arranged in an octahedron and a smaller ionic diameter of 
Mg2+, which requires a higher dehydration energy.  
EF-hand proteins can be divided in two classes: Ca2+-buffers and Ca2+-sensors. The 
main difference is that Ca2+-sensors change their structure upon cation coordina-
tion, and this makes them capable to interact with specific targets, while Ca2+-buff-
ers do not show any conformational change. Ca2+-sensors can be ubiquitous, such 
as calmodulin (CaM), or tissue-specific as recoverin (Rec) and guanylate cyclase 
activating proteins (GCAPs), which are expressed in the retina. 
 
 
 
 
 
 
 
Figure 1: Representation of EF-hand motif. A) Schematic representation of Ca2+ bound EF-
hand. Red tubes represent the entering and exiting helices, the numbered spheres represent the loop 
residues involved in Ca2+ coordination; W is the water molecule. B) Representation of the canonical 
EF-hand 1 from CaM with the pentagonal bi-pyramidal geometry highlighted (solid lines). This 
figure is an adaptation from Ref 1. 
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Figure 2: Structural organization of the ear: from macro to micro. 
 
Molecular basis of hearing 
Hearing is performed mainly in the auditory system, where a complex biomechan-
ical machinery allows the conversion of sounds into electrical signals, the universal 
language used for neuronal communication. The processing of sounds is a thou-
sand-fold faster respect to light processing4 and, since human communication is 
mainly mediated by hearing, deafness is considered more debilitating than blind-
ness.  
The ear is a complex structure (Figure 2A) that can be functionally divided into: i) 
outer ear, which collects and carries the sound waves through the tympanic mem-
brane; ii) middle ear, where three bones (malleus, incus and stapes) convert an air-
diffusing wave to a liquid-diffusing vibration; iii) inner ear, where the cochlea is 
located, and frequency, amplitude and tone are coded in a mechanism known as 
mechano-electrical transduction. This process occurs in hair cells, so called for the 
presence of modified microvilli named stereocilia, located in the upper part of the 
cell (Figure 2B). Thirty to 100 hair cells are organized like a staircase, ranked for 
increasing height, forming a hair-cell bundle5. The stereocilia are connected to each 
other via tip-links, mainly formed by cadherin 23, protocadherin 15 and harmonin, 
and side-links, formed by cadherin 23 and protocadherin 156 (Figure 2C). This 
spatial organization allows the mechano-electrical transduction, mainly driven by 
Mechano-Electrical Transduction channels (MET, Figure 2D). The MET process 
is quite known, but molecular information is missing, probably due to the low num-
ber of functional MET channels for the analysis, estimated to be no more than 200 
per cell in a cochlea, in a pool of 10’000 cells5.  
 
 
 
 
 
Figure 2: Structural org nization of the ear: from macro to micro. A) Anatomical description of 
the ear. B) Schematic representation of a hair cell. C) Zoom in the tip link organization. D) Putative 
arrangement of the six proteins within the MET channel. Figures are from Refs 6; 7; 8; 9. 
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Figure 3: Schematic representation of the mechano-electrical trans-
duction. 
The Mechano-electrical transduction process 
When the sound stimulus reaches the middle ear, the malleus, incus and stapes 
convert it into a moving wave that diffuses throughout the cochlea, leading to 
the displacement of the stereocilia (Figure 3). When the movement is directed 
towards the longest cilium, the tip-links stretching causes the opening of MET 
channels. These channels are selective for K+ and Ca2+: higher K+ concentration 
induces cell depolarization, while the higher Ca2+ concentration modulates many 
processes, such as the fusion of neurotransmitter vesicles to the synaptic ribbon4. 
The Ca2+ concentration in the stereocilia is fundamental for many processes, in-
cluding MET activation and adaptation, consisting in a decrease in MET channel 
sensitivity in the presence of high Ca2+ concentrations5. The MET channel is a 
complex structure, composed by at least six different proteins, among which  the 
transmembrane channel-like protein 1 and 2 (TMC1 and TMC2) forming the 
channel pore, which interacts with CIB210 (Figure 2D), whose real function is 
yet to be clarified. 
 
 
 
 
 
 
 
 
 
 
Figure 3: Schematic representation of the mechano-electrical transduction. Image in from Ref 11. 
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CIB2: an untypical calcium sensor protein and its biological target 
CIB2 (Calcium- and Integrin- Binding Protein 2) is a 21.7 kDa protein that belongs 
to the CIB family together with other three members (CIB1, CIB3, CIB4)12. CIB2, 
homolog of CIB1, binds divalent cations like Ca2+ and Mg2+ via two canonical EF-
hand motifs (Figure 4) and has the N-terminal consensus sequence for myristoy-
lation, that may allow the association with membranes. Although CIB2 is expressed 
in a variety of tissues, its biological function is still unknown. Two recent papers13; 
14 demonstrated the contribution of CIB2 in the auditory cell maintenance, since 
knockout CIB2 mice show profound hearing loss. Other studies show that CIB2 
exerts a role in: i) HIV entrance in cells15, ii) negative regulation of oncogenic sig-
naling in ovarian cancer16, iii) a compensation system in platelets where its homol-
ogous CIB1 is knocked down17. Focusing on the CIB2 role in auditory cells, many 
hypotheses are still under investigation. First, as a possible component of MET 
channel, the Ca2+ coordination may be associated with a conformational change 
that propagates through the channel, resulting in its lower sensitivity during adap-
tation. Moreover, the lack of a specific compartment for Ca2+-storage in the upper 
part of the hair cell, combined with the necessity to keep the Ca2+ concentration 
strictly controlled, may imply a role for CIB2 in Ca2+-homeostasis, together with 
other Ca2+-binding proteins such as parvalbumin β, calretinin and calbindin D28K6. 
Although some studies consider CIB2 as a Ca2+-buffer6, our results show that both 
Mg2+ and Ca2+-binding triggers a conformational change (Paper 118), a typical fea-
ture of Ca2+-sensor proteins. We furthermore measured the affinity for Ca2+ and 
Mg2+ and concluded that CIB2 is i) probably Mg2+-bound under physiological con-
ditions (Kd = 290 µM) and ii) an untypical Ca
2+-sensor with an apparent Kd of 500 
µM, not compatible with the Ca2+ concentration in the endolymph (20 µM), the 
extracellular liquid in contact with the stereocilia5. CIB2 is also part of the Usher 
interactome19 a group of proteins that, when mutated, lead to different types of 
Usher syndrome. In fact, CIB2 has been found localized in the upper part of the 
stereocilia where, together with myosin VIIa and whirlin, may mediate the tip-link 
assembly6. In fact, it was demonstrated that CIB2-/- mice show profound hearing 
loss mainly due to an abnormal assembly of the stereocilia14 and abolished MET 
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Figure 4: Structural features of CIB2. 
 
currents13. Finally, CIB2 has been hypothesized to interact with the ATP-gated IP3-
receptor, modulating purinergic response in outer hair cells19. 
 
 
 
 
 
 
 
 
 
Figure 4: Structural features of CIB2. Ca toon representation of monomeric WT CIB2 in its Ca2+-
bound form. The homology model is based on the X-RAY structure of Ca2+-bound CIB1. The N-
terminal region is colored in gray, while the C-terminal region (helix 10) is colored in yellow. EF1, 
EF2, EF3, and EF4 are colored in green, blue, orange, and magenta, respectively. Asn 121 and Glu 
64 are represented by sticks, as well as Arg 33, electrostatically interacting with Glu 64. The se-
quence alignment of CIB2 with CIB1, CIB3, and CIB4 is also shown, restricted to the metal-coor-
dinating EF-hands, namely EF3 and EF4. Amino acids contributing to the coordination of Ca2+ 
according to the canonical pentagonal bipyramid geometry are marked by their respective position 
and labeled in the zoomed-in protein cartoon on the right. Figure and legend are from Paper 118. 
 
Concerning the physiological targets, CIB2 can bind two integrins: αIIB, a common 
interactor of all CIB family members17, and α7B, which seems to be a specific part-
ner for CIB2. In this respect, the first interaction study was performed by Häger et 
al.20 who found a specific binding with the cytosolic region of the integrin. Later, 
Huang at al.21 firstly, and us later on (Paper 222), demonstrated that CIB2 prefer-
entially interacts with the fragment of α7B located close to the inner membrane, 
due to a conserved region consisting of eight residues, WK(V/L)GFFKR.  
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CIB2 related disease: Usher syndrome type 1J and Non syndromic 
deafness (DFNB48) 
Hearing loss is a debilitating disease increasingly widespread, caused by environ-
mental, genetic factors or both. The hear impairment due to defects in the inner ear 
is named sensory neuronal hearing loss, and it can have different causes: i) noise-
induced, a loud noise may cause the tympanic membrane impairment leading the 
stereocilia detachment; ii) drug-induced, triggered by ototoxic drugs as streptomy-
cin, iii) age-related, resulting in different age of onset, severity or location of the 
lesion; iv) genetic defects5. Hereditary hearing loss has an incidence of 1:1500, it’s 
mostly non-syndromic and monogenic23 with an autosomal recessive (AR) mecha-
nism of transmission. Up to date, 115 genes (https://hereditaryhearingloss.org/) 
have been found related to non-syndromic deafness, Cib2 is one of these. Five mis-
sense mutations have been found in the CIB2-encoding gene resulting in the fol-
lowing substitutions: E64D, F91S, C99W, I123T19 and R186W24. Four of them are 
associated with non-syndromic deafness (DFNB48) while E64D seems to be asso-
ciated with Usher Syndrome type 1J (USH1J), a rare genetic disease characterized 
by profound hearing loss and blindness due to retinitis pigmentosa19. During my 
PhD I focused my attention on the characterization of E64D CIB2, and our study 
demonstrated how this conservative point mutation unexpectedly makes E64D 
CIB2 able to fold correctly only in the presence of extremely high and non-physi-
ological Ca2+ and Mg2+ concentrations.  
Differently from fishes25, which have the capability to replace damaged hair cells, 
in mammals the damage is permanent, making deafness hard to treat without using 
hearing aids or cochlear implants. Such external supports can improve the patient’s 
quality life, but a deep understanding of the molecular bases of the disease could 
allow the development of a personalized therapy based on the mutations carried by 
each patient.   
 
 
 
 
 
 23 
 
 
Figure 5: Eye anatomy: from macro to micro. 
Molecular basis of sight 
Sight, together with hearing, touch, smell and taste, is one of the ways to acquire 
information from the environment, in particular, more than 80% of the total infor-
mation comes from vision26. The retina, a multi-layer tissue that allows the conver-
sion of the light stimuli into electrical signal is located at the bottom of the eyeball 
(Figure 5A). The retina is composed by many cell types, the photoreceptors are the 
ones responsible for light absorption (Figure 5B). In vertebrate, photoreceptor cells 
are classified as rods and cones, responsible for scotopic (dark) or photopic (light) 
vision, respectively. Photoreceptor cells are divided into three parts: the synaptic 
terminal, the inner and the outer segments (Figure 5C). The inner segment hosts 
the components required for the cell survival (nuclei, mitochondria, endoplasmic 
reticulum…), while the outer segment is constituted by a massive membrane sys-
tem arranged in discs, where the visual process starts. The phototransduction initi-
ates when a photon is absorbed by opsins, proteins belonging to the G-coupled re-
ceptor superfamily. At least three different opsins are present in cones, but only 
Rhodopsin (Rho) has been found in rods.  
 
 
 
 
Figure 5: Eye anatomy: from macro to micro. A) Anatomical description of the eye structures27. 
B) Schematic28 (left) and histochemical stain 29 (right) of the retina. C) Schematic representation of 
the rod structure30. 
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Phototransduction cascade 
In dark-adapted conditions, photoreceptors are partially depolarized, characterized 
by a membrane potential around -40 mV. This is the result of the equilibrium be-
tween the activity of two channels both located in the outer segment: i) cGMP-
gated channels (CNG-channels), that allow the continuous influx of Na+ and Ca2+, 
ii) a light-independent Na+/Ca2+ + K+ exchanger (NCKX) that lead to the Na+ intake 
and Ca2+ and K+ efflux (following a stoichiometry of 4Na+:1Ca2+ 1K+)31. When a 
photon is absorbed by Rho, the isomerization of the photopigment leads to the ac-
tivation of the G-protein transducin, responsible for the activation of the phos-
phodiesterase 6 (PDE6). The drop of cGMP concentration, due to the conversion 
of cGMP into 5’-GMP, leads to the closure of the cGMP-gated channels thus block-
ing Ca2+ and Na+ intake from the CNG-channels; at the same time NCKX activity 
is preserved, resulting in the Ca2+ concentration drop and thus an increase in the 
membrane potential, reaching values around -65 mV (depending on the stimulus 
intensity). In this context, a key role is played by Ca2+: due to the CNG-channel 
closure its concentration drops from 600-500 nM to less than 100 nM32 and this is 
sensed by Neuronal Calcium Sensor (NCS) proteins such as Rec and GCAPs, each 
involved in the cascade shut-off in different ways (Figure 6B). Low Ca2+ concen-
tration triggers: i) rhodopsin phosphorylation via rhodopsin kinase (GRK) and ii) 
guanylate cyclase (GC) activation. These mechanisms are mediated by: recoverin 
(Rec) and GCAPs respectively. At high Ca2+ concentrations (dark) Rec is com-
plexed to GRK, inhibiting the enzyme but, when Ca2+ concentration drops (light), 
the complex dissociates allowing GRK to phosphorylate rhodopsin, leading to the 
binding of arrestin33. How Rec is capable to change its conformation at these Ca2+ 
concentration is still under debate, especially because all the in vitro estimates of 
Rec affinity for Ca2+ pointed to an apparent Kd of 17 µM
34, a concentration way too 
high for physiological conditions in photoreceptor outer segments. The second 
mechanism involves GCAPs (GCAP1 and GCAP2), small proteins specifically ca-
pable in the activation of GC, the enzyme that converts the GTP into cGMP, restor-
ing its dark-state concentration and ultimately the dark current via CNG-channel 
re-opening35; 36 (Figure 6A). The specific role of GCAPs is described in the fol-
lowing paragraph.  
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Figure 6: Phototransduction cascade. 
A) Overview of the entire process37. B) 
Detail of the role of GCAP1 in the acti-
vation of GC38. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6: Phototransduction cascade.  
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Role of GCAP1 and its biological target 
Three are the GCAPs isoforms in human genome: GUCA1A and GUCA1B genes, 
coding for GCAP1 and GCAP2 respectively, organized in a tail-to-tail array on 
6p21.1 (probably from a duplication and inversion of the ancestral gene39); 
GUCA1C, coding for GCAP3, located on 3q13.1. Contrarily to GCAP3, expressed 
only in cones and apparently not involved in the phototransduction cascade40, 
GCAP1 and GCAP2 are expressed both in cone and rods and they are active players 
in the phototransduction process 40; 41. In detail, GCAP1 has 4 EF-hand motifs (Fig-
ure 7A), of which only EF2, EF3 and EF4 are functional, therefore able to bind 
Mg2+ and Ca2+ ions42. Like many other NCSs, GCAP1 has a myristoyl group cova-
lently bound to the N-terminal Gly, and even though it is not involved in the con-
formational change known as myristoyl-switch (like Rec and NCS1), such post-
translational modification has been proved to exert a pivotal role in the modulation 
of cations affinity and target recognition/interaction36. GCAP1 physiological target 
is the membrane protein GC35; 43; 44. Many studies demonstrated how the Ca2+/Mg2+ 
binding to the canonical EF2-4 led to a conformational change through the non-
canonical EF1 which became the GC-binding region43; 44; 45. Two are the human 
retinal GC isoforms: isoform 1 (GC1 or RetGC-E) expressed by GUCY2D on 
17p13.1, and isoform 2 (GC2 or RetGC-F) expressed by GUCY2F on Xp2246. Both 
are composed by: an extracellular domain, a transmembrane α-helix, a juxtamem-
brane domain (JMD), a dimerization domain (DD) and a catalytic domain, active 
only in a dimeric form. Both the GC isoforms participate to the phototransduction 
giving different contributions47. I focused my attention on GC1 regulation and func-
tion mediated by GCAP1. Very interesting is that GC1 per se it is not sensible to 
Ca2+ but, in the late ’80s Koch and Stryer postulated the existence of a Ca2+-medi-
ated negative feedback mechanism which makes the GC1 more active when the 
Ca2+ concentration is the photoreceptor is less than 100 nM48. The protein that me-
diates this process has been named GCAP. A peculiar feature about GCAP1 is its 
capability to exert on GC1 a role in activating and inhibiting it, based on the cation 
bound: at high Ca2+ concentrations (500-600 nM,) GCAP1 binds 3 Ca2+ ions keep-
ing the GC1 activity at a basal level; when a photon is absorbed and the signal 
transduction starts, GCAP1 releases Ca2+ (EF3 → EF2 → EF4)44 and binds Mg2+ 
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Figure 7: GCAP1 tridimensional structure and Ca2+-relay model. 
 
 
 
becoming a GC activator. Moreover, it has been proved the existence of a synergic 
activity between GCAP1 and GCAP2, at least in bovine, namely Ca2+-relay (Figure 
7B): when the light stimulus activate the cascade, the GCAP1 steps into action 
firstly, giving a first pulse of cGMP but, if the stimulus continues over time and the 
Ca2+ concentration further decreases, GCAP2 becomes an activator in turn. So, 
GCAP1 and GCAP2 are responsible for different light sensibilities 36; 49.  
 
   
 
 
 
 
Figure 7: GCAP1 tridimensional structure and Ca2+-relay model. A) Cartoon representation of 
human GCAP1 (PDB entry 2R2I). Myristoyl group is colored in deep purple; EF1, EF2, EF3, EF4 
are colored in green, yellow, orange and cyan respectively; Ca2+ ions are represented as red 
spheres. Red sticks represent the known mutations. B) Ca2+ relay model from Ref 49. 
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Diseases associated with GCAP1 point mutations 
Retinal dystrophies are a class of diseases that can be age-related or triggered by 
genetic mutations, characterized by autosomal dominant (AD) mechanism of trans-
mission. They can be classified as Macular dystrophy (MD), Cone dystrophy 
(COD) or Cone-Rod dystrophy (CORD) based on the area of the retina and the cells 
involved. The clinical phenotype is highly heterogeneous, and the most common 
symptoms include nystagmus, photophobia, abnormal color perception, nyctalopia, 
hemeralopia, loss of the central and/or peripheral vision. To date, 22 missense mu-
tations on the GUCA1A gene have been found in patients, namely P50L50, L84F51, 
G86R52, E89K53, Y99C54; 55, Y99S56, Y99N56, D100G/E57, E102H58, E111V59, 
N104K60, I107T51, T114I61, I143N/T61, D148E62, L151F46; 53, E155A/G63; 64, 
G159V53, L176F65 (Figure 7A). Even if the first disease-related mutation (Y99C) 
was found in 1998, 12 of these were identified in the last five years (Table 1), 
probably thanks to the Next Generation Sequencing spread and a more careful in-
vestigation during the diagnostic process. All these mutations were deeply investi-
gated and a common feature among them is the incapability in the regulation of GC 
under physiological conditions, leading to the accumulation of cGMP and Ca2+ that 
freely diffuse to the inner segment triggering the cellular death by mechanisms still 
under investigation. Two are the main hypothesis: on one hand the excess of the 
cGMP may have cytotoxic effects66, on the other hand the high [Ca2+] in inner seg-
ment may destroy the mitochondria membrane potential, causing the release of Cy-
tochrome C (CytC) and so the activation of the apoptosis process mediated by 
caspase63. However, it is still unclear the reason why some mutations cause COD 
and other CORD phenotypes.  
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TABLE 1: LIST OF ALL GCAP1 KNOWN MUTANTS ASSOCIATED WITH RETINAL 
DYSTROPHIES. 
NUCLEOTIDE 
CHANGE 
Protein 
change 
Protein region 
Clinical 
phenotype 
Ref. 
C.149C>T P50L EF1-EF2 link 
COD, 
CORD 
50 
C.250C>T L84F EF2 helix F 
COD, 
CORD 
51 
C.256G>C G86R EF2-EF3 link CORD 52 
C.265G>A E89K EF2-EF3 link 
COD, MD; 
COD CORD 
67 
C.295T>A Y99N EF3 helix E 
COD, 
CORD 
56 
C.296A>G Y99C EF3 helix E 
COD, 
CORD 
54 
C.296A>C Y99S EF3 helix E 
COD, 
CORD 
56 
C.299A>G D100G 
EF3 loop, Ca2+ 
binding 
CORD, MD 57 
C.300T>A D100E 
EF3 loop, Ca2+ 
binding 
COD 67 
C.304G>C D102H 
EF3 loop, Ca2+ 
binding 
CORD  
C.312C>A N104K 
EF3 loop, Ca2+ 
binding 
COD; COD, 
CORD; MD 
60 
C.320T>C I107T EF3 loop MD 51; 68 
C.322A>T E111V EF3 helix F CORD 59 
C.341C>T T114I EF3 helix F Atypical RP  
C.428DEL-
TINS ACAC 
I143T/N EF4 helix E COD 61 
C.444T>A D148E EF4 loop COD  
C.451C>T L151F EF4 loop COD 
46; 56; 
67 
C.464A>G E155G 
EF4 loop, Ca2+ 
binding 
COD 63 
C.464A>C E155A 
EF4 loop, Ca2+ 
binding 
CORD  
C.476G>T G159V EF4 helix F 
COD, 
CORD 
67 
C.526C>T L176F C-ter MD 43; 69 
Adaptation from Ref 62. 
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CaF2 nanoparticles as carrier of Ca2+-sensor protein 
As already mentioned, genetic disorders are a class of diseases for which therapeu-
tic treatments are not available yet, the sole treatment of symptoms is used in order 
to ameliorate the patient’s quality of life. Nowadays, gene therapy is fully consid-
ered for the treatment of genetic diseases, even if we should keep in mind the high-
risk drawbacks, such as the gene integration in unexpected positions. For these rea-
sons, a promising and safer strategy is represented by the protein therapy, an ap-
proach based on the replacement of the disease-related protein with the recombi-
nant wild-type (WT) in order to restore a WT-like condition70; 71. To do that, carri-
ers are needed that allow the specific delivery in the right compartment (tissue, cell 
or organelles), with a kinetics compatible with the treatment, and minor o absent 
side effects. Thanks to the high surface-to-volume ratio, nanodevices (NDs) such 
as liposomes and inorganic nanoparticles (NPs) represent promising tools. Even if 
liposomes are almost perfect deliverers thanks to the biocompatibility of the com-
ponents72, they cannot be traced in the organism, unless filled with signal emitting 
dyes. To overcome this problem, inorganic NPs may be considered as a valid 
choice. In the last years many studies were performed, also by us, in order to eval-
uate whether CaF2 NPs may work as nanodevices suitable for NCSs delivery. It has 
pointed out that there is a huge variability based on the NPs properties and the 
protein system considered73; 74; 75. In fact, protein integrity is fundamental, from a 
structural and functional point of view. We used a combination of biophysical tech-
niques in order to characterize the interaction between the prototypic Ca2+-sensor 
protein CaM and NPs composed by a CaF2 core doped with a mixture of Er
3+ and 
Yb3+. These NPs are intriguing because when properly doped (i.e. mix of rare earth 
mentioned) they show an anti-Stokes phenomenon named upconversion, which 
consists in the photons emission at a wavelength that is lower than the wavelength 
used for the excitation (Figure 8). These NPs, if irradiated with IR laser (not pen-
etrating or detrimental for tissue), show the emission at 550 nm. In the study pub-
lished in 2018 (Paper 576), we pointed out how this system may be suitable for 
CaM delivery since neither structure or function were compromised and that the 
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kinetics of protein dissociation from the NP was 
compatible with the usage in nanomedicine. Of 
course, a more detailed analysis is required in order 
to shed light about potential side effects or the or-
ganism responses. 
 
Figure 8: Upconverting NPs. The 
NPs in the figure converts the invis-
ible NIR light into green light77. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8: Upconverting 
NPs. 
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Aims of this thesis work 
Sight and hearing are two senses by which the brain acquires most of the infor-
mation about the environment so, genetic disorders causing blindness and deafness 
represent severe conditions, especially due to the absence of effective treatments. 
The aim of this PhD thesis is the characterization of the human WT and disease-
related variants of CIB2 and GCAP1 in order to gain insights in the molecular basis 
of the diseases, focusing the attention in the perturbation of the second messenger’s 
homeostasis. Going into details:   
- about CIB2  since it has been proposed to be involved in the Ca2+ homeo-
stasis in hair cells, I investigated its capability to work as a Ca2+ sensor and 
whether the conservative E64D-point mutation lead to the dysregulation of Ca2+ 
equilibrium and/or targets recognition capabilities; 
- about GCAP1  after the characterization of the new CORD-related point 
mutation (E111V), I extended the analysis to other known COD/CORD-related 
mutants, where residues directly involved in Ca2+ coordination are affected 
(E155A/G and D100G), to better understand whether common features are pre-
sent or not. Moreover, considering the AD nature of COD and CORD diseases, 
I explored the effect of WT GCAP1 extra delivery with the final aim to slow 
down the disease progression.  
Finally, since upconverting CaF2 NPs were demonstrated to be biocompatible and 
they can be tracked in cells, I investigated their potential employment in nanomed-
icine as specific nano-devices for NCSs.  
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Materials 
Chemicals 
The chemicals were purchased by Sigma Aldrich, Invitrogen, Biorad, Roche, Life 
Technologies and Thermo Scientific and the purity level was the highest available.  
 
DNA and peptides 
DNA plasmids: 
- pET 24a – WT CIB2 (Genscript) 
- pET 11a – WT GCAP1 (Genscript) 
- pBB131 - yNMT 
Primers:  
- Mutagenesis on CIB2 to obtain E64D CIB2: 
FW: 5’-ATCATTCAAATGCCGGACCTGCGTGAGAACCCGTT-3’ 
RV: 5’-AACGGGTTCTCACGCAGGTCCGGCATTTGAATGAT-3’ 
- Mutagenesis on GCAP1 to obtain E111V GCAP1: 
FW: 5’- GCATCGATCGCGACGTACTGCTGACCATTATC-3’ 
RV: 5’-GATAATGGTCAGCAGTACGTCGCGATCGATGCA-3’ 
Peptides were purchased by Genscript: 
- α7B_M, Ac-LLLWKMGGFFKRAKHPE-NH2, (HPLC purity = 96.7%) 
- α7B_Scrb, Ac-KEFWGLHAKPRLKLMF-NH2, (HPLC purity = 96.3%) 
- α7B_C, LAADHGPELGPDGHPGPGTA (HPLC purity = 98.8%) 
 
Instruments 
AKTA start FPLC 
AKTA Purifier FPLC 
Jasco J-710 spectropolarimeter equipped with a Peltier type cell holder 
Jasco FP-750 spectrofluorometer  
Zetasizer Nano-S Malvern 
SensiQ Pioneer FortèBio 
High-Mass Q-TOF II mass spectrometer, Water/MSVision 
Ultraflex III MALDI TOF/TOF mass spectrometer, Bruker Daltonik, Bremen 
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Jasco BS-997-01 High Performance Liquid Chromatography (HPLC) 
 
Columns 
HiPrep 26/60 Sephacryl S-200 HR (GE) 
Superose 12 10/300 GL (GE) 
HiPrep Q HP 16/10 (GE) 
HisTrap FF-crude (GE) 
LiChrosphere 100 RP-18 (Sigma-Millipore)  
Chromolith Performance 100-2 RP-18 (Sigma-Millipore) 
 
Software 
Spectra Analysis – Jasco corporation 
Zetasizer software, version 7.13 
SigmaPlot 12.5 
PyMOL Molecular Graphics System, version 2.2.3 
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Methods 
Guide: the paragraphs can be introduced by two symbols:  
 
 : they contain theoretical information concerning the technique 
 
 
: they report the experimental procedures. 
 
 
Expression and purification of the recombinant CIB2 and GCAP1 
WT CIB2 purification 
The cDNA of human CIB2 isoform 1 was cloned into a pET-24a vector (Genscript) 
containing a tail of 6 His residues followed by Tobacco Etch Virus protease (TEV) 
cleavage site. The plasmid was used to transform E. coli BL21 DE3 cells. Cells 
were grown in Luria Bertani (LB) broth at 37°C until the OD600 reached a value 
around 0.4, then the flasks were cooled down and, after the induction with 0.5 mM 
IPTG at OD600 = 0.6, bacteria were let grown at 15°C for 20h. After centrifugation 
(5500 rpm, 20 min, 4°C) pellets were suspended in lysis buffer (20 mM TRIS pH 
7.5, 500 mM NaCl, 20 mM imidazole, 1 mM DTT, 5 U/mL DNAse, 0.1 mg/mL 
lysozyme, 1 mM PMSF, 2.5 mM MgCl2) and incubated at 25°C for 30 min. In 
addition, 10-12 sonication cycles on ice, 10 sec each, were performed. Soluble and 
insoluble fractions were separated by centrifugation at 16000 g, 4°C for 30 min. 
WT CIB2 was found highly concentrated in soluble phase, thus it was filtered and 
directly loaded in a 5 mL His-trap FF crude column (GE) previously equilibrated 
with loading buffer (20 mM TRIS, 500 mM NaCl, 20 mM imidazole, 1 mM DTT). 
A one-step elution was chosen with 500 mM imidazole. To allow TEV-protease 
activity, His-CIB2 was dialyzed against 50 mM TRIS pH 8, 150 mM NaCl, 1 mM 
DTT and then incubated (ratio 1:30) with previously prepared His-tagged TEV-
protease (Paper 576) (or 1:100 ratio of commercial TEV by Promega) overnight at 
8-16°C. Tagged free CIB2 was purified from His-TEV by reloading it into the His-
trap column, collecting the flow-through. Protein concentration was measured by a 
CIB2-optimized Bradford assay where the standard line was prepared based on re-
sults of the amino acids analysis (Alphalyse). Finally, purified WT CIB2 was 
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washed in 20 mM TRIS pH 7.5, 150 mM KCl, 1 mM DTT using Amicon concen-
trator. Protein aliquots were shock-frozen and stored at -80°C. 
 
E64D CIB2: mutagenesis and purification 
E64D point mutation was obtained by site-directed mutagenesis on the complete 
cDNA of CIB2 using:  
 
FW primer:  5’-ATCATTCAAATGCCGGACCTGCGTGAGAACCCGTT-3’ 
RV primer: 5’-AACGGGTTCTCACGCAGGTCCGGCATTTGAATGAT-3’ 
 
and setting the thermocycler as follow: 
 I step: 30 sec at 95°C 
 II step: 30 sec at 95°C 
 1 min at 55°C      16 cycles 
 7 min at 68°C 
 
DNA sequencing was provided by Eurofins. Differently from WT, E64D was 
found highly concentrated in the insoluble phase, thus a purification from inclusion 
bodies (IB) was required. IB were suspended in the unfolding buffer (20 mM TRIS 
pH 7.5, 500 mM NaCl, 6M guanidine hydrochloride, 1 mM DTT) and incubated 
overnight at 4°C. After the loading of unfolded His-CIB2 into the His-trap, a 
renaturation gradient from 0 to 100% with renaturation buffer (unfolding buffer 
guanidine-hydrochloride free) was set, with a flow rate of 1 mL/min, 100 mL as 
total volume. After elution with 500 mM imidazole E64D CIB2 was treated as the 
WT.  
 
WT and E111V GCAP1 purification  
The cDNA of human GCAP1 (Uniprot: P43080) was cloned into a pET-11a vector. 
E6S point mutation was added to generate a suitable substrate for myristoylation 
by S. Cerevisiae N-myristoyl-transferase (yNMT). E. coli was co-transformed us-
ing both the plasmids and the selection was performed using the resistance for both 
ampicillin (from pET-11a plasmid) and kanamycin (from pBB131 plasmid). 
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E111V mutant was generated by polymerase chain reaction site-directed mutagen-
esis using: 
 
FW primer: 5’- GCATCGATCGCGACGTACTGCTGACCATTATC-3’ 
RV primer: 5’-GATAATGGTCAGCAGTACGTCGCGATCGATGCA-3’ 
 
and setting the thermocycler as follow: 
 I step: 30 sec at 95°C 
 II step: 30 sec at 95°C 
 1 min at 55°C      16 cycles 
 7 min at 68°C 
 
DNA sequencing was provided by Eurofins. Heterologous expression of GCAP1 
were obtained as previously59; 78. Briefly: E. coli BL21 DE3 cells were co-trans-
formed using both pET11a and pBB131 plasmids, encoding for GCAP1 variants 
and yeast NMT respectively. Protein expression was performed at 37°C following 
the OD600 values: at OD600 0.4 myristic acid (100 µg mg
-1, in 50% EtOH, pH 7.5) 
was added, at OD600 0.6 protein expression was induced by 1 mM IPTG. Cells were 
let grow for 4h at 37°C. Proteins were purified from insoluble fraction. Protein 
denaturation was performed using 6M guanidinium-hydrochloride and incubating 
resuspended IB at 4°C ON. After 24h dialysis against 20 mM TRIS, 150 mM NaCl, 
7.5 mM β-mercaptoethanol, size exclusion chromatography was performed. The 
purest fractions were then loaded in an anionic exchange column (for further details 
see below). Some milligrams of the protein obtained were washed against decalci-
fied NH4HCO3, lyophilized and used for Br2-BAPTA chelator assay. The rest of 
the protein was aliquoted in 20 mM TRIS, 150 mM KCl, 1mM DTT, flash frozen 
and kept at -80°C.  
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NPs preparation 
Er+3, Yb+3 co-doped CaF2 NPs were prepared using the hydrothermal technique 
described by Pedroni et al.79. Briefly, Ca2+, Yb3+ and Er3+ were combined at a stoi-
chiometric ratio of 0.78:0.20:0.02 respectively. Sodium citrate was used as capping 
agent and ammonium fluoride was used as the fluorine precursor. The solution was 
heat-treated in a Teflon lined autoclave at 190°C for 6 hours and the obtained NPs 
were precipitated and collected by centrifugation.   
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Chromatographic techniques 
Chromatography is a widely used technique based on the separation of the single 
components present in a mixture, thanks to the flow of a mobile phase on a station-
ary phase. The chromatography techniques can be classified as i) preparative, when 
used for the purification of molecules, or ii) analytic, when used for the quantifica-
tion of small amounts of molecules in a sample. During the PhD I had the chance 
to use many types of chromatography belonging to both categories and briefly de-
scribed below80. 
 
 
 
 
 
Figure 9: Schematic representation of the chromatographic techniques used. Picture is an adap-
tation from Ref 80. 
 
Size exclusion chromatography (SEC) 
Size exclusion chromatography allows the separation of molecules based on the 
hydrodynamic diameter: the smaller the diameter, the higher the retention time 
(Figure 9). I performed preparative SEC as first purification step of GCAP1 and 
analytic SEC in order to measure the proteins molecular weight (MW).  
 
Preparative SEC  
A HiPrep 26/60 Sephacryl S-200 HR column was used. The column was equili-
brated using 20 mM TRIS, 150 mM NaCl, 1 mM DTT. After the sample application 
(5-7 mL) the elution was followed monitoring the absorbance at 280 nm. 
 
Analytical gel filtration 
A Superose 12 10/300 GL column was used. Standard proteins were loaded in order 
to obtain a calibration line: cytochrome C (12.4 kDa), carbonic anhydrase (29 kDa), 
 
 
Figure 9: Schematic representation of the chromatographic techniques 
used. 
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alcohol dehydrogenase (150 kDa), β-amylase (200 kDa). The column was equili-
brated using a buffer containing 20 mM TRIS, 150 mM NaCl, 1 mM DTT with 
either 3 mM EGTA, 2 mM EGTA + 3 mM MgCl2, 3 mM MgCl2 + 2 mM CaCl2 or 
1 mM MgCl2 + 2 mM CaCl2. Seventy to 113 µM proteins were loaded and the 
elution was followed monitoring absorbance at 280 nm. The elution volumes (Ve) 
was used to measure the distribution coefficient (Kd) according to the equation:  
𝐾𝑑 = (𝑉𝑒 − 𝑉0)/(𝑉𝑖 − 𝑉0) 
in which Vi is the total column volume (25 mL) and V0 is the void volume (8 mL). 
The MW were determined from a calibration line of log(MW) vs Kd
 (Paper 118). 
 
Anionic exchange chromatography (AEC) 
Ionic exchange chromatography allows the separation based on the net charge of 
the protein when put in contact with a mobile phase at a given pH (Figure 9). The 
AEC is normally used when the protein’s net charge is above the pI, so it will bind 
positively charged matrixes, so-called anionic exchanger (AEC).  
 
AEC purification 
A HiPrep Q HP 16/10 column was used.  The column was equilibrated with 20 mM 
TRIS pH 8, 1 mM DTT and the separation was obtained performing a gradient 
using 20 mM TRIS pH 8, 1 M NaCl, 1 mM DTT. The protein elutes at an approxi-
mate NaCl concentration around 350 - 400 mM. 
 
Affinity chromatography (IMAC) 
The affinity chromatography is commonly used when a specific tag is added to the 
N- or C-terminal of the protein of interest (Figure 9). Normally, it guaranties a high 
purity grade of the final preparation. I used the Immobilized Metal Affinity Chro-
matography (IMAC) since 6 His residues (His-tag) were added to CIB2 N-terminal. 
The specific interaction between Ni-NTA resin and the His-tag allows to get rid of 
the other proteins present in the total extract of E. Coli.  
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His-trap purification 
The HisTrap FF-crude column (GE) was equilibrated using 20 mM TRIS pH 7.5, 
500 mM NaCl, 20 mM imidazole, 1 mM DTT and, after the sample application, a 
one-step elution was chosen using 20 mM TRIS pH 7.5, 500 mM NaCl, 500 mM 
imidazole, 1 mM DTT. The IMAC column was also used after the His-tag cleavage 
by TEV-protease. In this case the flow through was kept.  
 
Reverse phase chromatography (RPC) 
The reverse phase chromatography is so called since the mobile phase is more polar 
than the stationary phase. The resin of these columns is normally composed by sil-
ica spheres where C8 or C18 carbon-chains are covalently bound; hydrophilic mol-
ecules elute first. In the last years another kind of stationary phase has been intro-
duced, where the silica particles have been replaced by a monolithic matrix, char-
acterized by the presence of mesopores and macropore.  
 
Measure the efficiency of myristoylation for GCAP1 
After the column (LiChrosphere 100 RP-18, Sigma Aldrich) equilibration using 
ddH2O + 0.1% TFA (0.22 nm filtered and degassed), 50 µM of non-myristoylated 
and myristoylated GCAP1 were loaded. A 55 min gradient was applied using ace-
tonitrile + 0.1% TFA, from 0 to 100%. The comparison of the peak areas allows the 
measure of the myristoylation efficiency.  
 
Quantification of the cGMP produced during the GC assays  
The C18 (or monolithic) column was equilibrated using 5 mM KH2PO4 and, after 
sample application (50 µL), a methanol (or acetonitrile) scalar gradient was applied.  
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Guanylate Cyclase assay (GC assay) 
In order to establish the effect of point mutations on GC1 regulation in the presence 
of mutant GCAP1, specific enzymatic assays were performed. In the past GC1 
came from bovine retina conveniently treated for the extraction of functional rod 
outer segments (ROS)81. This meant that the raw materials were bovine eyes from 
slaughterhouses that required a specific treatment in order to avoid pigment photo-
bleaching. Partially to overcome this issue in 2003 eukaryotic cells, namely 
HEK293 were engendered in order to obtain a semi-permanent cell line for the ex-
pression of human recombinant GC140. Guanylate cyclase assays (GC assay) can 
be performed in three ways: 
- on-off mode: it allows to check whether GC1 is regulated or not in the absence 
(< 19 nM) or in the presence (  ̴30 µM) of Ca2+. K2H2EGTA or K2CaEGTA 
buffers are used (Figure 10A); 
- EC50 estimation: measuring the cGMP synthesis as function of [GCAP1] (Fig-
ure 10B) thus the concentration of protein at which GC1 activity is half maxi-
mal. Only K2H2EGTA is used in samples preparation. The obtained data are 
fitted using a ligand binding function with one site saturation: 
𝑦 =  
𝐵𝑚𝑎𝑥 ∗ 𝑥
𝐾𝑑 + 𝑥
 
where Bmax is the maximum number of cGMP pmol, x is the [GCAP1] and Kd 
is the EC50 value. 
- IC50 estimation: measuring the cGMP synthesis as function of [Ca2+] (Figure 
10C) thus calculating the concentration of Ca2+ at which GC1 is half inhibited. 
Combinations of K2H2EGTA and K2CaEGTA buffers are used to obtain a spe-
cific concentration of free calcium (measured using FURA2 dye). The obtained 
data are fitted using a Hill 4 parameter function.  
 
 
 
 
 
 
Figure 10: GC assay output. Possible output of GC assay experiments. 
 
Figure 10:  GC assay output. 
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Semi-permanent cell line 
A semi-permanent cell line expressing human GC1 was obtained transfecting 
HEK293 cells with pIRES-EGFP plasmid mixed with polyethylenimine (PEI) rea-
gent82, and selecting the transfected clones based on the resistance to geneticin 
(G418). Cells were cultured in DMEM media containing fetal bovine serum (10% 
v/v), streptomycin (100 µg/mL), penicillin (100 units/mL) and geneticin (500 
µg/mL). At 90% confluence cells were harvested, washed with sterile PBS and 
stored at -80°C. GC1 expression was checked monitoring the GFP fluorescent sig-
nal and via western blot analysis, using a polyclonal antibody kindly provided by 
Prof. Karl Koch from the University of Olbenburg, where I spent three months to 
learn how to perform GC assay. 
 
Guanylate Cyclase assay (GC assay) 
To perform the assay, membranes must be isolated so, firstly, cells pellets are sus-
pended in lysis buffer (10 mM HEPES pH 7.4, 1 mM DTT, protease inhibitor cock-
tail 1X) and incubated on ice for 20 min. After 15 up-and-down cycles with a 1 mL 
syringe on ice, cells are centrifugated for 20 min at 10000 rpm. The obtained pellets 
were suspended in resuspension buffer (50 mM HEPES pH 7.4, 50 mM KCl, 20 
mM NaCl, 1 mM DTT). GC assays were performed in three manners: i) on-off 
mode, 5-10 µM GCAPs was incubated with low (<19 nM) and high (30 µM) Ca2+ 
concentrations, ii) titrating GCAPs (0-20 µM) to calculate the EC50 value and iii) 
titrating 10 µM GCAPs with different Ca2+ concentrations (<19 nM - 1 mM) to 
calculate the IC50 value. Furthermore, to investigate the hypothesis for which an 
extra delivery of GCAP1 may compensate the presence of E111V GCAP1, special 
IC50 GC assay were designed incubating: 5µM WT GCAP1 + 5µM E111V GCAP1 
(simulation of the heterozygous conditions), 10 µM WT GCAP1 + 5µM E111V 
GCAP1 (2:1 ratio), 15 µM WT GCAP1 + 5µM E111V GCAP1 (3:1 ratio). The 
assay consists in the incubation for 5 minutes at RT of the diluted proteins with a 
fixed amount of extracted membranes, reaction buffer (30 mM MOPS pH 7.2, 20 
mM KCl, 10 mM, 4 mM NaCl, 1 mM DTT, 3.5 mM MgCl2, 1 mM GTP, 300 µM 
ATP, 160 µM Zaprinast) is added and the samples are incubated for 5 minutes at 
30°C. The reaction is stopped adding 50 mM EDTA and incubating the samples at 
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98°C for 5 minutes. After a centrifugation step at 13000 rpm, supernatant is loaded 
in C-18 reverse phase column (or monolith) and the amount of cGMP produced is 
evaluated calculating the area beneath the cGMP elution peak. Data are normalized 
based on the total amount of membrane-proteins measured via amido black assay. 
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Gel-based techniques 
Polyacrylamide Gel Electrophoresis (PAGE) is a simple and widely used technique 
that can be used in different ways. In denaturing conditions, thus in the presence of 
Sodium-Dodecyl-Sulphate (SDS-PAGE), not only the purity of a protein sample 
can be evaluated, but also it gives a rough idea about the capability of NCSs to bind 
Ca2+. In fact, it is known that some NCSs migrate in an SDS-PAGE with a different 
MW whether in the presence or absence of Ca2+, phenomenon named gel-shift83. 
Instead, in native conditions (Native-PAGE) it is possible to i) follow the complex 
formation between a protein and its biological target84, ii) roughly measure the 
MW, thus deducing the oligomeric state of a protein in certain conditions perform-
ing a Ferguson Plot85. 
 
SDS-PAGE gel shift  
Thirty µM of any protein were incubated 5 minutes at 25°C with 5 mM EDTA or 
5 mM EGTA + 1.1 mM Mg2+ or 1 mM Mg2+ + 5 mM Ca2+, loaded in a 15% poly-
acrylamide gel, let run for 40-45 min at 200 V (constant) and Coomassie blue 
stained. 
 
Ferguson plot 
Three native continuous gels were polymerized, using increasing acrylamide con-
centration (10%, 12% and 15%). Eight micrograms of CIB2 were incubated at room 
temperature in the presence of 4.5 mM EGTA, 3 mM EGTA + 4.5 mM Mg2+ and 
4.5 mM Mg2+ + 3 mM Ca2+ (Paper 118) and loaded on the gels. Three and 5 μg of 
fresh BSA were used as a standard, since the BSA propensity to run in a native gel 
as monomer (66 kDa), dimer (134 kDa) and trimer (205 kDa). Gels run at constant 
voltage (200V) for 35 minutes and Coomassie blue stained overnight. BSA bands 
were used for creating a Ferguson plot, thus calibration curve that allow for the 
calculation of the molecular weight of CIB2 bands85. 
 
Limited proteolysis 
CIB2: limited proteolysis experiments were performed incubating 25 µM CIB2 in 
the presence of 1 mM EDTA or 500 µM EGTA + 1 mM Mg2+ or 1 mM + 2 mM 
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Ca2+ with Trypsin (Sigma) in ratio 1:100 (enzyme:CIB2). Working buffer was 20 
mM TRIS pH 7.5, 150 mM KCl, 1 mM DTT. The reactions were blocked adding 
sample buffer (4X) and boiling the sample 5-10 min. Samples were loaded in pol-
yacrylamide gel (15% or 18%), let for 45 min at 200 V and Coomassie blue stained.   
CaM: 6 µg of CaM were incubated in the presence of 2 mM Ca2+ or EGTA with 
0.3 µM Trypsin (ratio 1:60 enzyme:CaM) at 25°C using 5 mM TRIS, 150 mM KCl, 
1 mM DTT as working buffer. Proteolysis samples were collected at different 
times, from 30 min to 120 min. Since 30 min were found to be enough for a com-
plete proteolysis, the experiment was repeated in order to assess the role of NPs. 
Thus, 3.8 mg/mL NPs (ratio 1:139, stoichiometric ratio calculated is in Ref73) were 
incubated with 21 µM CaM both in the presence and in the absence of 250 µM 
EGTA. A further sample was prepared, where 21 µM CaM was incubated with 250 
µM EGTA or Ca2+. Reactions were blocked after 30 min and treated as previously 
described.  
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Biophysical techniques 
Br2-BAPTA chelator assay 
The chelator assay is an indirect technique that allows the measurement of macro-
scopic binding constants following the competition for Ca2+ binding between Ca2+-
binding proteins and chromophoric chelators such as Br2-BAPTA
86. The assay is 
relatively simple to perform and requires only a spectrophotometer and highly de-
calcified material (protein, buffer, cuvettes). The technique is based on the two dif-
ferent maxima exhibited by Br2-BAPTA when in Ca
2+-free (263 nm) or Ca2+-satu-
rated (239.5 nm) condition (Figure 11). Thus, if the NCS and Br2-BAPTA have 
roughly the same affinity for Ca2+, is possible to perform a titration where the A263 
progressively decreases: the higher the competition, the slower the absorbance de-
creases. The data are then analyzed using CaLigator87 a 
specific software that, knowing total concentration of 
Ca2+, chelator and protein can solve the macroscopic 
binding constant for each binding site. Both CIB2 and 
GCAP1 were tested in this sense, but only GCAP1 
showed a real competition with Br2-BAPTA (see Re-
sults). In order to measure the CIB2 affinity for Ca2+ I 
optimized an alternative method based on the variation in 
secondary structure (see below).    
Figure 11: Br2-BAPTA fea-
tures. Structure and compari-
son of the Ca2+-free (dashed 
line) and Ca2+-saturated (solid 
line) spectra. The figure is and 
adaptation from Ref 86. 
 
Chelator assay 
Lyophilized proteins were dissolved in decalcified buffer (20 mM TRIS, 150 mM 
KCl, 1 mM Mg2+, 1 mM DTT) in the presence of 24-25 µM Br2-BAPTA; protein 
concentration was measured by Bradford Assay optimized for human GCAP1 
based on determination of precise protein content by amino acids analysis of initial 
stocks (Alphalyse). Absorbance at 263 nm was followed upon addition of small 
volumes (0.8 µL) of 3 mM Ca2+ stock. For both WT and E111V GCAP1 variants 
 
 
Figure 11: Br2-
BAPTA features. 
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the experiment was performed in triplicate. Data fitting was performed using Ca-
Ligator87 software, which allows to calculate the macroscopic binding constant (and 
then apparent affinity constants) fixing parameters like protein and chelator con-
centrations, the first and last points of the titrations, starting Ca2+ concentration. 
Since the fitting with 3 calcium binding sites gave extremely unreliable results, the 
model with two bind sites was considered. Presented data were normalized as fol-
low: 
 
 
 
where [Q] and [P] are Br2-BAPTA and GCAP1 concentrations respectively. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
𝑦𝑛𝑜𝑟𝑚 =  
𝐴263 − 𝐴𝑚𝑖𝑛
𝐴𝑚𝑎𝑥 − 𝐴𝑚𝑖𝑛
 𝐶𝑎2+𝑛𝑜𝑟𝑚 =  
[𝐶𝑎2+]
[𝑄] + 3 ∗ [𝑃]
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Figure 12: Origin of CD effect. 
 
Circular dichroism 
An electromagnetic radiation such as light consist of an electric and a magnetic 
field that oscillates perpendicularly to one another and to the direction of propaga-
tion, like a transverse wave. Light can be linearly polarized, by selecting one plane 
in which the electric field can oscillate in a fixed direction, or circularly polarized, 
by a combination of two linearly polarize perpendicular light planes, either clock-
wise (right-handed, R) or counterclockwise (left-handed, L). When circularly po-
larized light passes through an absorbing optically active medium (a solution con-
taining chiral centers as amino acids), the L-component and the R-component are 
differently absorbed, with the resulting light being elliptically polarized (Figure 
12).  
 
 
 
 
 
 
Figure 12: Origin of the CD effect. The left (L) and right (R) circularly polarized components of 
plane polarized radiation: (I) the two components have the same amplitude and when combined 
generate plane polarized radiation; (II) the components are of different magnitude and the resultant 
(dashed line) is elliptically polarized. Figure and legend are an adaptation from Refs 8; 88 
 
The instrument that allows the circularly polarized light analysis is called spectro-
polarimeter (or CD) that, based on his internal architecture, measures the different 
adsorption of L and R components88. CD output is a plot in which on abscissa there 
is wavelength, while on ordinate the ellipticity variation (measured in mdeg), math-
ematically express as: 
𝜃 =  𝑡𝑎𝑛−1 (
𝑏
𝑎
) 
where a and b are defined as the major and the minor ellipse components. Usually 
CD signal is particularly weak, with an ellipticity around 10 mdeg. CD allows to 
obtain different information, according to the setting of the instrument. Working in 
the far UV window (200-240 nm), one can gain information about the secondary 
structure since α-helix, β-sheet or random coil have typical spectra (Figure 13A). 
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Figure 13: FarUV and nearUV spectra.   
Moreover, in the presence of a protein formed by a combination of them, is possible 
to perform the spectra deconvolution using specific algorithms, in order to measure 
the contribution of each to the final structure. Working in the near UV window 
(260-320 nm) is possible to have information about the tertiary structure monitor-
ing the aromatic amino acid environment (Figure 13B). In fact:   
• phenylalanine (Phe) shows weaker but sharper bands with fine structure be-
tween 255- 270 nm;  
• tyrosine (Tyr) shows a band between 275-282 nm; 
• tryptophan (Trp) shows a band close to 290 nm with fine structure between 
290-305. 
 
 
 
 
 
 
 
 
 
 
 
Figure 13: Far UV and near UV spectra. (A) Far UV CD spectra associated with various types of 
secondary structure. Solid line, a-helix; long dashed line, anti-parallel β-sheet; dotted line, type I 
h-turn; cross dashed line, extended 31-helix or poly (Pro) II helix; short dashed line, irregular 
structure. (B) The near UV CD spectrum for type II hydroquinone from Streptomyces coelicolor. 
The wavelength ranges corresponding to signals from Phe, Tyr and Trp side chains are indicated, 
but it should be emphasized that there can be considerable overlap between the Tyr and Trp signals. 
Figure and legend are an adaptation from Ref 88. 
 
Near-Far UV spectra and thermal denaturation profiles 
Near UV spectra were recorded at 37°C using 20-30 µM proteins after sequential 
additions of 0.5 mM EGTA, 1 mM MgCl2 and 1 mM CaCl2. Far UV spectra were 
collected at 37°C using 10-12 µM proteins after sequential additions of 300 µM 
EGTA, 1 mM MgCl2 and 600 µM CaCl2. Spectra of the sole solvent (20 mM TRIS, 
150 mM NaCl, 1 mM DTT) were collected and considered as blank. Quartz cuvette 
were used for both near UV (1 cm) and far UV (0.1 cm) recordings.  
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Thermal denaturation profiles were collected in the same conditions used for far 
UV measurements, monitoring the ellipticity at 222 nm in a temperature range be-
tween 20°C to 96°C (scan rate 90°C/h). Data were fitted using the Hill 3 parameter 
function.  
 
Affinity estimation for Ca2+ and Mg2+ binding on CIB2  
Since CIB2 showed a low affinity for Ca2+ (see Results), I optimized a titration 
method based on the huge variation in the secondary structure upon ions binding. 
Each titration point represents an independent sample where 0.5 µL of Ca2+/Mg2+ 
stock solutions were added to the fixed volume (200 µL) of 12 µM WT or E64D 
CIB2 aliquots in the presence of 1 mM EGTA. After 3 min incubation at 25°C, 
three replicas were collected. The free ions concentrations in the stock solutions 
were determined using MaxChelator software (http://maxchelator.stanford.edu/), 
fixing ionic strength, pH and temperature. The titrations were performed either in 
the absence and in the presence of α7B_M peptide. 
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Fluorescence spectroscopy 
Fluorescence is a physical phenomenon based on the capability of some molecules 
to emit light at a higher wavelength (low energy) after the excitation of their exter-
nal electronic states. In fact, after the excitation, the promoted electrons must come 
back to the ground state. If collisions with other molecules take place, the promoted 
electrons lose part of the vibrational energy and return to the ground state emitting 
a photon89; 90. Proteins can act as fluorophores thanks to the presence of aromatic 
amino acids such as Phe, Tyr, Trp, and fluorescence spectroscopy can be used for 
many different investigations. Trp is the most commonly used natural probe thanks 
to the presence of the indole group that has a maximum of absorption at 280 nm 
and a peak of emission between 310-350 nm. Trp fluorescence gives information 
about the protein folding state: denaturation or increased solvent exposure of Trp 
lead a red-shift (bathochromic shift) of the maximum of emission, vice versa a more 
compact structure or interaction with other molecules leads to a blue-shift (hypso-
chromic shift)90; 91. In the absence of Trp residues, as for CIB2, to gain this infor-
mation, I used a fluorescent probe named 8-anilino-1naphtalensulfonic acid (ANS), 
an organic compound that has different fluorescence properties when bound to the 
hydrophobic patches of a protein. I used fluorescence spectroscopy to i) investigate 
structural variations on CIB2-ANS upon metal binding, ii) estimate a Kd
app and the 
stoichiometric ratio in the formation of the CIB2 – α7B_M/scrb complex, monitor-
ing the peptide intrinsic fluorescence.  
 
ANS fluorescence 
Two micromolar CIB2 was incubated in the presence of 30 µM ANS in 20 mM 
HEPES pH 7.5, 150 mM KCl, 1 mM DTT. Fluorescence spectra were measured at 
37°C after sequential additions of 500 µM EDTA, 1 mM MgCl2 and 1 mM CaCl2 
using λexc = 380 nm and recording in a range between 400-650 nm, 5 nm band-
widths. Three spectra for each condition were collected and averaged.  
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Peptide titrations 
Four micromolar of α7B_M peptide was titrated at 37°C adding increasing concen-
trations of WT or E64D CIB2 in 20 mM HEPES, 150 mM KCl, 1 mM DTT, 1 mM 
MgCl2 and 1 mM CaCl2. The Trp residue on the peptide was specifically excited at 
295 nm and the spectra were recorded between 300-400 nm. Concerning the 
α7B_scrb, only three WT CIB2 concentrations were tested (2, 4, 8 µM). The ap-
parent equilibrium dissociation constant (Kd) was calculated using the equation: 
𝑦 =  𝑦0 + 𝑎𝑥 /(𝐾𝑑 + 𝑥) 
where y0 is the wavelength of the maximum emission peak of α7B_M without pro-
teins, x is the protein concentration, and a is the difference between the maximum 
and normalized value (1/λ)*105 of the peptide emission peak as function of x (Pa-
per 118). 
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Dynamic light scattering 
Dynamic Light Scattering (DLS) is a in solution technique that allow the estimation 
of size, volume and number of the particles that makes a sample. The technique is 
based on the fact that shining a coherent and monochromatic light beam (laser) onto 
a solution, the particles that are moving following Brownian motions, scatter the 
light behaving as a second light source. Performing measurements at increasing 
time intervals, the instrument follows the variations in intensity, correlating them 
with the diffusion coefficient which is inversely related to the particle size: the 
smaller the particle, the higher the diffusion coefficient (Figure 14). Since DLS 
measurements assume that the particles are spherical, using the Stokes-Einstein 
equation is possible to calculate the hydrodynamic radius (R):  
𝐷 =  
𝑘𝑇
6𝜋𝜂𝑅
 
In order to have a reliable estimation of the particle size, a monomodal Gaussian 
distribution is recommended.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 14: How DLS works92. 
 
 
 
 
 
 
 
Figure 14: How DLS works. 
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DLS measurements 
DLS was used to investigate size variations upon ions binding. In order to estimate 
the hydrodynamic diameter of the proteins after analytical SEC separation, samples 
were tested both at 25°C and 37°C after 2 min equilibration. The estimation was 
based on 15-30 measurements, each consisting in 12 repetitions. Viscosity and re-
fractive index were set to 0.6864 cP and 1.33 respectively (default values for water), 
measurement angle was 173° backscatter and the analysis model was multiple nar-
row modes. Performing measurements for longer time is possible to follow the pro-
tein propensity to form large aggregates monitoring the variation of the parameter 
named mean count rate (MCR), defined as the average scattering intensity. Varia-
tions in MCR are related to changes in colloidal properties of the solution, thus the 
identification of aggregation or precipitation processes. 
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Surface plasmon resonance  
Surface Plasmon Resonance (SPR) is a technique used for studying of binding phe-
nomena between molecules, ranging from ions to viruses. The very low amount of 
material required, and the high sensitivity make SPR a powerful tool for the inves-
tigation of binding kinetics and specificity. The technique is based on the measure-
ments of the variation in the refractive index of a light beam that collide with the 
chip surface, composed by a glass slide covered by a thin gold surface. The gold 
surface is covered by a dextran matrix where the target is immobilized and provide 
the hydrophilic environment for the interaction with the analyte (Figure 15A). Sur-
face plasmon resonance phenomenon causes shift of the dip corresponding to the 
angle at which total internal reflection occurs. When a binding event takes place, 
the reflective index in proximity of the glass side changes. The results in monitoring 
the refractive index variation is named sensorgram (Figure 15B), a plot that show 
the binding response in y axis over time, x axis93.  
SPR was used to investigate i) CIB2 oligomerization process, ii) kinetics of the 
interaction of CIB2 with three peptides (α7B_M, α7B_Scrb and α7B_C); two im-
mobilization protocols were used. 
Figure 15: How SPR works. A) Schematic representation of the SPR principle 94. B) Example of 
sensorgram95. 
 
SPR measurements 
Approach 1: heterogenous immobilization on COOH5 sensor chip 
CIB2 was immobilized on the surface of a COOH5 sensor chip (FortèBio) using 
HBS (20 mM HEPES, 150 mM KCl, 1 mM DTT, 1mM MgCl2, 50 µM EDTA, 
0.005% Tween 20) as immobilization- and running-buffer. Carboxyl groups were 
mobilized performing sequential injections of 60 µL of 10 mM H2PO4 (or HCl), 
HBS, 10 mM NaOH and HBS, twice (flow rate 5 µL min-1). Then, the sensor chip 
 
Figure 15: How SPR works. 
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surface was activated performing 7 min injection of a mixture of 10 mM H-hy-
droxysuccinimide (NHS) and N-ethyl-N’(dimethylaminopropyl)carbodiimide 
(EDC) at a flow rate of 5 µL min-1. Fifty nanomolar of CIB2 in Na-acetate buffer 
(pH 3.1, 1.52 pKa units below the pI) was injected at 10 µL min-1; 130 RU were 
immobilized in the flow cell (FC) 1, 226 in the FC3 (1 RU = 1 pg mm-2). The 
reactive group in excess were blocked injecting 70 µL of 1M ethanolamine hydro-
chloride-NaOH, pH 8.5. FC2 was activated and deactivated and considered as ref-
erence.  
In order to test the oligomerization process, several CIB2 concentrations (ranging 
from 92 nM to 46 µM) were injected on the immobilized protein at a FR of 20 µL 
min-1. The same sensor chip was used to investigate the interaction with three pep-
tides: α7B_M, α7B_Scrb and α7B_C were diluted in a range between 0.9 – 30 µM 
and injected four times for 2 minutes with a FR of 20 µL min-1 (Paper 222). 
 
Approach 2: homogenous immobilization on HisCap sensor chip 
His-CIB2 was uniformly immobilized by the specific interaction between the His-
tag and the functional group of Nitrilotriacetic resin (NTA) that specifically bind 
Nickel ions. Since previous experiments performed with the same sensor chip type 
showed a drift in the protein content over time, after the CIB2 orientation via His-
tag, the activation of carboxy group as above allows a more stable protein immobi-
lization. On the approximately 2250 RU immobilized, several peptide concentra-
tions were injected ranging from 230 nM – 30 µM. Each injection was repeated 
four times. Running buffer (HBS) was composed by 20 mM HEPES, 150 mM KCl, 
1 mM DTT, 1 mM MgCl2, 0.005% Tween 20. Two millimolar CaCl2 was further 
added to check whether the process was influenced by Ca2+.   
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Figure 16: Workflow followed for XL-MS experiments. 
Chemical cross-linking and mass spectrometry 
To date, three are the mainly used techniques for the protein structure resolution: 
X-ray crystallography, Nuclear Magnetic Resonance (NMR) and cryo-electron mi-
croscopy (Cryo-EM). Unfortunately, all have limits that sometimes make them not 
reliable for studying protein’s structure or protein-protein interactions. In fact, the 
huge amounts of purified protein required, combined with the high concentration, 
may lead the formation of artifact structures/complexes. Moreover, different pro-
teins need different crystallographic conditions, and it’s not sure that a protein can 
form diffracting crystals. To overcome these limits, in the last two decades a new 
technique has been getting popularity, named chemical cross-linking coupled with 
mass spectrometry96. It consists in blocking a protein, or a complex, in a certain 
structure using cross-linker molecules, which works as molecular ruler: only resi-
dues with a specific group can react with the cross-linker forming a covalent bound 
that keeps them together (Figure 16). I had the chance to use 3 different cross-
linkers namely disuccinimidyls-dibutirric-urea (DSBU), 1,1’-carbonyldiimidazole 
(CDI) and photomethionine (PhotoMet) characterized by different lengths and re-
activity, summarized in Table 2. Normally, after the cross-linking reaction the sam-
ples are digested and analyzed by mass spectrometer (Orbitrap Fusion Tribrid, Life 
Technologies); the output is processed using a specific software named MeroX97 
that allows the assignment of the interacting peptides with a library of proteins se-
quences. This kind of analysis is normally used for proteomic investigations and 
the protocol is fully described in Ref98. For my analysis, I used cross-linking in 
order to investigate i) the CIB2 oligomeric state and ii) to obtain stable complexes 
of CIB2 in the presence of three different peptides; the cross-linked samples I had 
were analyzed by using Matrix Assisted Laser Desorption Ionization (MALDI-
TOF). To learn this technique, I spent around three months in Prof. Andrea Sinz lab 
in Halle (Leipzig). 
 
 
 
 
 
Figure 16: Workflow followed 
for XL-MS experiments. 
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Chemical cross-linking reaction 
Cross-linking reactions were performed as described in Ref 98 and published by us 
in Paper 222. Briefly, 10 µM CIB2 (in 20 mM HEPES pH 7.5, 150 mM KCl, 1 mM 
DTT, 1 mM MgCl2, 2 mM CaCl2) was incubated at RT for 10 min with increasing 
concentrations of peptides α7B_M, α7B_Scrb and α7B_C, ranging from 1:0.5 to 
1:2 protein:peptide ratios. Then, freshly prepared DSBU solution (dissolved in neat 
DMSO) was added at a 50-fold molar excess compared to CIB2 concentration. As 
the final volume of the reaction mixture was 50 µL, 1 µL of 25 mM DSBU was 
added to each sample. After 20 min, the cross-linking reactions were quenched by 
adding excess of primary ammines (ammonium bicarbonate or TRIS) to a final 
concentration of 20 mM and then incubated for other 10 min. Cross-linking prod-
ucts were first analyzed loading the samples on an SDS-PAGE and then prepared 
for the MALDI-TOF measurements. In addition, ESI-MS (Native MS)99 was used 
in order to investigate the protein oligomeric state under “physiological” condi-
tions, namely in the absence of chemical modifications.  
 
MALDI-TOF measurements 
Samples for MALDI-TOF-MS were desalted by ZipTip C4 (Millipore). Protein was 
eluted with 70% (v/v) acetonitrile / 1% (v/v) formic acid. Each sample was mixed 
with a saturated solution of sinapinic acid (in 50% (v/v) methanol / 0.1% (v/v) TFA) 
at 1:1 ratio and spotted onto the MALDI target. Each MALDI-TOF spectrum rep-
resents the accumulation of 1000-3000 laser shots. Baseline subtraction and spectra 
smoothing were performed.  
 
ESI-MS measurements 
For native ESI-MS analyses (High-Mass Q-TOF II mass spectrometer, Waters/MS 
Vision), CIB2 and the peptides were prepared in 200 mM ammonium acetate, pH 
6.8. collision energy was set at 60 V (Paper222). 
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TABLE 2: CHEMICAL FEATURES OF CROSS-LINKING MOLECULES. 
Molecule React. 
Length 
(Å) 
#re
s1 
Name  Structure    
DSBU 
(BuUrBu) 
Disuccinimidyl dibutyrric urea 
 
 
Lys, 
N-term 
12.5 
(spacer 
arm)98 
1
3 
CDI 
1,1’-carbonyldiimidazole 
 
Lys, 
N-term 
hydroxy 
groups 
2.6100 7
1 
Photo-Met 
Photo-methionine 
 
No speci-
ficity101 
  
1 Number of residues in CIB2 sequence. 
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Alexa Fluor 532 conjugation and luminescence titrations 
Dye conjugation  
Alexa Fluor 532 (Thermofisher) is the dye used to covalently label CaM. The pres-
ence of maleimide-functional group allows the specific binding to thiol groups and, 
since WT CaM lacks Cys, site directed mutagenesis (performed by Doc. Helge 
Meyer, University of Oldenburg) was performed in order to replace the Thr26 to 
Cys. The dye was suspended in pure DMSO and a 10-fold excess was added drop-
wise (at room temperature, in the dark to prevent light quenching) to the protein 
previously diluted in 50 mM TRIS pH 7.2, 150 mM KCl buffer. To get rid of un-
conjugated dye the sample was loaded on a PD10 desalting column. Considering 
that the conjugated dye exhibits λmaxexc = 532 nm and λmaxemi = 554 nm, the conju-
gation efficiency was calculated as follow:  
 
𝐸𝑓𝑓𝑖𝑐𝑖𝑒𝑛𝑐𝑦 (%) =  
𝐴532 
𝜀𝐴𝑙𝑒𝑥𝑎
∗
𝑀𝑊𝐶𝑎𝑀
[𝐶𝑎𝑀]
∗ 100 
 
where εAlexa is the dye extinction molar coefficient (78000 M-1cm-1), the MWCaM is 
16800 g/mol and [CaM] is expressed in mg/mL.  
 
Titrations experiments 
To study the interaction between CaM and CaF2 NPs, titrations experiments were 
performed moving from a protein free to a protein saturated solution. Each titration 
point consisted in 8.05 µL addition of a CaM stock (31 µM) to a 500 µL sample 
where of 0.5 mg/mL NPs were present. After 12 sequential additions the measured 
volume was  ̴̴ 600 µL and the final CaM concentration was 5.5 µM (concentration 
calculated considering the dilution factor). Thanks to the upconversion phenome-
non, for each protein addition fluorescence emission spectra were collected (410-
750 nm) upon excitation at 980 nm, following the Resonance Energy Transfer 
(RET). In this system, the fluorescence emission of upconverting NPs works as 
donor while conjugated Alexa Fluor 532 works as acceptor. Since the maximum 
efficiency in the energy transfer is inversely proportional to the sixth power of the 
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distance between donor and acceptor, RET intensity gives information about the 
NPs-CaM complex formation allowing the estimation of the affinity. 
 
Instrumentation for luminescence measurements 
The upconversion spectra were acquired using a 980-diode laser as excitation 
source. The emission was analyzed using a monochromator equipped with 1200 
g/mm grating and CCD detector with a spectra resolution of 0.15 nm.  
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Calcium and integrin binding protein 2 
Expression and purification  
The optimized protocol for the expression and purification of CIB2 allowed us to 
obtain at least 10-15 mg of pure WT and E64D CIB2 per liter of LB. During SDS-
PAGE CIB2 migrates with a profile compatible with a 21.7 kDa protein, even if its 
apparent MW is slightly higher (as already seen by Blazejczyk et al 2009102, Huang 
et al 2012103, Figure 17A). Moreover, a faint band is visible at lower MWs but 
since it has been recognized by the anti-CIB2 antibody (Abnova, Figure 17B), we 
excluded the presence of contaminants. Circular dichroism analysis was performed 
in order to check whether the presence of His-tag compromises the protein structure 
or its capability to coordinate cations, since His-CIB2 was immobilized on the sur-
face of the His-Cap chip during SPR measurements (see below). We pointed out 
that the small differences seen comparing His-CIB2 (Figure 17C) and CIB2 (Fig-
ure 17D) were related to the presence of the TEV binding site that didn’t compro-
mise the capability of CIB2 to bind ions. 
 
Figure 17: CIB2 purity check. A) 
SDS-PAGE of 15 μM WT and 
E64D CIB2 before and after TEV 
incubation, in the presence of 1 
mM DTT, 1 mM Mg2+ and 2 mM 
Ca2+. B) Western blot of 100 ng of 
WT and E64D CIB2 in the same 
ionic concentrations as in (A), ex-
position time 30 sec. C-D) Near 
UV CD spectra (250-320 nm) of 
20-30 µM His-CIB2 (C) and CIB2 
(D) were collected at 37°C start-
ing from the apo protein (500 µM 
EGTA, black lines) and after se-
quential additions of 1 mM Mg2+ 
(blue lines) and 2 mM Ca2+ (red 
lines). Data were normalized on 
proteins concentrations and each 
spectrum represents the average 
of 5 accumulations. Figure and 
legend have been adapted from 
Paper 222. 
 
 
 
 
 
 
 
Figure 17: CIB2 purity check. 
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Structural analysis: CIB2 response to cations 
Circular dichroism analysis highlights the molten globule state of WT CIB2 and 
the incapability of E64D mutant to reach the functional folding. 
CIB2 structural properties were investigated using high- and low-resolution tech-
niques, namely CD spectroscopy, NMR and SDS-PAGE. CD spectra were col-
lected in the far UV and near UV regions in order to gain information about sec-
ondary and tertiary structures respectively. Since CIB2 lacks tryptophan, the near 
UV spectra were the result of the contribution of 16 phenylalanine and 5 tyrosine 
residues. In the absence of ions (0.5 mM EGTA), the combination of an almost flat 
near UV spectrum (Figure 18A, black dotted line) and the detection of the helical 
content in the far UV region (Figure 18B), indicates that apo-CIB2 is in a molten 
globule state. The addition of 1 mM Mg2+ leads to an increase in dichroic signal 
both in near UV (Phe and Tyr bands) (Figure 18A, dashed blue line) and far UV 
regions, suggesting a more compact and well-defined structure. Furthermore, the 
physiological Mg2+ allows CIB2 to reach the typical spectrum of an α-helices pro-
tein, characterized by the two minima at 208 nm (localized at 206 nm in the apo 
protein) and 222 nm. The incubation with saturating Ca2+ (1 mM) completes the 
structural transition that consists in a further increase in ellipticity in the Tyr band 
(Figure 18A, solid red line), together with a slight increase in the far UV spectrum 
intensity (Figure 18B). E64D CIB2 showed a totally different ions response (Fig-
ure 18C-D). In fact, upon additions of Mg2+ and Ca2+ only slight changes in the 
near UV region were detected, while the far UV spectra were substantially over-
lapped in all the tested conditions, with the first minima stable at 206 nm. These 
evidences allowed us to conclude that replacing Glu with Asp in position 64 blocks 
the mutant in a molten globule conformation.  
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Figure 18: Conformational changes in WT and E64D upon addition 
of Ca2+ and Mg2+. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 18: Conformational changes i  WT a d E64D upon coordination of Ca2+ a d Mg2+. A-C) 
Near UV spectra of 28 μM WT (A) and 30 µM E64D (C) CIB2 in the presence of 500 µM EGTA 
(black dotted lines) and after sequential additions of 1 mM Mg2+ (dashed blue lines) and 1 mM Ca2+ 
(solid red lines). B-D) Far UV spectra of 12 µM WT (B) and E64D (D) CIB2 in the presence of 300 
µM EGTA (black dotted lines) and after sequential additions of 1 mM Mg2+ and 600 µM Ca2+. 
Figure and legend are adapted from Paper118. 
 
 
Limited proteolysis experiment identifies Mg2+ and Ca2+ as CIB2 stabilizers  
Even if CD and NMR (see below) measurements suggested that the presence of the 
sole Mg2+ or both Mg2+ and Ca2+ generate very similar tertiary structures, it is also 
known that the binding of ligands may lead to the exposure of different regions thus 
changing the accessibility to proteases. Limited proteolysis is an easy and informa-
tive technique that allows us to obtain information about protein structure proper-
ties, like flexibility104. WT CIB2 was incubated with trypsin in the absence of ions 
(1 mM EDTA), in the presence of sole Mg2+ (0.5 mM EGTA + 1 mM Mg2+) and in 
co-presence of Mg2+ and Ca2+ (1 mM Mg2+ + 2 mM Ca2+). After a time-scan in 
search of the best conditions (Figure S2, Paper 222), 5 min and 30 min (Figure 
19B) were chosen as representative of the fact that ions work as stabilizers: after 30 
min the apo-CIB2 was totally lost, while a mixture of undigested CIB2 and prote-
olytic bands were still present when ions were included. Molecular simulation per-
formed by Dr. Valerio Marino (University of Verona) allowed us to hypothesize 
that the proteolytic bands may have derived from exposing the pseudo-EF1 motif, 
the link between EF3-EF4, the exiting helix of EF4, and the C-terminal (Paper 222). 
We also noticed that CIB2 per se is prone to auto-degradation, as represented not 
 72 
 
 
 
Figure 19: Stabilization effect of ions. 
 
 
only by the appearance of a faint band in the absence of trypsin (Figure 19A) but 
also by the presence of 16-17 kDa fragments detected after MALDI measurements 
of CIB2 samples left at room temperature (data not shown). 
 
 
 
 
 
 
 
Figure 19: Stabilization effect of ions. A) Ten micromolar CIB2 was incubated at 25°C for 10 min 
in the presence of 1 mM EDTA (Apo), 500 µM EGTA + 1 mM Mg2+ (Mg2+) and 1 mM Mg2+ + 2 
mM Ca2+ (Mg2+ Ca2+). Samples were boiled and loaded on a 18% polyacrylamide gel. B) Limited 
proteolysis experiments of 25 μM CIB2 were performed in the same ionic concentrations used for 
(A). Samples were incubated with trypsin (1:100 enzyme:protein ratio), loaded on 18% polyacryla-
mide gel and Coomassie blue stained. Figure and legend are adapted from Paper 222. 
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Hydrophobicity evaluation  
The molten globule apo-form of both WT and E64D CIB2 suggests that many hy-
drophobic patches may be solvent exposed. In order to evaluate this feature, fluo-
rescence spectra were collected in the presence of ANS, a molecule with different 
fluorescence properties based on its binding to hydrophobic surfaces (Figure 20). 
Both WT (Figure 20A) and E64D (Figure 20B) appear more hydrophobic than the 
sole ANS (green line) when in the absence of ions (dotted lines), as demonstrated 
by the intense blue shift (27 nm for the WT and 31 nm for the mutant). The sequen-
tial addition of 1 mM Mg2+ and 1 mM Ca2+ led to a slight reduction in fluorescence 
emission combined with a 1-2 nm red shift. However, even if both variants appear 
highly hydrophobic, the presence of ions exerted a more prominent effect on the 
WT compared to E64D (Table 3). To further investigate the protein structure sta-
bility, thermal denaturation profiles were collected monitoring the ellipticity varia-
tion at 222 nm at increased temperatures, ranging from 4-70°C (Figure 20C-D). In 
this respect, the experiments were performed in the absence of ions (grey circles) 
and the presence of sole Ca2+ (red squares), Mg2+ (blue diamonds) and in the co-
presence of both (green triangles). All the distributions obtained were fitted with 
Hill 4 parameters function, data are reported in Table 3. As expected, apo-WT 
CIB2 was quite unstable showing a Tm = 35.1°C. The addition of 1 mM Mg
2+ led 
to an 11°C stabilization as did the addition of 1 mM Ca2+, even if its effect was less 
pronounced (8°C). The co-presence of cations did not result in a higher effect com-
pared to the sole Mg2+ as proved by the Tm = 45.9°C. The lower hc value of apo-
WT CIB2 (hc = 7.5) compared to the cations-bound forms (hc = 11-12.5) showed a 
faster transition when Mg2+ and/or Ca2+ were present, even if the persistence of 
ellipticity at high temperature suggests that CIB2 can retain some secondary struc-
ture. Concerning the mutant, no transition was detected in the apo conditions, in 
line with the partially unfolded structure, and the further additions of Mg2+ and/or 
Ca2+ showed Tm values that resembles the apo-WT ones (34.2-36.7°C).  
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Figure 20: CIB2 hydrophobicity and thermal stability investigation. A-B) ANS fluorescence spec-
tra of WT (A) and E64D (B) CIB2 in the presence of 0.5 mM EDTA (dotted black lines), 1 mM Mg2+ 
(dashed blue lines), 1 mM Ca2+ (solid red lines). ANS alone is also shown (dash dotted lines). C-D) 
Thermal denaturation profiles of 12 µM WT (C) and E64D (D) CIB2 were recorded between 4-
70°C in the presence of 0.5 mM EDTA (grey dots), 2 mM Ca2+ (red squares), 2 mM Mg2+ (light blue 
diamonds) and 1 mM Mg2+ + 1 mM Ca2+ (green triangles). Solid lines represent the result of data 
fitting using Hill 4 parameters function. Figure and legend have been adapted from Paper 118. 
 
 
TABLE 3: ANALYSIS OF ANS FLUORESCENCE AND CD THERMAL DENATURATION DATA FOR WT 
AND E64D CIB2.  
 Blue shift (nm)1 Fmax/Fref 2 Tm (°C)3 hc 
3 
WT – Apo 27 2.6 35.1 7.5 
+ Mg2+ 25 2.2 45.7 11 
+ Ca2+ 25 2.1 43.4 12.5 
+ Mg2+/Ca2+ - - 45.9 11.2 
 
E64D – Apo 31 2.8 - - 
+ Mg2+ 30 2.6 34.2 9.5 
+ Ca2+ 29 2.5 34.5 8.6 
+ Mg2+/Ca2+ - - 36.7 8.9 
1 blue shift refers to the observed shift of the wavelength of maximum emission of the protein + ANS 
mixture upon excitation of 380 nm as referred to that of ANS alone. 
2 refers to the ratio between maximal fluorescence emission of the protein + ANS mixture and that 
of ANS alone. 
3 Tm and hc represents the melting temperature and hill coefficient obtained by data fitting in thermal 
denaturation profiles. 
Table is from Paper 118 
 
 
 
 
Figure 20: CIB2 hydrophobicity and thermal stability investiga-
tion. 
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Affinity for cations  
Nuclear Magnetic Resonance measurements reveal a preferential binding of 
Mg2+ over Ca2+ and the presence of an allosteric long-range communication. 
A well-established technique for the evaluation of Ca2+ affinity, is the spectroscopic 
method based on the measurements of the competition for Ca2+ between the protein 
of interest and a chromophoric chelator, namely 5,5’-Br2 BAPTA. This was the first 
method applied for the characterization of WT CIB2’s capability to work as a Ca2+ 
binding protein, but no competition was detected, excluding a Kd below 6 μM (data 
not shown).  
One of the main features of Ca2+ sensor proteins is their capability to undergo con-
formational changes upon coordination of cations. This aspect was fully investi-
gated thanks to the collaboration with Prof. Mariapina D’Onofrio (Dept. of Bio-
technology), who collected two-dimensional HSQC NMR spectra of WT and E64D 
CIB2 (Figure 21). 1H-15N HSQC spectrum of apo-WT CIB2 is characterized by 
poorly dispersed peaks, a pattern compatible with a protein in a molten globule state 
(Figure 21A-B, black distribution). The addition of saturating Ca2+ and Mg2+ in-
duce a more disperse NMR signal (Figure 21A-B, blue and green distributions) 
and the appearance of downfield peaks are compatible with cations coordination. 
To better investigate the Ca2+ binding mechanism, Ca2+ was titrated on 15N-WT 
CIB2 collecting several HSCQ spectra. Three were the peaks that showed interest-
ing chemical shifts: E64, N121 and G162 which can be considered as indicators for 
non-functional EF1, and the EF3 and EF4 loops respectively. Following the chem-
ical shifts of these residues through the titration (Figure 21D to F), we saw that 
E64 (mutated in Asp in USH1J) and N121 follow the same hyperbolic shape, indi-
cating that they belong to the same allosteric network. The data were fitted using a 
single one-site binding model that gives the Kd for both residues: 0.55 ± 0.13 mM 
for E64 and 0.48 ± 0.15 mM for N121. G162 on the other hand, showed a sigmoidal 
shape with positive cooperativity, data fitted gave Kd
app = 2.22 ± 0.25 mM and hc = 
2.27 ± 0.38. It was noted that when E64 and N121 peaks appear, the protein is 
already well structured and further additions of Ca2+ lead only to small rearrange-
ments.  
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Using NMR, we also investigated whether a preferential binding for Mg2+ or Ca2+ 
was present. To do that, the downfield peaks were considered as indicators of EF 
hands occupancy when solutions with different ratios of Mg2+ and Ca2+ were used. 
When Mg2+ is in excess, N121 appears in the Mg2+-bound chemical shift while 
G162 (reporter for Ca2+ binding) is present but with low intensity. When Ca2+ is in 
excess, the N121 peak is still present in the Mg2+-bound chemical shift, suggesting 
it retained its capability to bind with Mg2+, while EF4 became occupied by Ca2+ 
(see Figure S5 in Paper 118).   
 
 
 
 
 
 
 
 
 
 
 
Figure 21: 1H-15N HSQC spectra of WT CIB2 in its apo form and in the presence of Mg2+ and 
Ca2+ highlight an allosteric communication between E64 and N121. A) Superimposition of the 
two-dimensional 1H-15N HSQC spectra of the apo- (black) and Ca2+-bound (green) 15N-WT CIB2. 
B) Superimposition of the HSQC spectra of the apo- (black) and Mg2+-bound (blue) 15N-WT CIB2 
in the insets, zoom of the HSQC spectra of the downfield peaks of the metal-bound forms of 15N-WT 
CIB2. Metal ions were presented at a protein:metal ratio of 1:15. C) Superimposition of downfield 
region of the 1H-15N HSQC NMR spectra recorded on 15N-WT CIB2 containing 15 equivalents of 
Mg2+ (blue), 15 eq. Mg2+ + 15 eq. Ca2+ (ref). and 15 eq. Ca2+ (green). (D-F) Variation of 1H-15N 
HSQC peak intensities or WT CIB2 as a function of Ca2+ concentration. The peak intensities were 
normalized with respect to maximum value. The continuous line represents the data fitted against 
equations as indicated in Material and Methods in Paper 1. The plots refer to the amide peaks of 
residues E64 (D), G162 (E) and N121 (F). All the spectra were recorded at 600 MHz and 25°C. All 
samples were at protein concentration of 320 μM in 20 mM HEPES, 100 mM KCl, 1 mM DTT, pH 
7.5. Figure and legend are from Paper 118. 
 
 
 
 
 
 
 
Figure 21: 1H-15N HSQC s   WT CIB2 in its apo form a  in the presence of 
Mg2+ and Ca2+.
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Kdapp for Mg2+ and Ca2+ estimation following variations in CIB2 secondary struc-
ture. 
At this point we sought to quantify the affinity of CIB2 for Mg2+ and Ca2+ for both 
WT and E64D, in order to explore the role of CIB2 under physiological and disease-
related conditions. Thus, titration experiments were designed monitoring the vari-
ation in CIB2 secondary structure upon addition of cations on the apo-CIB2 (1 mM 
free EGTA) looking for the concentration of Ca2+/Mg2+ at which the structural 
change is half maximal (Kd
app). All the data (Figure 22) were fitted with a Hill 4 
parameters function (Table 4), suggesting the presence of cooperativity in struc-
tural conformation triggered by ions coordination. Going into details, we found for 
WT CIB2 (Figure 22A and B, gray dots) lowered Kd
app and higher cooperativity 
for Mg2+ binding (290 μM, hc =2.3) compared to Ca2+ (500 μM, hc = 1.1), excluding 
its role as Ca2+ sensor under physiological conditions and confirming its preferen-
tial binding for Mg2+. Concerning the USH1J-mutant (Figure 22A and B, red tri-
angles), it preserved a higher affinity for Mg2+ (Kd
app = 1.5 mM) compared to Ca2+ 
(Kd
app = 2 mM), even if totally out of the physiological window.   
Since we could detect the E64D’s capability to respond to non-physiological ions 
concentrations in the far UV, we wondered if these may trigger the gain of a WT-
like tertiary structure. Thus, further near UV spectra of E64D were collected in-
creasing the cations concentrations (2 mM to 10 mM) and it was shown that E64D 
starts the conformational change when Ca2+ concentration was at least 5 mM, reach-
ing a WT-like structure only in the presence of 10 mM Ca2+ (Figure 22C). The 
same was not detected for Mg2+, for which even at 10 mM the spectrum was still 
far from the WT, both in shape and intensity (Figure 22D).  
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Figure 22: Ca2+ and Mg2+ affinity assayed by monitoring secondary structure variations. (A-B) 
WT (grey circles) and E64D (red triangles) were titrated with Ca2+ (A) and Mg2+ (B) starting from 
apo- protein (1 mM EGTA). (C-D) Near UV spectra of E64D CIB2 after sequential additions of 
Ca2+ (C) and Mg2+ (D) ranging from 2 mM to 10 mM. Figure and legend are an adaptation from 
Paper 118. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
TABLE 4: APPARENT AFFINITY FOR Ca2+ AND Mg2+ OF WT AND E64D CIB2 
ASSESSED BY CD TITRATIONS.   
 Mg2+ Ca2+ 
 Kdapp (mM) hc Kdapp (mM) hc 
WT CIB2 0.29 ± 0.02 2.3 ± 0.3 0.5 ± 0.1 1.1 ± 0.3 
E64D CIB2 1.5 ± 0.1 1.7 ± 0.2 2.0 ± 0.2 2.2 ± 0.6 
Table is an adaptation from Paper 118 
 
 
Figure 22: Ca2+ and Mg2+ affinity by monitoring secondary structure 
variations. 
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Oligomeric state investigation: a controversial issue 
The CIB2 oligomeric state analysis was the tricky part of the investigation, since 
some results suggested a dimeric organization while others a monomeric one. To 
shed light on this feature many techniques were employed, from the old-fashion 
Ferguson plot to the advanced chemical cross-linking coupled with mass spectrom-
etry. 
 
Lines of evidence of dimeric state (Paper 118) 
In the very first part of the project, the investigation of CIB2’s oligomeric state was 
performed using three different techniques: native PAGE, analytical SEC, and 
DLS. While in the presence of SDS (Figure 19A) CIB2 had an electrophoretic mo-
bility compatible with a 21.7 kDa protein, in native PAGE (see Figure S1 in Paper 
1) multi bands appeared when reducing agent was absent, thus indicating the ten-
dency to form high MW oligomers via oxidation of thiol groups of the 4 Cys resi-
dues. The multi band pattern disappeared when 1 mM DTT was included in sample 
preparation. To further investigate the single bands nature seen in native PAGE, 
analytical size exclusion chromatography measurements were performed. CIB2 
was loaded into the previously equilibrated column and the elution volumes were 
used to extrapolate the MW via a calibration line obtained by loading standard pro-
teins (see methods); this was done for both WT and E64D CIB2. Data are summa-
rized in Table 5. Both WT and E64D in the presence of Mg2+ and/or Ca2+ eluted 
from the column as only one peak with an apparent MW of 37-39 kDa (Figure 23), 
suggesting that all CIB2 molecules is structured in dimers. Even if less precisely, 
the Ferguson plot analysis confirmed the high MWs for both WT and E64D CIB2 
(Table 5) in all the tested conditions (52-53 kDa). The eluted proteins were imme-
diately analyzed by DLS to check the variations in hydration shell upon cations 
coordination (Figure 24). While apo-WT CIB2 showed an intensity profile charac-
terized by multiple unresolved peaks (Figure 24A), the further addition of Mg2+ or 
Ca2+ (Figure 24B and C) improved the colloidal properties allowing us to deter-
mine the hydrodynamic diameters, estimated to be: dMg = 8.43 nm and dCa = 8.18 
nm. On the other hand, E64D never showed any amelioration in colloidal properties 
(Figure 24E-G), resulting in a high polydispersion index and thus preventing a 
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Figure 23: SEC analysis. 
 
reliable hydrodynamic diameter determination. The combination of all these factors 
led us to conclude that CIB2 forms dimers under the tested conditions.  
With the aim to identify the precise dimerization interface, we found some lines of 
evidence of the monomeric nature of CIB2.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 23: SEC analysis. Gel filtration elution profiles under reducing conditions of WT CIB2 (A) 
and E64D CIB (B) in the presence of 3 mM EGTA (black line), 2 mM EGTA + 3 mM Mg2+ (blue 
line) and 3 mM Mg2+ + 2 mM Ca2+ (red line). C-D) Determination of MW for apo-, Mg2+ and Ca2+-
bound WT and E64D CIB2. Calibration curve were prepared by plotting the Log10 MW value for 
each standard protein versus its corresponding Kd value. Standard globular proteins were used for 
the preparation of the calibration line (1. Β-amylase, 2. Alcohol Dehydrogenase, 3. Carbonic an-
hydrase, 4. Cytochrome C). Figure and legend are an adaptation from Paper 1. 
 
 
Figure 24: Dynamic light scattering spectroscopy. Comparison between diameters measured at 
37°C for WT (A-D) and E64D (E-H) CIB2 in the presence of 3 mM EGTA (A, E), 2 mM EGTA + 3 
mM Mg2+ (B, F), 3 mM Mg2+ + 2 mM Ca2+ (C, G). Superimposition of the average curves obtained 
by (A-C) for the WT and (E-G) for the E64D CIB2. Figure and legend are an adaptation from Paper 
1. 
 
 
 
 
Figure 24: Dynamic light scattering spectroscopy. 
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TABLE 5: MOLECULAR WEIGHT OF WT AND 
E64D CIB2 ESTIMATED BY ANALYTICAL SEC AND 
FERGUSON PLOTS (FP). 
 
 
MWSEC (kDa) MWFP (kDa) 
WT-apo 51.1 51 
+ Mg2+ 38.6 52 
+ Ca2+ 38.1 53 
E64D-apo 68.4 53 
+ Mg2+ 38.5 53 
+ Ca2+ 36.9 53 
Table is an adaptation from Paper 1. 
 
Lines of evidence of monomeric state (Paper 222) 
With the purpose to identify and characterize the dimerization interface, and thus 
the residues directly involved in dimer formation, chemical cross linking coupled 
with mass spectrometry (XL-MS) experiments were performed97. Surprisingly, 
none of them showed CIB2 dimers, not even after using shorter molecules as CDI 
or photo-methionine. Native-MS spectra were also collected (Figure 25A) and 
CIB2 appeared in charge states from +8 to +10 with signals at m/z 2178, 2420 and 
2722 respectively. The spectrum deconvolution gave a mass equal to 21787 Da, 
fully compatible with monomeric CIB2. Dimers or higher oligomers were never 
detected. Since these last pieces of evidence appeared in contradiction with the pre-
vious analytical SEC findings, both SEC and DLS measurements were repeated in 
the same conditions used for XL-MS (Figure 25C), and the product loaded on SEC 
column. Figure 25B shows how native CIB2 (black line, peak #1) and cross-linked 
CIB2 (green line, peak #2) elute at the same retention volume, which gives MW 
values of 35.9 kDa and 36.7 kDa respectively, very similar to those previously pub-
lished (Paper 1). The second peak (green curve, peak #3) represents DSBU reac-
tion products (confirmed by NMR measurements, data not shown), visible also in 
the sole presence of reacted DSBU (black line, peak #4). To shed light on this weird 
behavior that shows CIB2 as a monomer but with a Stokes radius more similar to a 
dimer, the analysis was extended to other two Ca2+ sensors namely Rec and CaM 
(Figure 25C). As we did with CIB2, the eluted peaks of CaM and Rec were imme-
diately assessed by DLS (Figure 25D), and their tridimensional structure was used 
to calculate the theoretical hydrodynamic radius using HydroPro (measurements 
performed by Dr. Valerio Marino). Results are summarized in Table 6. The elution 
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peaks of Ca2+-bound CIB2, Rec and CaM gave MWs equal to 37.8 kDa, 33.5 kDa 
and 20 kDa respectively, slightly higher with respect to the theoretical values. 
Moreover, zooming on the CIB2 elution profile (Figure 25C, inset) it was possible 
to identify a shoulder (band A1) whose estimated MW is 81.3 kDa. In previous 
measurements, bands A1 and A2 were collected together, resulting in a hydrody-
namic diameter of 8.18 nm. In this experiment the two bands were collected sepa-
rately, and the prominent one (band A2) resulted in a lower hydrodynamic diameter 
(5.4 nm), similar to Rec (5.0 nm) and CaM (5.8 nm). A common feature of CIB2 
and Rec is the significantly higher MW with respect to the theoretical values; Hy-
droPro measurements pointed out that both share a high hydrophobic solvent-ac-
cessible surface (SAS) that may interfere with the column resin, leading to elution 
at lower volumes, and therefore higher MWs. Moreover, the size measured by DLS 
and the radius of gyration seemed to correlate for CIB2 and Rec, while CaM 
showed a higher radius of gyration, probably due to the elongated forms assumed 
upon Ca2+ binding.  
Finally, to further confirm the monomeric nature of CIB2, a low amount of WT 
proteins was immobilized on the surface of a SPR sensor chip, and several CIB2 
(0.4 µM – 140 µM) concentrations were poured on the immobilized protein in the 
presence of 1 mM Mg2+ and 1 mM Mg2+ + 2 mM Ca2+. All the obtained sensor-
grams were flat (data not shown) thus excluding the formation of dimers. 
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Figure 25: Lines of evidences of monomeric CIB2. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 25: Lines of evidences of monomeric CIB2. A) Native ESI mass spectra collected in the 
presence of 14 µM WT CIB2 in 200 mM ammonium acetate, pH 6.8. Collision energy was set to 
60V. B) MW investigation of CIB2 before (black) and after (green line) modification with DSBU. 
One reaction was performed in the presence of sole DSBU (red line). C) CIB2 (  ̴70 µM), Rec ( ̴ 80 
µM) and CaM (  ̴110 µM) were loaded into an analytical SEC column previously equilibrated with 
20 mM HEPES pH 7.5, 150 mM KCl, 1 mM DTT, 1 mM Mg2+, 2 mM Ca2+. The inset shows the 
zoom of CIB2 elution profile that was collected in two different fractions, represented by the colored 
areas. D) The hydrodynamic diameters of the eluted peaks were assessed by DLS: 15 to 30 meas-
urements were collected for each sample at 37°C, consisting in at least 13-15 repetitions. The pre-
sented curves represent the average distribution. The protein concentrations in the eluted fractions 
was found to be: 11 µM (Rec), 7.4 µM (CaM), 1.8 µM (CIB2). Figure and legend are an adaptation 
from Paper2.  
 
TABLE 6: COMPARISON OF THE HYDRODYNAMIC PROPERTIES OF CIB2, CaM AND Rec. 
 Hydro-
Pro Ø 
(nm) 
Gyration 
radius 
(nm) 
DLS Ø 
[n] (nm)a 
Hydro-
phobic 
SAS (nm2) 
Hydrophilic 
SAS (nm2) 
MW 
(kDa) 
MWSEC 
(kDa) 
CIB2 
(13-184)b 
4.736 1.88 5.4 ± 0.2 
[15] 
59.64 55.34 21.3 37.8 (A2 
band) 
Rec 
(1-201)b 
5.112 1.94 5.0a ± 0.1 
[18] 
62.54 64.68 23.3 33.5 
CaM 
(1-149)b 
5.076 2.22 5.8 ± 0.1 
[30] 
50.28 54.97 16.8 20.5 
aData are reported as mean ± SEM; n represents the number of measurements used for the calcula-
tion. 
bSequence coverage of the structural models used for hydrodynamic diameter calculation. 
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Interaction with the target peptide 
As described in the introduction, several targets have been identified for CIB2, 
based on the cells, tissue or mechanism considered. One of these is the integrin 
α7B, even if the exact portion involved in the interaction was still under investiga-
tion. Two were the main hypothesis: Hager et at20 identified the entire cytosolic 
portion, especially the one close to the C-terminal stretch, while later Huang et al.21 
demonstrated this region as restricted to a short sequence close to the membrane. 
To shed light on this open question, we purchased (Genscript) two peptides cover-
ing the portions named α7B_C (for the cytosolic) and α7B_M (for the proximal-
membrane portion) of the human α7B integrin, plus a negative control peptide with 
the same amino acid content of α7B_M, but whose sequence was scrambled 
(α7B_Scrb). The investigation of the interaction between WT CIB2 and these pep-
tides was assayed using a combination of indirect (fluorescence spectroscopy) and 
direct (MALDI-TOF and SPR) techniques. 
 
Fluorescence spectroscopy suggests a specific interaction between WT/E64D 
CIB2 and the α7B_M peptide  
Fluorescence spectroscopy allowed us to investigate the interaction between 
WT/E64D CIB2 with α7B_M and α7B_Scrb peptides; α7B_C was excluded due to 
the lack of Trp residue which was instead present in the mouse sequence (used for 
the first interaction study2, 5). Since CIB2 is also Trp-free, the fluorescence on the 
only Trp residue present in the peptides was monitored. In Figure 26A is reported 
the comparison between the fluorescence emission of the sole α7B_M peptide 
(solid line), and after the incubation with saturating concentration of CIB2 (dashed 
line). The 17 nm blue shift and the 1.7-fold increase in fluorescence signal support 
the presence of a specific interaction, never seen in the presence of α7B_Scrb pep-
tide (Figure 26B). Based on this evidence, titration experiments were performed 
incubating increasing protein concentrations on a fixed amount of α7B_M peptide 
(Figure 26C). This led us to have an estimation of the stoichiometry and the Kd
app 
for both WT and E64D. Surprisingly, despite its molten globule conformation, 
E64D is capable to interact with the peptide, with an affinity similar to the WT 
(Kd
app = 4.99 ± 1.01 μM for WT CIB2 and Kdapp = 3.1 ± 0.2 μM for E64D) and a 
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stoichiometric ratio of 2:1 protein : peptide. This appears to agree with the for-
mation of a complex formed by 2 CIB2 and one peptide molecule, as described 
below (see SPR results).   
Figure 26: Interaction between CIB2 variants and a7B_M peptide monitored by fluorescence 
spectroscopy. A) Trp fluorescence emission spectra of 4 µM α7B_M peptide alone (solid line) and 
incubated with 8 µM CIB2 (dotted line) in the presence of 1 mM Mg2+ and 2 mM Ca2+. B) Trp 
fluorescence emission spectra in 1 mM Mg2+ + 1 mM Ca2+ of 4 µM Scrb peptide alone (solid black 
line) and in the presence of increasing CIB2 concentrations: 2 µM (red dotted line), 4 µM (short-
dashed blue line) and 8 µM (green dashed-dotted line). C) Fluorescence titration of 4 µM α7B_M 
peptide with WT (black circles) and E64D (red triangles) CIB2 in the presence of 1 mM Mg2+ and 
1 mM Ca2+. Figure and legend are from Paper 118. 
 
 
MALDI measurements show the formation of 1:1 complex between WT 
CIB2:α7B_M  
In order to assess the complex formation, chemical cross-linking reactions of CIB2 
in the presence of increasing concentrations of α7B_M/α7B_Scrb peptides were 
performed, and the samples were examined by MALDI-TOF MS (Figure 27). 
CIB2 should be able to specifically interact with α7B_M, therefore no interactions 
were expected for α7B_Scrb. CIB2 without chemical modifications appeared in 
MALDI-TOF MS as an only one peak at m/z 21770 (fully compatible with the the-
oretical MW). Figure 27A shows how increased concentrations of the α7B_M pep-
tide led to the formation of 1:1 complex with m/z between 24000-26000 (the calcu-
lated mass of the complex formed by one CIB2 molecule, one peptide and at least 
one DSBU reacted molecule is 23964 Da). Also 1:2 complexes appear at m/z be-
tween 26500-28000, but the explanation for this can be found in the highly crowded 
environment. Contrary to our expectations, the peak of non-complexed CIB2 never 
disappeared, not even in the presence of a huge amount of α7B_M peptide; this may 
be due to the low affinity of the complex formation. Cross linking reactions were 
performed also in the presence of α7B_Scrb peptide (Figure 27B), where the 
mainly found peak is the one represented by non-complexed CIB2 decorated by 
 
 
Figure 26: Interaction between CIB2 variants and a7B_M peptide monitored by fluores-
cence spectroscopy. 
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Figure 27: Evidences of 1:1 complex formation between WT CIB2 and a7B_M peptide. 
 
one to five DSBU molecules, even though a weak signal of 1:1 complex appeared. 
Of course, this interaction has not biological meaning, and can find an explanation 
in the highly hydrophobic surface that characterizes CIB2. Also in this case, α7B_C 
was excluded due to the absence of lysine residues that specifically react with 
DSBU. 
 
 
 
 
 
 
 
Figure 27: Evidences of 1:1 complex formation between WT CIB2 and a7B_M peptide. MALDI-
TOF MS measurements of cross-linked CIB2 samples with peptides α7B_M (A) and α7B_Scrb (B). 
Ten micromolar CIB2 was cross-linked with 50-fold molar excess of DSBU with increasing peptide 
concentrations: 5 µM (red line), 10 µM (blue line) and 20 µM (green line). Between 1000-3000 
laser shots were accumulated to one MALDI-TOF mass spectrum. CIB2 without DSBU cross-linker 
was included as initial control (black line). Figure and legend have been adapted from Paper 222. 
 
 
Surface plasmon resonance analysis reveals a low-affinity interaction with α7B 
integrin 
To directly measure the kinetics and affinity describing the interaction between 
CIB2 and all the peptides (overcoming the absence of Trp and Lys residues on 
α7B_C) SPR measurements were performed. To do that, we immobilized CIB2 via 
i) non-specific amine coupling and ii) specific coupling of His-CIB2 on the His-
cap sensor chip (after having checked that the presence of His-tag does not modify 
CIB2’s structural properties, Figure 17C-D). We also tried the immobilization of 
sole peptides, but the signals obtained were low and non-reproducible, therefore 
this approach was not investigated any further. Sensorgrams from the two different 
immobilization approaches (Figure 28A-B) gave reproducible results, though with 
different shapes, which suggested a more specific interaction with α7B_M peptide 
compared to α7B_Scrb, and the absence of interaction with α7B_C peptide. The 
sensorgram’s shape is incompatible with the 1:1 Lagmuir model and characterized 
by a different association but similar dissociation kinetics, far from a mono expo-
nential process.  
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To better investigate the affinity that led to the CIB2 – α7B_M complex formation, 
several peptide concentrations (230 nM – 30 µM, Figure 28C) were injected into 
the homogenously immobilized His-CIB2, in the presence of sole 1 mM Mg2+ and 
in the co-presence of 1 mM Mg2+ + 2 mM Ca2+. The obtained sensorgrams were 
fitted using the bivalent analyte model (see Methods in paper 2), which considers 
the possibility of one α7B_M peptide to bind with two CIB2 molecules in a process 
driven by the avidity effect (Figure 28D). In fact, data suggested that the first CIB2 
- α7B_M binding event may trigger the binding with another CIB2 molecule, re-
sulting in a sort of dimerization process, as already seen in fluorescence spectros-
copy (Figure 26). This phenomenon resulted in two sets of constants (Table 7) and 
may explain the high RU signal obtained during the experiment, even if its biolog-
ical meaning remains to be clarified. Moreover, ions seemed to influence the ki-
netic: the two binding events took place faster when only Mg2+ was present, while 
the presence of Ca2+ sped up the second dissociation event. Thus, considering only 
the first binding event, the presence of the sole Mg2+ resulted in a higher affinity 
(11.6 μM) with respect to the time when both cations were present (25 μM). On the 
other hand, keeping the avidity contribution in mind and considering that Ca2+ ac-
celerates the second dissociation event, the affinity of α7B_M was higher in the co-
presence of Ca2+ and Mg2+ (154 µM) than in the presence of only Mg2+ (210 μM).  
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Figure 28: SPR measurements of CIB2-peptide interaction. A) Either α7B_M, α7B_Scrb or α7B_C 
peptides (7.5 µM) were injected over His-CIB2 homogeneously immobilized by His-tag on the chip 
surface. B) Thirty micromolar of the same peptides were injected over untagged CIB2 previously 
immobilized on the surface of a COOH5 chip via amine coupling. C) Increasing concentrations of 
α7B_M peptide were injected on His-CIB2 immobilized as in A). Experimental data (black curves) 
were fitted to a bivalent analyte kinetic model (red curves). All the experiments were performed 
using 20 mM HEPES pH 7.5, 150 mM KCl, 1 mM DTT, 1 mM Mg2+, 2 mM Ca2+, 50 µM EDTA, 
0.005% Tween as buffer. Two minutes injections were performed using a flow rate of 20 µL min-1, 
dissociations were followed for 200 seconds. D) A possible interaction scheme of CIB2-α7B_M 
interaction compatible with the kinetic model. The interaction of a CIB2 monomer immobilized on 
the chip (green) with a peptide (orange) can lead to the binding of another CIB2 molecule; all steps 
are fully reversible. Figure and legend are from Paper 222. 
 
 
 
 
 
 
 
 
 
TABLE 7: RESULTS FROM SURFACE PLASMON RESONANCE ANALYSIS OF CIB2 – Α7B_M 
INTERACTION. 
 ka1 (M-1s-1) ka2 (RU-1s-1) kd1 (s-1) kd2 (s-1) KDapp1 
(µM)b 
KDappTOT 
(µM)c 
(N=28) 
1 mM Mg2+ 
(N = 16) 
(3.1 ± 0.1) x 104 (1.9 ± 0.4) x 10-3 (3.6 ± 0.5) x 10-1 (2.0 ± 1.7) x 10-2 11.6 ± 1.8 220 ± 20 
1 mM Mg2+  
2 mM Ca2+ 
(N = 15) 
(1.6 ± 0.2) x 104 (4.2 ± 0.5) x 10-4 (4.0 ± 0.3) x 10-1 (5.3 ± 0.5) x 10-2 25 ± 5 154 ± 8 
a Kinetic constants were determined according to a bivalent analyte model as explained in Methods 
of Paper 2. N refers to the number of independently analyzed sensorgrams. Results refer to average 
± SEM. 
b Apparent affinity for the first binding event, determined by the ratio kd1/ka1.  
c Apparent affinity constants accounting for avidity, determined by steady state analysis, measured 
by taking the maximum response RUmax for a series of 4 repetitions of 7 injections of α7B_M at 
increasing concentrations. Table and legend are from Paper 222. 
 
 
Figure 28: SPR measurements of CIB2-peptide interaction. 
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The interaction with α7B_M peptide does not increase significantly the affinity 
for cations 
Frequently, the presence of the biological target induces in the Ca2+ sensor protein 
an increase in the affinity for Ca2+ 84. Based on this, new titrations were performed 
in order to assess whether the presence of the α7B_M peptide (Figure 29). WT 
CIB2 showed an increase in Ca2+ (from 0.5 mM to 0.2 mM) and a decrease in Mg2+ 
affinity (from 0.29 mM to 0.49 mM) as E64D, whose Ca2+ affinity increased from 
2 mM to 1.5 mM while the Mg2+ affinity decreased from 1.5 mM to 1.8 mM (Table 
8). Even so, E64D is still uncapable to bind cations under physiological conditions 
and WT CIB2 is still far from being functional under relevant Ca2+ concentrations. 
 
 
 
 
 
 
 
Figure 29: Ca2+ and Mg2+ affinity assayed by monitoring secondary structure variations in the 
presence of a7B_M peptide. Twelve micromolar of WT (grey diamonds) and E64D (downwards 
triangles) CIB2 were titrated with Ca2+ (A) and Mg2+ (B) starting from apo- protein (1 mM EGTA). 
The titrations were performed at 37°C, ions concentrations ranged between 1 µM and 10 mM, each 
point represents 3 accumulations and data were normalized for protein concentrations and fitted 
using the Hill 4 parameters function. Figure and legend are an adaptation from Paper 118. 
 
 
TABLE 8: APPARENT AFFINITY FOR Ca2+ AND Mg2+ OF WT AND E64D CIB2 ASSESSED BY 
CD TITRATIONS. 
 Mg2+ Ca2+ 
 Kdapp (mM) hc Kdapp (mM) hc 
WT CIB2 + α7B_M 0.49 ± 0.03 1.4 ± 0.1 0.2 ± 0.2 0.9 ± 0.6 
E64D CIB2 + α7B_M 1.8 ± 0.2 1.4 ± 0.2 1.5 ± 0.3 1.4 ± 0.3 
Table is an adaptation from Paper 1. 
 
 
 
 
 
 
 
Figure 29: Ca2+ and Mg2+ affinity assayed by mon tori g secondary structure 
variations in he presence of a7B_M peptide. 
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Conclusions 
All the evidences described here show that the features and properties of CIB2 
make this “Ca2+-sensor protein” worth to be further investigated, first its low affin-
ity for Ca2+. In fact, contrary to its homologous CIB1, which has Asn and Glu res-
idues in positions -X and -Z (N169 and E172) in EF4 (Ca2+ binding motif), optimal 
for the pentagonal bipyramidal geometry, CIB2 has Gly and Asp (G165 and D168) 
thus losing the side chain contribution and the possibility to work as bidentate res-
idue respectively. The combination of three different techniques, namely CD, 
NRM, and chelator assay, showed a Ca2+ affinity for CIB2 in the high mM range 
(0.5 mM) and, even though the presence of the target peptide doubled the affinity 
(0.2 mM), it is still insufficient to make CIB2 a Ca2+ sensor under physiological 
conditions. The affinity for Mg2+ (290 µM) was higher, fully compatible with the 
fluctuations in cells, which also make the interaction with the target peptide (con-
firmed to be the membrane-proximal region of the α7B integrin) easier. Our hy-
pothesis consists in the formation of a 1:1 protein:peptide complex that may lead to 
the attachment of another CIB2 molecule, forming some sort of CIB2 dimer bridged 
by one peptide molecule. This may explain the sensorgram’s shapes incompatible 
with the Langmuir model, as suggested by the reaching of saturation in all the tested 
conditions. This hypothesis found support in the fluorescence emission upon titra-
tion, where the signal appeared when the double concentration of CIB2 was incu-
bated with a fixed peptide amount.  
The highly hydrophobic surface made the oligomeric state investigation tricky, 
driving to an erroneous interpretation of the first dataset collected (Paper 118). 
Now, the combination of mass spectrometry, chemical cross-linking, SEC and DLS 
(Paper 222) allowed us to identify CIB2 as a monomeric protein, just like its ho-
mologous CIB1. Finally, NMR measurements identified an allosteric communica-
tion between E64 (located in the N-terminal, far away from the metal binding loop) 
and N121 (in EF3), which stabilized the EF1 structure via electrostatic interaction 
mediated by R33 (hypothesis based on the homology model). Results from the 
NMR titrations showed EF3 as the putative EF hand for Mg2+ coordination and EF4 
for Ca2+ coordination under physiological conditions. The replacement of Glu64 
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with Asp, an extremely conservative mutation, blocked the allosteric communica-
tion thus making the mutant incapable to reach its functional folding. Our hypoth-
esis is that the extremely low Ca2+ affinity coupled with the loss in Mg2+ binding 
capability may mediate the lack of correct folding. Despite this, E64D CIB2 is still 
capable to interact with the biological target showing a WT-like affinity, thus lead-
ing us to conclude that the disease-related phenotype doesn’t resides in a compro-
mised interaction with the integrin.   
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Guanylate Cyclase Activating Protein 1 (GCAP1) 
A novel mutation p.(Glu111Val) in GUCA1A appears in an Italian 
family with Cone-Rod Dystrophy 
In 2018 a new GCAP1 mutation was found in an Italian 53-years old patient who 
reported symptoms like congenital nystagmus, photophobia and low vision acuity 
since childhood. After the first physical examination he reported to have three 
daughters, two of them (16 and 22 years old) afflicted by the same but milder fa-
ther’s symptoms, due to the age of the disease. Figure 30A-C reports the fundus of 
the proband (A) and the two daughters (B-C), where is clearly visible the macular 
degeneration over time. The segregation study (Figure 30D) and the genetic anal-
ysis validation highlighted a novel mutation in GUCA1A gene (p.Glu111Val). This 
mutation was never detected before but hypothesized as detrimental and deleterious 
by in silico pathogenicity prediction software. Indeed, located in the EF3 (the 
GCAP1’s EF hand motif with the highest affinity for Ca2+) E111 is the bidentate 
residue that supports the Ca2+ coordination with two oxygen atoms. Thus, the re-
placement with the hydrophobic Val leads to the loss of two out of seven oxygens 
required for a stable and functional Ca2+ coordination. 
 
Figure 30: Clinical and ge-
netic data.  A-C) Color fundus 
image of the right eye of pa-
tient II:1 (A, age 53), III:1 (B, 
age 22) and III:3 (C, age 16). 
D) Family tree showing the 
matching genotype-phenotype 
segregation of the mutant al-
lele of GUCA1A harboring 
the c.332A>T transition caus-
ing the substitution E111V. 
Legend: square, male subject; 
circles, female subjects; black 
symbols, affected subjects; 
white symbols, healthy sub-
jects. Figure and legend are 
an adaptation from Paper 359. 
 
 
 
 
 
 
 
 
Figure 30: Clinical and genetic data. 
. 
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Proteins expression and purification  
WT and E111V GCAP1 purification  
In order to raise the knowledge about the molecular mechanism behind the patho-
logical phenotype, recombinant WT and E111V GCAP1 were expressed in heter-
ologous system (E. Coli). Despite the accumulation of GCAP1 in the inclusion bod-
ies, the protocol based on 6M guanidium hydrochloride denaturation followed by 
in dialysis renaturation allowed a total yield of  ̴ 15 mg of pure protein per liter of 
LB. The myristoylation efficiency was tested and calculated to be >98% (data not 
shown). 
 
Semi-permanent cell line   
In order to reconstruct the system in vitro, human GC1 was permanently expressed 
in Human Embryonic Kidney flip cells (HEK293), upon transfection via PEI rea-
gent and selection with G418 antibiotic. The GC1 expression was monitored by 
following the fluorescence emission (due to the GFP expression) and via western 
blot.  
 
GC assay 
In order to assess the capability of WT and E111V GCAP1 to exert the role of GC1 
regulator, the system was reconstituted in vitro combining purified GCAPs and 
HEK’s membranes conveniently prepared. WT and E111V GCAP1 show an ap-
proximately equal capability to stimulate the GC1 in the absence of free Ca2+ (< 19 
nM) but, raising the Ca2+ concentration at value at which WT GCAP1 totally inhib-
its the enzyme, E111V shows a residual activation profile ( ̴ 60%) (Figure 31A). 
Evaluating the cGMP synthesis as function of Ca2+ (IC50), WT GCAP1 showed an 
activating-to-inhibiting switch at physiological Ca2+ concentration (IC50 = 0.26 
µM), differently E111V showed an IC50 = 10 µM, leading to the generation of a 
constitutively active enzyme (Figure 31C). To exclude the dysregulation as conse-
quence of decreased affinity of E111V GCAP1 for GC1, EC50 measurements were 
performed ([GCAP1] at which the GC1 activity is half maximal). The quite similar 
values obtained (EC50
WT = 3.2 µM vs. EC50
E111V = 3.5 µM) suggest no compromised 
complex formation (Figure 31B). 
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Figure 31. Guanylate cyclase 1 (GC1) regulation by WT and E111V GCAP1. A) Membranes con-
taining GC were reconstituted with 5 μM WT or E111V GCAP1 and <19 nM Ca2+ (black) or ∼30 
μM free Ca2+(grey); membranes with no GCAP1 were used as control. B) GC activity as a function 
of WT (black) or E111V (grey) GCAP1concentration (0–20 μM) in the presence of <19 nM free 
Ca2+. C) GC activity as a function of Ca2+ concentration (<19 nM – 1 mm) of 5 μM WT (black) or 
E111V (grey) GCAP1. The physiological window of variation in Ca2+ concentration during the 
phototransduction cascade is shaded in grey. Figure and legend are an adaptation from Paper 359. 
 
 
a IC50 is the half-maximal activating Ca2+ concentration. 
b hc is the Hill Coefficient.  
c EC50 is the half-maximal activating GCAP1 concentration.  
d X-fold activation is (GCmax − GCmin)/GCmin.  
e Decimal logarithm of the macroscopic Ca2+-binding constants after fitting data to a two independ-
ent binding sites model with CaLigator87. 
f Apparent affinity is the average of the significant log Ki (see Materials and Methods for details). 
Table and legend are an adaptation from Paper 359 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
TABLE 9: RESULTS OF GC REGULATION AND Ca2+ BINDING EXPERIMENTS. 
 IC50 
(µM)a 
hcb EC50 
(µM)c 
X-foldd log k1e log k2e Kdapp f 
WT 0.26 ± 0.01 2.05 ± 0.21 3.2 ± 0.3 16 7.07 ± 0.13 5.55 ± 0.19 0.49 
E111V 10 ± 5 0.83 ± 0.27 3.5 ± 0.9 15.7 4.3 ± 1.1 0.46 ± 1.6 ̴  40 
 
 
Figure 31: Guanylate cyclase (GC1) regulation made by WT and E111V GCAP1. 
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Oligomeric state investigation  
In a recent publication it was demonstrated that bovine GCAP1 forms active di-
mers105 and to assess whether the E111V mutation leads to a different oligomeric 
state, SEC and DLS measurements were performed (Figure 32). WT and E111V 
GCAP1 elution profiles were collected both in the presence of sole Mg2+ (500 µM 
EGTA + 1 mM Mg2+) and in the co-presence of Mg2+ and Ca2+ (1 mM Mg2+ + 1 
mM Ca2+) to check the effect of the two cations. Figure 32A-B shows no differ-
ences in both GCAP1 variants, with an estimated MW of 43.7 kDa (WT) and 47.8 
kDa (E111V), fully compatible with dimeric organization, considering that 22.9 
kDa is the MW of monomeric GCAP1. The eluted peaks were analyzed by DLS 
(25°C), resulting in monodisperse peaks with hydrodynamic diameters of 6.33 ± 
0.03 nm for WT GCAP1 and 5.98 ± 0.05 nm for E111V, in the presence of sole 
Mg2+. The addition of Ca2+ didn’t change neither the size nor the mean count rate 
(MCR, indicator of the aggregation propensity). Increasing the measurement time 
at physiological temperature to assess the stability, something different was seen 
(Figure 33). In the sole presence of Mg2+, WT GCAP1 shows a moderate tendency 
to form large aggregates, as highlighted by the MCR variations over time. MCR 
values for WT remain approximately stable for the first 4 hours, starting to increase 
with a constant slope describing a slow aggregation process, culminating in a 4-
fold increase in MRC at the end of the data collection. Conversely, E111V GCAP1 
shows a more prominent aggregation tendency in the Mg2+-bound GC1-activating 
condition, that starts immediately with a steep linear slope, ending after 16 hours 
with a 10-fold MCR value increased, compatible with a severe and constant protein 
aggregation.  
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Figure 32: Results from Size Exclusion Chromatography and Dynamic Light Scattering experi-
ments. Chromatograms of Size Exclusion Chromatography of ~40 μM WT (A) and E111V (B) 
GCAP1 in the presence of 500 μM EGTA and 1 mM Mg2+ (blue), or 1 mM Mg2+ and 500 μM Ca2+ 
(red). Hydrodynamic diameter estimation of ~20 μM WT (C) and E111V (D) GCAP1 in the presence 
of 500 μM EGTA and 1 mM Mg2+ (blue), or 1 mM Mg2+ and 500 μM Ca2+ (red). DLS measurements 
were collected approximately every minute, each measurement was an accumulation of 6 runs. Fig-
ure and legend are from Paper 359 
 
 
 
Figure 33: Aggregation propensity at physiolog-
ical temperature. Mean Count Rate evolution 
over 16 h of ~20 µM WT GCAP1 in 20 mM Tris-
HCl pH 7.5, 150 mM KCl, 1 mM DTT, in the pres-
ence of 500 µM EGTA and 1 mM Mg2+ (grey di-
amonds), or 1 mM Mg2+ and 500 µM Ca2+ (black 
line), and ~20 µM E111V in the presence of 500 
µM EGTA and 1 mM Mg2+ (black circles), or 1 
mM Mg2+ and 500 µM Ca2+ (light grey squares). 
Measurements were collected at 37 °C approxi-
mately every minute; each measurement was an 
accumulation of 6 runs. Figure and table are 
from Paper 359. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 32: Results from Size Exclusion Chromatography and Dy-
namic Light Scattering experiments. 
 
 
 
 
 
Figure 33: Aggregation propensity at 
physological temperature. 
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Hydrophobicity evaluation 
Considering the replacement of the hydrophilic Glu with the hydrophobic Val, and 
the propensity to form large aggregates of both variants in the presence of Mg2+, 
ANS fluorescence was used to detect changes in the protein surface properties. The 
comparison between fluorescence emission of sole ANS and apo-WT GCAP1 
shows an intense blue shift (31 nm) and an increased intensity, thus suggesting a 
highly hydrophobic surface. The addition of 1 mM Mg2+ causes a 7 nm red shift 
and a reduction of fluorescence emission, then slightly increased by the addition of 
saturating Ca2+ concentration. This trend is partially shared by E111V GCAP1 
which showed an intense blue shift (29 nm) and an increased fluorescent emission 
in the absence of ions but only 3 nm red shift upon addition of Mg2+ and Ca2+ (Ta-
ble 10). Taken together, these evidences suggest that different aggregation propen-
sity were not related to changes in protein’s surface.  
 
 
 
 
 
 
 
 
 
 
 
 
Structural properties 
As mentioned in the introduction, GCAP1 is a small protein formed by 4 EF-hand 
motifs, a helix-loop-helix structural organization that, when irradiated by circularly 
polarized light in the far UV range (200-250 nm), is described by a typical spectrum 
characterized by the presence of two minima (208 nm 222 nm). The ratio between 
the ellipticity signals at 222 nm and 208 nm (θ222/θ208) is used for describing the 
total structural variation as consequence of cation-coordination events. To obtain 
the fingerprint of human WT and E111V GCAP1, near UV CD spectra were col-
TABLE 10: RESULTS FROM ANS MEASUREMENTS. 
 λmax I/Imax Δλ 
ANS alone 517   
WT GCAP1 
EDTA 
+ Mg2+ 
+ Ca2+ 
 
468 
493 
493 
 
1 
0.73 
0.76 
 
31 
24 
24 
E111V GCAP1 
EDTA 
+ Mg2+ 
+ Ca2+ 
 
488 
494 
494 
 
1 
0.62 
0.70 
 
29 
23 
23 
Δλ is the variation of the maximal wavelength w.r.t 
ANS alone. 
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lected in different conditions (Figure 34). In the absence of ions both GCAP1 var-
iants were correctly folded and, while the addition of 1 mM Mg2+ had no effect in 
WT GCAP1 folding, small but significant changes were instead detected for E111V 
(Table 11). When saturating Ca2+ was added on Mg2+, a   ̴6% and   ̴4% variation 
was detected for WT and E111V respectively.  
Sliding the wavelength window in the near UV region (250-320 nm), information 
describing the tertiary structure can be obtained, more specifically due to changes 
in the aromatic amino acid environment. Apo-WT and -E111V GCAP1 showed 
very similar spectra in shape, but not in intensity, and the mutant spectrum was 
shifted to more positive values. The addition of 1 mM Mg2+ induced in E111V a 
more intense structural variation toward negative values, not seen for WT GCAP1. 
Finally, in the presence of saturating Ca2+, a further shift to more negative values 
was detected for both WT and E111V resulting in similar final shape. In general, 
the structural variations detected were more pronounced for E111V than WT 
GCAP1.  
Many evidences suggest a crucial role of Mg2+ in E111V structural properties. To 
better investigate the role of Ca2+ and Mg2+ in structure stabilization, thermal dena-
turation (20-96°C) profiles were collected in the same conditions used for far UV 
spectra. As expected, the presence of saturating Ca2+ prevents the clear transition 
from a folded to an unfolded state, as already seen for other Ca2+ sensors. Instead, 
the presence of 1 mM Mg2+ led in E111V a 5.5°C stabilization with the respect to 
WT GCAP1 (Tm
E111V = 54.5°C vs Tm
WT = 49°C), further emphasizing the crucial 
role of magnesium. 
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Figure 34: Structural features and stability changes in WT and E111V GCAP1 upon ion binding 
monitored by circular dichroism. A) Cartoon representation of the three-dimensional homology 
model of Ca2+-loaded human GCAP1; EF1 is colored in yellow, EF2 in green, EF3 in orange and 
EF4 in light blue. N- and C-terminal are represented in light grey and light cyan, respectively; the 
myristoyl group is represented in grey spheres, Ca2+ ions are shown as red spheres and residue 
E111 is shown as sticks. B) Thermal denaturation profiles of ∼10 μM WT GCAP1 in the presence 
of 300 μM EGTA and 1 mM Mg2+ (blue), or 1 mM Mg2+ and 300 μM Ca2+ (red), and ∼10 μM E111V 
in the presence of 300 μM EGTA and 1 mM Mg2+ (green), or 1 mM Mg2+ and 300 μM Ca2+ (grey). 
Thermal denaturation was performed in 20 mM TRIS-HCl pH 7.5, 150 mM KCl by following the 
decrease in ellipticity at 222 nm over the 20–96°C temperature range. When possible, data were 
fitted to a four-parameter Hill sigmoid (Table 11). Near UV CD spectra of ∼35 μM WT (C) and 
E111V (D) GCAP1 in the presence of 500 μM EGTA (black) and after sequential additions of 1 mM 
Mg2+ (blue) and 500 μM free Ca2+ (red). CD spectra were recorded at 37°C in 20 mM TRIS-HCl 
pH 7.5, 150 mM KCl, 1 mM DTT. Figure and legend are from Paper 359. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
TABLE 11: RESULTS FROM CD FAR UV SPECTROSCOPY AND THERMAL DE-
NATURATION PROFILES. 
 θ222/θ208 Δθ/θ (%) Tm (°C) 
WT GCAP1 
EGTA 
+ Mg2+ 
+ Ca2+ 
 
0.94 
0.94 
0.96 
 
 
2 
6 
 
 
49.0 
> 96 
E111V GCAP1 
EGTA 
+ Mg2+ 
+ Ca2+ 
 
0.92 
0.93 
0.93 
 
 
-1 
4 
 
 
54.5 
> 96 
θ222/θ208 is the intensity ratio at λ = 222 and λ = 208 nm, Δθ/θ is calculated 
as ((θion- θEGTA)/θEGTA)*100 at λ = 222 nm, Tm is the transition after fitting 
the signal at 222 nm to a 4-parameter Hill sigmoid. Table is an adaptation 
from Paper3. 
 
 
Figure 34: Structural and stability changes in WT and E111V GCAP1 
upon ion binding monitored by circular dichroism. 
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Calcium affinity evaluation 
Functional assays showed IC50 value for E111V GCPA1 shifted to non-physiolog-
ical [Ca2+], implying a constitutive activity of the enzyme. To shed light on this, 
Ca2+ binding properties of GCAP1 variants were assayed by two methods: gel shift 
(low-resolution) and chelator assay (high-resolution). 
The gel-shift is an easy and informative low-resolution technique that allows to 
assess whether the Ca2+-binding properties are affected or not by the mutations. It 
is based on the fact that some Ca2+ binding proteins retain a partial folding when 
Ca2+-bound, leading to the resistance to both thermal and detergent-induced dena-
turation. In fact, apo- and Mg2+-bound WT GCAP1 have the same electrophoretic 
mobility, compatible with a 23 kDa proteins, but the presence of Ca2+ make WT 
GCAP1 faster, with an apparent MW of   ̴17 kDa (Figure 35A). Something differ-
ent was seen for E111V, which also showed the gel-shift, even if less pronounced, 
suggesting compromised Ca2+-binding properties. To quantitatively determine the 
affinity, a spectroscopic-based method was used, namely chelator assay, consisting 
in the measurement of the competition for Ca2+ binding in the presence of 5-5’-Br2 
BAPTA (Figure 35B). The sigmoidal shape of WT GCAP1 data distribution high-
lights the presence of competition that resulted in a high-affinity (low nM) and a 
moderate-affinity (low µM) Ca2+ binding sites (Table 9), with a physiologically 
relevant apparent affinity (Kd
app = 490 nM). The same didn’t happen with E111V, 
whose profile was more similar to the sole chelator, implying the absence of com-
petition. In fact, two low-affinity binding sites were recognized upon data fitting, 
resulting in a Kd
app = 40 µM, extremely incompatible with physiological Ca2+-sens-
ing. 
 
 
 
 
 
 
 
 
 102 
 
 
 
 
 
 
 
 
 
 
Figure 35: Ca2+ sensitivity of WT and E111V monitored by gel mobility shift SDS-PAGE and 
absorption spectroscopy. A) 15% SDS-PAGE of ∼30 μM WT or E111V GCAP1 in the absence of 
ions (5 mM EDTA), in the presence of Mg2+ (5 mM EGTA and 1 mM free Mg2+) and in the presence 
of Mg2+ and Ca2+ (1 mM Mg2+ and 5 mM Ca2+). B) Normalized Ca2+ titration curves obtained by a 
competition assay with the chromophoric 5,5’Br2-BAPTA of WT (black circles) and E111V GCAP1 
(grey squares) in the presence of 1 mM Mg2+. Ca2+ concentrations include dilution effects upon 
titration; normalization details are reported in the Methods section. Experimental data are shown 
together with the optimal curve obtained by computer fitting (black and grey solid lines, respec-
tively) and the theoretical (Chelator) curve simulating the titration of the chelator (grey dashed 
line); estimation of log ki is reported in Table 9. Figure and legend are an adaptation from Paper 
359. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 35: Ca2+ sensitivity of WT and E111V monitored by gel 
mobility shift SDS-PAGE and absorption spectroscopy. 
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New hypothesis: replacement of mutant protein by extra 
delivery of WT-GCAP1  
GCAP2 doesn’t regulate GC1 activity  
Collectively, all these evidences highlight the higher sensitivity of E111V GCAP1 
for Mg2+ (GC-activating form) with respect to Ca2+ (GC-inhibiting form), as con-
firmed by chelator assays and IC50 measurements. However, the IC50 was evaluated 
in the sole presence of E111V GCAP1, condition that never occurs because of the 
autosomal dominant mechanism of inheritance; in fact, COD/CORD patients carry 
half WT and half mutated GCAP1. Moreover, GCAP1 is not the only regulator of 
phototransduction shut-off; other GCAPs isoforms are present in human, as GCAP2 
and GCAP3. Particularly, GCAP2 is directly involved in the calcium-relay, mech-
anism for which while GCAP1 is responsible for the first boost of cGMP upon 
illumination, GCAP2 is activated by prolonged light stimulation (at least in mouse 
and bovine). In this respect, our initial hypothesis was to investigate whether the 
presence of GCAP2 may lead to a compensation effect, thus shifting the total IC50 
to WT-like values with the final aim to slow down the progression of the disease. 
After having checked the GCAPs variants via gel-shift (Figure 36A) and the pres-
ence of GC1 in HEK cells (Figure 36B), GC assays were performed in the on-off 
mode to confirm GCAP2 capability in GC regulation (Figure 36C). Surprisingly, 
the cGMP synthesis in GCAP2-GC1 reconstructed system was very similar to the 
basal activity (in the absence of regulators). The measurements were also performed 
incubating equal amounts of GCAP1 and GCAP2 (5 µM GCAP1 + 5 µM GCAP2) 
looking for synergic activity but even if cGMP was detected, the lower amount 
(compared to the yield of cGMP in the presence of sole GCAP1) and the highly 
scattered data, suggested no significant contribution by GCAP2. To exclude that 
this unexpected result was due to a decreased affinity of GCAP2 for Mg2+, the 
measurements were also performed at higher non-physiological Mg2+ concentra-
tions (12 mM, Figure 36C, right), resulting in the same trend.  
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Figure 36: Ca2+-induced gel shift, GC1 western blot and enzymatic assay. A) SDS-PAGE of 
WT/E111V GCAP1 and GCAP2 in the presence of 5 mM EDTA, 4 mM EGTA + 1.4 mM Mg2+, 1 
mM Mg2+ + 4 mM Ca2+. Twenty micromolar WT GCAP1, E111V GCAP1 and WT GCAP2 were 
incubated for 10 min at 30°C in the presence or absence of ions and loaded in a 15% SDS-PAGE. 
Gel was Coomassie blue stained. B) Western blot of GC1 extracted from the membranes used for 
the assay. After have quantified the total amount of proteins by amido black assay, samples were 
boiled for 5 min and loaded in a 10% polyarylamide gel. Ab#3 against GC1 (1:1000) was diluted 
in 3% milk + 0.01% tween and icubated overnight at 4°C. Secondary antibody was incubated 
(1:10000) at room tempererature for 1 h and chemoluminescence was revealed by ECL reagent. C) 
GC enzymatic assay of 10 µM GCAP1 or GCAP2 were performed in the presence of low (< 19 nM) 
and high (  ̴30 µM) Ca2+ concentration and in the presence of 1 mM Mg2+ (left) and 12 mM Mg2+ 
(right). Each measurement represent the avarage of 3 replicas ± standard deviation. Figure and 
legend are an adatation from Paper 4106.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 36: a2+-induced gel shift, GC1 w stern blot and enzymatic assay. 
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Exploring the effect of WT GCAP1 extra delivery 
Since GCAP2 seems not to participate in GC1 regulation, the compensatory effect 
was studied by monitoring the Ca2+-dependent cGMP synthesis at increased WT 
GCAP1 concentration thus mimicking sort of extra delivery (Figure 37). Firstly, 
keeping in mind the AD nature of the disease, IC50 measurements were performed 
simulating the heterozygous patient who carries 50% WT and 50% E111V GCAP1 
(Figure 37, green line). Comparing the trend obtained with the one in the sole 
presence of E111V (Figure 37, red line) the amelioration of the IC50 was clearly 
visible, from 10 ± 5 µM (sole E111V) to 694 ± 75 nM. This means that the func-
tionally active WT GCAP1 partially buffers the presence of the mutant, explaining 
the time-related progression of the disease. To investigate the effect of the extra 
delivery, 3-fold WT GCAP1 concentration was used on a heterozygous background 
(Figure 37, yellow line). Interestingly, a statistically significant positive effect was 
detected both in Ca2+-sensibility (IC50 = 497 ± 49 nM, one-tailed p = 0.029) and in 
cooperativity (hc = 1.49 ± 0.35 vs 0.87 ± 0.18), even if the E111V residual activity 
is still quite high ( ̴ 45%) (Table 12).  
In order to better investigate the role of each of the GCAPs variant (WT and E111V 
GCAP1, GCAP2) in shaping the photoresponse, system biology simulations were 
performed by Prof. Daniele Dell’Orco by using a comprehensive biochemical 
model of phototransduction in mouse rod (Paper 4106). Two conditions were ini-
tially simulated namely heterozygosis (WT/E111V), found in CORD-patient, and 
homozygosis (E111V/E111V) (Figure 37B). Figure 37B right shows how the 
presence of the sole mutant led to a prolonged photoresponse with increased time 
to peak. This behavior seems to be related to the E111V relative abundance since a 
similar but milder trend was detected in the heterozygosis case (Figure 37B left). 
In fact, in the co-presence of WT and E111V GCAP1 the detected increase in dark 
levels of Ca2+ (3.1-fold) and cGMP (1.4-fold) were significantly lower with respect 
to homozygosis case (X-fold [Ca2+] = 12.5, X-fold [cGMP] = 2.0) (Table 13). The 
IC50 values from in vitro measurements were also used to simulate the effect of the 
3-fold extra delivery of WT GCAP1 on the heterozygous background, both includ-
ing (in line with the Ca2+-relay mechanism) and excluding (in line with last find-
ings) the contribution of GCAP2. The results obtained showed that the presence of 
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Figure 37: In vitro and in silico results. 
 
GCAP2 is fundamental in shaping a WT-like photoresponse (Figure 37C left), as 
confirmed by the fact that its absence led to a trend more similar to the heterozygo-
sis (Figure 37C right).  
Taken together, these results allow to conclude that the calcium-relay mechanism 
involving GCAP1 and GCAP2 might be species-dependent and the identification 
of alternative molecular partners, capable to exert in human the same effect exerted 
by GCAP1 and GCAP2 in mouse or bovine, remain to be clarified.  
 
Figure 37: in vitro and in silico results. A) 
The GC1 activity as function of [Ca2+] was 
measured in the presence of 10 µM WT 
GCAP1 (black circles), 5 µM WT GCAP1 + 5 
µM E111V GCAP1 (green diamonds) and 15 
µM GCAP1 + 5 µM E111V GCAP1 (yellow 
triangles). E111V GCAP1 activity is referred 
to the curve reported in Paper 359. Each data 
set is relative to 4-6 replicas and data are nor-
malized according to both total content in 
membranes and maximum and minimum GC1 
activity recorded in each replica. Error bars 
represent s.e.m. Solid lines represent the re-
sults of data fitting while the gray box the 
physiological Ca2+ fluctuations in rod photo-
receptors. B-C) Simulations of flash responses 
from dim to bright light conditions. After equi-
libration of the rod outer segment in the dark, 
24 ms flashes were delivered, leading to 1.54, 
18, 87 and 500 photoisomerizations of rho-
dopsin. Black traces: WT GCAPs-containing 
rods. Dash-dotted gray lines: photoresponses 
in a WT/E111V heterozygous case (B, left), 
E111V/E111V homozygous case (B, right) and 
in the presence (C, left) and in the absence (C, 
right) of endogenous GCAP2. Photocurrents 
represent the suppression of the dark current 
at each light intensity and have been normal-
ized. Figure and legend are an adaptation 
from Paper 4106. 
 
 
 
 
 
TABLE 12: RESULTS FROM ENZYMATIC ASSAY: HUMAN GC1 ACTIVITY AS A FUNCTION OF FREE 
[Ca2+]. 
 GCAP1WT 
(n = 6) 
GCAP1E111V b 
(n = 4) 
GCAP1WT/E111V 
(n = 6) 
3xGCAP1WT / GCAP1E111V 
(n = 6) 
IC50 (nM) 251 ± 19a (10 ± 5) x103 694 ± 75 497 ± 49 
hc 2.60 ± 0.42 0.83 ± 0.27 0.87 ± 0.18 1.49 ± 0.35 
a mean ± s.e.m; b data from Paper 4106 
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TABLE 13: INCREASE IN DARK LEVEL OF Ca2+ AND CGMP ACCORDING TO NUMERICAL SIMU-
LATION OF A MOUSE ROD OUTER SEGMENT COMPARED TO A WT CASE. 
 GCAP1WT/E111V 
 
GCAP1E111V/E111V 
 
3xGCAP1WT / 
GCAP1E111V 
+GCAP2 
3xGCAP1WT / 
GCAP1E111V 
-GCAP2 
X-fold 
[Ca2+]free 
3.1 12.5 1.4 3.0 
X-fold 
[cGMP] 
1.4 2.0 1.1 1.4 
Table and legend are an adaptation from Paper 4106, for further elucidation see Methods of 
Paper 4106. 
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Conclusions 
E111V GCAP1 point mutation has been found in an Italian family where three 
members (father and two daughters) are affected by CORD. The biochemical and 
biophysical analysis suggested that the mutation doesn’t affect the protein structure 
or the oligomeric state, even if E111V GCAP1 shows a higher sensitivity to Mg2+. 
This leads to an increased thermal stability and a serious propensity to form large 
aggregates at physiological temperature not mediated by changes on surface hydro-
phobicity. As other GCAP1 mutants, E111V is characterized by a decreased affin-
ity for Ca2+ that find explanation in the replacement of the bidentate residue in EF3 
with a hydrophobic Val residue, thus losing two out of seven oxygen residues re-
quired for Ca2+ coordination. Molecular simulations performed by Dr. Valerio Ma-
rino pointed out a more rigid structure of Mg2+-E111V that explains the higher ther-
mostability but also highlights a structural distortion of EF3 loop. The crucial dif-
ference between WT and E111V is the total loss of GC regulation, leading to a 
constitutive active enzyme. This triggers the increase of the free Ca2+ and cGMP 
concentrations in the outer segment. These can diffuse through the inner segment 
mediating cellular death mechanisms causing the disease phenotype. Since CORD 
are autosomal dominant diseases, in vitro and in silico experiments were performed 
in order to investigate the effect of GCAPs extra delivery. Surprisingly, GCAP2 
seems to be incapable in GC1 regulation in human (evidence obtained also in others 
independent laboratories), even if it actively participates to Ca2+-relay in mouse and 
bovine. Thus, the extra delivery of 3-fold WT GCAP1 was investigated resulting 
in an amelioration of the IC50 values. Unfortunately, it is not enough to totally buffer 
the presence of E111V. Our hypothesis is that, even if GCAP1 has been demon-
strated to be a dimer, GC1 is regulated by monomeric GCAP1 so, probably, the 
combination of high amounts of protein during the assay and different equilibria 
between WT and E111V GCAP1, decrease the concentration of monomeric 
GCAP1 available for GC1 regulation. Moreover, system biology simulation under-
lines the pivotal role played by GCAP2 in shaping WT-like photoresponses in a 
heterozygous context. Thus, the Ca2+ relay mechanism seems to be species-depend-
ent, implying the presence of alterative compensatory effects in human capable to 
exert the same role played by GCAP2 in mouse and bovine.  
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Work in progress: study of point mutations on residues di-
rectly involved in Ca2+ coordination  
As mentioned in the introduction, 22 point mutations have been found in GUCA1A 
gene, some of them affecting residues that actively participate in Ca2+ coordination 
(i.e. E111V), others located in the surrounding areas. Sometimes, more than one 
substitution on the same amino acid is possible, for instance Ile143 was found mu-
tated in Thr and Asn (I143T/N)61. The aim of this manuscript still under prepara-
tion, is to focus the attention on residues directly involved in Ca2+ coordination 
namely D100G, E155A and E155G, in order to identify distinctive features that 
may improve the knowledge on the molecular basis of the disease and, combined 
with bioinformatic tools, predict the effects of different mutations on the same res-
idue. For these reasons an extensive analysis is ongoing, involving Asp100Gly 
(D100G), located in EF3, and the double mutation on Glu155, bidentate residue of 
EF4, into Ala or Gly (E155A/G) (Figure 38). These mutants have been already 
partially described with specific focus on genic validation, clinical evidences and 
some experimental data (mostly fluorescence spectroscopy experiments). A com-
prehensive biochemical and biophysical characterization is still missing.  
 
 
 
 
 
 
 
 
Figure 38: GCAP1 Ca2+ bound tridimensional model. Myristoyl-moiety was colored in deep pur-
ple, EF1, EF2, EF3 and EF4 are colored in green, yellow, orange and cyan respectively. Red sticks 
represent residues D100 and E155. 
 
 
 
 
 
 
 
Figure 38: GCAP1 Ca2+-bound tridi en-
sional m d l. 
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State of art 
D100G GCAP1 was found in three family members afflicted by symptoms like 
nystagmus, intraretinal pigment migration, loss of RPE and macular atrophy with a 
childhood onset (first decade) that led to CORD diagnosis57. E155G point mutation 
was found during an extensive genetic study where 67 individuals were involved, 
33 of those were found affected by CORD63. The phenotype consisted in decreased 
visual acuity with early onset (8-24 years old with a mean of 16 years) and central 
macular lesion with pigmentary changes. Some biochemical analyses were per-
formed including fluorescence titration and enzymatic assay for the determination 
of the EC50 and IC50 values. The authors concluded that the structural properties of 
the mutant were preserved, and, even if EC50 value was similar to WT GCAP1, the 
IC50 was shifted to higher values (  ̴1 µM)63. Finally, E155A was found in one of 
130 unrelated Chinese probands, and its analysis was extended to four generations. 
Nine people were found afflicted by CORD, having symptoms like poor vision, 
photophobia, myopia, defective color perception and showing signs as temporal 
disc pallor, attenuated retinal arterioles, macular atrophy, or pigmentary anomaly 
in the central macula64. 
 
Evaluation of hydrophobicity and aggregation propensity 
To test whether the replacement of the negatively charged side chain of Asp and 
Glu residues with a small (Gly) or hydrophobic (Ala) side chain led changes in the 
hydrophobicity, ANS fluorescence was used (Figure 39). As already seen for 
E111V, all the mutants were more hydrophobic when in the absence of ions, show-
ing a 34-35 nm blue shift (Table 14). The addition of 1 mM Mg2+ (blue solid lines) 
caused in D100G effects similar to those in WT GCAP1, considering both red-shift 
(7 nm upon Mg2+ addition and 1-2 nm upon Ca2+ addition) and variation in fluores-
cence emission. Interestingly, Mg2+ exerts different effects on E155A and E155G 
(Figure 39C-D). In fact, while E155G shows a more pronounced Δint with respect 
to WT GCAP1 upon Mg2+ addition (0.54 vs. 0.73 respectively), Mg2+-bound 
E155A shows a spectrum located in between apo- and Ca2+-bound suggesting its 
higher hydrophobic surface, despite the 4-nm red shift. The addition of Ca2+ exerts 
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Figure 39: ANS fluorescence results. 
 
small changes in E155G hydrophobic properties, while it allows E155A to com-
plete structural transition. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 39: ANS florescence results. ANS fluorescence spectra of WT (A), D100G (B), E155G (C) 
and E155A (D) collected at 37°C incubating 2 µM GCAPs and 30 µM ANS in the presence of 250 
µM EDTA (black lines) and after sequential additions of 1 mM Mg2+ (blue lines) and 50 µM Ca2+ 
(red lines). Spectra of sole ANS in represented by dotted lines. Fluorescence intensity is reported as 
normalized with respect to the maximum value.  
 
 
TABLE 14: ANS FLUORESCENCE. 
 λmax Δλ* I/IMax 
WT - Apo 
+ Mg2+  
+ Ca2+ 
487 
494 
496 
34 
27 
25 
1 
0.73 
0.69 
D100G - Apo 
+ Mg2+  
+ Ca2+ 
487 
494 
493 
34 
27 
28 
1 
0.68 
0.66 
E155G - Apo 
+ Mg2+  
+ Ca2+ 
486 
502 
500 
35 
19 
21 
1 
0.54 
0.50 
E155A - Apo 
+ Mg2+  
+ Ca2+ 
486 
490 
491 
34 
30 
29 
1 
0.77 
0.65 
*With respect to ANS alone. 
 
Looking for correlations between the hydrophobicity properties and the protein sta-
bility, DLS measurements were performed following the MCR variation over time 
at physiological temperature. Samples were incubated in the presence or absence 
of ions, Anotop filtered (0.02 µm) before each measurement and MCR was moni-
tored for   ̴3.5 h (Figure 40). All the mutants showed fluctuations of MCR when in 
the presence of 500 µM EGTA and a tendency to form large aggregates following 
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a slow process, more pronounced for E155G (Figure 40B). The addition of 1 mM 
Mg2+ stabilized all mutants in the time frame analyzed, exerting its maximum effect 
for E155G (Figure 40B), contrarily to D100G that, even if stable, showed contin-
uous fluctuations. The same happened adding saturating Ca2+, except for E155G 
that immediately showed higher MCR values. It has to be clarified whether the 
addiction of Ca2+ trigger an immediate aggregation or if something wrong happened 
with the sample.  
 
 
 
 
 
 
 
 
Figure 40: DLS measurement for the analysis of aggregation propensity. DLS data were collected 
incubating   ̴30 µM GCAPs in the presence of 500 µM EGTA (green), 500 µM EGTA + 1 mM Mg2+ 
(cyan) and 1 mM Mg2+ + 1 mM Ca2+ (red) using 20 mM TRIS pH 7.5, 150 mM KCl, 1 mM DTT as 
working buffer. Each data set represent independent sample fleshly prepared, Anotop filtered and 
equilibrated at 37°C for 2 min before data collection. Plots represents the variation of mean count 
rate (MCR) over time ( ̴ 3.5 h). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 40: DLS measurements for the analysis of the aggregation propensity. 
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Oligomeric state investigation 
The oligomeric state investigation, performed as previously described, suggested 
no compromised capability in dimer formation. All the GCAP1 variants analyzed 
elute from the column at 14.23-14.35 mL, giving MWs between 45-47 kDa, all 
compatible with dimeric organization (Figure 41). The colloidal properties of the 
eluted peaks were also assessed at 25°C by DLS (Table 15) where small differences 
were detected comparing the presence or not of Ca2+. In general, all the mutants 
were slightly bigger in the presence of Ca2+ respect to Mg2+. The only exception is 
represented by D100G (Figure 41A, Table 15), which didn’t show any changes in 
both the conditions tested.  
Figure 41: Analytical gel filtration. Oligomeric state investigation of D100G (A), E155G (B) and 
E155A (C) in the presence of 500 µM EGTA + 1 mM Mg2+ (black lines) and in the copresence of 1 
mM Mg2+ + 500 µM Ca2+. Measurements were performed at room temperature. Insets represent 
the peaks zoom between 12-17 mL.  
 
 
TABLE 15: OLIGOMERIC STATE INVESTIGATION. 
  
VE
a 
(mL) 
MWSEC 
(kDa) 
d (nm) ± std devb 
[#meas.]c 
PdId 
WT 
Mg2+ 14.32 45.9 
6.3±0.4 
[27] 
0.342±0.1 
Mg2+ Ca2+ 13.26 47.8 
6.9±0.6 
[19] 
0.306±0.1 
D100G 
Mg2+ 14.32 45.9 
6.9±0.7 
[29] 
0.434±0.1 
Mg2+ Ca2+ 14.33 45.6 
7.1±0.7 
[9] 
0.272±0.1 
E155G 
Mg2+ 14.35 45 
6.4±0.5 
[52] 
0.381±0.1 
Mg2+ Ca2+ 14.33 45.6 
7.2±0.8 
[23] 
0.217±0.1 
E155A 
Mg2+ 14.35 45.9 
6.2±0.5 
[71] 
0.384±0.1 
Mg2+ Ca2+ 14.23 47.7 ND e ND e 
aVE: elution volume; bdiameter ± standard deviation, c number of measurements, 
dpolydispersion index, e non determined yet 
 
 
 
Figure 41: Analytical gel filtration. 
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Structural characterization  
The structural characterization of GCAP1 variants was performed by monitoring 
variations in secondary and tertiary structure upon addition of ions. Spectra col-
lected in the near UV region (Figure 42A-D) highlight a major response to Mg2+ 
by mutants where the bidentate residue was involved. In fact, comparing the spectra 
of apo-E155A and E155G (Figure 42C-D, black likes) with Mg2+-E155A and 
E155G (Figure 42C-D, blue lines) a significative transition to more positive values 
was observed (similar to E111V, Figure 34), not seen for WT and D100G GCAP1. 
Moreover, D100G had a tertiary structure very similar to E111V, characterized by 
a totally positive spectrum when in the absence of ions or in the presence of sole 
Mg2+ (Figure 42B). The more intense structure variation took place when saturat-
ing Ca2+ was added (red lines): while a slight loss of structure was detected for 
D100G and E155G in the Phe and Tyr bands (less refined respect to the WT), a 
totally negative Tyr band was seen for E155A (Figure 42C). This evidence, to-
gether with small differences in Phe band, suggest that this mutation may lead a 
structural rearrangement of all the other hydrophobic residues. Moreover, E155A 
appeared more dichroic respect the other GCAP1 variants, even if the working con-
ditions were the same. These changes in the near UV region didn’t appear such 
intense in the far UV. Far UV spectra (Figure 42E-H) confirmed that none muta-
tion led to protein unfolding, since all mutants displayed the typical spectrum char-
acterized by the two minima (208-222 nm), however small variations are notewor-
thy. In general, none of the mutants showed an intensity variation trend as WT 
GCAP1, whose progressively increased ellipticity upon cations coordination was 
explained by a more compact structure. E155A and D100G showed far UV spectra 
overlapped in all the tested conditions, suggesting no changes in protein compact-
ness; the only exception was E155G, whose ellipticity decreased upon Mg2+ coor-
dination, indicating a more opened conformation, even if the θ222/θ208 remained 
constant (apo = 0.88, Mg2+ = 0.89) (Table 16). Considering the total structural re-
arrangement in the transition from apo to Ca2+ bound (Δθ/θ), all the mutants ap-
peared less compact with respect to the WT, as demonstrated by low Δθ/θ values, 
(0.2% for E155G and D100G and 1% for E155A, against 7.7% of WT GCAP1). 
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Thermal denaturation profiles showed that all the mutants were generally less stable 
in the Ca2+ bound form (Figure 42I-L). In fact, while WT GCAP1 didn’t show 
transition from the folded to unfolded structure (making the data fitting impossible, 
Figure 42I), all the mutants were characterized by an almost complete transition, 
even if the final structure was never associated with the total folding loss (residual 
signal was present at the high temperature). Interesting is the effects exerted by 
magnesium: Mg2+-D100G GCAP1 was the only mutant characterized by a higher 
thermal stability compared to WT GCAP1 ( ̴ 3°C more stable) while, concerning 
E155A and E155G, it is clear how the replacement with Gly or Ala exerts different 
effects. In fact, E155G appeared ̴ 5°C less stable with respect to E155A GCAP1, 
which showed a Tm very similar to WT GCAP1 (Table 16). Apparently, the sub-
stitution of bidentate residues (E111, E155) with hydrophobic amino acids (i.e. Val, 
Ala) in EF hands that do not directly coordinate Mg2+ (bound in EF2), may generate 
a more packed structure of those EF hand, making the protein more stable at high 
temperature. The fact that this effect was seen only in the presence of Mg2+ might 
suggest this ion as an allosteric stabilizer.  
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Figure 42: Structural characterization by circular dichroism. 
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TABLE 16: SHAPE OVERVIEW. 
GCAP1 θ222/θ208 Δθ/θ (%)* Tm (°C) 
WT – Apo 
+ Mg2+ 
+ Ca2+ 
0.90 
0.90 
0.95 
7.7 
49.8 
50.4 
- 
D100G – Apo 
+ Mg2+ 
+ Ca2+ 
0.91 
0.92 
0.90 
0.2 
48.4 
53.1 
 
E155G – Apo 
+ Mg2+ 
+ Ca2+ 
0.88 
0.89 
0.90 
0.2 
45.4 
45.7 
74.9 
E155A – Apo 
+ Mg2+ 
+ Ca2+ 
0.92 
0.89 
0.90 
1 
47.1 
50.4 
 
*calculates as (θ222Ca2+- θ222EGTA)/ θ222EGTA 
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Calcium binding evaluation 
The affinity for Ca2+ was studied by using the two techniques previously men-
tioned. Gel shift experiments gave the first evidence of decreased Ca2+ affinity, 
since all the mutants showed lower electrophoretic mobility in the presence of Ca2+, 
compared to the WT (Figure 44A). This was confirmed and quantified by chelator 
assay (Figure 44B). A feature shared by all the mutants was the loss of one binding 
site, since the log k values measured by CaLigator were too far from the one of Br2-
BAPTA to be considered reliable (see methods). Thus, the comparison between 
GCAP1 variants could be done only considering the high affinity site (nM). As 
expected, all the mutants showed lower affinity for Ca2+, especially D100G that had 
a 10-fold reduction in Kd
app (0.9 µM) respect to WT GCAP1 (84 nM); this is not 
surprising considering that EF3 is the highest affinity EF hand motif. Also the re-
placement of E155 had a deleterious effect in calcium sensing, less pronounced for 
E155G (Kd
app = 117 nM, 1.4-fold) than for E155A (453 nM, 5.4-fold) suggesting 
that the presence of hydrophobic Ala may compromise the loop conformation, de-
stabilizing the geometry required for Ca2+ coordination (Figure 43).  
 
Figure 43: Cartoon representations of WT monomeric GCAP1. A) N-terminal and C-terminal are 
colored in grey; myristoyl group is colored in deep purple; EF1, EF2, EF3 and EF4 are colored in 
green, yellow, orange and cyan, respectively; Ca2+ ions are represented as red spheres. B) Zoom in 
the EF3 and EF4. Amino acids contibuting to Ca2+ coordination are represented as sticks and 
colored by element. D100 and E155 residues are marked in red. 
 
 
 
 
Figure 43: Cartoon representations of WT monomeric GCAP1.  
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Enzymatic activity 
Finally, the capability of GCAP1 variants to regulate the cyclase activity was as-
sayed in on-off GC assay experiments (Figure 44C). In activating conditions, the 
mutants showed profile very similar to WT GCAP1, except for E155G that seems 
50% more active with the respect of WT. However, the real deleterious feature is 
the compromised capability in GC1 shut-off. Even if these are still preliminary re-
sults (EC50 and IC50 measurements are in progress), apparently none of these mu-
tants showed a WT-like profile, especially D100G which is characterized by the 
presence of the same amount of synthesized cGMP in both the conditions tested. In 
fact, contrarily to E111V that showed a partial regulation, D100G is apparently 
uncapable to regulate GC1 in the tested range.  
Figure 44: mutations effects on Ca2+ binding capability and enzymatic regulation. A) Gel shift of 
20 µM GCAP1 variants incubated in the presence of 2 mM EDTA, 1 mM EGTA + 1.1 mM Mg2+ or 
1 mM Mg2+ + 1 mM Ca2+. After 5 min incubation at room temperature, samples were boiled, loaded 
on 15% polyacrylamide gel. After 40-45 min at 200V gel was Coomassie blue stained. B) Repre-
sentative chelator assay results. Date were normalized as follow: ynorm = (A263 – Amin)/(Amax-Amin) 
and xnorm = [Ca2+]/([Q]+3*[GCAP1]), where Q is the Br2-BAPTA concentration. C) The GC1 ac-
tivity was assayed in the presence of different GCAP1 mutants at low (< 19 nM) and high (  ̴30 µM) 
Ca2+ concentrations.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 44: Mutations effect on Ca2+ binding capability and enzymatic regulation. 
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Conclusions (partial) 
Many are the pathogenic mutations known in GUCA1A gene and most of them were 
fully characterized by a clinical and biochemical point of view. The aim of this still-
running project is to identify specific features among mutants that affect specifically 
Ca2+ binding residues; for this reason, D100G, E155A and E155G were taken in 
consideration. The results collected so far suggest that none of this point mutations 
led to alteration of the oligomeric state, since all were dimeric under the tested con-
ditions. Moreover, even if small changes in the hydrophobic surface were detected, 
all of them followed a WT-like trend and no one showed aggregation propensity as 
E111V, except for E155A that seems to aggregate upon the addition of saturating 
Ca2+ (to confirm). As expected, a reduced capability in Ca2+ sensing was detected 
for all mutants, most severe for D100G. This found demonstrations in the compro-
mised capability in GC1 shut-off, at least till 30 µM (the calcium concentration in 
the K2CaEGTA buffer). Further enzymatic experiments are required, as the evalu-
ation of IC50, EC50 and catalytic efficiency, as previously done by Huang J. et al
40. 
The more interesting finding is about the variations in tertiary structure upon Ca2+ 
addition showed by E155A.  Looking the structure of the homology model of hu-
man WT GCAP1 (Figure 45) three residues were identified as possibly disturbed 
by the mutation: I143, L151, V145 (all found mutated in COD/CORD). Performing 
a mutagenesis in silico and measuring the variation of the distances between the Cβ-
Ala and the side chains of these residues, the Cγ1-I143, Cγ2-V145 and Cδ-L151 
were found closer to each other ( ̴ 5Å, Figure 45A)), thus leading the F140 and 
L151 approaching (Figure 45B), that on one hand may distort the EF4 loop con-
formation, on the other hand may explained the enhanced thermal stability (com-
pared to E155G). Since it has already demonstrated the presence of an allosteric 
communication between the myristoyl group (fundamental for the GC regulation) 
and EF443; 45, mutations in EF4 might have crucial effects in the transmission of the 
information through the protein structure. This hypothesis needs to be further con-
firmed by MD simulations. 
 
 
 121 
 
Figure 45: Effect of E155A mutation in amino acids distances. After the in silico mutagenesis the 
measurements of the distances between I143, V145 and L151 (A) and between F140 and L151 (B) 
were performed using PyMOL.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 45: Effect of E155A mutation in amino acids distances. 
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Figure 46: Structure of human CaM in the 
Ca2+-bound form. 
 
Inorganic NPs as specific carriers for Ca2+ sensor protein in 
nanomedicine 
Introduction 
NPs are defined as small particles characterized by a size lower than 100 nm and a 
high surface-to-volume ratio. They can be easily produced through a hydrothermal 
technique which consists in putting together the different elements at defined stoi-
chiometric ratio (see methods) and put the solution in an autoclave at high temper-
ature (190°C): the longer the incubation the bigger the resulting NPs. For this study 
CaF2 NPs were used since their specific binding with Ca
2+ sensor proteins as Rec73, 
GCAP175 and CaM74 has been previously demonstrated. The special feature of 
these NPs is the strong upconversion triggered by the presence of a coating com-
posed by a mix of rare earth as erbium (Er3+) and ytterbium (Yb3+) meaning that, 
when irradiated with infrared laser (980 nm), they emit in the visible range wave-
length, which makes them traceable using non-detrimental light source. 
CaM is a ubiquitous prototypical Ca2+ sensor protein, highly conserved in eukary-
otic cells, formed by four functional EF-hands (EF1-4) organized in two domains 
namely N-terminal and C-terminal lobe, linked by a central flexible α-helix. In the 
apo state the protein is mostly globular but upon Ca2+ coordination a conformational 
change takes place resulting in a more opened structure (Figure 46). CaM is in-
volved in many processes including cells proliferation, apoptosis, ions transport, 
cell motility, cytoskeleton remodeling, metabolic homeostasis and protein fold-
ing107; 108. Moreover, in the last years many point mutations on CaM encoding genes 
(CALM1, CALM2 and CALM3) have been associated with arrhythmogenic diseases, 
such as long QT syndrome (LQTS) and catecholaminergic polymorphic ventricular 
tachycardia (CPVT)109. In this study (Paper 576) we optimized a protocol for the 
characterization of the interactions that occur between CaF2 NPs and human CaM 
using a combination of biochemical and biophysical techniques.  
 
 
 
Figure 46: Structure of human CaM in the Ca2+ bound form. EF1, EF2, EF3 and EF4 are 
colored in orange, yellow, cyan and blue respectively; the central linker is colored in green and 
Ca2+ ions are represented as red spheres. PDB entry 1CLL. 
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CaM had the same structure when in the presence of sole Ca2+ or 
CaF2 NPs.  
Circular dichroism analyses were performed monitoring CaM secondary and ter-
tiary structures upon Ca2+ addition or in the presence of sole NPs. Figure 47 shows 
that in all the tested conditions CaM was correctly folded, showing the typical spec-
tra of all-α-helix proteins. In the presence of saturating Ca2+ (Figure 47, red line) 
or sole NPs (Figure 47, blue line) CaM shows the same secondary structure, char-
acterized by equal values of θ222/θ208 ratio (Table 17), even if holo CaM is slightly 
more compact as suggested by the more negative ellipticity. Interestingly, the addi-
tion of saturating EGTA resulted in two spectra totally overlapped (Figure 47A, 
black and green lines), suggesting that the detachment of CaM from the NP’s sur-
face is perfectly reversible and that its structural properties were not compromised 
(Table 17). Thermal denaturation profiles further confirmed this finding, since 
holo-CaM and CaM+NPs showed almost identical profiles where the transition 
from folded to unfolded was never reached, contrary to what happened to apo-CaM.  
The behavior showed by CaM in the far UV was confirmed in the near UV range, 
even if the only 8 Phe and 2 Tyr residues resulted in less intense structural variations 
(Figure 47B). Despite this, holo CaM and CaM+NP had very similar spectra, but 
significantly different from apo-CaM.  
Figure 47: Circular dichroism characterization of CaF2 NPs and CaM. A-B) Far- and near UV 
spectra (of ~12 µM CaM or 30 µM, respectively) in the presence of equal amounts (400 µM) of 
saturating EGTA (black) or Ca2+ (red), and CaM previously incubated with 5.7 mg/mL NPs (blue). 
c) Thermal denaturation profiles of ~12 µM CaM previously incubated with 1.7 mg/mL NPs (blue) 
and in the presence of saturating (120 µM) EGTA (black) and Ca2+ (red). θ222 has been normalized 
to account for different starting values (θ222, normalized= θ222/ θ222 at 20°C). Figure and legend are an 
adaptation from Paper 576. 
 
 
 
 
 
Figure 47: Circular dichroism characterization of CaF2 NPs and CaM. 
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To further investigate these structural differences, limited proteolysis experiments 
were performed. Figure 48A shows how Ca2+ is a structure stabilizer, as demon-
strated by the persistence of undigested protein after 90 min incubation with trypsin. 
Differently, in the presence of EGTA the protein is almost totally digested after 30 
min. In order to assess the effect of the NPs on the proteolysis pattern, the experi-
ment was repeated incubating CaM with saturating NPs (1:139 NPs:protein ratio) 
for 30 minutes. Figure 48B shows that holo-CaM and CaM+NPs share the same 
proteolysis pattern (Figure 48B, downwards arrows) and that the addition of EGTA 
results in the same trypsin susceptibility, regardless whether NPs were present or 
not (Figure 48B, upwards arrows). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 48: Limited proteolysis pattern of CaM in the presence and in the absence of NPs. A) 
Proteolysis reactions were performed at 25°C by 30-120 min incubation with saturating (2 mM) 
EGTA or Ca2+, using a CaM:TPCK-trypsin ratio equal to 1:60. Lane M refers to the protein marker. 
B) Proteolysis experiments in the presence of NPs were performed by 30 min incubation with satu-
rating (240 µM) EGTA or Ca2+, using a CaM:TPCK-trypsin ratio equal to 1:60.  Lanes 3 and 5 
refer to the digested apo (lane 3) and Ca2+-bound (lane 5) CaM. Lanes 8 and 10 refer to the digested 
CaM previously incubated with NPs (lane 8) and after the addition of EGTA (lane 10). Undigested 
CaM was loaded in the same conditions in lanes 2, 4, 7 and 9. The similar effect exerted by either 
free Ca2+ or NPs and excess EGTA on the proteolytic patterns is highlighted by downwards and 
upwards arrows, respectively. Figure and legend are from Paper 576. 
 
TABLE 17: FARUV CD DATA: SPECTRAL SHAPES OF CAM 
IN THE PRESENCE AND ABSENCE OF NPS. 
 
θ222/θ208 
Δθ/θ 
(%) 
CaM Ca2+ 1.00 
21.7 
CaM EGTA 0.95 
CaM + NPs 1.00 
17.6% 
CaM + NPs+ EGTA 0.95 
Adapted from Paper 576. 
 
 
 
Figure 48: Limited proteolysis pattern of CaM in the presence and in he 
absence of NPs. 
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Affinity and kinetic investigations highlighted physiological rele-
vance 
To directly study the binding of CaM to CaF2 NPs, Resonance Energy Transfer 
(RET) was used. Upconverting NPs emit light at a wavelength that can be absorbed 
by CaM previously labeled with Alexa Fluor 532 fluorophore (see methods). Titra-
tion experiments (Figure 49) showed a RET phenomenon characterized by concen-
tration dependency, with decreased emission at 540 nm and 544 nm but conserved 
spectral properties in 650-670 range (Figure 49A). Fitting the fluorescence varia-
tion (ΔF) as function of [CaM] a KD = 2.5 µM was calculated (Figure 49C-D), in 
line with previous findings obtained by CaM from A. Thaliana74.  
 
Figure 49: RET analysis of CaM-NP interac-
tion A) Upconversion spectra of CaF2 NPs in 
CaM titration experiments. The resonance en-
ergy transfer (RET) phenomenon is evident by 
a strong decrease of the Er3+ emission in the 
520-560 nm optical range. Band assignment: 
(i) 2H1/2→4I15/2; (ii) 4S3/2→4I15/2; (iii) 
4F9/2→4I15/2. B-D) Example of titration experi-
ments of Alexa Fluor 532-conjugated CaM 
with a 0.5 mg/mL NPs dispersion. B) Zoom of 
the spectral area showing the RET phenome-
non. Notice the change in NPs emission at 540 
(C) and 544nm (D). Figure and legend are 
from Paper 576. 
 
 
 
 
 
 
 
 
 
 
To better investigate the kinetics of this mechanism, SPR was used. First, NPs were 
incubated with CaM to form a protein-corona (0.1 mg/mL NPs + 1.6 µM CaM) and 
the so-complexed NPs were directly injected on the chip resulting in their incapa-
bility to interact with the immobilized protein (Figure 50A, grey line), as previ-
ously seen with GCAP75. Then, several concentrations of bare NPs, ranging from 
0.1 to 0.5 mg/mL, were injected; Figure 50A (black line) shows an example. The 
 
 
Figure 49: RET-analysis of CaM-NP inter-
action. 
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sensorgram obtained can be divided in three parts, which give us different infor-
mation: i) the binding process does not follow a Langmuir absorption model, as no 
dependency on NPs concentration was detected (data not shown); ii) at least 400 
seconds are needed before the real dissociation starts, explained by a combination 
of phenomena like protein structural rearrangements and NPs diffusion on the dex-
tran matrix. Finally, iii) when the dissociation starts, it can be described by a single 
exponential function resulting in koff = (3.5 ± 0.4) x 10-3 s-1, a fairly fast dissociation 
that is completed in 2000 sec (Figure 50B).  
 
Figure 50 SPR analysis of CaM-NP interaction. 
A) Example of sensorgram obtained by flowing 
NPs (0.1mg/mL) on a flow cell where 2400 RU of 
CaM were previously immobilized via amine cou-
pling. Injections were performed for 600 s (flow 
rate 10 µL/min) and dissociation was followed for 
1800 s. The red curve refers to data fitting using 
a single exponential function. The dashed grey 
line refers to injection of the same amount of NPs 
previously incubated with 1.6 µM CaM. B) Exam-
ple of dissociation curves obtained by SPR over-
lapped to the fitting curves according to a single 
exponential in the 0.1-0.5 mg/mL NP range. Fig-
ure and legend are from Paper 576. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 50: SPR analysis of CaM-NP in-
teraction. 
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Conclusions 
The data reported here further emphasize the suitability of CaF2 NPs as nanodevices 
for the delivery of Ca2+ sensor proteins such as CaM. The investigation performed 
by CD and limited proteolysis suggests that the presence of CaF2 NPs or Ca
2+ as 
free ion exert on the CaM structure the same effect, as shown by almost identical 
far UV and near UV spectra together with proteolysis patterns. Our results also 
show the reversibility of this process, fundamental for nanodevices, since the addi-
tion of saturating EGTA in samples where Ca2+ or NPs were present results in CD 
spectra and digestion patterns very similar to those of the apo-CaM. Moreover, PRE 
experiments performed by Dr. Helge Meyer (University of Oldenburg, Paper 576), 
shed light on the detailed mechanism through which CaM recognizes the NP’s sur-
face. This occurs via two steps: after the first recognition of the NP’s surface by the 
CaM N-terminal, CaM can i) dissociate from the NP or ii) be converted to a more 
stable conformation that involves the two EF-hands in the N-terminal lobe (Figure 
51). Our hypothesis is that the presence of saturating EGTA may hide the Ca2+ ions 
on the NP surface, thus preventing these interactions and leaving CaM molecules 
free in solution. Finally, RET and SPR were used in order to better investigate the 
affinity and the kinetics that trigger the CaM – NPs interaction. The results obtained 
allowed us to conclude that the affinity for the CaM – NPs complex formation (KD 
= 2.5 µM) together with the fast dissociation (complete in 2000 seconds), may sug-
gest that CaF2 NPs are nanodevices suitable for nanomedicine applications, such as 
protein delivery for the treatment of complex diseases.  
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Figure 51: Schematic representation of NP-CaM interac-
tion. 
 
 
 
 
 
 
 
 
 
 
Figure 51: Schematic representation of NP-CaM interactions. Left side: when apo CaM is incu-
bated with NPs, two different equilibria establish. CSP experiments suggest that the first contact 
between CaM and NP is mediated by the N-terminal domain. At this point, CaM can either return 
to the apo state (1) through a rapid dissociation by the NP surface or be converted into a more 
stable NP-bound conformation (holo), in a linker-mediated process (2), as suggested by PRE ex-
periments (Paper 5). Right side: when an excess of EGTA (black blocks) is added, the chelator binds 
Ca2+ ions on the NP surface, thus restoring the apo-CaM conformation (3), as suggested by near- 
and far UV spectra. Blue thick lines represent the areas mostly involved in CaM/NPs interaction. 
Figure and legend are an adaptation from Paper 576. 
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Introduction to papers 
Paper 118: Preferential binding of Mg2+ over Ca2+ to CIB2 triggers an 
allosteric switch impaired in Usher Syndrome Type 1J. 
Rosario Vallone, Giuditta Dal Cortivo*, Mariapina D’Onofrio and Daniele 
Dell’Orco 
Front. Mol. Neurosci. (2018), 11:274, doi: 10.3389/fnmol.2018.00274.   
*co-first author 
 
Calcium- and integrin binding protein 2 is a small protein whose properties and 
function are still under investigation. In the last years, many studies described CIB2 
as involved in Ca2+ homeostasis in hair cells in the inner ear since four point muta-
tion have been linked to deafness. Particularly, in 2012 E64D point mutation has 
been related to Usher syndrome type 1J, a rare autosomal recessive disorder char-
acterized by the co-presence of deafness and blindness (due to retinitis pigmentosa). 
Since the lack of information about CIB2, we focused our attention in its charac-
terization combining low- and high-resolution techniques, namely circular dichro-
ism, size exclusion chromatography and nuclear magnetic resonance in order to 
elucidate its role in physiological and pathological conditions. Our findings sug-
gested a dimeric organization of WT CIB2, and lower affinity for Ca2+ (Kd
app = 0.5 
mM) respect to Mg2+ (Kd
app = 290 µM) making CIB2 preferentially bound to Mg2+ 
and uncapable to work as a Ca2+ sensor under physiological conditions. Moreover, 
by NMR, a long-range allosteric communication between E64 (pseudo-EF1) and 
N121 (EF3) was identified as crucial for the correct folding upon addition of cati-
ons, since its conservative mutation into Asp lead the impaired capability of CIB2 
to switch to its Mg2+-bound form. The interaction with its α7B integrin target, hy-
pothesized to occur with the portion close to the membrane, was investigated by 
fluorescence spectroscopy resulting in a stoichiometric ratio of 2:1 CIB2:α7B_M 
characterized by a low affinity. Since both WT and E64D CIB2 were found able to 
interact with α7B_M showing approximately the same affinity, we concluded that 
the pathological phenotype is not associated with a compromised target recognition.  
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Paper 222: Oligomeric state, hydrodynamic properties and target 
recognition of human calcium and integrin binding protein 2 (CIB2) 
Giuditta Dal Cortivo, Valerio Marino, Claudio Iacobucci, Rosario Vallone, Chri-
stian Arlt, Anne Rehkamp, Andrea Sinz and Daniele Dell’Orco 
Scientific Reports (2019), 9:15058, doi: 10.1038/s41598-019-51573-3 
 
In paper 2 a deeper characterization of WT CIB2 was performed since, looking for 
the dimerization interface, lines of evidences of monomeric organization were 
found. In fact, combining chemical cross-linking and analytic gel filtration we 
found that cross-linked CIB2 (monomeric) elutes with an apparent molecular mass 
of a dimer. Performing in silico analysis using HydroPro software it has been 
pointed out that CIB2 has a large hydrophobic surface exposed to the solvent that 
lead interactions with the column’s resin resulting in a misleading interpretation. 
Further investigations were performed to better characterize the interaction with the 
integrin peptide, in order to shed light on binding specificity and kinetics. By SPR 
analysis we found that the specific binding with the integrin portion proximal to the 
membrane occurs with a low affinity and consists in the formation of a 1:1 complex 
that may trigger the binding to another CIB2 molecule. The kinetics of recognition 
is influenced by cations since the presence of physiological Mg2+ favor the binding 
process.  
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Paper 359: A novel p.(Glu111Val)  missense mutation in GUCA1A 
associated with cone-rod dystrophy leads to impaired calcium sensing 
and perturbed second messenger homeostasis in photoreceptors. 
Valerio Marino, Giuditta Dal Cortivo*, Elisa Oppici, Paolo Enrico Maltesi, Fabiana 
D’Esposito, Elena Manara, Lucia Ziccardi, Benedetto Falsini, Adriano Magli, Mat-
teo Bertelli and Daniele Dell’Orco 
Human Molecular Genetics (2018), Vol. 27, No. 24, doi: 10.1093/hmg/ddy311 
*co-first author 
 
Guanylate cyclase activating protein 1 (GCAP1) is the molecular regulator of reti-
nal guanylate cyclase (GC1), an enzyme responsible for restoring the dark state in 
photoreceptors upon photons absorption. A novel point mutation was found in 
CORD-patients consisting in the replacement of Glu111 into Val (E111V), the bi-
dentate residue of the high-affinity EF3. The thorough biochemical characterization 
presented in this paper highlighted that the impaired Ca2+ affinity ( ̴ 80-fold higher 
Kd
app with respect to the WT) triggers the GC1 dysregulation. In fact, E111V loses 
the capability to switch from the activating (Mg2+-bound) to inhibiting (Ca2+-
bound) form over a physiological range of [Ca2+], thus leading to constitutively 
active enzyme (IC50 = 10 µM) even if the affinity for the enzyme is unchanged. 
Both WT and E111V GCAP1 form dimers independently on the presence of cati-
ons, even if a time-dependent aggregation was observed in E111V Mg2+-bound 
form. Molecular dynamics simulations suggested a more flexible EF3 loop with a 
distorted geometry and a more rigid backbone that explains the higher thermal sta-
bility.  
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Paper 4106: Normal GCAPs partially compensate for altered cGMP 
signaling in retinal dystrophies associated with mutations in 
GUCA1A. 
Daniele Dell’Orco and Giuditta Dal Cortivo 
Sci Re 9, 20105 (2019), doi: 10.1038/s41598-019-56606-5 
 
Missense point mutations in GUCA1A gene are associated with cone- and cone-rod 
dystrophies (COD, CORD), autosomal dominant diseases characterized by photo-
phobia, congenital nystagmus and progressive vision loss. From Paper 3 we found 
that WT and E111V GCAP1 have similar EC50 values for the target GC1. Consid-
ering that the autosomal dominant inheritance pattern implies the co-presence of 
50% WT and mutant GCAP1 and that GCAP2 is involved in phototransduction 
regulation by Ca2+ relay mechanism, we further investigate whether GCAP1 and 
GCAP2 can similarly regulate GC1 in the presence of E111V GCAP1 combining 
in vitro and in silico approaches. Surprisingly, GC assay experiments highlighted 
that human GCAP2 contribution in GC1 regulation is negligible, while the presence 
of WT GCAP1 only partially attenuates the presence of E111V GCAP1. Neverthe-
less, in silico simulations performed using a well-established model of phototrans-
duction in murine system resulted in a crucial role of GCAP2 in the attenuation of 
the phenotype due to the presence of E111V GCAP1. For these reasons we propose 
a species-dependent compensatory mechanism that may mitigate the mutant pres-
ence in human as GCAP2 does in mouse. 
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Paper 576: Luminescent and paramagnetic properties of nanoparti-
cles shed light on their interactions with proteins. 
Giuditta Dal Cortivo, Gabriel E. Wagner, Paolo Cortelletti, Krishna Mohan Pad-
manabha Das, Klaus Zangger, Adolfo Speghini, Daniele Dell’Orco and N. Helge 
Meyer 
Scientific Reports (2018), 8:3420, doi: 10.1038/c41598-018-21571-y 
 
Nanoparticles are considered a promising tool for the delivery of proteins for ther-
apeutic treatments. However, the dynamic of nanoparticles-protein interaction is 
protein-dependent and not totally understood. In paper 5 we propose a methodology 
for the characterization of the interaction between CaF2 nanoparticles and calmod-
ulin, a prototypical Ca2+ sensor protein highly conserved but found mutated in rare 
cardiac diseases such as catecholaminergic polymorphic ventricular tachycardia 
(CPVT) and long QT syndrome (LQTS). A combination of circular dichroism, lim-
ited proteolysis, nuclear magnetic resonance and resonance energy transfer were 
used. CD and limited proteolysis suggest that the CaM structural features are pre-
served, since its structure in the presence of Ca2+ is the same also in the presence of 
NPs. Thanks to nuclear magnetic resonance it has been pointed out that the nano-
particles-CaM interaction occurs in two phases consisting firstly in the formation 
of a transient complex (mediated by N-terminal lobe), that became more stable 
when the central linker is involved. Finally, the combination of resonance energy 
transfer and surface plasmon resonance experiments resulted in a fully reversible 
NP-CaM interaction characterized by an affinity compatible with nanomedicine ap-
plications.  
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DTT: 1,4-dithiothreitol 
DSBU: disuccinimidyl dibutyric urea 
EC50: [GCAP1] at which GC1 is half activated 
EDC: N-ethyl-N’(dimethylaminopropyl)carbodiimide 
ESI-MS: electrospray ionization mass spectrometry 
FC: flow cell 
G418: geneticin 
GC: guanylate cyclase 1 
GCAP: guanylate cyclase activating protein 1 
GFP / EGFP: green fluorescent protein / enhanced green fluorescent protein 
GRK: rhodopsin kinase 
hc: Hill coefficient 
HEK293: human embryonic kidney 293 
HIV: human immunodeficiency virus 
IB: inclusion bodies 
IC50: [Ca
2+] at which GC1 is half inhibited 
IMAC: immobilized metal affinity chromatography 
IPTG: Isopropyl β- d-1-thiogalactopyranoside 
LB: Luria Bertani 
LQTS: Long QT Syndrome 
MALDI-TOF: matrix-assisted laser desorption ionization time of flight 
MD: macular dystrophy 
MET: mechano-electrical transduction 
MW: molecular weight 
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NCKX: Na+/Ca2+ + K+ exchanger 
NCS: neuronal calcium sensor 
NDs: nanodevices 
NMR: nuclear magnetic resonance 
Ni-NTA: Nickel-Nitrilotriacetic acid  
NHS: H-hydroxysuccinimide 
NPs: nanoparticles 
OD: optical density 
PCR: polymerase chain reaction 
PDB: protein data bank 
PDE6: phosphodiesterase 
PEI: polyethylenimine 
Rec: recoverin 
PRE: paramagnetic relaxation enhancement 
RPC: reverse phase chromatography 
RET: resonance energy transfer 
ROS: rod outer segment 
SDS-PAGE: sodium-dodecyl-sulphate poly acrylamide gel electrophoresis 
s.e.m.: standard error of the mean 
SEC: size exclusion chromatography 
SPR: surface plasmon resonance 
TEV: tobacco etch virus protease 
TFA: trifluoroacetic acid 
Tm: melting temperature 
TMC1/2:  transmembrane channel-like  
USH1J: Usher syndrome type 1J 
WT: wild type 
XL-MS: cross-linking mass spectrometry 
YNMT: yeast N-myristoyl transferase 
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Calcium and integrin binding protein 2 (CIB2) shares with the other members of the
CIB family the ability to bind Ca2+ and Mg2+ via two functional EF-hand motifs,
namely EF3 and EF4. As a cation sensor, CIB2 is able to switch to a conformation
likely associated with specific biological functions yet to be clarified. Recent findings
demonstrate the involvement of CIB2 in hearing physiology and a single, conservative
point mutation (p.E64D) has been related to Usher Syndrome type 1J (USH1J) and
non-syndromic hearing loss. We present an exhaustive biochemical and biophysical
characterization of human wild type (WT) and E64D CIB2. We found that CIB2 does not
possibly work as a calcium sensor under physiological conditions, its affinity for Ca2+
(Kd
app = 0.5mM) being too low for detecting normal intracellular levels. Instead, CIB2
displays a significantly high affinity for Mg2+ (Kd
app = 290µM), and it is probably Mg2+
-bound under physiological conditions. At odds with the homologous protein CIB1, CIB2
forms a non-covalent dimer under conditions that mimic the physiological ones, and as
such it interacts with its physiological target α7B integrin. NMR spectroscopy revealed a
long-range allosteric communication between the residue E64, located at the N-terminal
domain, and the metal cation binding site EF3, located at the C-terminal domain. The
conservative E64Dmutation breaks up such inter-domain communication resulting in the
impaired ability of CIB2 to switch to its Mg2+-bound form. The ability to bind the target
integrin peptide was substantially conserved for E64D CIB2, thus suggesting that the
molecular defect associated with USH1J resides in its inability to sense Mg2+ and adopt
the required conformation.
Keywords: calcium sensor, Usher syndrome 1J, DFNB48, nuclear magnetic resonance, hearing loss, calcium and
integrin binding protein, allostery, magnesium
INTRODUCTION
Calcium and integrin binding protein 2 (CIB2) is a 21.6 kDa protein sharing with the other
members of the CIB family the ability to bind Ca2+ and Mg2+ via two functional EF-hand
motifs, namely EF3 and EF4, therefore switching to a specific conformation likely associated with
specific biological functions (Huang et al., 2012). Since its discovery as a ubiquitously expressed
DNA-dependent protein kinase interacting protein (Seki et al., 1999), CIB2 has been found to be
Vallone et al. Calcium and Magnesium Sensing of CIB2
expressed in a variety of tissues but its physiological role
remains largely unknown. It has been established that CIB2 binds
specifically to the integrin α7B cytoplasmic domain (Häger et al.,
2008; Huang et al., 2012), however the protein interacts also
with the αIIb integrin (Huang et al., 2012), thus broadening
its potential involvement in a variety of signal transduction
processes.
Recent lines of evidence demonstrate the direct involvement
of CIB2 in hearing physiology, as CIB2 knockout mice
showed abolished mechanoelectrical transduction in auditory
cells leading to profound hearing loss (Wang et al., 2017).
Interestingly, four missense mutations in the gene encoding
for CIB2 [p.F91S, p.C99W, p.I123T (Riazuddin et al., 2012)
and more recently p. R186W (Patel et al., 2015)] have been
found to be associated with non-syndromic deafness (DFNB48)
while a single, conservative point mutation (p.E64D) (Riazuddin
et al., 2012) has been related to Usher Syndrome type 1J
(USH1J, OMIM entry: 614869), a genetic disorder characterized
by hearing loss and progressive vision loss due to retinitis
pigmentosa. Altogether, these recent findings suggest that CIB2
is an essential component for the normal development of both
hair cells and photoreceptor cells.
Among the members of the CIB family, CIB1 is the protein
that has been characterized in deeper biochemical and structural
detail (Yamniuk et al., 2004, 2006, 2007; Gentry et al., 2005;
Yamniuk and Vogel, 2005; Huang et al., 2011). CIB1 and
CIB2 are homologous proteins, but both the sequence identity
(37.4%) and the overall similarity (60%) are not extremely
high. Differences are found throughout the primary structure
and importantly, key residues are substituted in the metal-ion
binding sites EF3 and EF4 (Figure 1). These differences may
be reflected in an overall distinct structure/function behavior
of CIB2 as compared to CIB1. To date, only few studies have
focused on the biochemical and biophysical characterization of
CIB2 (Häger et al., 2008; Blazejczyk et al., 2009; Huang et al.,
2012) and a comprehensive picture that allows a molecular-level
understanding of its biological properties under physiological
conditions as well as their alteration in USH1J is currently
missing.
In this work, we present an exhaustive characterization of
human wild type (WT) and E64D CIB2 by using an integrated
biochemical and biophysical approach to highlight the molecular
defects of the variant associated with USH1J. Interestingly, we
found that CIB2 does not possibly work as a calcium sensor
under physiological conditions, because its affinity for Ca2+
is too low for normal intracellular levels. Instead, CIB2 has a
fairly high affinity for Mg2+ and it is probably Mg2+-bound
under physiological conditions. At odds with CIB1, which is
monomeric both when isolated and when interacting with its
target (Gentry et al., 2005), we found that CIB2 is a non-covalent
dimer under conditions that mimic the physiological ones, and as
such it interacts with its physiological target α7B integrin. NMR
spectroscopy revealed a long range allosteric communication
between the residue E64, located at the N-terminal domain, and
the metal cation binding site EF3, located at the C-terminal
domain (Figure 1). The E64D mutation associated with USH1J,
although conservative, apparently breaks up such inter-domain
communication resulting in the impaired ability of CIB2 to
switch to its Mg2+ (and Ca2+)-bound form, thus suggesting that
the molecular defect associated with CIB2 and causing USH1J
resides in its inability to sense Mg2+ and adopt the required
conformation.
MATERIALS AND METHODS
Materials
QuikChange II Site-Directed Mutagenesis kit was purchased
fromAgilent. The Bradford reagent was purchased fromBio-Rad.
Chromatographic columns were purchased from GE Healthcare,
and synthetic oligonucleotides were from Eurofins. All other
chemicals were purchased from Sigma Aldrich. All purchased
chemicals were of the highest commercially available purity
grade.
Expression and Purification of Human Wild
Type and E64D CIB2
The cDNA of human CIB2 isoform 1 (Uniprot entry 075838-
1) was cloned into a pET24a(+) vector (Genscript) containing
a 6xHis-tag at the N-terminal, followed by Tobacco Etch Virus
(TEV) cleavage site. The plasmid was used to transform BL21
DE3 cells. Cells were grown in LB medium or in M9 minimal
medium supplemented with 15NH4Cl (1 g L−1) as a sole nitrogen
source for NMR studies, at 37◦C until the OD600 reached a value
around 0.4. Flasks were then cooled down and, after induction
by 0.5mM ITPG at OD600 = 0.6, bacteria were grown at 15◦C
for 20 h. After centrifugation at 5,500 g (20min at 4◦C) the
obtained pellets were suspended in lysis buffer (20mM TRIS
pH = 7.5, 0.5M NaCl, 20mM imidazole, 1mM DTT, 5 U/mL
DNAse, 0.1 mg/mL lysozyme, 1mM PMSF, 2.5mM MgCl2) and
incubated at 25◦C for 30min. In addition, 10–12 sonication
cycles on ice, 10 s each, were performed. Soluble and insoluble
fractions were separated by centrifugation at 16,000 g, 4◦C for
30min. WT CIB2 was found in high amount in the soluble
phase and it was directly leaded in a 5mL His-trap FF Crude
column (GE Healthcare) previously equilibrated with loading
buffer (20mM TRIS, pH = 7.5, 0.5M NaCl, 1mM DTT, 20mM
imidazole). A one-step elution by 500mM imidazole was chosen
after initial tests with a gradient. In order to remove the imidazole
excess to allow for TEV-protease activity, His-CIB2 was dialyzed
against 50mM TRIS pH 8, 150mM NaCl, 1mM DTT and then
incubated with a previously prepared His-tagged TEV-protease
(Dal Cortivo et al., 2018) (ratio 1:30) overnight at 8◦C. Tag-
free CIB2 was purified from His-TEV and cleaved His-tails
by reloading into a His-trap column and collecting the flow-
through. Protein concentration was measured by a Bradford
assay optimized for homolog calcium sensor proteins or by
using the predicted molar extinction coefficient (ε280 = 6,400
M−1cm−1, http://protcalc.sourceforge.net/) and the purity was
verified by SDS-PAGE to be at least 90%. Purified WT CIB2 was
washed in 20mM TRIS pH 7.5, 150mM KCl, 1mM DTT, using
an Amicon concentrator. Protein aliquots were then flash-frozen
and stored at−80◦C until use.
The E64D point mutation was obtained by site-directed
mutagenesis on the complete cDNA of CIB2 using a forward
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FIGURE 1 | Cartoon representation of monomeric WT CIB2 in its Ca2+-bound form. The homology model is based on the X-RAY structure of Ca2+-bound CIB1 (see
section Materials and Methods). The N-terminal region is colored gray, while the C-terminal region (helix 10) is colored yellow. EF1, EF2, EF3, and EF4 are colored
green, blue, orange, and magenta, respectively. Asn 121 and Glu 64, found to be involved in an allosteric connection, are represented by sticks, as well as Arg 33,
electrostatically interacting with Glu 64. The sequence alignment of CIB2 with CIB1, CIB3, and CIB4 is also shown, restricted to the metal-coordinating EF-hands,
namely EF3 and EF4. Amino acids contributing to the coordination of Ca2+ according to the canonical pentagonal bipyramid geometry are marked by their respective
position and labeled in the zoomed-in protein cartoon on the right.
primer (5′-ATCATTCAAATGCCGGACCTGCGTGAGAAC
CCGTT-3′) and a reverse primer (5′-AACGGGTTCTCA
CGCAGGTCCGGCATTTGAATGAT-3′). Protein expression
was performed as for the WT but the mutant protein was
found to concentrate in the insoluble fraction, thus requiring
purification from the inclusion bodies. After cell lysis, the
insoluble pellets were suspended in the unfolding buffer
(20mM TRIS pH 7.5, 0.5M NaCl, 6M guanidine hydrochloride,
20mM imidazole, 1mM DTT) and incubated overnight at 4◦C.
Unfolded CIB2 was loaded into a His-trap column and then
renatured by a gradient from 0 to 100% of refolding buffer
(unfolding buffer guanidine hydrochloride-free) setting the
flow rate to 1 mL/min (100mL total volume). After elution
with 500mM imidazole E64D CIB2 was treated as the WT
protein.
Peptides
The peptide corresponding to the membrane proximal
segment of the cytoplasmic domain of α7B integrin
(Uniprot entry: Q13683) comprised between residues
1101–1116 (α7B_M, Ac-LLLWKMGFFKRAKHPE-NH2)
and a scrambled peptide obtained by shuffling the α7B_M
sequence (Scrb, Ac-KEFWGLHAKPRLKLMF-NH2) were
synthesized by GenScript USA Inc. (New Jersey, 144 USA).
The purity of peptides, estimated by HPLC, was ≥95%
and concentration was determined using the predicted
molar extinction coefficient (ε280 = 5,690 M−1cm−1,
http://protcalc.sourceforge.net/).
Circular Dichroism Spectroscopy and
Thermal Denaturation Profiles
Secondary and tertiary structures of WT and E64D CIB2 and
thermal denaturation profiles were investigated by using a Jasco
J-710 spectropolarimeter equipped with a Peltier type cell holder,
using protocols previously described (Astegno et al., 2014;
Marino et al., 2014, 2015a,b; Vocke et al., 2017). Briefly, near UV
(320–250 nm) and far UV (250–200 nm) spectra of ∼30µM and
12µMCIB2 respectively were collected at 37◦C after consecutive
additions of 0.5mMEDTA, 1mMMg2+ and 1mMCa2+. Quartz
cuvettes were used both for near UV (1 cm) and far UV (0.1 cm).
Solvent spectra were recorded and considered as a blank.
Thermal denaturation profiles were collected in the same
conditions as for far UV spectra by monitoring ellipticity signal
at 222 nm in a temperature range between 4 and 70◦C (scan rate
90◦C/h).
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Titration experiments were designed starting from the apo
WT and E64D CIB2 in order to estimate an apparent Kd
value (Kd
app) for calcium and magnesium binding, similar
to what was done previously for calmodulin (Maune et al.,
1992). The dichroic signal (in terms of molar ellipticity
per residue (MRE) at 2 = 222 nm, indicative of typical
acquirement of secondary structure, was followed as a
function of the concentration of free Mg2+ or Ca2+. In
order to obtain a controlled free ion concentration under
well-defined pH and salt conditions, the MaxChelator
software (http://maxchelator.stanford.edu/) was used. Each
titration point represents an independent sample where 0.5
µL of a Ca2+ or Mg2+ stock solution at the appropriate
concentration was added to the fixed volume (200 µL) of
12µM CIB2 aliquots in the presence of 1mM EGTA. After
3min incubation at 25◦C, three replicas of each spectrum were
collected.
Fluorescence Spectroscopy
Fluorescence spectra were obtained with a Jasco FP750
spectrofluorimeter. The interaction of WT CIB2 with α7B_M
and Scrb peptides and that of E64D with α7B_M was studied
by monitoring the peptide intrinsic fluorescence. The only
Trp residue of both peptides was selectively excited at 295 nm
and fluorescence emission was recorded from 300 to 400 nm,
setting 5 nm excitation and emission bandwidths. Two scan
averaged spectra were recorded. α7B_M (4µM) was titrated with
increasing concentrations ofWT or E64D CIB2 in 20mMHepes,
150mMKCl, 1mMDTT pH 7.5 at 37◦C in the presence of 1mM
Mg2+ and 1mM Ca2+. Titration experiments were performed
by monitoring the change (blue-shift) in wavelength (λ) of
the peptide emission peak on the fluorescence spectrum. The
apparent equilibrium dissociation constant (Kd) was calculated
by using the following equation:
y = y0 + ax/(Kd + x) (1)
where y0 is the wavelength of the peptide emission peak in
the absence of WT/E64D CIB2, a is the difference between the
maximum and minimum (1/λ) × 105 values of the peptide
emission peak as a function of x, the concentration of CIB2.The
intrinsic fluorescence emission of the single Trp of the Scrb
peptide (4µM) was measured in the same buffer at 37◦C, in the
presence of 2, 4, and 8µMWT CIB2.
8-Anilinonaphthalene-1-sulfonic acid (ANS) fluorescence was
used to probe the changes in hydrophobicity of WT and E64D
CIB2 upon Mg2+ and Ca2+ binding. Two micromolar of WT or
E64D CIB2 in 20mM Hepes pH 7.5, 150mM KCl, 1mM DTT,
was incubated with 30µM ANS and fluorescence was measured
after the addition of 0.5mMEDTA, 1mMMg2+ and 1mMCa2+.
ANS fluorescence spectra were recorded at 37◦C in the 400–
650 nm range after excitation at 380 nm, with 5 nm bandwidths.
Three scan averaged spectra were recorded.
Size Exclusion Chromatography
The molecular weight (MW) of the Ca2+-free, Mg2+-bound
and Mg2+/Ca2+ -bound states of WT and E64D CIB2 was
determined by size exclusion chromatography (SEC) in an
ÄKTA FPLC system using a Superose 12 column (10/300GL,
GE Healthcare). Standard proteins for calibration were: carbonic
anhydrase (29 kDa), alcohol dehydrogenase (150 KDa), β-
amylase (200 kDa), and cytocrome c (12.4 kDa). The column was
equilibrated with a buffer containing 20mMTris pH 7.5, 150mM
KCl, 1mM DTT with either 3mM EGTA or 2mM EGTA +
3mMMg2+ or 3mMMg2+ + 2mM Ca2+ added. WT (100µM)
or E64D (70µM) CIB2 were incubated with 3mM EGTA or
2mM EGTA + 3mM Mg2+ or 3mM Mg2+ + 2mM Ca2+ at
25◦C for 5min before being applied to the column. The protein
elution profile was recorded at 280 nm; elution volumes Ve were
determined and the distribution coefficient Kd was calculated
according to the equation:
Kd = (Ve − V0)/(Vt − V0) (2)
in whichVt is the total column volume andV0 is the void volume.
Molecular weights were determined from a calibration plot of
log(MW) vs. Kd.
Native Page
In order to investigate CIB2 oligomeric state with another
approach, the Ferguson plot technique (Ferguson, 1964) was
used. Three continuous gels (lacking a stacking phase) under
non-denaturing conditions were polymerized at increasing
acrylamide concentration (10%, 12%, 15%) using two different
BSA concentrations as standards (0.25, 0.41 mgmL−1). Twenty
micromolar of CIB2 was incubated at room temperature with
EGTA (4.5mM), Mg2+ (3mM EGTA + 4.5mM Mg2+) or both
Ca2+ and Mg2+ (3mM Ca2+, 4.5mM Mg2+) in the presence of
1mM DTT for 20min. Samples were loaded in each gel and let
run as in a normal electrophoresis experiment for 40min, 200V
at room temperature. Bands were visualized by Comassie Blue
staining. Data analysis was performed as explained in (Ferguson,
1964).
Dynamic Light Scattering
Dynamic light scattering (DLS) measurements were performed
with a Zetasizer Nano-S (Malvern Instruments) and polystyrene
low volume disposable sizing cuvettes (ZEN0112) using a general
setup optimized previously (Sulmann et al., 2014; Marino et al.,
2015a, 2017; Vocke et al., 2017).Viscosity and refractive index
were set to 0.6864 cP and 1.33 (default values for water),
respectively; the temperature was set to 37◦C, with 2min
equilibration time. The measurement angle was 173◦ backscatter,
and the analysis model was set to multiple narrow modes.
For each measurement, 12 determinations were performed,
each consisting of 14–16 repetitions. DLS measurements were
performed on the samples of dimeric WT or E64D CIB2
in 20mM Tris–HCl pH 7.5, 150mM KCl, 1mM DTT with
3mM EGTA or 2mM EGTA + 3mM Mg2+ or 3mM Mg2+
+ 2mM Ca2+, immediately after their purification by SEC.
Each measurement was run for 5 h. The samples were filtered
through an Anotop 10 filter (Whatman, 0.02µm) before each
measurement.
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Nuclear Magnetic Resonance Experiments
and Data Analysis
NMR spectra were acquired on a Bruker Avance III spectrometer
(Bruker, Karlsruhe, Germany) operating at 600.13 MHz proton
Larmor frequency, and equipped with a cryogenic probe. The
spectra were recorded at 25◦C, the samples were at protein
concentration of 320µM (unless otherwise specified) in 20mM
Hepes, 100mM KCl, 1mM DTT, pH 7.5 and 7% D2O.
A standard 1H-15N heteronuclear single-quantum coherence
(HSQC) pulse sequence was used, with pulsed field gradients for
suppression of the solvent signal and cancellation of artifacts. 1H-
15N HSQC spectra were acquired with a data matrix consisting
of 2K (F2, 1H)× 256 (F1, 15N) complex points, spectral windows
of 8417.509Hz (1H) × 2189.44Hz (15N), 8 transients, and 1.5 s
relaxation delay.
NMR titration experiments were run on 320µM 15N-WT
CIB2 with Ca2+ ion added stepwise from a concentrated stock
solution. The following protein/ligand ratios were analyzed by
1H-15NHSQC spectra: 1:1, 1:3, 1:5, 1:7, 1:10, 1:15, 1:20. Intensity
perturbations were computed as: I/Imax, where I is the signal
intensity at titration step analyzed, and Imax is the maxium signal
intensity at the last titration point.
The Kd values were obtained by fitting the NMR isotherms to
a singlestep one-site binding model (Equation 3: Figures 5D,F)
or to a single step with Hill slope binding model (Equation 4:
Figure 5E), using GraphPad software according to the following
equations:
I/Imax = ((Kd + [L]t + [P]t)− ((Kd + [L]t
+[P]t)
2
− 4[L]t[P]t)
0.5)/2[P]t; (3)
I/Imax = Bmax[L]
h/(K
apph
d
+ [L]h) (4)
where I/Imax is the relative intensity observed at each titration
point, [P]t and [L]t represent the total protein and ligand
concentration, respectively, [L] is approximated by [L]t and Kd
is the dissociation constant of the complex.
For Equation (4) Kd
app is the apparent equilibrium
dissociation constant, h is the Hill slope, and Bmax is the
maximum intensity observable. All data were processed and
analyzed using TOPSPIN 3.2 (Bruker, Karlsruhe, Germany) and
CARA software.
Building of WT CIB2 Homology Model
The homology model of WT CIB2 monomer was built using the
MODWEB-MODBASE server version r189 (Pieper et al., 2014).
Briefly, 4 out of 189 structural models were selected based on
the MPQS, TSVMOD, LONGEST_DOPE and DOPE criteria.
The most reliable model, covering the 13–187 region of the
full protein sequence, was built based on the X-ray structure
of human CIB1 [PDB entry: 1XO5 (Gentry et al., 2005) chain
A], which shares 39% sequence identity with CIB2. Ca2+ ions
were manually positioned in EF3 and EF4 binding sites based on
the experimental coordinates of the Ca2+-loaded CIB1 structure
(1XO5.pdb) (Gentry et al., 2005). The structure was energy-
minimized in two steps, first with the steepest descent and then
with the conjugate gradients algorithm, keeping in both cases
the position of the backbone atoms restricted, according to a
previous protocol used for other Ca2+ sensor proteins (Marino
et al., 2015b; Marino and Dell’Orco, 2016).
RESULTS
Wild-Type and E64D CIB2 Form
Non-covalent Dimers With Different
Colloidal Properties
We investigated the oligomeric state of both WT and E64D
CIB2 by three different approaches, namely PolyAcrylamide
Gel Electrophoresis under non-denaturing conditions (native-
PAGE), analytical SEC and DLS. Figure S1a shows that, under
denaturing conditions (SDS-PAGE), the electrophoretic mobility
of CIB2 is compatible with that of a 21.6 kDa protein, although
the band is shifted to a slightly higher molecular weight, as
previously observed in other studies (Blazejczyk et al., 2009;
Huang et al., 2012). Gels obtained under non-denaturing
conditions show that in the presence of a reducing agent (1mM
DTT) both apo (lane 2) and Ca2+-bound (lane 4) CIB2 run
as single bands (Figure S1b). However, multiple bands were
observed in the absence of DTT independent of the presence of
Ca2+ (lanes 1 and 3). This is compatible with the formation of
covalent oligomers due to disulfide bridges resulting from the
oxidation of thiol groups in either of the four Cys residues.
In order to investigate the nature of the single bands observed
in the native-PAGE experiments, we performed analytical SEC
of both WT and E64D CIB2 in the apo form as well as in the
presence ofMg2+ and Ca2+/Mg2+ and determined themolecular
weight (MW) by using a calibration curve shown in Figure S2.
As previously observed for other Ca2+/Mg2+ sensor proteins
(Sulmann et al., 2014; Marino et al., 2015a; Astegno et al., 2016,
2017; Vallone et al., 2016) the elution profile was sensitive to the
metal ion loading state (Figure S2) and resulted in an apparent
lower MW for the Ca2+/Mg2+ bound form of CIB2 compared to
the apo-form (Table S1). Under reducing conditions, the elution
profiles for both WT and E64D CIB2 variants in the Ca2+/Mg2+
form (MW = 37–39 kDa, Table S1) were compatible with a
dimer and incompatible with a monomer (MW∼22 kDa). The
dimeric nature of CIB2 under all the tested conditions was further
confirmed by Ferguson plots, which estimated a MW in the 51–
53 kDa range for both WT and E64D variants independent on
the cation loading state (Table S1).
Samples from SEC experiments were further analyzed by DLS
immediately after elution. Results are reported in Figure 2. The
DLS intensity profile of WT CIB2 in the absence of Ca2+ and
Mg2+ showed multiple peaks and a generally high polydispersity
(Figure 2A), with two not-well separated prevailing peaks.
However, the addition of Mg2+ (Figure 2B) or Ca2+ (Figure 2C)
led to a general improvement of the colloidal properties and
a single prominent peak was distinguished in both cases,
which allowed the determination of the hydrodynamic diameter
(dMg = 8.43 ± 0.12 nm and dCa = 8.18 ± 0.01 nm, respectively;
see Figure 2D). The E64D CIB2 variant instead showed less
satisfactory colloidal properties, as under no tested condition,
apo (Figure 2E), Mg2+ (Figure 2F), or Ca2+ (Figure 2G) could
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FIGURE 2 | Dynamic light scattering spectroscopy. Comparison between hydrodynamic diameters measured (T = 37◦C) for WT (A–D) and E64D (E–H) CIB2 in the
presence of: 3mM EGTA (A,E), 3mM Mg2+ + 2mM EGTA (B,F), 3mM Mg2+ + 2mM Ca2+ (C,G). (D,H) Superimposition of the average curves obtained by (A–C)
for the WT (D) and (E–G) for the E64D CIB2 (H).
a single, prevailing peak be observed in the intensity profile. The
constant presence of higher-size aggregates and the overlapping
of peaks (Figure 2H) prevented an estimate of the hydrodynamic
diameter to be made for this CIB2 variant.
The differences observed in the DLS profiles of WT and E64D
CIB2 under the tested conditions prompted us to analyze the
time-dependent properties of the dispersions. The mean count
rate (MCR) of the samples, which can be indicative of time-
dependent protein aggregation, was thus followed over time for
5 h (Figure S3). Interestingly, forWTCIB2 (Figure S3a) no trend
was observed under the investigated conditions, but significant
fluctuations in the MCR were observed especially in the apo
conditions (150–600 kcps), in line with a partly reversible protein
aggregation process. Less prominent but still significant MCR
fluctuations were observed in the presence of Ca2+ or Mg2+
(150–300 kcps). A somewhat different pattern was detected for
E64D CIB2 (Figure S3b). Both in apo conditions and in the
presence of Ca2+ and Mg2+ a slow, constantly increasing trend
in MCR was observed. In the sole presence of Mg2+, significantly
broad fluctuations of MCR (150–400 kcps) were detected, which
also showed a slowly increasing trend.
Apo, Mg2+- and Ca2+-Loaded WT and
E64D CIB2 Show Different Levels of
Folding
One-dimensional (1D) 1H NMR spectroscopy and far/near UV
CD spectroscopy were used to monitor the folding state of WT
and E64D CIB2 under different conditions (Figure 3).
1D 1H NMR spectroscopy is a fast and powerful technique
that can provide information on the global fold of a protein.
In 1D 1H NMR spectra, the signal dispersion in the regions of
the amide (6–10 ppm), and methyl (−0.5 to 1.5 ppm) protons
provides indications on the folded globular state of the proteins.
Moreover calcium binding proteins show typical downfield-
shifted NMR peaks at ∼10.5 ppm belonging to residues of the
EF-hands upon binding of divalent metals (Huang et al., 2012).
The 1D 1H NMR spectrum of WT CIB2 in the absence of metal
ions displayed evidence of chemical shift dispersion but also
line broadening in the amide region (Figure 3A, black line).
Addition of 1mM Mg2+ promoted a large change in the WT
CIB2 spectrum (Figure 3A, blue line); the signals appeared more
disperse and sharp indicating the ability of the protein to assume
a globular folded structure upon binding of the metal cation.
Further addition of 1mM Ca2+ (Figure 3A, red line) caused
slight changes in the 1D 1H NMR spectrum, indicating a low
degree of structural rearrangement upon binding of the second
ion.
The NMR data recorded on samples of E64D CIB2 drive
to different conclusions. The 1D 1H NMR spectrum of the
E64D CIB2 in the absence of metal ions displayed narrow signal
dispersion throughout the spectrum and especially in the region
of amide protons (Figure 3D, black line). The addition of 1mM
Mg2+ (Figure 3D, blue line) did not promote changes in the
NMR spectrum clearly indicating the inability of the E64D CIB2
to bind Mg2+. Upon subsequent addition of Ca2+ the NMR
signals appeared more disperse as a consequence of the binding
of the metal ion, however the 1D spectrum suggests that the
protein still retains a certain degree of flexibility and it is not
characterized by a rigid tertiary structure (Figure 3D, red line).
Near UV (250–320 nm) CD spectroscopy provides
information as to the microenvironment of the aromatic
amino acids Phe, Tyr, and Trp, which contribute to the
stabilization of protein tertiary structure. CIB2 lacks Trp,
therefore near UV CD spectra represent a fingerprint of
the possible variations in tertiary structure in the Tyr (5
residues) and Phe (16 residues) microenvironments upon
metal cation binding. Monitoring the CD signal in the far
UV region (200–250 nm) provides instead information as to
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FIGURE 3 | Conformational changes in WT and E64D CIB2 upon interaction with Mg2+ and Ca2+. (A–D) Superimposition of the 1H NMR spectra of WT (A) and
E64D (D) CIB2 in their apo form (black), and in the presence of 1mM Mg2+ (blue) and 1mM Mg2+ + 1mM Ca2+ (red). Both unlabeled proteins were at a 50µM
concentration. The spectra were recorded at 600 MHz and 25◦C. The intensity of the spectra has been rescaled for better spectra visualization. (B,C,E,F) Near UV
spectra of ∼28µM WT CIB2 (B) and 30µM E64D CIB2 (E) and far UV spectra of 12µM WT CIB2 (C) and E64D CIB2 (F) after sequential additions of 0.5mM EDTA
(black dotted), 1mM Mg2+ (solid blue lines) and 1mM Ca2+ (red solid lines). Temperature was fixed at 37◦C, each spectrum represents the mean of 5 accumulations.
variations of the protein secondary structure. The near UV
CD spectrum of WT CIB2 in the absence of metal cations
was almost flat (Figure 3B, black dotted line), nevertheless
some helical content was clearly observed in the far UV region
(Figure 3C), thus suggesting that apo CIB2 forms a molten
globule state, in line with NMR findings. Addition of 1mM
Mg2+ led to a significant response both in the Phe and Tyr
bands (Figure 3B, blue dashed line) and to a remarkable
increase in the helical content as observed in the far UV
region (Figure 3C). Notably, upon addition of physiological
concentrations of Mg2+ the far UV spectrum acquired the
typical α-helix minima at 208 and 222 nm, while the first
minimum was shifted to 206 nm in the apo form (black dotted
line). Further addition of 1mM Ca2+ refined the near UV CD
spectrum especially in the Tyr region (Figure 3B, solid red
line) and further increased the intensity of the far UV spectrum
(Figure 3C).
The behavior of E64D CIB2 was substantially different.
When exposed to the same Mg2+ and Ca2+ conditions, E64D
CIB2 showed only minor variations in the near UV region,
in line with a substantial conservation of the molten globule
conformation independent of the metal cation (Figure 3E). Only
a slight response to Ca2+ was observed in the far UV region
(Figure 3F), however the first minimum at 206 nm did not shift
to 208 nm upon addition of Mg2+ or Ca2+, at odds with the WT
variant.
Hydrophobicity and Thermal Denaturation
Profiles of WT and E64D CIB2
In their apo form, both WT and E64D CIB2 present a
partially folded, molten globule conformation, thus suggesting
a significant solvent-exposition of hydrophobic patches. We
investigated the surface hydrophobicity of CIB2 by using the
fluorescent probe ANS, whose fluorescent properties will change
as it binds to hydrophobic regions on the protein surface.
Results are shown in Figure S4. Both ANS fluorescence spectra
of WT and E64D CIB2 highlight a significant hydrophobicity
of the protein surface under all the tested conditions, as clearly
displayed by the remarkable blue-shift of the fluorescence
emission maximum (27 nm for WT CIB2, 31 nm for E64D
CIB2, in the apo state, Table S2) and the relative increase in
fluorescence intensity as compared to the emission of ANS
alone (2.6- to 2.8-fold, in the apo state, Table S2). Addition of
1mM Mg2+ or 1mM Ca2+ slightly reduced the blue-shift (1–
2 nm, depending on the CIB2 variant, Table S2), however the
change in relative fluorescence (Fmax/Fref) was higher for WT
(2.1–2.2 vs. 2.6) than for E64D CIB2 (2.5–2.6 vs. 2.8). Overall,
fluorescence data confirm that both WT and E64D CIB2 are
highly hydrophobic and the pathogenic variant maintains higher
hydrophobicity in the presence ofMg2+ or Ca2+ compared to the
WT.
The thermal stability of WT and E64D CIB2 in the 4–70◦C
range was investigated by monitoring the dichroic signal at
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FIGURE 4 | Thermal denaturation of WT and E64D CIB2. Thermal denaturation profiles were recorded between 4 and 70◦C with 12µM WT CIB2 (A) and E64D CIB2
(B) in the presence of 0.5mM EDTA (gray circles), 1mM Ca2+ (red squares), 1mM Mg2+ (light blue diamonds) and 1mM Ca2+ + 1mM Mg2+ (green triangles). Data
fitting was performed using a Hill 4 parameter function, results are shown by solid lines and parameters are reported in Table S2.
FIGURE 5 | 1H-15N HSQC NMR spectra of WT CIB2 in its apo form and in the presence of Mg2+ and Ca2+ highlight an allosteric communication between E64 and
N121. (A) Superimposition of the two-dimensional 1H-15N HSQC NMR spectra of the apo- (black), and Ca2+-bound (green) 15N-WT CIB2. (B) Superimposition of
the HSQC spectra of apo (black), and Mg2+-bound (blue) 15N-WT CIB2. In the insets, zoom of the HSQC spectra of the downfield peaks of the metal-bound forms of
15N-WT CIB2. Metal ions were present at a protein:metal ratio of 1:15. (C) Superimposition of downfield region of the 1H-15N HSQC NMR spectra recorded on
15N-WT CIB2 containing 15 equivalents of Mg2+ (blue), 15 eq Mg2+ + 15 eq Ca2+ (red), and 15 eq Ca2+ (green). (D–F) Variation of 1H-15N HSQC peak intensities
of WT CIB2 as a function of Ca2+ concentration. The peak intensities were normalized with respect to the maximum value. The continuous lines represent the data
fitted against equations as indicated in section Materials and Methods. The plots refer to the amide peaks of residues E64 (D), G162 (E), and N121 (F). All the spectra
were recorded at 600 MHz and 25◦C. All samples were at protein concentration of 320µM in 20mM Hepes, 100mM KCl, 1mM DTT, pH 7.5.
222 nm, where a minimum was observed in the far UV CD
spectrum (Figure 3). Thermal denaturation profiles are reported
in Figure 4. Apo WT CIB2 was found to be rather unstable,
having a melting temperature of 35.1◦C (Table S2). Addition of
Mg2+ increased the thermal stability of ∼11◦C, and a similar
effect was observed for addition of 1mM Ca2+, although the
stabilization was lower (∼8◦C). In the presence of both cations
the thermal stability resembled that of Mg2+ (Tm = 45.9◦C,
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Table S2). The transition was faster in the metal-bound states
compared to the apo-state (Hc = 11–12.5 vs. 7.5, Table S2). The
persistent CD signal at 222 nm (Figure 4A) suggests that the
transition ended in a still partially folded structure, independent
of the presence of Mg2+ or Ca2+. Interestingly, the thermal
profile of apo E64D CIB2 was unperturbed in the scanned
range of temperature, as no transition was observed (Figure 4B).
Addition of Mg2+ resulted in a Tm-value ∼ 11.5◦C lower than
that of WT CIB2, and a very similar effect was observed after
the addition of 1mM Ca2+ (Table S2). Only the co-presence
of both cations slightly increased the thermal stability of E64D
CIB2, which however was ∼9◦C lower than the respective WT
case (Table S2). All the transitions observed for E64D CIB2 were
significantly slower compared to the respective cases inWT CIB2
(compare the Hc values, Table S2).
Mg2+ and Ca2+ Binding to WT CIB2
Explored by NMR Spectroscopy Reveals
an Inter-domain Allosteric Switch
Two-dimensional 1H-15N HSQC NMR spectra are often
employed to investigate protein structural changes. The NMR
chemical shift of the signals belonging to all HN groups of the
protein is a sensitive reporter of the local and global structure
rearrangements occurring upon ligand binding events. The NMR
signals of the 1H-15N HSQC spectrum of the apo 15N WT
CIB2 were broad and poorly dispersed in line with the previous
observation that apo CIB2 forms a molten globule state.
In line with previously reported data (Huang et al., 2012),
the 1H-15NHSQC spectrum changed dramatically upon addition
of either Ca2+ or Mg2+ ions; the NMR signals became more
disperse and sharp and new downfield peaks appeared, indicative
of metal binding (Figures 5A–C).
In order to investigate at a deeper level the structural
mechanisms associated with Ca2+ binding, NMR titration
experiments of Ca2+ into 15N-WT CIB2 have been performed
collecting a series of 1H-15N HSQC spectra. Notably, the
variation of the intensity of the peaks belonging to residues E64,
which belongs to the kinked H3b helix in the non-functional
EF1 motif and N121 of EF3 loop appeared to be correlated
(Figures 5D,F), thus indicating that these amino acid residues
belong to the same allosteric network. The NMR titration data
were fitted assuming a simple one-site binding model which
better describes a hyperbolic shape of the curve and Kd values
of 0.55 ± 0.13 and 0.48 ± 0.15mM were obtained for E64 and
N121, respectively.
Moreover, we were able to follow the peculiar behavior of the
G162 belonging to the EF4 loop, upon addition of increasing
amount of Ca2+ (Figure 5E). Interestingly, the intensity variation
upon addition of Ca2+ had a sigmoidal shape, indicative of
positive cooperativity of the bindingmechanism. From the fitting
of the data a Kd
app value of 2.22± 0.25mM and a Hill coefficient
h = 2.27 ± 0.38 were obtained. The data of the two sites
with different affinities for the Ca2+ ion are consistent with the
analysis of the 1H-15N HSQC spectra of the protein in the early
steps of titration (data not shown). When only the peaks of E64
and N121 are visible, the protein already adopts a well-folded
structure, further addition of Ca2+ promotes only small changes
in the spectrum, thus confirming that the binding of Ca2+ into
the first site triggers the structural rearrangement of WT CIB2.
NMR spectroscopy was also employed to investigate whether
WT CIB2 had a preferential binding capability toward Ca2+
or Mg2+. To this aim we recorded a 1H-15N HSQC spectrum
of 15N-WT CIB2 after addition of a solution containing equal
concentration of the two cations (Figure 5C) and we analyzed
the downfield peaks as indicators of the binding site occupancy.
Interestingly, WT CIB2 displayed a preferential binding site for
Mg2+ in the EF3 loop and for Ca2+ in the EF4 loop. This
observation was confirmed by analyzing the 1H-15N HSQC
spectra of the protein in the presence of different ratios of Ca2+
or Mg2+ (Figure S5). As expected, when Mg2+ was in excess we
could observe the peak of N121 at the chemical shift of the Mg2+
bound form, and the peak of G162, although with low intensity,
as a reporter of Ca2+ bound to the EF4 loop. Notably, when Ca2+
was in excess the protein still retained its capability to bind Mg2+
in EF3 and we could still observe the peak of N121, typical of the
Mg2+ bound form, while EF4 became occupied by Ca2+.
The Affinity of WT and E64D CIB2 for Ca2+
Is Incompatible With a Role as a
Physiological Ca2+ Sensor
NMR experiments suggest that the affinity of WT CIB2 for
Ca2+ is in the submillimolar range. We sought to quantify the
affinity for Ca2+ and Mg2+ of both WT and E64D CIB2 in
a comparative fashion in order to assess the potential role of
CIB2 as a sensor protein under physiological and USH1J-related
conditions. Titration experiments were performed bymonitoring
the CD signal at 222 nm, under very carefully determined pH
and free cation (Ca2+ or Mg2+) conditions spanning over
their known physiological range. Although the method does
not allow attributing the macroscopic association constant to
each individual EF-hand, it provides an estimate of the cation
concentration at which the conformational change, starting from
the apo-state, is half maximal (Kd
app). Therefore, it is a useful
approach for comparisons of the two CIB2 variants over a
physiological range of cation stimuli. Results are reported in
Figure 6 and Table 1.
In line with the data from NMR titrations, the measured
apparent affinity for Ca2+ of both WT (500µM) and E64D
(2mM) CIB2 was extremely low, thus excluding a possible
role of CIB2 as a Ca2+ sensor under physiological conditions
(see the section Discussion for further details). An alternative
well-established spectroscopic method based on the competition
with the chromophoric chelator 5,5
′
Br2-BAPTA was applied for
WT CIB2, but it failed to detect any individual macroscopic
binding constant in the low µM range (results not shown),
thus confirming the overall low affinity for Ca2+. Interestingly,
WT CIB2 showed a relatively high affinity for Mg2+ (290µM),
compatible with a fully loaded state under physiological
conditions. On the contrary, E64D CIB2 is likely incapable of
detecting Mg2+ under physiological conditions due to the low
affinity (Kd
app = 1.5mM).
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FIGURE 6 | Ca2+ and Mg2+ titrations of CIB2 in the presence or in the absence of target peptide α7B_M. (A,B) WT (circles) and E64D (triangles) CIB2 were titrated
with Ca2+ (A) and Mg2+ (B) starting from the apo-form (1mM free EGTA). (C,D) Ca2+ (C) and Mg2+ (D) titrations of WT (diamonds) and E64D (downwards
triangles) CIB2 in the presence of α7B_M peptide. Ions concentration ranged between 1µM and 10mM, the obtained data were fitted using the Hill 4 parameters
function. Data were normalized on protein concentration (MRE). Titrations were performed at 25◦C, each point represents the mean of 3 accumulations.
All the titration curves could be fitted to a Hill sigmoid
function (Figure 6), thus suggesting in some cases a cooperative
effect of the cation binding on the structural transition.
Interestingly, while Ca2+ binding to WT CIB2 was substantially
non-cooperative (Hc = 1.1, Table 1), binding of Mg2+ showed
evidence of positive cooperativity (Hc = 2.3, Table 1). As for
E64D CIB2, data suggest positive cooperativity both in the case
of Mg2+ (Hc = 1.7, Table 1) and Ca2+ binding (Hc = 2.2,
Table 1).
The fact that we detected for E64D CIB2 a significantly
low affinity for both Ca2+ and Mg2+ (Table 1) made us
wonder if higher concentration of cations could trigger
a WT-like conformation. Near UV-CD spectra were thus
recorded following sequential additions of increasing Ca2+ or
Mg2+ (Figure S6). In line with the results from far UV-CD
spectroscopy and titration experiments, our data show that
at a Ca2+ concentration up to 5mM E64D CIB2 did not
switch to a WT-like three-dimensional conformation; however,
at 10mM Ca2+ the near UV spectra became similar (compare
Figure S6a with Figure 3B). Interestingly, the same finding
did not apply to Mg2+. Even at 10mM Mg2+ the near
UV CD spectrum did not reach the shape and the intensity
observed for the WT case (compare Figure S6b with Figure 3E).
Therefore, our data are overall consistent with the inability
of E64D CIB2 to sense Mg2+ under physiological conditions,
and even under conditions that exceed the intracellular
levels.
TABLE 1 | Apparent affinity for Ca2+ and Mg2+ of WT and E64D CIB2 assessed
by CD titrations.
Mg2+ Ca2+
Kd
app (mM) Hc Kd
app (mM) Hc
WT CIB2 0.29 ± 0.02 2.3 ± 0.3 0.5 ± 0.1 1.1 ± 0.3
WT + α7B_M 0.49 ± 0.03 1.4 ± 0.1 0.2 ± 0.2 0.9 ± 0.6
E64D CIB2 1.5 ± 0.1 1.7 ± 0.2 2.0 ± 0.2 2.2 ± 0.6
E64D + α7B_M 1.8 ± 0.2 1.4 ± 0.2 1.5 ± 0.3 1.4 ± 0.3
α7B Integrin Is a Specific Target of Both
WT and E64D CIB2
We askedwhether E64DCIB2was still capable of interacting with
specific targets ofWTCIB2. Based on the results of previous work
(Huang et al., 2012), we focused on a peptide (α7B_M) covering
the membrane-proximal CIB2-specific sequence of recognition
of the integrin α7B cytosolic domain. As a negative control, we
generated a scrambled peptide (Scrb) by shuffling the α7B_M
sequence, thus conserving general physicochemical properties
such as net charge and hydrophilicity while losing biological
specificity. Both peptides have a single Trp residue, which allowed
us to exploit their fluorescence for studying the interaction with
both WT and E64D CIB2, which lack Trp residues (see section
Materials and Methods). Results from fluorescence experiments
are reported in Figure 7.
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FIGURE 7 | Interaction between CIB2 variants and α7B_M peptide monitored by fluorescence spectroscopy. (A) Trp fluorescence emission spectra of 4µM α7B_M
peptide alone (solid line) and incubated with of 8µM CIB2 WT) (dotted black line) in the presence of 1mM Mg2+ and 1mM Ca2+. (B) Trp fluorescence emission
spectra in 1mM Mg2+ and 1mM Ca2+of 4µM Scrb peptide alone (solid black line) and in the presence of 2µM CIB2 WT (dotted red line), 4µM CIB2 WT (short
dashed blue line) and 8µM CIB2 WT (dash dotted green line). (C) Fluorescence titration of 4µM α7B_M peptide with WT (black circles) and E64D (red triangles) CIB2
in the presence of 1mM Mg2+ and 1mM Ca2+.
The interaction between WT CIB2 and the α7B_M peptide
was apparent, as assessed from the 1.7-fold increase in the
maximal fluorescence emission and the 12 nm blues shift
(Figure 7A) indicative of an augmented hydrophobicity of the
peptide Trp residue upon interaction with the protein. On
the contrary, no significant change in either the fluorescence
emission intensity and the relative maximum wavelength was
observed when the experiments were performed with the
Scrb peptide, even when the concentration of WT CIB2 was
brought up to 8µM, thus indicating the lack of specific binding
(Figure 7B). Similar results were obtained for the E64D CIB2
variant (results not shown).
Titration experiments were performed to estimate the
stoichiometry of interaction between WT/E64D CIB2 and
α7B_M peptide and to assess the apparent affinity. Results
are reported in Figure 7C. The curves showed that both WT
and E64D CIB2 interact with the target peptide with a 2:1
stoichiometry, that is, a CIB2 dimer binds a single peptide. The
estimated affinities are similar (Kd
app = 4.99 ± 1.01µM for WT
CIB2; Kd
app = 3.1± 0.2µM for E64D CIB2; mean± s.d. of 4 and
3 repetitions, respectively), therefore the USH1J-related variant
is still capable of binding the α7B_M target peptide, with even
higher affinity compared to the WT case.
In order to assess if the binding of the target peptide
could influence the sensing of Ca2+ or Mg2+ and the protein
conformation, far UV CD spectra were recorded and titration
experiments performed in the same conditions as with the
protein alone. Figure S7 clearly shows that the peptide does
not possess any secondary structure and that its incubation
with WT CIB2 led to the same spectral properties observed in
response to additions of Ca2+ for the protein alone (compare
with Figure 3C). Therefore, we conclude that the interaction with
the α7B_M peptide does not induce any appreciable structural
change in WT CIB2. Moreover, the interaction with the α7B_M
peptide had a relatively small effect on the Ca2+ or Mg2+ sensing
abilities of CIB2. While a 1.6-fold increase in the Kd
app was
observed for Mg2+ binding to WT CIB2 (Table 1 and Figure 6),
a slightly increased affinity for Ca2+ was detected, although the
Kd
app was still quite high for physiological relevance (0.2mM,
Table 1). Minor differences were observed in the variation of
Kd
app in the presence of α7B_M peptide for E64D CIB2 (1.2-fold
increase for Mg2+ and 1.2-fold decrease for Ca2+; Figure 6 and
Table 1).
DISCUSSION
The ubiquitous expression of CIB2 in various tissues suggests
that it may exert yet unknown biological functions in a broad
range of biochemical processes. Besides being involved in hearing
physiology and pathology (Riazuddin et al., 2012; Jan, 2013; Patel
et al., 2015; Seco et al., 2016; Wang et al., 2017), CIB2 has been
indeed found to play a role in congenital muscular dystrophy
type 1A (Häger et al., 2008), in the N-methyl-D-aspartate
receptor-mediated Ca2+ signaling in cultured hippocampal
neurons (Blazejczyk et al., 2009), in the promotion of HIV-
viral infection (Godinho-Santos et al., 2016), and very recently
it was found to act as a negative regulator of sphingosine
kinase 1-mediated oncogenic signaling in ovarian cancer (Zhu
et al., 2017). Available mechanistic studies focusing on the Ca2+
and Mg2+ sensing properties of CIB2 are just a few, and a
comprehensive characterization of the protein in comparison to
its disease-associate variants was missing. Indeed, so far much
of the molecular interpretation of the processes in which CIB2
is involved has been based on the significantly better explored
structure-function properties of the homologous protein CIB1
(Leisner et al., 2016), although the relatively low sequence
identity and similarity call for particular caution when inferring
common functions for the two proteins.
In this work, we present a thorough characterization of two
variants of human CIB2, namely the WT form and the E64D
mutant associated with USH1J. It should be reported that a recent
study disqualified CIB2 as a USH1J-related gene, however the
E64D variant was found to be associated with autosomal recessive
non-syndromic hearing loss (Booth et al., 2018). Our biochemical
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and biophysical study highlights a number of clear structural
and functional differences with CIB1, which may thus pose the
molecular basis for understanding the malfunctioning of CIB2
in USH1J and possibly other genetic diseases causing hearing
loss.
While the general topology of CIB2 is similar to that of
CIB1 (Figure 1), a first clear difference between CIB1 and
CIB2 resides in their oligomeric states. While analytical SEC
experiments performed with CIB1 detected a monomeric
protein independently on the presence of Ca2+ and target
peptide (Gentry et al., 2005), our SEC data, electrophoresis
experiments under non-denaturing conditions (Figure S2
and Table S1) and DLS experiments (Figure 2) all converge
to CIB2 forming non-covalent dimers both in the apo and
in Ca2+/Mg2+-bound conditions. The oligomeric state
of CIB2 is particularly relevant for its interaction with
biological targets. Although we cannot exclude different
situations with different targets, fluorescence titration
experiments (Figure 7) point to a 1:1 stoichiometry for a
CIB2 dimer:α7B_M peptide complex, at odds with the results
observed for CIB1:αIIb peptide complex, where the 1:1
stoichiometry involved a monomeric protein (Gentry et al.,
2005).
The stability of the oligomeric state of WT CIB2 was found
to be significantly affected by the presence of metal cations and
by the presence of the E64D point mutation. DLS spectroscopy
highlighted how, in order to achieve a substantiallymonodisperse
protein solution, the saturation with Ca2+ or Mg2+ was
necessary, as the apo-form was observed to dynamically fluctuate
between oligomers of different size (Figure 2 and Figure S3).
Surprisingly, the USH1J-associated E64D mutation, that does
not change the physicochemical properties of the substituted
amino acid, still leads to a dimeric protein (Figure S2), which
is however more prone to form heterogeneous aggregates over
time independent of the presence of Ca2+ orMg2+ (Figure 2 and
Figure S3).
Important differences between WT and E64D CIB2 were
found in their cation-dependent folding state. A general
agreement between 1H NMR and near and far UV-CD spectra
was obtained for both protein variants (Figure 3). Indeed,
WT CIB2 was found to respond to both Ca2+ and Mg2+
by adopting a similar secondary (Figure 3C) and tertiary
structure (Figures 3A,B), at odds with the E64D variant, for
which 1mM Mg2+ was not enough to trigger any detectable
switch (Figures 3D–F). Further addition of 1mM Ca2+ led
to a detectable increase in E64D CIB2’s tertiary structure
(Figures 3D,E) although the change was significantly lower
compared to that observed for the WT. Besides showing a
lower structural responsiveness to Ca2+ and Mg2+ compared
to the WT, E64D CIB2 was found to have a significantly
lower thermal stability under all the tested conditions (Figure 4
and Table S2), and its apo-form apparently maintains a more
hydrophobic surface that persists upon exposition to Ca2+ and
Mg2+ (Figure S4). This could also explain while no transition
was observed for apo E64D CIB2 upon thermal denaturation
in the 4–70◦C range (Figure 4B), this form being particularly
unstable and unstructured.
2D HSQC NMR experiments shed light on the mechanisms
related to Ca2+ and Mg2+ binding to WT CIB2 (Figure 5).
While confirming the molten globule conformation of the apo
form, NMR highlighted that the Ca2+- and Mg2+-bound states
of WT CIB2 have a rather similar three-dimensional structure.
The analysis of the downfield regions permits the distinction
of specific Ca2+- or Mg2+-related fingerprints in the observed
pattern. In particular, by performing Ca2+ titrations we observed
that the intensity of the peak attributed to N121, which is
located in the sixth position of the EF3 metal binding loop
(Figure 1) shows a very similar trend compared to that of
E64, the residue substituted by Asp in USH1J, which is located
in the N-terminal domain, far from the metal binding loops
(Figure 1). This surprising finding suggests that an inter-domain
allosteric communication occurs between the EF3 binding loop
and E64, which according to the homology model based on the
structure of CIB1, forms an electrostatic interaction with R33
(Figure 1) and is therefore likely contributing to the stability
of the EF1 subdomain. The titration patterns observed by
NMR (Figures 5D–F) further confirm that EF3 is the first
EF-hand to be occupied by Ca2+, followed by EF4, whose
structural probe is the G162 residue in the sixth position of the
loop (Figure 5E). Our data support a model, in which under
physiological conditions EF3 is never occupied by Ca2+ but
is instead always Mg2+-bound (Figure S5). Ca2+ will however
bind to the EF4 loop under conditions of particularly high Ca2+
concentration. Moreover, no replacement of Mg2+ was observed
in EF3 following additions of equal amounts of Ca2+ into Mg2+-
bound WT CIB2 (Figure 5C).
These findings appear particularly relevant for their
physiological implications when considered together with
the estimated affinities for Ca2+ and Mg2+ of WT and E64D
CIB2 (Figure 6 and Table 1). The intracellular concentration of
free Ca2+ oscillates in the 0.1–10µM range (Berridge et al., 1998,
2000) and it is even lower in the outer segments of photoreceptor
cells, where a fine regulation of the phototransduction cascade by
Ca2+ and cGMP operates (Koch and Dell’Orco, 2013, 2015). The
level of free Mg2+ in most cells, however, is relatively constant
and ranges in the 0.5–1mM interval (Romani and Scarpa, 1992,
2000). While a 290µM apparent affinity for Mg2+ (Table 1)
is consistent with the binding of Mg2+ to WT CIB2 under
physiological conditions, the affinity measured for the E64D
variant (1.5mM) is too low for ensuring sensing capabilities
under normal conditions. Moreover, neither WT nor E64D
CIB2 could possibly work as Ca2+ sensors with the apparent
affinities detected in our study (500µM and 2mM, respectively).
It should be noticed that other authors (Blazejczyk et al., 2009)
previously determined a much higher affinity for Ca2+ for
GST-fused CIB2 by using a TNS fluorescence assay (apparent
Kd = 0.l4µM). Such a high affinity is in contrast with our data
based on three different experimental approaches, namely NMR
and CD spectroscopic titrations and competition experiments
with the 5,5
′
Br2-BAPTA chromophoric chelator. This latter
approach excluded apparent Kd values below 6µM (results not
shown) and was instead able to detect binding of Ca2+ to CIB1
(Yamniuk et al., 2008). We don’t have an explanation for such
discrepancy, except for pointing out that all our experiments
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were performed with unlabeled and untagged human proteins,
while those in Blazejczyk et al. used a TNS-labeled rat CIB2 fused
with GST, which might introduce artifacts when probing the
protein sensing capabilities.
The lower affinity for Ca2+ is one of the elements
distinguishing CIB2 from CIB1, which binds Ca2+ with high
affinity in EF4 (Kd = 0.5µM) and with lower affinity in EF3
(Kd = 1.9µM); binding of Mg
2+ is instead limited to EF3
(Kd = 120µM) (Yamniuk et al., 2004, 2007). A closer look at
the sequence alignment of the EF3 and EF4 Ca2+-binding motifs
(Figure 1) explains, at least in part, such difference. The high
affinity of the EF4 loop for Ca2+ in CIB1 can be attributed
to the optimal pentagonal bipyramid geometry of the Ca2+-
coordinating oxygens, also due to the presence of an Asn residue
(N169) in the -X position and especially to a Glu residue in
the -Z position (E172). This latter constitutes a bidentate ligand
providing the highly conserved coordination via the two γ-
carboxyl groups to the Ca2+ ion (Gagné et al., 1997; Grabarek,
2011). In CIB2, positions -X and -Z are occupied respectively
by G165, lacking contributions from the side chain, and D168,
which does not possibly act as a bidentate ligand (Figure 1).
Moreover, the position occupied by the side chain of D159 in the
structural model of CIB2 does not seem optimal for contributing
to Ca2+ coordination even after energy-minimization, at odds
with that of the aligned residue D163 in CIB1 (Figure 1). Overall,
the geometry of the Ca2+-coordinating oxygens in the EF4 loop
of CIB2 is thus likely distorted with respect to the canonical
one, hence leading to a low affinity for Ca2+. Differences in
the sequence of the EF3 loop also distinguish CIB2 from CIB1,
which may explain the lower affinity for Ca2+ shown by the
first protein. Position Y in CIB1 is occupied by the negatively
charged D118, which is substituted by N118 in CIB2, moreover
the -X position, again occupied by an Asn (N124) in CIB1 is
occupied by a Cys (C124) in CIB2. Interestingly, CIB1 like CIB2
does not have a Glu at position -Z, but has an Asp instead
(D127), thus explaining the lower affinity for Ca2+-compared
to EF4.
The fact that all four CIBs have an Asp instead of a Glu
residue at position -Z (Figure 1) suggests that EF3 can serve
as a Mg2+-binding specific motif. Previous mutagenesis studies
showed that the replacement of the Asp residue in the 12th
position (-Z) of an EF-hand metal binding loop with a Glu
increases the affinity for Ca2+and abolishes binding of Mg2+,
rendering the site calcium-specific, probably due to the reduced
ability of side chains to change conformation (da Silva et al.,
1995). We are therefore tempted to generalize that EF3 is the
Mg2+-specific binding motif among the CIB family, while Ca2+
might bind to EF4 under physiological conditions, although this
is clearly not the case for CIB2. The conformational switch
from a molten globule to a well-defined tertiary structure is
likely governed by the acidic residue in the 12th position (-
Z) of an EF-hand (Gifford et al., 2007), therefore Mg2+ seems
to be the initiator of the functional switch among the CIB
family.
We have also studied the potential effect of a CIB2-
specific target on the protein metal cation-sensing ability.
Although our investigation has been limited to one of the many
possible binding targets of CIB2, namely a peptide covering
the membrane-proximal sequence of the integrin α7B cytosolic
domain, our data show that the interaction with the target
doubles the apparent affinity of CIB2 for Ca2+ (Table 1), however
the detected Kd
app is still incompatible with a physiological
capability of Ca2+ sensing. We cannot exclude, however, that
in specific cell compartments and/or under specific conditions
related to disease and/or cell death, the increased intracellular
Ca2+ and the concomitant presence of a specific target would
render CIB2 capable of Ca2+ sensing, therefore providing specific
functions. This is however not possibly the case of E64D CIB2,
which showed a mM affinity for Ca2+ under all the tested
conditions, including the presence of the target peptide (Table 1
and Figure 6).
Both WT and E64D CIB2 were shown to bind specifically
the α7B_M target peptide with a low µM affinity comparable
to that shown for CIB1-αIIb interaction (Kd = 1.41–1.02µM,
in the presence of Ca2+ and Mg2+, respectively) (Shock
et al., 1999; Yamniuk and Vogel, 2005). Future studies will
be necessary to further elucidate the binding thermodynamics
of CIB2 to its putative targets, including those belonging to
the Usher interactome. A broader set of conditions including
different cation concentrations and models that account for
the dimeric nature of CIB2 shall be specifically tested.
Nevertheless, our data seem sufficient to exclude that the
principal dysfunction of the USH1J-associated E64D CIB2
be related to the lack of recognition of specific targets.
Instead, our data point clearly to the incapability of this CIB2
mutant to switch to its native, Mg2+-bound conformation
(Figures 3, 5, 6). E64D CIB2 was indeed observed to maintain,
under physiological levels of Mg2+, a partially unfolded
conformation that makes it significantly less stable and
prone to aggregation compared to the WT (Figure 2 and
Figure S3).
The switch that allows WT CIB2 to acquire a functional
conformation at physiological Mg2+ appears to be finely
regulated by an allosteric, long-range communication connecting
EF1 with EF3. Our data are inconsistent with mutations in
CIB2 disrupting auditory hair cell calcium homeostasis (Jan,
2013) as with such a low affinity not even the WT protein is
expected to be involved in Ca2+ sensing under physiological
conditions. Instead, we propose that the inability to bind Mg2+
of E64D CIB2 prevents the allosteric regulation that makes the
protein switch to the native conformation required for its normal
function.
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Figure S1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S1: SDS and Native-PAGE of CIB2. a) SDS-PAGE of 20µM CIB2 before (lane 1) and after 
(lane 2) TEV-cleavage of the His-tag in the presence of 1mM DTT. b)  Continuous native-PAGE 
(12% acrylamide/bis- acrylamide) of 14µM CIB2 in the presence of 5mM EGTA (lanes 1-2) or 5mM 
Ca2+ (lanes 3-4). 1mM DTT was added in lanes 2 and 4. 
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Figure S2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S2: SEC analysis. Gel filtration elution profiles under reducing conditions of : a) WT CIB2  
and b) E64D CIB2 in the presence of 3 mM EGTA (black line), 3 mM Mg2+ + 2 mM EGTA (blue 
line) and 3 mM Mg2+  + 2 mM Ca2+  (red line). c-d) Determination of MW for apo-, Mg2+ and Ca2+ -
bound WT and E64D CIB2.  Calibration curve prepared by plotting the Log10 MW value for each 
standard protein versus its corresponding Kd value. 1. β-amylase; 2. Alcohol Dehydrogenase; 3. 
Carbonic anhydrase; 4. Cytochrome c. Chromatograms in a) and b) were used to determine the MW 
for apo-, Mg2+ and Ca2+ -bound WT CIB2 and E64D CIB2, respectively (Table S1).    
 
 
 
 
 
 
 
 3 
Figure S3 
 
Figure S3: Time-resolved dynamic light scattering.  Mean count rate time-course of a) WT and b) 
E64D CIB2 in the presence of 3 mM EGTA (black line), 3 mM Mg2+ + 2 mM EGTA (blue line) and 
3 mM Mg2+ + 2 mM Ca2+ (red line). 
 
 
 
 
Figure S4 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S4: ANS fluorescence spectroscopy. ANS fluorescence spectra of: a) WT CIB2 and b) E64D 
CIB2 in the presence of 0.5 mM EDTA (dotted black line), 1 mM Mg2+ (short dashed blue line) and 
1 mM Mg2+ + 1 mM Ca2+ (solid red line). The fluorescence spectrum of ANS alone is also shown 
(dash dotted green line). 
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Figure S5 
 
Figure S5: 2D NMR spectra. Two-dimensional 1H-15N HSQC NMR spectra of 15N-WT CIB2 with 
addition of 3 mM Mg2+ + 7 mM Ca2+ (panels a, d), 5 mM Mg2+ + 5 mM Ca2+ (panels b, e), 7 mM 
Mg2+ + 3 mM Ca2+ (panels c, f). The complexes were obtained by adding to the protein different 
solutions containing both Mg2+ and Ca2+ ions yielding the same overall ionic strength. The spectra 
were recorded at 600 MHz and 25°C, the samples were at protein concentration of 150 µM in 20 mM 
Hepes, 100 mM KCl, 1 mM DTT, pH 7.5 and 7% D2O. 
 
 
Figure S6 
 
 
 
Figure S6: Near UV CD spectra of E64D CIB2 after sequential additions of increasing concentrations 
of: a)  Ca2+ and: b) Mg2+ in the 2-10 mM range. The experimental conditions were the same as those 
of Figure 3e.  
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Figure S7 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S7: Effect of the α7B_M peptide on the secondary structure of WT CIB2. 12µM Mg2+ 
bound-WT CIB2 was incubated at 37°C in the presence of 6µM α7B_M peptide (ratio 2:1). Spectra 
were collected in the presence of low (100µM, grey line) and high (1mM, red line) Ca2+ concentration. 
Spectra obtained for the α7B_M peptide in the absence of CIB2 are also shown (dashed lines).  
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Table S1:  Molecular weight of WT and E64D CIB2 estimated by Analytical SEC and Ferguson 
Plots 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table S2: Analysis of ANS fluorescence and CD thermal denaturation data for WT and E64D 
CIB2 
 
 MWSEC (KDa)  MWFP (KDa) 
WT -apo 51.1 51 
+ Mg2+ 38.6 52 
+Mg2++ Ca2+ 38.1 53 
E64D -apo 68.4 53 
+ Mg 2+ 38.5 53 
+Mg2+ + Ca2+ 36.9 53 
 blue shift (nm)1 Fmax/Fref Tm (°C) Hc 
WT -apo 27 2.6 35.1 7.5 
+ Mg2+ 25 2.2 45.7 11 
+ Ca2+ 25 2.1 43.4 12.5 
+Mg2+/Ca2+ - - 45.9 11.2 
     
     
E64D –apo 31 2.8 - - 
+ Mg2+ 30 2.6 34.2 9.5 
+ Ca2+ 29 2.5 34.5 8.6 
+Mg2+/Ca2+ - - 36.7 8.9 
1 Blue shift refers to the observed shift of the wavelength of maximum emission of the protein + ANS 
mixture upon excitation at 380 nm as referred to that of ANS alone. 
2 Fmax/Fref refers to the ratio between maximal fluorescence emission of the protein + ANS mixture and that 
of ANS alone. 
3 Tm and Hc represent, respectively, the melting temperature and the Hill coefficient obtained by data fitting 
in thermal denaturation profiles. 
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oligomeric state, hydrodynamic 
properties and target recognition 
of human calcium and integrin 
Binding protein 2 (CIB2)
Giuditta Dal cortivo1, Valerio Marino1,2, claudio iacobucci3, Rosario Vallone1,4, christian Arlt3, 
Anne Rehkamp3, Andrea Sinz3 & Daniele Dell’orco1*
Calcium- and Integrin-Binding protein 2 (CIB2) is a small and ubiquitously expressed protein with largely 
unknown biological function but ascertained role in hearing physiology and disease. Recent studies 
found that CIB2 binds Ca2+ with moderate affinity and dimerizes under conditions mimicking the 
physiological ones. Here we provided new lines of evidence on CIB2 oligomeric state and the mechanism 
of interaction with the α7B integrin target. Based on a combination of native mass spectrometry, 
chemical cross-linking/mass spectrometry, analytical gel filtration, dynamic light scattering and 
molecular dynamics simulations we conclude that CIB2 is monomeric under all tested conditions and 
presents uncommon hydrodynamic properties, most likely due to the high content of hydrophobic 
solvent accessible surface. Surface plasmon resonance shows that the interaction with α7B occurs with 
relatively low affinity and is limited to the cytosolic region proximal to the membrane, being kinetically 
favored in the presence of physiological Mg2+ and in the absence of ca2+. Although CIB2 binds to an 
α7B peptide in a 1:1 stoichiometry, the formation of the complex might induce binding of another CIB2 
molecule.
Calcium- and Integrin-Binding protein 2 (CIB2) is a small (21.7 kDa) Ca2+ and Mg2+-binding protein initially 
discovered as a DNA-dependent protein kinase interacting protein1. It is a member of the CIB family, which 
contains homolog EF-hand proteins showing evolutionary relationship with the class of neuronal calcium sensor 
proteins2. Its broad expression levels in a variety of tissues suggests the direct involvement of CIB2 in a hetero-
geneous group of physiological and disease-associated processes, which include congenital muscular dystrophy 
type 1A3, promotion of HIV-viral infection4, N-methyl-D-aspartate receptor-mediated Ca2+ signaling in cultured 
hippocampal neurons5, and very recently sphingosine kinase 1-mediated oncogenic signaling in ovarian cancer6. 
While its physiological role remains largely unknown, some general functional features of CIB2 have been estab-
lished: (i) CIB2 can bind Ca2+ and Mg2+ ions via two functional EF-hand motifs, namely EF3 and EF4, therefore 
switching to a specific conformation7,8; (ii) CIB2 specifically binds to the cytoplasmic domain of integrin α7B3,7, 
as well as to αIIb integrin7, thus being presumably involved in a variety of signal transduction processes.
In spite of its evidently broad biological role, recent findings suggest that CIB2 is deeply involved in hearing 
physiology. CIB2 knockout mice showed abolished mechanoelectrical transduction in auditory cells leading to 
profound hearing loss9, moreover missense mutations in the gene encoding for CIB2 have been found to be 
associated with hereditary non-syndromic deafness (DFNB48) and possibly Usher Syndrome type 1J, a genetic 
disorder characterized by hearing loss and progressive blindness10,11. Altogether, these recent findings suggest that 
CIB2 is an essential component for the normal development of hair cells.
In a recent study8 we investigated the capability of CIB2 to bind Ca2+ and Mg2+ thereby switching to a func-
tionally distinct structural state. By integrating several biochemical and biophysical techniques we could estab-
lish that in the absence of any cation CIB2 forms a molten globule state that essentially lacks tertiary structure. 
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Binding of either Ca2+ or Mg2+ leads to a highly similar tertiary structure although the apparent affinity for Ca2+ 
(Kdapp = 0.5 mM) was found to be significantly lower compared to that for Mg2+ (Kdapp = 290 μM). This is quite 
unusual for Ca2+-sensor proteins, but it could be explained by the relatively low sequence similarity in key func-
tional regions when comparing CIB2 with the homologue CIB1 and other members of the CIB family8. We also 
found that the binding of cations to the functional motif EF3 at the C-terminal domain (Fig. 1) triggers a confor-
mational transition that puts the EF3 loop in allosteric communication with the N-terminal domain, specifically 
with residue E64, that has been found mutated into an aspartic acid in Usher Syndrome type 1J11. Surprisingly, the 
apparently conservative E64D mutation abolishes the conformational switch and significantly lowers the affinity 
for both cations8, indicating that even a small difference such as the presence or absence of a methylene bridge 
between acidic amino acids can be critical to whether an essential interaction can take place or not. Both wild 
type (WT) and E64D-CIB2 were found to recognize and bind a peptide from the known target integrin α7B3,7 
with similar affinity in the micromolar range, and based on analytical size exclusion chromatography (SEC), 
dynamic light scattering (DLS) and non-denaturing electrophoresis assays we concluded that CIB2 is dimeric, in 
line with independent previous observations11,12.
In an attempt to define the structural features of the CIB2 dimeric interface and its interaction with putative 
target peptides by employing cross-linking/mass spectrometry13–15, we found evidence of monomeric CIB2, but 
surprisingly no evidence of dimers. In this work we therefore sought to thoroughly characterize the oligomeric 
state of CIB2 and the interaction with its established target. A variety of mass spectrometry (MS)-based tech-
niques, including native ESI-MS, MALDI-TOF-MS, and cross-linking/MS (XL-MS) experiments of the intact 
protein, were integrated with novel SEC and DLS experiments based on a more accurate selection of the hetero-
geneous components of the elution bands. The analysis of the newly assessed hydrodynamic properties of CIB2, 
in comparison with those of two other Ca2+-sensors, namely calmodulin (CaM) and recoverin (Rec), helped 
explaining the misinterpretation in our previous results as to the dimeric nature of CIB2, thus calling for particu-
lar caution when using analytical SEC for assessing the apparent molecular weight of Ca2+-sensor proteins. The 
MS-based techniques as well as surface plasmon resonance (SPR) analysis exclude dimerization of CIB2 over the 
broad range of conditions tested in this study, and highlight a specific interaction only with the membrane proxi-
mal segment of the cytoplasmic domain of α7B integrin, in line with previous results by us8 and others7, revealing 
no significant interaction with the C-terminus proximal region.
Results and Discussion
Native Mass Spectrometry and XL-MS analyses do not show evidence of CIB2 dimers. Native 
electrospray ionization (ESI)-MS served to investigate the oligomeric state of CIB2. Figure 2A shows that under 
native pH conditions CIB2 appears in the three main charge states 8+ to 10+ with signals at m/z 2178, 2420, and 
2722. Deconvolution of the mass spectrum yielded a molecular mass of 21,767 Da, which is in perfect agreement 
with the mass of 21.7 kDa. Strikingly, no signals of CIB2 dimers, nor higher order oligomers were detected in 
native MS experiments.
In addition, CIB2 was subjected to chemical cross-linking with DSBU (disuccinimidyl dibutyric urea) in the 
presence of the two peptides α7B_M and α7B_Scrb (Fig. 2B,C). While peptide α7B_M is supposed to bind to 
CIB2, the scrambled peptide α7B_Scrb should not show complex formation with CIB2. CIB2 appears in the 
MALDI-TOF mass spectrum at m/z 21,770 (Fig. 2B, black line). With increasing amount of peptide α7B_M, a 
1:1 CIB2/peptide complex appears in the mass spectra, as is visible from the signals between m/z ~ 24,000 and 
26,000 (Fig. 2B). The calculated mass of a 1:1 CIB2/peptide complex with one cross-linker molecule is 23,964 Da. 
The mass spectrum indicates the additional attachment of two to five cross-linker molecules to the 1:1 complex 
where the cross-linker DSBU has either reacted at both sides or is partially hydrolyzed. A weak signal for a 1:2 
CIB2/α7B_M peptide complex is also visible in the mass spectrum (signals between m/z 26,500 and 28,000). 
Moreover, CIB2 was detected without peptide, but decorated with one to five DSBU cross-linker molecules. As 
such, the signal at m/z 21,967 corresponds to CIB2 that is intramolecularly cross-linked with one DSBU molecule 
(Δm = 196 u).
Figure 1. Three-dimensional structure of the homology model of Ca2+-bound human CIB2. Protein secondary 
structure is shown as cartoons, EF1 is colored in yellow, EF2 is colored in green, EF3 is colored in orange, EF4 is 
colored in blue, the C-terminal helix is colored in cyan and Ca2+ ions are shown as red spheres. Residue E64 is 
shown as sticks. The structural model is from ref.8 (see Methods).
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In contrast, cross-linking between CIB2 and peptide α7B_Scrb showed only minor signals for a 1:1 complex 
(Fig. 2C), but CIB2 was mainly found to be modified with one to five DSBU molecules (signals between m/z ~ 
22,000 and 23,000).
Given that native ESI-MS only showed a CIB2 monomer and furthermore, in cross-linking experiments, a 
2:1 CIB2 and peptide α7B_M complex was never observed, this clearly points to monomeric rather than dimeric 
CIB2.
Analytical size exclusion chromatography and dynamic light scattering of CIB2, CaM and Rec 
highlight different hydrodynamic properties. Previous analytical SEC experiments of CIB2 under 
reducing conditions displayed elution profiles corresponding to an apparent MW in the 37–39 kDa range in 
different cation-bound states, thus compatible with a dimer and incompatible with a monomer8. Moreover, DLS 
experiments performed with the samples collected immediately after elution from the SEC column measured 
a relatively high hydrodynamic diameter (dMg = 8.43 nm and dCa = 8.18 nm), which was also interpreted as an 
evidence of a dimeric protein8. Since the present MS-based data appear to be in clear contradiction with previous 
findings, we repeated both analytical SEC and DLS using identical conditions as for the XL-MS experiments. 
Results are reported in Fig. 3.
In the presence of 1 mM Mg2+, 2 mM Ca2+ and DSBU cross-linker (same conditions as those used in XL-MS 
experiments) CIB2 showed a SEC elution profile (Fig. 3A, green curve) that substantially overlapped with that of 
the protein without cross-linker (Fig. 3A, black curve) when the first elution peak is concerned (see peaks #1 and 
#2). According to a calibration curve obtained with globular proteins of known MW, these bands would corre-
spond to an apparent MW (MWSEC) of 35.9 kDa in the absence and of 36.7 kDa in the presence of the cross-linker, 
thus very similar to those obtained in our previous work under slightly different conditions. The second promi-
nent peak at higher elution times observed for cross-linked CIB2 (Fig. 3A, green curve, peak #3) corresponds to 
Figure 2. Results from MS experiments. (A) Native ESI mass spectra collected in the presence of 14 µM CIB2 
in 200 mM ammonium acetate, pH 6.8. Collision energy was set to 60 V. (B,C) MALDI-TOF-MS measurements 
of cross-linked CIB2 samples with peptides α7B_M (B) and α7B_Scrb (C). 10 µM CIB2 was cross-linked with 
50-fold molar excess of DSBU with increasing concentrations (5 μM, red line; 10 μM, blue line; 20 μM, green 
line) of α7B_M (B) and α7B_Scrb (C) peptides in the presence of 1 mM Mg2+ and 2 mM Ca2+. Between 1000 to 
3000 laser shots were accumulated to one MALDI-TOF mass spectrum. CIB2 without DSBU cross-linker was 
included as internal control (black line).
Figure 3. Investigation of apparent MW of CIB2 including other two Ca2+-sensor proteins by analytical SEC 
(A,B) and DLS (C). (A) MW investigation of CIB2 before (black line) and after (green line) modification with 
DSBU. One reaction was performed in the presence of sole DSBU (red line). (B) CIB2 (∼70 µM), Rec (∼80 µM) 
and CaM (∼110 µM) were loaded into an analytical SEC column previously equilibrated with 20 mM HEPES 
pH 7.4, 150 mM KCl, 1 mM DTT, 1 mM Mg2+ , 2 mM Ca2+. The inset shows the zoom of CIB2 elution profile 
that was collected in two different fractions, represented by the colored areas. (C) The hydrodynamic diameters 
of the eluted peaks were assessed by DLS: 15 to 30 measurements were collected for each sample at 37 °C, 
consisting in at least 13–15 repetitions. The presented curves represent the average distribution. The protein 
concentration in the eluted fractions was found to be: 11 µM (Rec), 7.4 µM (CaM) and 1.8 µM (CIB2).
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the elution of DSBU compounds, as proved by the complete overlapping with the band obtained when eluting 
DSBU alone (red curve, peak #4). The chemical nature of the eluate was further confirmed by NMR spectroscopy 
(data not shown). Therefore, although an MWSEC of 37–39 kDa previously drove us to the conclusion that a pro-
tein with actual MW of 21.6 kDa eluted as a dimer, our MS and XL-MS results clearly show that the interpretation 
was not correct in the case of CIB2, which remained monomeric in all tested conditions.
To further investigate the nature of the misleading result we performed analytical SEC of two other 
Ca2+-sensors of similar size in the same conditions in which CIB2 was shown to elute with a significantly higher 
MW than that expected for a monomer. For this purpose, we used CaM (16.8 kDa) and Rec (23.3 kDa), which 
are both well characterized, Ca2+-sensor proteins. The three-dimensional structure of the three proteins was also 
used to estimate the theoretical value of the hydrodynamic diameter by the HydroPro software16 and compare 
it with that measured by DLS right after the elution from the SEC column. Quantitative results are reported in 
Table 1.
SEC elution profiles (Fig. 3B) showed a main elution peak for each Ca2+-sensor, which corresponds to an 
MWSEC of 37.8 kDa for CIB2, 33.5 kDa for Rec and 20 kDa for CaM (Table 1). A closer look at the elution profile 
of CIB2, however, showed the presence of a lower intensity shoulder at lower elution time (Fig. 3B; inset). This 
shoulder (here denominated A1) was collected together with the main peak (A2) in our previous work8. In con-
trast, the two fractions were separately collected and analyzed in the present study. Interestingly, the effect of 
A1, with a predicted MWSEC of 81.3 kDa was that of rendering the colloidal suspension analyzed by DLS more 
disperse and to confer CIB2 an apparently higher hydrodynamic radius. Indeed, when A2 was analyzed by DLS 
as separated from A1 (Figs 3C and S1), a lower hydrodynamic diameter was determined (5.4 ± 0.2 nm; Table 1 
and Fig. S1), which was similar to that of Rec (5.0 ± 0.1 nm; Table 1 and Fig. S1) and CaM (5.8 ± 0.1 nm; Table 1 
and Fig. S1), and significantly lower compared to that previously measured for CIB2 when both A1 and A2 were 
collected in one sample (dMg = 8.4)8. We thus conclude that our inferences as to the dimeric nature of CIB2 based 
on previous DLS experiments were affected by the presence of the A1 band, as current DLS data based on a more 
accurate selection of the elution peak confirm the monomeric form of CIB2.
An apparent joint feature of Rec and CIB2 is that their estimated MWSEC is significantly higher than that of 
a monomer (Table 1). Although Rec has been shown to dimerize in the presence of Ca2+ 17, dimers were clearly 
isolated at protein concentrations above 100 μM, so we assume that in our experiments Rec was mostly mon-
omeric. We speculate that this fact could be related to the significantly higher hydrophobic solvent-accessible 
surface of Rec and CIB2 compared to that of CaM (60–62 nm2 vs 50 nm2, Table 1; Fig. 4). Solvation of their large 
hydrophobic surfaces might influence the interaction of CIB2 and Rec with the column matrix and result in lower 
retention time, that is higher MWSEC compared to CaM. On the other hand, DLS data show a significantly better 
correlation between the measured and the theoretical hydrodynamic diameter estimated by HydroPro, especially 
considering that the structural model used for CIB2 was missing the first 12 residues (Table 1). The size measured 
by DLS seems to correlate to some extent with the radius of gyration of the protein, which accounts for molecu-
lar geometry and shape and the space distribution of amino acids. In spite of its lower MW, due to its elongated 
HydroPro Ø 
(nm)
Gyration 
radius (nm) DLS Ø [n] (nm)a
Hydrophobic SAS 
area (nm2)
Hydrophilic SAS 
area (nm2)
Total 
SAS area 
(nm2)
MW 
(kDa)
MWSEC
(kDa)
CIB2
(13–184)b 4.736 1.88 5.4 ± 0.2 [15] 59.94 55.34 115.38 21.3
37.8 (A2 
band)
Rec
(1-201)b 5.112 1.94 5.0
a ± 0.1 [18] 62.54 64.68 127.23 23.3 33.5
CaM
(1–149)b 5.076 2.22 5.8 ± 0.1 [30] 50.28 54.97 105.26 16.8 20.5
Table 1. Comparison of the hydrodynamic properties of CIB2, CaM and Rec. aData are reported as 
mean ± SEM; n represents the number of measurements used for the calculation. bSequence coverage of the 
structural models used for hydrodynamic diameter calculation.
Figure 4. Three-dimensional structures of bovine Rec (left), human CaM (center) and human CIB2 (right) 
used for hydrodynamic diameter estimation. Proteins secondary structure is shown as grey tubes, Ca2+ ions 
are represented as red spheres, myristoyl group is shown as orange sticks, hydrophilic and hydrophobic solvent 
accessible surfaces are represented in transparency as blue and grey surfaces, respectively.
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form (Fig. 4) CaM has a significantly higher radius of gyration (2.22 nm) compared to Rec (1.94 nm) and CIB2 
(1.88 nm), which is reflected by a significantly higher size detected by DLS (Table 1).
Although analytical SEC has been widely used to determine the molecular weight of proteins by comparing 
elution volume parameters with those of different known calibration standards, the elution profile of proteins is 
closer to their Stokes radius rather than to their effective molecular weight, and particular care should be taken 
when the shape of the protein is different from the generally globular shape of the standards18. For Ca2+-sensor 
proteins, that significantly change their conformation as well as their solvation properties upon Ca2+ binding19–21, 
this aspect appears to be especially relevant. When a comparison of the hydrodynamic properties was made for 
a single Ca2+-sensor protein in the presence of several point mutations, a significant correlation between SPR, 
DLS, and SEC data was observed21, but comparisons cannot be easily extended to different proteins with different 
shapes and hydration shells due to different hydrophobic SAS. In conclusion, one should be extremely careful 
when using analytical SEC for assessing MWSEC based on a standard of unrelated proteins and should always look 
for other independent estimates.
ca2+ and Mg2+ binding stabilize CIB2 tertiary structure. It was previously shown by NMR spec-
troscopy that saturation with either Mg2+ or Ca2+ makes CIB2 switch from a molten globule state to a 
structurally-folded state with very similar tertiary structure7,8. We performed limited proteolysis experiments to 
assess the sensitivity of CIB2 structural states to protease digestion. It is indeed known that binding of specific 
ligands may significantly affect the accessibility of proteins to proteases, thus providing useful information as to 
protein flexibility22.
Incubation of CIB2 with trypsin showed a clear time-dependent proteolytic pattern, which was found to 
depend on the cation-bound state (Fig. S2). We chose to further analyze the proteolytic pattern after 5 minutes 
and 30 minutes for apo-CIB2, as well as for the protein in the presence of 1 mM Mg2+ and after the further addi-
tion of 2 mM Ca2+ (Fig. 5).
Even without the addition of trypsin, CIB2 showed some propensity to degradation, as shown by the faint 
band appearing after 10 minutes at 25 °C under all tested conditions (Fig. 5A). The band was impossible to elimi-
nate completely with the purification procedure and was observed previously before and after the cleavage of the 
His-tag8. MALDI experiments confirmed the presence of 16–17 kDa fragments (results not shown). The fact that 
the intensity of this band increased significantly in the time frame of the proteolysis experiments (Fig. 5B, control 
lane) supports its presumed nature.
Limited proteolysis clearly showed that after 30 min incubation with trypsin the native band of apo-CIB2 was 
completely lost, and several proteolytic fragments at lower molecular weight appeared. Interestingly, incubation 
with either Mg2+ or Ca2+ and Mg2+ permitted the detection of the native CIB2 band even after 30 min, although 
some smaller proteolytic fragments of comparable MW as to the ones for apo-CIB2 were clearly detected 
(Fig. 5B). Thus, Mg2+ and Ca2+ seem to exert a protective role in terms of accessibility to the protease, as a result 
of more rigid conformation, in line with previous observations7,8. It should be pointed, however, that some flexi-
ble regions remain even in the cation-complexed state, as clearly shown by the smaller MW bands.
In order to investigate the nature of the most flexible regions observed in cation-complexed CIB2, we per-
formed 400 ns Molecular Dynamics (MD) simulations of Ca2+-CIB2 and computed the Root Mean-Squared 
Fluctuation index (RMSF) of Cα atoms. RMSF provides information as to the average displacement of selected 
atoms with respect to the initial position during the time course of the simulation, thus providing information 
Figure 5. CIB2 limited proteolysis. (A) 10 µM CIB2 was incubated at 25 °C in the presence of 1 mM EDTA 
(Apo), 500 µM EGTA + 1 mM Mg2+ (Mg2+) and 1 mM Mg2+  + 2 mM Ca2+ for 10 minutes at 25 °C. Samples 
were boiled and loaded in a 18% SDS polyacrylamide gel. (B) Limited proteolysis was performed incubating 
trypsin with 25 µM CIB2 in the same concentrations of ions used for (A) (protein:enzyme ratio was 100:1). 
Samples were collected at different times, boiled and loaded on a 18% SDS-PAGE. Both gels run for 45–50 min, 
then they were Coomassie Blue-stained. The figure results from two separate gels, which have been reported in 
full length in Fig. S6.
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on protein flexibility. The RMSF profile of Ca2+-saturated CIB2 (Fig. S3) is that of a somewhat flexible protein, as 
other WT Ca2+-sensors that underwent the same MD simulation procedure displayed significantly lower RMSF 
distributions23–26. The structural regions that showed higher flexibility are the pseudo EF1 motif (yellow seg-
ment, Figs 1 and S3), the loop linking EF3 and EF4 (orange and blue), the end of the exiting helix in EF4 and the 
C-terminus (blue and cyan). We speculate that these regions could be those that remain accessible to trypsin even 
when CIB2 is bound to Ca2+, due to their high intrinsic flexibility.
Surface plasmon resonance points to monomeric CIB2 and highlights a low-affinity interaction 
with the membrane proximal segment of α7B integrin. SPR is a powerful and versatile technique to 
detect at real time biomolecular interactions, and it can be applied to study protein oligomerization, in particular 
dimerization, when care is taken to immobilize on the surface of a sensor chip low amounts of proteins under 
controlled conditions27–29. Two independent experiments were run following low levels of amine-coupling of 
CIB2 (130 RU and 226 RU, respectively) on the surface of a sensor chip. In no case was a signal detected when 
injecting uncoupled CIB2 in the 92 nM – 46 μM range in the presence of Ca2+ and Mg2+ (results not shown). 
Hence, SPR did not detect dimerization for CIB2 over a broad range of concentrations.
SPR was also used to study quantitatively the interaction of CIB2 with one of its established targets, namely 
the cytoplasmic domain of integrin α7B3,7. Three different peptides were used in the interaction experiments. A 
peptide corresponding to the membrane proximal segment of the cytoplasmic domain of α7B integrin (α7B_M), 
another peptide with the same amino acid content, but randomized sequence (α7B_Scrb) and a peptide covering 
the C-terminal region of the cytoplasmic domain of α7B integrin (α7B_C). Three different approaches were used. 
In a first approach, His-tagged CIB2 was initially coupled to the surface of a His-cap sensor chip (see Methods), 
thus ensuring homogeneous site-specific orientation, and then blocked via standard amine coupling. Near-UV 
CD spectroscopy (Fig. S4) confirmed that the His-tagged CIB2 had substantially the same tertiary structure of 
the untagged protein, and identically responded to Mg2+ and Ca2+. The minor differences in the spectra at the 
level of the phenylalanine band can be ascribed to the TEV-protease recognition site (ENLYFQ), uncleaved in the 
His-tagged protein. In a second approach, the α7B_M peptide was immobilized on the surface of a sensor chip by 
amine coupling at levels comparable to those for CIB2 in the former approach (2250 RU). In a third approach, we 
used the same low levels of CIB2 immobilization via amine coupling described in the experiments to probe CIB2 
dimerization (100–200 RU) and flowed the three peptides. Examples of the obtained sensorgrams are reported 
in Fig. 6.
Figure 6. SPR measurements of CIB2-peptide interaction. (A) Either α7B_M, α7B_Scrb or α7B_C peptides 
(7.5 µM) were injected over His-CIB2 homogeneously immobilized by His-tag on the chip surface. (B) 30 µM of 
the same peptides were injected over untagged CIB2 previously immobilized on the surface of a COOH5 chip 
via amine coupling. (C) Increasing concentrations of α7B_M peptide were injected on His-CIB2 immobilized 
as in (A). Experimental data (black curves) were fitted to a bivalent analyte kinetic model (red curves). All the 
experiments were performed using 20 mM HEPES pH 7.5, 150 mM KCl, 1 mM DTT, 1 mM Mg2+, 2 mM Ca2+, 
50 µM EDTA, 0.005% Tween as buffer. Two minutes injections were performed using a flow rate of 20 µL min−1, 
dissociations were followed for 200 seconds. (D) A possible scheme of CIB2-α7B_M interaction compatible 
with the kinetic model. The interaction of a CIB2 monomer immobilized on the chip (green) with a peptide 
(orange) can lead to the binding of another CIB2 molecule; all steps are fully reversible.
7Scientific RepoRtS |         (2019) 9:15058  | https://doi.org/10.1038/s41598-019-51573-3
www.nature.com/scientificreportswww.nature.com/scientificreports/
The second approach (direct peptide immobilization) led to very low signals and unreproducible results and 
was not pursued any further. Interestingly, both homogenous and site-specific coupling of CIB2 via its His- tag 
(approach 1) and heterogeneous coupling via non-specific amine coupling (approach 2) showed sensorgrams 
incompatible with a typical 1:1 Langmuir adsorption process. The two experiments showed clearly different asso-
ciation kinetics, and yet very similar dissociation kinetics incompatible with a monophasic exponential profile 
(Fig. 6A,B). In spite of such differences, which might reflect both the heterogeneity of the surface and the different 
chemistry of immobilization, interaction results were consistent with one another. Indeed, both experiments 
confirmed that α7B_M binds to CIB2 significantly stronger than the control peptide α7B_Scrb, which was shown 
to interact with low affinity also in MALDI experiments (Fig. 2B,C), where a band was detected in the same 
stoichiometric conditions, although with lower intensity. Moreover, the assays could not detect any interaction 
with the α7B_C peptide over the whole range of tested conditions. In this respect, our results are in line with 
those by Huang et al.7, who by fluorescence spectroscopy detected a much stronger interaction of CIB2 with the 
membrane-proximal region of the cytosolic tail of α7B integrin (corresponding to α7B_M), and a much weaker 
interaction with the C-terminal region, corresponding to the α7B_C peptide, at odds with Häger et al.3, who 
tested and detected interaction with the C-terminal region of α7B. It should be noted that both Huang et al.7 and 
Häger et al.3 used peptides from mouse integrin, while we used the corresponding human sequences, which in 
the case of α7B_C lacks the tryptophan residue present in the mouse sequence. It is not uncommon that fluo-
rescence spectroscopy interaction studies based on the peptide intrinsic fluorescence (CIB2 has no tryptophan 
residue) reveal some non-specific binding, especially when a highly hydrophobic protein such as CIB2 is the 
ligand. Indeed, in our previous work we observed some non-specific signal when titrating CIB2 with α7B_Scrb, 
although fluorescence variation upon titration with α7B_M was much higher8. It cannot be excluded that a simi-
lar phenomenon occurred for murine α7B_C in the work by Häger et al.3. Our present results, based on accurate, 
label-free interaction studies clearly identify the region covered by α7B_M as the preferential binding site of CIB2 
with α7B integrin.
SPR titrations of α7B_M over homogeneously coupled CIB2 (approach 1) gave very reproducible results and 
were performed both in the presence of 1 mM Mg2+ and in the co-presence of 1 mM Mg2+ and 2 mM Ca2+. 
Peptide concentration was varied in the 230 nM–30 μM range. An example of such titration is reported in Fig. 6C. 
As anticipated, sensorgrams could not fit to a 1:1 binding model, and the kinetic model that better fit the data 
was a bivalent analyte model (see Methods), in which one α7B_M peptide could bind to two CIB2 molecules. 
According to this scheme, binding of the peptide to the first CIB2 molecule would direct the binding to the sec-
ond one, thus resulting in two sets of kinetic constants. Data fitting to this model was very good over the broad 
range of concentrations tested (Fig. 6C) and resulted in the kinetic parameters reported in Table 2. The same table 
also shows the results from steady state analysis, which allows an estimate of the total apparent affinity KDappTOT 
accounting for avidity effects, as compared to that determined by the first binding event (one peptide to one CIB2 
molecule, KDapp1).
Our data suggest that CIB2 binds the α7B_M peptide with a relatively low affinity and that the formation of 
a protein-peptide complex may drive the binding of a second CIB2 molecule. Since CIB2 per se is monomeric, 
our data cannot exclude that binding of a target peptide induced dimerization of CIB2 on the chip, which would 
explain the high maximal response in terms of RU obtained in our binding experiments (Fig. 6C). Whether this 
process has a physiological meaning remains to be clarified. Interestingly, both the association process of α7B_M 
to the first CIB2 molecule, and then the association of the complex with a second CIB2 molecule occurred faster 
in the sole presence of Mg2+ compared to the co-presence of Ca2+ (2-fold for the first and 5-fold for the second 
binding event, respectively; Table 2). The dissociation process was not found to significantly depend on the cation 
conditions, the only significantly difference being the 2.5 times faster dissociation of the second CIB2 molecule 
in the co-presence of Mg2+ and Ca2+. In conclusion, the presence of Ca2+ seems to affect the recognition pro-
cess of CIB2 and α7B in a complex way: it induces slower association and a slightly faster dissociation of the 
first CIB2-peptide complex, thus resulting in roughly half affinity compared to Mg2+ alone (KDapp1 = 25 μM vs 
11.6 μM), however when the whole binding process is considered avidity comes into play and the apparent affinity 
in the presence of both Mg2+ and Ca2+ (KDappTOT = 154 μM) seems to be slightly higher compared to that meas-
ured in the sole presence of Mg2+ (KDappTOT = 210 μM).
To our knowledge, no other kinetic study was performed so far for CIB2-target recognition, the only possi-
ble comparison is thus with previous SPR experiments performed with the homolog CIB1 protein interacting 
with a peptide from αIIb integrin30, which according to a 1:1 binding model revealed a very similar apparent 
ka1 (M−1s−1)a ka2(RU−1s−1) kd1(s−1) kd2(s−1) KDapp1 (µM)b
KDappTOT (µM)c
(N = 28)
1 mM Mg2+
(N = 16) (3.1 ± 0.1) × 10
4 (1.9 ± 0.4) × 10−3 (3.6 ± 0.5) × 10−1 (2.0 ± 1.7) × 10−2 11.6 ± 1.8 210 ± 20
1 mM Mg2+
2 mM Ca2+
(N = 15)
(1.6 ± 0.2) × 104 (4.2 ± 0.5) × 10−4 (4.0 ± 0.3) × 10−1 (5.3 ± 0.5) × 10−2 25 ± 5 154 ± 8
Table 2. Results from Surface Plasmon Resonance analysis of CIB2-α7B_M interaction. aKinetic constants 
were determined according to a bivalent analyte model as explained in Methods. N refers to the number of 
independently analyzed sensorgrams. Results refer to average ±  SEM. bApparent affinity for the first binding 
event, determined by the ratio kd1/ka1. cApparent affinity constant accounting for avidity, determined by steady 
state analysis, measured by taking the maximum response RUmax for a series of 4 repetitions of 7 injections of 
α7B_M at increasing concentrations.
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affinity (KDapp = 12 μM) without significant dependency on Ca2+. It should be noted, however, that sequence and 
presumably structural/functional features of CIB2 could significantly differ from those of CIB18 and that even 
for the same system different studies reported quite different affinities, probably due to the heterogeneous set of 
experimental techniques used (see ref.31 for a review).
Interaction between CIB2 and α7B_M and structural rearrangement. SPR data suggest a relatively 
low affinity interaction of CIB2 with the α7B_M peptides, and results from MALDI experiments seem to support 
this finding (Fig. 2B).
Near-UV CD spectroscopy was used to study the structural effects of the binding of α7B_M peptide to CIB2 
in the presence and in the absence of cations (Fig. S5). The isolated peptide was unfolded in all the tested cases, 
but interestingly, when incubated with CIB2 some structural effects could be observed both for 1:1 and 2:1 pep-
tide:protein conditions. For apo-CIB2, although the spectrum was still compatible with a molten globule state 
(Fig. S5A), peptide induced a finer spectrum in the phenylalanine and tyrosine bands, thus suggesting interaction 
between CIB2 and α7B_M even in the absence of cations. When the incubation was done in the presence of Mg2+ 
as well as in the co-presence of Ca2+, the intensity of the resulting spectrum was lower compared to that of CIB2 
without the peptide (Fig. S5A,B) and the decrease was proportional to the stoichiometric peptide:protein ratio, 
being especially apparent for the 2:1 ratio. A closer inspection showed mild alterations of the spectrum especially 
of the level of the phenylalanine band, with some smoothening of the tyrosine region in the case of incubation 
with only Mg2+, however no clear signal was visible in the typical 285–305 nm tryptophan region. Since α7B 
has one tryptophan and CIB2 has none, the lack of signal following incubation suggests that the peptide did 
not acquire a defined structure upon interaction, at least not completely. If this was the case, the effect would 
have been likely visible, such as in the case of calmodulin-target interaction32,33. The decrease in the intensity 
of near-UV CD spectrum, more prominent for the case of Mg2+ alone, could then be attributed to some global 
effect such as increased flexibility and/or solvent accessibility of CIB2 upon interaction with the peptide, or even a 
dimerization of CIB2 induced by the bound peptide, which would lead to enhanced exposure of aromatic residues 
to the solvent.
conclusions
Ca2+-binding proteins belonging to the EF-hand superfamily may exist in a variety of conformational states34 and 
many were found to form dimers depending on their cation-loading state and concentration35. CIB2 has been 
found to form dimers in previous studies, where it was fused with GFP11,12 and tdTomato fluorescent protein11 
and studied in FRET and co-immuno precipitation experiments. Our previous work with untagged purified CIB2 
also concluded that CIB2 is dimeric8. We now provide new lines of evidence that allow us to reconsider some of 
the previous findings in the light of MS and SPR data. Based on our extensive analysis performed in a variety of 
conditions and over a broad range of concentrations we can conclude that CIB2 is per se monomeric, but pre-
sents uncommon hydrodynamic properties likely due to the high content of hydrophobic solvent accessible sur-
face, which may lead to the erroneous appearance of a dimer. This feature, together with the possible interaction 
between fusion-proteins or tags and the highly hydrophobic surface of CIB2 calls for special care when assessing 
its oligomeric state.
Interaction with α7B occurs in the region proximal to the membrane and not close to the C-terminus of the 
cytosolic domain of the integrin. The recognition between CIB2 and the α7B target is kinetically favored in the 
presence of physiological Mg2+ and in the absence of Ca2+ and it might induce binding of another CIB2 molecule. 
This hypothesis seems to be in line with our previous fluorescence data where CIB2 was shown to interact with 
the target peptide with a 2:1 stoichiometry8. However, CIB2 per se binds a single peptide as a monomer, and the 
complex could then induce CIB2 dimerization, where the dimer is bridged by the target. Considering the largely 
unknown biological function of CIB2 and that the homolog protein CIB1 allows a high degree of promiscuity in 
target recognition31, this putative mechanism of target-induced dimerization might play a role in integrin signa-
ling. Whether this intriguing scenario may have any physiological consequence needs to be further investigated.
Methods
Protein and peptide preparation and purification. Recombinant human CIB2 was obtained exactly 
as explained in our previous work8. Untagged protein was used for all experiments except for one case of SPR 
interaction where the TEV protease recognition site and the Histag were kept. Human CaM and bovine Rec were 
expressed and purified as described in previous work36,37.
Peptides were purchased from Genscript and had the following sequence: α7B_M LLLWKMGFFKRAKHPE (HPLC 
purity = 96.7%), α7B_Scrb KEFWGLHAKPRLKLMF (HPLC = 96.3%), α7B_C LAADGHPELGPDGHPGPGTA 
(HPLC = 98.8%). Both α7B_M and α7B_Scrb were C-terminal amidated and N-terminal acetylated, while α7B_C 
was N-terminal acetylated. All peptides were initially resuspended in pure water and then diluted at final concentration 
in the working buffer.
Cross-linking reactions. CIB2 samples were cross-linked with DSBU in the presence of peptide α7B_M 
or α7B_Scrb as described in ref.14 Briefly, 10 µM CIB2 was diluted in 20 mM HEPES, pH 7.5, 1 mM DTT, 1 mM 
Mg2+ and 2 mM Ca2+ and incubated with increasing peptide concentrations (5 µM, 10 µM, and 20 µM) for 10 min 
at room temperature. Then, 50-fold molar excess of DSBU was added and the reactions were conducted for 
20 min at room temperature. As control, CIB2 was treated with DSBU without peptide. Reactions were blocked 
by adding ammonium bicarbonate to a final concentration of 20 mM.
Mass spectrometry. Cross-linked CIB2 samples were desalted via ZipTip C4 tips (Millipore) before 
MALDI-TOF-MS analysis (Ultraflex III MALDI-TOF/TOF mass spectrometer, Bruker Daltonik, Bremen) was 
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conducted using sinapinic acid as matrix. For further details see Supplementary Methods. Baseline subtraction 
and spectra smoothing were performed.
For native ESI-MS analyses (High-Mass Q-TOF II mass spectrometer, Waters/MSVision), CIB2 was prepared 
in 200 mM ammonium acetate, pH 6.8.
Analytical size exclusion chromatography. The molecular weight (MW) of the proteins was determined 
before and after DSBU-modification as previously described7 in the same buffer (20 mM HEPES, pH 7.5, 1 mM 
DTT, 1 mM Mg2+ and 2 mM Ca2+). Protein concentration was determined by Bradford Assay and was found to 
be 113 µM for CaM and between 70–80 µM for CIB2 and Rec. Standard calibration curve for MW estimation was 
the same used in our previous study8.
DLS experiments. DLS measurements were performed using Zetasizer Nano-S (Malvern Instruments) at 
37 °C by setting the same parameters for hydrodynamic diameter estimation as in ref.26. The estimation was based 
on 15–30 measurements, each consisting of at least 13 repetitions; data in Table 1 are reported as mean ± stand-
ard error of mean (SEM). DLS samples for each protein are the same collected in the Analytical Size Exclusion 
Chromatography. Protein concentration was measured by Bradford Assay for Rec, CaM and CIB2 and was found 
to be 11 μM, 7.4 μM and 1.8 μM respectively.
Circular dichroism spectroscopy. CIB2 tertiary structure was investigated by using a Jasco J-710 spec-
tropolarimeter equipped with a Peltier type cell holder as previously described37. Briefly: near-UV (250–320 nm) 
CD spectra of 20 μM of sole CIB2 or CIB2/α7B_M complexes (1:1 and 1:2 ratios) were collected in the presence of 
500 μM EGTA and after sequential additions of 1 mM Mg2+ and 2 mM free Ca2+. A 1 cm quartz cuvette was used, 
temperature was set at 37 °C, integration time and data pitch were set to 4 s and 1 nm, respectively. Each spectrum 
represents the average of 5 accumulations.
Limited proteolysis experiments. Limited proteolysis experiments were performed incubating 25 µM 
CIB2 in the presence of Trypsin (Sigma) in a ratio 1:100 enzyme:CIB2 at 25 °C. Three conditions were tested: 
1 mM EDTA, 500 µM EGTA + 1 mM Mg2+ and 1 mM Mg2+  + 2 mM Ca2+. Time-resolved proteolysis patterns are 
reported in Supplementary Materials (Fig. S2), results shown in Fig. 5 refer to reactions stopped after 5 min and 
30 min. Proteolysis products were loaded on a 15% or 18% SDS gel, as indicated.
Molecular dynamics simulations. The homology model of Ca2+-bound human CIB2 was built using 
the X-ray structure (resolution: 1.99 Å) of human CIB1 as a template (PDB entry: 1XO5)2, which shares 39% 
sequence identity with CIB2. Modeling details are provided in our previous work8. The PDB file of the model 
is available upon request for research purposes. MD simulations of Ca2+-bound CIB2 were performed using 
GROMACS 2016.1 simulation package38 and CHARMM36m39 all-atom force field (system size 47780 atoms). 
All simulation details were the same as in previous work25,40. Root-Mean Square Fluctuation of Cα along the 
400-ns trajectory was calculated with respect to the equilibrated structure using “gmx rmsf ” function included in 
GROMACS 2016.1 as previously explained23.
Hydrodynamic diameter estimation. Estimation of the hydrodynamic diameter was performed using 
Hydropro16 on the structure of bovine Rec after removal of the GRK1 peptide41, and human CIB28. Details on the 
preparation of human CaM structure as well as on the determination of the hydrodynamic diameter are given in 
the Supplementary Information.
Surface plasmon resonance. Details of the protein and peptide immobilization procedures and experi-
mental settings are elucidated in the Supplementary Information.
Kinetic data were fitted according to a bivalent analyte model, were a CIB2 monomer (L) can bind an α7B_M 
peptide (A), and the resulting complex (AL) can bind to a second CIB2 molecule (AL2), with all processes being 
possibly reversible, as follows:
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→ +
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where [A](t) is the molar concentration of α7B_M peptide at time t; L is the available CIB2 immobilized; 
[AL](t) is the concentration of the CIB2-α7B_M complex at time t; [AL2](t) is the concentration of the 
CIB2-α7B_M-CIB2 complex at time t; ka1 is the association rate constant for the CIB2-α7B_M complex (M−1s−1); 
kd1 is the dissociation rate constant for the CIB2-α7B_M complex (s−1); ka2 is the association rate constant for the 
CIB2-α7B_M-CIB2 complex (RU−1s−1), driven by the first association; kd2 is the dissociation rate constant for the 
CIB2-α7B_M-CIB2 complex (s−1).
Data fitting was performed using the software QDAT (Pall FortéBio, LCC 2016).
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Supplementary Methods 
 
Cross-linking reactions and Mass Spectrometry 
Cross-linking reactions were performed with 10 µM CIB2 (in 20 mM HEPES pH 7.5, 150 mM KCl, 
1 mM DTT, 1 mM Mg2+, 2 mM Ca2+) and increasing concentrations of peptides α7B_M and 
α7B_Scrb, ranging from 0.5:1 to 2:1 peptide:protein ratios. After incubating the samples for 10 
minutes at room temperature, DSBU (freshly prepared solution, dissolved in neat DMSO) was added 
to the mixture at 50-fold molar excess compared to CIB2 concentration. As the final volume of the 
reaction mixture was 50 µL, 1 µL of 25 mM DSBU was added to each sample. After 20 minutes, the 
cross-linking reactions were quenched by adding ammonium bicarbonate to a final concentration of 
20 mM. Samples were incubated for 10 minutes before SDS-PAGE analysis was performed (data not 
shown). Samples for MALDI-TOF-MS measurements were desalted by ZipTip C4 (Millipore) and 
desalted protein was eluted with 70% (v/v) acetonitrile / 1% (v/v) formic acid. Each sample was 
mixed with a saturated solution of sinapinic acid (in 50% (v/v) methanol / 0.1% (v/v) TFA) at 1:1 
ratio and spotted onto the MALDI target. 
 
Hydrodynamic diameter estimation 
Since human CaM (pdb 1CLL)1 was lacking the first 4 residues at the N-term, they were modeled 
using pdb structure 4e53 as template.2 After superimposition of the Cα of residues 4-8, residues 1-7 
of 4e53 were fused with residues 8-148 from 1CLL. Analogously, the missing Lys 149 at the C-term 
was modeled using the pdb structure 4djc3 as a template by fusion of residues 146-149 of 4djc with 
residues 1-145 of 1CLL after superimposition of residues 146-148 Cα. 
Hydrodynamic diameter was estimated using default values for radius of atomic elements (2.84 Å), 
solvent density (1 g/ml) and solvent viscosity (0.01 poise), temperature was set to 25 °C and the mode 
was set to shell-model from atomic level. Specific volume for each protein structure was calculated 
 2 
by summing the volume of each residue and correcting the final volume for electrostriction as 
explained in Ref.4, therefore the specific volume for Rec, CaM and CIB2 were 0.712, 0.694 and 0.715 
cm3/g respectively. The molecular weight used for the estimation of hydrodynamic diameter was 
calculated based on the effective protein sequence of each pdb file using Protein Calculator 3.4 
(http://protcalc.sourceforge.net/). 
 
Surface plasmon resonance analysis 
A SensiQ Pioneer surface plasmon resonance instrument (FortéBio Pall) was employed for the 
investigation of the CIB2 dimerization and for the real-time monitoring of its interaction with selected 
peptides. For studies of on-chip CIB2 dimerization, HBS buffer (20 mM HEPES, pH 7.5, 150 mM 
KCl, 1 mM MgCl2, 50 µM EDTA, 0.005% Tween 20), was used both as immobilization and running 
buffer, with the addition of fresh 1 mM DTT just before each experiment. 
CIB2 was immobilized on the surface of a COOH5 sensor chip (FortéBio Pall) coated with a 
carboxylated polysaccharide hydrogel spacer. Carboxyl groups were mobilized with sequential 
injections (5 μl min−1 flow rate) of 60 μl of 10 mM H3PO4, 60 μl HBS, 60 μl 10 mM NaOH and 2 × 
60 μl HBS. The sensor chip surface was then activated with a 7 min injection of a mixture of 10 mM 
N-hydroxysuccinimide (NHS) and N-ethyl-N′-(dimethylaminopropyl)carbodiimide (EDC) at a 
flow rate of 5 μl min−1. Previously frozen samples of untagged CIB2 in HBS were thawed and diluted 
to a final concentration of 50 nM in Na-acetate buffer (pH 3.1), 1.52 pKa units below its isoelectric 
point. Amine coupling of CIB2 was achieved with a slow and prolonged sequential injection of 
protein at flow rate of 10 μl min−1 leading to a final amount of 130 RU in one case and 226 RU in 
another experiment (1 RU = 1 pg mm-2). The surface was blocked via injection of 70 μl 1M 
ethanolamine hydrochloride-NaOH, pH 8.5. In all SPR experiments, one of the three flow cells was 
activated and then blocked without protein immobilization, and was used as a reference. CIB2 was 
diluted to final concentrations of 92 nM – 46 μM and injected at a flow rate of 20 μl min−1 (2 min 
injection) resulting in all cases in flat sensorgrams, except for some non-specific bulk effect.  
In the experiments concerning the interaction with peptides, the same chips with amine-coupled CIB2 
were used and the three peptides α7B_M, α7B_Scrb and α7B_C were diluted to a final concentration 
of 7.5 – 30 µM in HBS and injected in the same conditions (20 μl min−1, 2 min injection); experiments 
were repeated 4 times. 
CIB2 was also homogeneously immobilized at higher levels using the capture-coupling technique, 
where His-tagged CIB2 is first site-specifically driven on the surface of a His-Cap sensor chip 
(FortéBio Pall), based on a three-dimensional non-dextran hydrogel polymer modified with 
Nitrilotriacetic acid (NTA) functional groups that chelate Nickel ions for the selective capture of 6X 
 3 
His-tagged proteins, and then blocked via amine coupling as explained above. Preparation of the 
sensor chip and immobilization followed the instructions from the manufacturer and resulted in 
approximately 2250 RU of CIB2 immobilized. In binding experiments, peptide concentration was 
varied in the 230 nM- 30 μM range for both α7B_M, and α7B_C, and experiments were repeated 4 
times, both with the HBS buffer described above (containing 1 mM MgCl2) and with further addition 
of 2 mM CaCl2. Flow rate was set to 20 μl min−1 in all binding experiments, and the dissociation 
process was followed for 240 s, resulting in complete protein-peptide dissociation.  
 
 
Supplementary figures 
 
Figure S1 
 
 
 
Figure S2 
 
 
Figure S1: DLS measurements of the SEC collected peaks. CIB2 band A2 (A), Rec (B) and 
CaM (C). Each data set consisted of 15-30 measurements (grey lines), with 13-15 repetitions 
each. Colored lines are referred to the average distribution. Temperature was set to 37°C and 
samples were equilibrated for 2 min before measurements.  
Figure S2: Time-resolved proteolysis experiments. 25 µM CIB2 was incubated with 
Trypsin (1:100 enzyme:CIB2 ratio) in the presence of 1 mM EDTA (A) or 500 µM EGTA 
+ 1 mM Mg2+ (B) for 90 minutes, samples were collected at different times. Temperature 
was set to 25°C and CIB2 without enzyme was used as control. Reaction products were 
loaded on a 15% SDS-PAGE.  
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Figure S3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S4 
 
 
 
 
 
 
 
 
 
Figure S4: Structural comparison of His-CIB2 (A) and CIB2 (B). Near-UV CD spectra 
(250-320 nm) of 20-30 µM CIB2 were collected at 37°C in a quartz cuvette with 1 cm length 
path. Sequential additions of 500 µM EGTA (black), 1 mM Mg2+ (blue) and 2 mM Ca2+ (red) 
were performed. Near-UV CD spectra of the buffer (20 mM HEPES pH 7.5, 150 mM KCl, 1 
mM DTT) was considered as blank and subtracted. Each spectrum represents the mean of 5 
accumulations. Data were normalized according to the protein concentration and the number 
of residues (Molar Residue Ellipticity, MRE). 
 
Figure S3: Analysis of MD simulations. Three-dimensional structure of the homology model 
of Ca2+-bound human CIB2 (top left), protein secondary structure is shown as cartoons, EF1 is 
colored in yellow, EF2 is colored in green, EF3 is colored in orange, EF4 is colored in blue, C-
term helix is colored in cyan and Ca2+ ions are shown as red spheres. Root-Mean Square 
Fluctuation of Cα (top right) calculated over 400 ns MD simulations, inset shows protein 
secondary structure where EF hands and Ca2+ ions are colored according to the left panel. 
Projection of the Cα-RMSF (bottom) on the three-dimensional structure of CIB2, Ca2+ ions are 
shown as spheres, protein is shown as cartoons, both are colored in a blue-to-red scale 
according to their Cα-RMSF, ranging from 1.1 to 13.9 Å. Thickness of the cartoon is also 
proportional to the Cα-RMSF. 
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Figure S5 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S6 
 
 
 
Figure S5: Near-UV CD spectra of CIB2 in the presence of different stoichiometric 
ratios of alpha7B_M peptide. Near-UV CD spectra (250-320nm) of 20 μM CIB2 in the 
absence of peptide (black lines) and in the presence of two different protein/peptide ratios 
(1:1 blue lines; 1:2 red lines) collected at 37°C in the presence of 500 μM EGTA (A) and 
after sequential additions of 1 mM Mg2+ (B) and 2 mM free Ca2+ (C).  The spectrum of 
alpha7B_M peptide in the absence of CIB2 is shown in dashed grey lines.  
Figure S6. CIB2 limited proteolysis. A) 10 µM CIB2 was incubated at 25°C in the 
presence of 1 mM EDTA (Apo), 500 µM EGTA + 1 mM Mg2+ (Mg2+) and 1 mM Mg2+ 
+ 2 mM Ca2+ for 10 minutes at 25°C. Samples were boiled and loaded in a 18% SDS 
polyacrylamide gel. B) Limited proteolysis was performed incubating trypsin with 25 
µM CIB2 in the same concentrations of ions used for (A) (protein:enzyme ratio was 
100:1). Samples were collected at different times, boiled and loaded on a 18% SDS-
PAGE. Both gels run for 45-50 min, then they were Coomassie Blue-stained. Uncropped 
single gels are shown. 
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Abstract
Guanylate Cyclase-Activating Protein 1 (GCAP1) regulates the enzymatic activity of the photoreceptor guanylate cyclases
(GC), leading to inhibition or activation of the cyclic guanosine monophosphate (cGMP) synthesis depending on its Ca2+- or
Mg2+-loaded state. By genetically screening a family of patients diagnosed with cone-rod dystrophy, we identified a novel
missense mutation with autosomal dominant inheritance pattern (c.332A>T; p.(Glu111Val); E111V from now on) in the
GUCA1A gene coding for GCAP1. We performed a thorough biochemical and biophysical investigation of wild type (WT) and
E111V human GCAP1 by heterologous expression and purification of the recombinant proteins. The E111V substitution
disrupts the coordination of the Ca2+ ion in the high-affinity site (EF-hand 3, EF3), thus significantly decreasing the ability of
GCAP1 to sense Ca2+ (∼80-fold higher Kdapp compared to WT). Both WT and E111V GCAP1 form dimers independently on
the presence of cations, but the E111V Mg2+-bound form is prone to severe aggregation over time. Molecular dynamics
simulations suggest a significantly increased flexibility of both the EF3 and EF4 cation binding loops for the Ca2+-bound
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form of E111V GCAP1, in line with the decreased affinity for Ca2+. In contrast, a more rigid backbone conformation is
observed in the Mg2+-bound state compared to the WT, which results in higher thermal stability. Functional assays confirm
that E111V GCAP1 interacts with the target GC with a similar apparent affinity (EC50); however, the mutant shifts the GC
inhibition out of the physiological [Ca2+] (IC50E111V ∼10 μM), thereby leading to the aberrant constitutive synthesis of cGMP
under conditions of dark-adapted photoreceptors.
Introduction
Phototransduction is the first biochemical cascade in pho-
toreceptors, which triggers the visual process. The underlying
signaling machinery is complex and requires adaptation and
shut-off mechanisms that are finely regulated by Ca2+ and
cyclic guanosine monophosphate (cGMP), which work as strictly
interconnected second messengers (1–3). The concentration of
Ca2+ in the photoreceptor outer segments is precisely controlled,
and during the phototransduction cascade, it drops from several
hundred nanomolar Ca2+ in the dark to below 100 nM in the
light (4,5). Guanylate Cyclase-Activating Protein 1 (GCAP1) is
a neuronal calcium sensor expressed in both rods and cones,
which is crucial for phototransduction regulation. GCAP1 indeed
detects subtle changes in Ca2+ concentration and responds by
adopting conformations that control the activity of the target
membrane-bound guanylate cyclases (GC) responsible for the
cGMP synthesis. At high [Ca2+], GCAP1 adopts a Ca2+-loaded
state that inhibits GC activity, while it switches to a slightly
different,Mg2+-bound conformation following the drop in [Ca2+]
(6–8), thus stimulating the synthesis of cGMP by GC to rapidly
restore dark-adapted cell conditions (3,9).
In recent years, an increasing number of point mutations (18
up to date) have been identified in GUCA1A, the gene coding for
GCAP1, in patients suffering from autosomal dominant retinal
dystrophies (10–21). These forms of vision-threatening diseases
including cone dystrophy (COD), cone-rod dystrophy (CORD)
and macular dystrophy (MACD) are all characterized by central
vision loss, impaired color vision and photophobia. In the case of
CORD andMACD, early and important changes in themacula are
followed by progressive loss in peripheral vision, when the pri-
mary cone dysfunction is followed by rod degeneration (22–24).
Biochemical investigations of some of the pathogenic GCAP1
variants allowed the elucidation of some common features
of the GCAP1-related retinal dystrophies (20,25–30); however,
detailed biophysical investigations showed that clinically similar
phenotypesmay result from very different molecular features of
the affected GCAP1 variant (31), thus calling for the importance
of a thorough characterization of each individual disease-
associated variant. Photoreceptor degeneration is probably
triggered by apoptosis (28,32), although different mechanisms
have been proposed (33). It is well established, however, that a
dysregulation of the homeostasis of Ca2+, and consequently of
cGMP, is deeply implicated in retinal degeneration (10,34,35).
We identified a novel c.332A>T missense mutation in
GUCA1A with autosomal dominant inheritance pattern in a
family of patients diagnosed with CORD. The clinical phenotype
calls for a severe form of the disease, characterized by congenital
nystagmus, photophobia, marked decrease in visual acuity
progressing to central scotoma and central outer retinal
dysfunction progressing to atrophy. The effect of the point
mutation c.332A>T at the protein level [p.(Glu111Val), from now
on E111V] is the substitution of a highly conserved glutamic
acid directly involved in the coordination of Ca2+ at the high
affinity binding site (EF-hand 3, EF3) with a hydrophobic residue;
therefore,we investigated whether the cation sensing capability,
the structure and thus the function of the resulting E111V GCAP1
were compromised.
We report a detailed biochemical and biophysical character-
ization of wild type (WT) and E111V GCAP1 variants integrating
in vitro experiments and molecular dynamics (MD) simulations.
Our data suggest that the CORD-associated E111V GCAP1 is
incapable of sensing Ca2+ and inhibiting the target GC under
physiological conditions, but it rather adopts a conformationally
rigid, aggregation-prone Mg2+-bound form that constitutively
activates GC even in dark-adapted conditions. The resulting
excessive synthesis of cGMP in the absence of light stimuli is
thought to trigger cell-death mechanisms responsible for the
degeneration process.
Results
Clinical phenotype and genetic characterization
Our probandwas amale patient, aged 53 at the time of our obser-
vation. He reported a congenital nystagmus, relatively improved
over time, photophobia and low vision since early childhood.
His visual acuity was 1.3 LogMAR (not improving with pinhole
or lens correction) in both eyes (Table 1). Fundus imaging and
optical coherence tomography (OCT) (data not shown) led us
to confirm the initial clinical diagnosis of COD. When defining
the pedigree (Fig. 1C), the patient reported to have three daugh-
ters, two of them suffering from the same condition (aged 22
and 16). We therefore asked to examine them and confirmed
they were affected too. Indeed, their phenotype matched their
father’s one, being just slightly less severe due to the lesser
duration of the disease. We confirmed that the middle daughter
and the patient’s mother were unaffected, while the deceased
father was reported to be unaffected, but no ophthalmological
records were available. At this stage, electrophysiologic testing
was performed in all patients in order to define precisely the
different components of the dysfunction.
Layouts of dark- and light-adapted electroretinogram (ERG)
signals from the proband and his family members are reported
in Figure 1B. Electrophysiological testing showed markedly
reduced a- and b-wave amplitudes of the dark-adapted ERGs
and increased a- and b-wave implicit times as compared to age-
matched controls. The light-adapted responses showed reduced
amplitude and increased implicit time values as well. The traces
were, however, detectable with good level of reproducibility
(Fig. 1B). This led us to redefine the condition as a CORD,
although the symptoms of the cone dysfunction (low vision
acuity and photophobia) were prevalent and no nyctalopia was
reported.
The pedigree showed a clear dominantmode of transmission.
Following patient’s written consent, a genetic testing of our
proband has been undertaken through next generation sequenc-
ing (NGS) of a panel of candidate genes. The NGS coverage of
targeted bases was 291.87 X with 95.54% covered to at least
25 X. Genetic testing showed that the probandwas heterozygous
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Table 1. Clinical phenotype of patients with the GUCA1A mutation c.332A>T / p.(Glu111Val)
Patient
ID
Age First
symptoms
and course
VA
(logMAR)
Visual
field
Light-/dark-
adapted/ ERG
amplitudes
// implicit time
EOG OCT Anterior
segment
II:1 53 Cong. Nys.
Low VA,
minor
progression,
photophobia
1.3 (NI) Central
scotoma
Severely
reduced
(cone = rod)
// Delayed
(cone = rod)
Normal CNA Normal
III:1 22 Cong. Nys.
Low VA,
minor
progression
photophobia
1.08 Central
scotoma
Severely
reduced
(cone > rod)
// Delayed
(cone = rod)
Normal CNA Normal
III:3 16 Low VA,
minor
progression,
photophobia
0.79 Central
scotoma
Severely
reduced
(cone > rod)
// Delayed
(cone = rod)
Normal CNA Normal
VA: visual acuity, ERG: electroretinogram, EOG: electrooculogram, OCT: optical coherence tomography, CNA: Central neuroretinal atrophy.
for the variant GUCA1A: NM 000409: c.332A>T: p.(Glu111Val)
(Supplementary Material, Fig. S1A). The variant is new since
it is not listed in any public database and was predicted to
be disease-causing, deleterious and probably damaging by in
silico pathogenicity prediction software. This missense variation
changes the negatively charged glutamate into a hydrophobic
valine. TheGUCA1A glutamate in position 111 seems to be highly
conserved during evolution (Supplementary Material, Fig. S1B;
see Discussion). Sanger sequencing confirmed the presence of
the identified variant in the two affected daughters, so confirm-
ing the pathogenicity through segregation.
Functional assays: regulation of the target GC by WT
and E111V GCAP1
The capability of WT and E111V GCAP1 to regulate the target
GC over Ca2+ levels spanning the physiological range pertinent
to phototransduction was tested. For this purpose, recombi-
nant human GCAP1 was expressed, purified and reconstituted
with membranes from Human Embryonic Kidney flip cells 293
(HEK293) stably expressing human ROS-GC1 (GC) (HEK293-GC).
Results are summarized in Figure 2 and Table 2. Both WT and
E111V GCAP1 activated the target GC at low [Ca2+] at similar
levels; however,while theWT form induced a substantially com-
plete inhibition of cGMP synthesis at high [Ca2+], E111V GCAP1
induced an important residual activation (∼60%) of the target
(Fig. 2A). The incapability of E111V GCAP1 to fully inhibit the
target GC was also confirmed by the remarkably high IC50 values
([Ca2+] at which GC activation was half-maximal) observed in
the GC activation profiles in experiments where the concen-
tration of the GCAP1 variant was kept fixed (IC50WT = 0.26 μM,
IC50E111V = 10 μM, Fig. 2C; Table 2). The dysregulation of the
Ca2+-dependent catalytic activity of the target, however, did not
depend on changes in apparent affinity for GCAP1, as clearly
proven by the very similar EC50 values obtained for WT (3.2 μM)
and E111V (3.5 μM) GCAP1 (Fig. 2B and Table 2). Moreover, no sig-
nificant alterations in the X-fold activation of the target enzyme
were detected (X-fold = 16.0 for the WT; 15.7 for E111V).
Oligomeric state and aggregation propensity of WT and
E111V GCAP1
It was recently established that bovine GCAP1 is a functional
dimer (36); therefore, we investigated whether the oligomeric
state of human GCAP1 is the same under conditions correspond-
ing to the GC-activating/inhibiting states. We used a combi-
nation of analytical size exclusion chromatography (SEC) and
dynamic light scattering (DLS), which allowed us to study the
time evolution of the detected average hydrodynamic size of the
protein dispersion.
SEC profiles (Supplementary Material, Fig. S2A and B) showed
a major elution band for both WT and E111V persisting almost
unaltered in the presence of either Mg2+ or Mg2+ and Ca2+.
The molecular mass (Table 3) assessed by the elution peaks
ranged from 43.7 kDa to 47.8 kDa independent of the cations,
thus clearly indicating that both WT and E111V human GCAP1
are dimeric (the theoretical molecular mass of the monomer is
22.9 kDa, https://www.uniprot.org/uniprot/P43080).
Results from DLS spectroscopy were in line with those from
SEC (Supplementary Material, Fig. S2C and D) and displayed rel-
atively monodisperse samples. At 25◦C, the estimated hydrody-
namic diameter in the presence of Mg2+ was slightly smaller for
E111V (5.98 ± 0.05 nm) compared to WT GCAP1 (6.33 ± 0.03 nm),
but no significant difference could be observed in the hydrody-
namic diameter of either variant upon addition of Ca2+ (Table 3).
Moreover, the mean count rate (MCR) also remained substan-
tially stable.
In order to probe whether the detected dimeric state of WT
and E111V GCAP1 persisted at physiologically relevant temper-
ature, DLS experiments were repeated at 37◦C. Interestingly,
under conditions of co-presence of physiological levels of Mg2+
(1 mm) and saturating Ca2+, the colloidal properties of the WT
and E111V dispersions were substantially unaltered and the
proteins kept dimeric; however, the absence of Ca2+ led to very
different behaviors (Fig. 3). The MCR of WT GCAP1, which in
the first 4 h was on average unperturbed, started to increase
with a constant slope and oscillatory behavior, consistent with a
relatively slow aggregation process that led to ∼4-fold increase
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Figure 1. Clinical, genetic and electrophysiological data. (A) Color fundus image of the right eye of patients II:1 (age 53, left), III:1 (age 22, center) and III:3 (age 16,
right). (B) Layouts of dark- and light-adapted electroretinographic signals from patients II:1, III:1 and III:3 showing severely reduced a-, b-wave amplitudes and delayed
implicit times. (C) Family tree showing the matching genotype–phenotype segregation of the mutant allele of GUCA1A harboring the c. 332A>T transition causing the
substitution E111V. Legend: square,male subject; circle, female subject; black symbol, affected subject; white symbol, healthy subject; ∗ Documented clinical evaluation;
yr, subject age at last clinical evaluation; P, proband; E-, negative to genetic test; square brackets ([;];[;]),maternal and paternal chromosome; =, no change.
in the average MCR after 16 h. The MCR of E111V GCAP1 instead
started to increase linearly from the beginning and doubled from
∼200 kcps to ∼400 kcps in the first 4 h. It then followed an even
steeper rise, which led to a ∼10-fold increase of MCR compatible
with a severe, constant protein aggregation process.
Hydrophobic properties of WT and E111V GCAP1
probed by ANS fluorescence
Time-resolvedDLS experiments suggested that the E111VGCAP1
variant could show altered surface properties compared to
the WT, which may give rise to the observed aggregation in
the absence of Ca2+. To investigate whether the substitution
of a hydrophilic glutamic acid for a hydrophobic valine
could lead to appreciable changes in surface properties, we
performed fluorescence experiments using the hydropho-
bic probe 8-Anilinonaphthalene-1-sulfonic acid (ANS) (see
Methods), whose fluorescence emission changes upon binding
to hydrophobic patches on the protein surface. Results reported
in Supplementary Material, Figure S3A and B confirm that both
apo WT and E111V were somewhat hydrophobic, as clearly
showed by the blue-shift and increased intensity in fluorescence
emission of the ANS dye compared to the case in the absence of
proteins (Supplementary Material, Table S1). Addition of Mg2+
generated a 7-nm red shift in the case of WT GCAP1 and a
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Figure 2. Guanylate cyclase 1 (GC) regulation by WT and E111V GCAP1. (A) Membranes containing GC were reconstituted with 5-μM WT or E111V GCAP1 and <19-
nM Ca2+ (black) or ∼30-μM free Ca2+(grey); membranes with no GCAP1 were used as control. (B) GC activity as a function of WT (black) or E111V (grey) GCAP1
concentration (0–20 μM) in the presence of<19-nM free Ca2+ ; activationwas half-maximal (EC50, Table 2) at 3.2 μM and 3.5 μM, respectively. (C) GC activity as a function
of Ca2+ concentration (<19 nM – 1 mm) of 5-μM WT (black) or E111V (grey) GCAP1; activation was half-maximal (IC50, Table 2) at 0.26 μM and 10 μM, respectively. The
physiological window of variation in Ca2+ concentration during the phototransduction cascade is shaded in grey.
Table 2. Results of GC regulation and Ca2+ binding experiments
IC50
a (μM)a hb EC50 (μM)
c X-foldd log K1e log K2
e Kd
app (μM)f
WT 0.26 ± 0.01 2.05 ± 0.21 3.2 ± 0.3 16.0 7.07 ± 0.13 5.55 ± 0.19 0.49
E111V 10 ± 5 0.83 ± 0.27 3.5 ± 0.9 15.7 4.3 ± 1.1 4.5 ± 1.6 ∼40
a IC50 is the half-maximal activating Ca
2+ concentration.
b h is the Hill Coefficient.
c EC50 is the half-maximal activating GCAP1 concentration.
d X-fold activation is (GCmax − GCmin)/GCmin.
g Decimal logarithm of the macroscopic Ca2+-binding constants after fitting data to a two independent binding sites model with CaLigator (57).
f Apparent affinity is the average of the significant log Ki (see Materials and Methods for details).
Table 3. Results of DLS and SEC experiments
PdI ± σ (10−1) d ± σ (nm) n [r] MCR ± σ (kcps) SEC MW (kDa)
WT
Mg2+ 1.7 ± 0.05 6.33 ± 0.03 32 [15] 244.6 ± 1.2 45.9
Mg2+ Ca2+ 1.5 ± 0.03 6.47 ± 0.03 36 [15] 249.6 ± 2.1 47.8
E111V
Mg2+ 1.8 ± 0.03 5.98 ± 0.05 77 [6] 148.1 ± 1.0 45.9
Mg2+ Ca2+ 2.0 ± 0.05 6.08 ± 0.04 74 [6] 142.4 ± 0.6 43.7
PdI: polydispersity index, σ : standard error, d: hydrodynamic diameter, n: number ofmeasurements, each consisting of r runs,MCR:mean count rate, SECMW,estimated
molecular weight from analytical SEC using calibration curve from ref. (60).
6-nm red shift in the case of E111V GCAP1, together with a
decrease in fluorescence emission. Addition of Ca2+ on top did
not significantly change the observed patterns, leading for both
variants to a minimal increase in fluorescence emission without
appreciable wavelength shifts. In conclusion, the prominent
aggregation observed for E111V GCAP1 in the presence of Mg2+
cannot be attributed to significantly different hydrophobic
properties of the two variants.
Changes in secondary and tertiary structure of WT and
E111V GCAP1 in the presence of Ca2+
GCAP1 is a relatively small protein formed by the assembly of
four α helix-loop-α helixmotifs called EF-hands (Fig. 4A), three of
which (EF2, EF3 and EF4) have the correct consensus sequence to
bind cations (37).The overall fold of GCAP1 is that of an all-α helix
protein; therefore, any change of its secondary structure can be
ideallymonitored by circular dichroism (CD) spectroscopy,which
in the far UV range (200–250 nm) is particularly sensitive to the
fold of the main chain.
Far UV CD spectra of both WT and E111V GCAP1 showed
the expected α helix pattern, with minima at 208 and 222 nm
(Supplementary Material, Fig. S3). Addition of 1-mm Mg2+ to the
apo-proteins did not significantly change the spectra of the WT
(Supplementary Material, Table S2), as shown by the unaltered
(θ222/θ208) ratio (0.94), while a small but significant change in the
spectral shape could be appreciated for E111V (θ222/θ208 = 0.92
in the apo form, 0.93 in the presence of Mg2+). The addition of
saturating Ca2+ led to a ∼6% increase of signal for the WT and
to a smaller increase for E111V (∼4%). While the shape of the
spectrumwas slightly changed for theWT (θ222/θ208 shifted from
0.94 to 0.96), no appreciable spectral changes could be observed
for the mutant (Supplementary Material, Table S2).
The strong signal in the far UV allowed us to monitor the sta-
bility of both GCAP1 variants upon thermal denaturation in the
20–96◦C range (Fig. 4B).While the stabilizing presence of saturat-
ing Ca2+ prevented a clear structural transition to be observed
for either variant (Fig. 4B), in the sole presence of Mg2+ a clear
difference could be observed, since E111V displayed a ∼5.5◦C
higher melting temperature compared to the WT (Tm = 49.0◦C
for WT GCAP1 compared to 54.5◦C for E111V, Supplementary
Material, Table S2). Magnesium has therefore a significantly
increased stabilizing effect on E111V GCAP1 compared to theWT
form.
D
ow
nloaded from
 https://academ
ic.oup.com
/hm
g/article-abstract/27/24/4204/5090204 by U
niversity of Verona user on 03 D
ecem
ber 2019
Human Molecular Genetics, 2018, Vol. 27, No. 24 4209
Figure 3. Results from dynamic light scattering experiments. Mean count rate
evolution over 16 h of ∼20-μMWT GCAP1 in 20-mm Tris-HCl pH 7.5, 150-mm KCl,
1-mm DTT, in the presence of 500-μM EGTA and 1-mm Mg2+ (grey diamonds), or
1-mm Mg2+ and 500-μM Ca2+ (black line), and ∼20-μM E111V in the presence of
500-μM EGTA and 1-mm Mg2+ (black circles), or 1-mm Mg2+ and 500-μM Ca2+
(light grey squares). Measurements were collected at 37◦C approximately every
minute; each measurement was an accumulation of six runs.
CD spectra recorded in the near UV region (250–320 nm)
provide information as to the local environment of the aromatic
residues, namely Phe, Tyr and Trp, and therefore on protein
tertiary structure. Near UV CD spectra of apo and Mg2+-
bound WT GCAP1 were almost indistinguishable from one
another (Fig. 4C), indicative of no major conformational change
occurring upon Mg2+ binding. When saturating Ca2+ was
added an increase of intensity of the signal was observed,
with significant changes especially in the Phe and Tyr bands.
Interestingly, the near UV CD spectrum of apo E111V GCAP1
was more intense compared to the WT and displayed a
completely positive ellipticity. A significant decrease in the
spectral intensity was observed in the whole near UV range
upon addition of Mg2+, and major changes were displayed
upon addition of saturating Ca2+, especially in the Phe and Tyr
bands. Overall, the presence of cations seems to induce more
appreciable changes in the tertiary structure of E111V GCAP1
compared to the WT, although the comparison between both
far and near UV CD spectra points to fairly modest structural
variations.
Binding of Ca2+ to WT and E111V GCAP1
Since nomajor structural change was observed for E111V GCAP1
compared to the WT, nor was a substantial difference in protein
surface hydrophobicity detected under condition of saturating
Ca2+, we investigated whether the E111V substitution affected
GCAP1 Ca2+ sensitivity. In order to probe the Ca2+ sensing prop-
erties of the CORD-related variant in comparison with the WT,
we used two different approaches. Figure 5A shows results from
gel mobility shift assays. The mobility of WT GCAP1 on SDS-
PAGE was typically shifted toward lower apparent molecular
weight (MW) in the presence of saturating Ca2+, as observed
previously with the bovine ortholog (38). The same experiment
performed with E111V GCAP1 highlighted significantly slower
electrophoretic mobility for the mutant in the presence of satu-
rating Ca2+, indicative of a less pronounced Ca2+-induced effect
on the conformation of the mutant suggestive of decreased
affinity for Ca2+.
Ca2+-titration experiments performed with the chro-
mophoric chelator 5,5’-dibromo-BAPTA (Fig. 5B and Table 2)
in the presence of 1-mm Mg2+ confirmed the significantly
compromised Ca2+ sensing ability of E111V GCAP1. A high affin-
ity Ca2+-binding site (K1, low nM range) and a moderate affinity
site (K2, low μM range) were detected for WT GCAP1, resulting in
a physiologically relevant apparent affinity (Kdapp = 490 nM;
Table 2). The titration profile of E111V GCAP1 was instead
compatible with two very low affinity sites (K1 and K2, high μM
range). The resulting extremely low apparent affinity (estimated
Kdapp ∼40 μM; Table 2) appears inconsistent with physiological
Ca2+ sensing for E111V GCAP1.
Dynamic structural properties of WT and E111V
GCAP1: insights from MD simulations
Major conformational changes associated with the E111V
substitution were excluded by CD spectroscopy; however, a
number of structure-related differences remained to be clarified,
namely (i) the significant propensity of the mutant to form
aggregates; (ii) its higher thermal stability in the presence of
physiological Mg2+; and (iii) its compromised Ca2+ sensing. In
order to shed light on such subtle differences, we performed
200-ns all-atom MD simulations of both WT and E111V GCAP1
in their Ca2+-loaded states (all three EF-hands binding a Ca2+
ion, corresponding to GC-inhibiting state) and EF2-Mg2+ states
(a Mg2+ ion bound to EF2, corresponding to the GC-activating
state). Although the overall Cα root-mean square fluctuation
(RMSF) was comparatively similar for WT and E111V under both
tested conditions, some important local differences could be
noticed, highlighting a substantially altered flexibility of specific
protein structural regions far apart from the EF2motif,where the
cation was bound (Supplementary Material, Fig. S4, top panels).
Interestingly, theMg2+-bound form of E111V displayed an overall
lower RMSF compared to the WT. The flexibility of the WT was
in fact significantly higher for residues belonging to the entering
helix and cation-binding loop of the EF3 motif as well as parts
of the EF4 exiting helix (Fig. 6A). The dynamically more rigid
conformation of Mg2+-bound E111V also resulted in a distortion
of the EF3 loop, which shortened of approximately 4 Å the
distance between the Cα atoms of residues 111 and V101, located
at the N-terminal extreme of the EF3 loop (Supplementary
Material, Fig. S4C). In contrast, placing three Ca2+ ions in the
respective EF-hands of E111V GCAP1 led to significant structural
fluctuations of the EF3 and EF4 binding loops, as highlighted
by the prominent RMSF values in these regions compared to
the WT case (Fig. 6A and Supplementary Material, S4B). MD
simulations highlighted how forcing the binding of Ca2+ to EF3
in the absence of the bidentate coordinator provided by the
side chain carboxyl group of Glu111 results in severe instability
of the loop conformation and loss of optimal coordination of
the Ca2+ ion, which was also characterized by high flexibility
(Fig. 6A). Interestingly, the structural perturbation induced
by the point mutations extended to the neighbor EF4 motif,
whose cation binding loop and relative Ca2+ ion also showed
remarkably higher flexibility compared to the WT case (Fig. 6A
and Supplementary Material, S4B).
The irreversible distortion of the EF3 loop, responsible for
the apparent loss of affinity for Ca2+ of the mutant became
apparent when analyzing the distance between residue 111
and Val 101 (Fig. 6B and Supplementary Material, S4D). While
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Figure 4. Structural and stability changes occurring inWT and E111V GCAP1 upon ion bindingmonitored by circular dichroism spectroscopy. (A) Cartoon representation
of the three-dimensional homology model of Ca2+-loaded human GCAP1; EF1 is colored in yellow, EF2 in green, EF3 in orange and EF4 in light blue. N- and C-terminal
are represented in light grey and light cyan, respectively; the myristoyl group is represented in grey spheres, Ca2+ ions are shown as red spheres and residue E111
is shown as sticks. (B) Thermal denaturation profiles of ∼10-μM WT GCAP1 in the presence of 300-μM EGTA and 1-mm Mg2+ (blue), or 1-mm Mg2+ and 300-μM Ca2+
(red), and ∼10-μM E111V in the presence of 300-μM EGTA and 1-mm Mg2+ (green), or 1-mm Mg2+ and 300-μM Ca2+ (grey). Thermal denaturation was performed in
20-mm Tris-HCl pH 7.5, 150-mm KCl by following the decrease in ellipticity at λ = 222 nm over the 20–96◦C temperature range. When possible, data were fitted to a
four-parameter Hill sigmoid; estimation of the Tm is reported in Supplementary Material, Table S2. Near UV CD spectra of ∼35-μM WT (C) and E111V (D) GCAP1 in the
presence of 500-μM EGTA (black) and after sequential additions of 1-mm Mg2+ (blue) and 500-μM free Ca2+ (red). CD spectra were recorded at 37◦C in 20-mm Tris-HCl
pH 7.5, 150-mm KCl, 1-mm DTT.
in Ca2+-loaded WT GCAP1 the optimal packing of the EF3 motif
ensured a constant distance of ∼6 Å between the Cα carbons,
the cation binding loop opened up in the case of E111V, resulting
in an almost doubled distance between the same atoms (Fig. 6B
and Supplementary Material, S4D).
Discussion
CORD is a severe vision-threatening disease, affecting 1/30,000
to 1/40,000 individuals (22). Several genes encoding for pro-
teins involved in the phototransduction cascade have been
found to be associated with CORD, and among them, 19
mutations, including the one presented in this study, were
found in GUCA1A (10–21). It is important to notice that,
while the first GUCA1A mutation associated with retinal
dystrophy (p.(Tyr99Cys)) was discovered almost 20 years ago
(19), 9 out of these 19 mutations have been found in the
last 5 years. The number of CORD-associated mutations
is probably going to increase due to higher attention to
molecular diagnostics and to the significant improvement
of sequencing techniques. Defining precisely the genotype
of patients affected by CORD and other retinal dystrophies
seems to be an essential step to move towards personalized
medicine. Previous biochemical and biophysical investigations
performed on COD/CORD-associated GCAP1 variants, on the
other hand, showed that specific molecular phenotypes do
not necessarily correlate with the clinical disease phenotype,
thus pointing to an urgency for highly defined molecu-
lar characterization of the effect of each individual point
mutation at the protein level as well as at the system level
(10,39,40).
In this work, we identified a novel mutation in GUCA1A
affecting a highly conserved glutamate residue (Supplementary
Material, Fig. S1B), which is essential for the correct coordination
of the Ca2+ ion in the high affinity site EF3 (Fig. 6B). The family
study involved four members of the proband’s family, including
his mother and three daughters. In line with the autosomal
dominant model of Mendelian inheritance, the GUCA1A variant
was only found in the two affected daughters and not in the
other two healthy relatives (Fig. 1B), showing that the disease
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Figure 5. Ca2+-sensitivity of WT and E111V GCAP1 monitored by gel mobility shift SDS-PAGE and absorption spectroscopy. (A) 15% SDS-PAGE of ∼30-μM WT or E111V
GCAP1 in the absence of ions (5-mm EDTA), in the presence of Mg2+ (5-mm EGTA and 1-mm free Mg2+) and in the presence of Mg2+ and Ca2+ (1-mm Mg2+ and 5-mm
Ca2+). (B) Normalized Ca2+ titration curves obtained by a competition assay with the chromophoric 5,5’Br2-BAPTA ofWT (black circles) and E111V GCAP1 (grey squares)
in the presence of 1-mm Mg2+. Ca2+ concentrations include dilution effects upon titration; normalization details are reported in the Methods section. Experimental
data are shown together with the optimal curve obtained by computer fitting (black and grey solid lines, respectively) and the theoretical (Chelator) curve simulating
the titration of the chelator (grey dashed line); estimation of log Ki is reported in Table 2.
Figure 6. Structural insights from MD simulations. Final conformations after 200-ns MD simulations (A) of WT (right panels) and E111V (left panels) GCAP1 in their
EF2-Mg2+ (top panels) and Ca2+-loaded forms (bottom panels). Proteins are shown as cartoons, the myristoyl group is represented as magenta sticks, ions are shown
as spheres and proteins and ions are colored in a blue-to-red scale according to their Cα -RMSF, ranging from 0.5 to 4.2 Å (Supplementary Material, Fig. S4). (B) Detail of
the Ca2+-binding loop of EF3 of Ca2+-loaded WT (left) and E111V (right); helices are shown as cartoons colored according to Figure 4A, Ca2+ coordinating residues are
represented as sticks where C atoms are green, N atoms are blue and O atoms are red. Residues V101 and E/V111 are represented as magenta sticks; Ca2+ ion is shown
as a red sphere.
gene is fully penetrant in this family. The clinical phenotype
was severe in all patients at the congenital presentation (nystag-
mus, photophobia) and suggestive of further progressive retinal
degeneration of both cone and rod elements when comparing
the younger family members to the older proband, who showed
evolution to macular atrophy (Fig. 1, Table 1).
D
ow
nloaded from
 https://academ
ic.oup.com
/hm
g/article-abstract/27/24/4204/5090204 by U
niversity of Verona user on 03 D
ecem
ber 2019
4212 Human Molecular Genetics, 2018, Vol. 27, No. 24
Our detailed biochemical and biophysical characterization
comparing human WT GCAP1 and the CORD-associated E111V
variant permits to elucidate some hallmarks of the pathogenic
variant. While the molecular features of the WT form, including
the sensitivity to Ca2+ and the oligomeric properties as well
as the induced regulation of the target GC, were all compatible
with a physiological function, E111V GCAP1 displayed important
differences. Although the point mutation did not significantly
alter protein secondary and tertiary structures (Fig. 4, Supple-
mentary Material, Table S2, Fig. S3), the substitution significantly
stabilized the Mg2+-bound, GC-activating state, as highlighted
by thermal denaturation studies (Fig. 4B). MD simulations sup-
ported this finding and suggested a more rigid conformation of
themutant compared to theWT in theMg2+-bound state (Fig. 6).
The less flexible conformation acquired at low Ca2+ induced a
severe aggregation for E111V GCAP1 (Fig. 3), which could have
important functional consequences.
In terms of alteration in protein structure, our data clearly
show that the E111V substitution leads to important distortion
of the EF3 loop, as well as to an increased flexibility of
the EF4 loop (Fig. 6), which in the WT case hosts the first
Ca2+ dissociating from GCAP1 during GC activation (6–8–,41).
Such structurally important perturbations are reflected into a
significantly decreased affinity for Ca2+ of the mutant (Fig. 5B,
Table 2). The ∼40-μM apparent affinity for Ca2+ measured for
E111V GCAP1 appears to be incompatible with the changes
of intracellular Ca2+ in photoreceptor outer segments during
the phototransduction cascade, which all occur in the sub-
micromolar range of [Ca2+] (1,4,5). Interestingly, the impressive
difference in affinity for Ca2+ of E111V GCAP1 compared to
the WT (∼80-fold) did not impact the apparent affinity of
GCAP1 for the target GC, as shown by the very similar EC50
values (Table 2, Fig. 2B). However, a dramatic effect of the
point mutation was detected in the regulation of the catalytic
activity of the GC target (Fig. 2). As expected, WT GCAP1 was
found to regulate the switch between maximal and minimal
GC enzymatic activity over the physiological range of [Ca2+]
(IC50 = 0.26 μM). In contrast, the IC50 value measured for E111V
GCAP1 was ∼40-fold higher (IC50 = 10 μM), thus shifting the GC-
inhibiting capability of the mutant GCAP1 to non-physiological,
extremely high [Ca2+] levels. In other words, at sub-micromolar
physiological [Ca2+] typical of the phototransduction processes,
E111V GCAP1 would keep the target GC in a constitutively
active state (Fig. 2, Table 2), which would result in aberrant
synthesis of cGMP in the absence of light stimulus, therefore
severely perturbing the homeostasis of both secondmessengers
(10).
Although it might be tempting to associate a reduced affinity
for Ca2+ with a severe dysregulation of the target GC, this is
not always the case. Previous studies demonstrated that most of
the COD/CORD-related GCAP1 mutants indeed showed reduced
affinity for Ca2+ and IC50 values for the GC activity shifted to non-
physiologically high Ca2+ levels (15,20,25,30,31); however, cases
have been found in which the Ca2+ sensing was substantially
unaltered with respect to the WT case, and yet a constitutive
regulation of the target GC was observed (31). The subtle effects
of COD/CORD point mutations should therefore be considered
in the context of altered molecular communication between the
GCAP1 protein and its molecular target, which is highly depen-
dent on the cation-loaded state (42). However, other factors have
been established to modulate the activity of GC especially in
cones (43,44), the first photoreceptors affected in CORD/COD,
which renders the GCAP1-GC complex a highly modular and
finely regulated signaling network unit (45).
System-level analyses performed on the biochemical data
available for some COD/CORD-associated GCAP1 mutants sug-
gest that the severity of the disease in terms of deregulation
of the second messenger homeostasis eventually depends on
the deregulation of the GC-GCAP enzymatic complex (46). In
particular, in the case of high expression levels of pathogenic
GCAP1 mutants with extremely high IC50 values, GCAP1 would
not possibly contribute to shaping the cGMP rate synthesis,
therefore the GC enzymatic activity would become dynamically
regulated solely by the other present Ca2+ sensor GCAP2, for
which no CORD/COD associated mutation is known so far.
The aberrant regulation of GC by pathogenic GCAP1 could
be potentially overcome by the compensatory effect of other
GCAPs. This possibility would come as a direct consequence of
the calcium-relaymechanism,which finely regulates the activity
of GC and ensures the correct physiological control of cGMP
synthesis by GC (1). As to date, no cure exists for COD/CORD; this
is an interesting concept for the development of protein therapy–
based approaches aimed at the delivery of controlled amounts
of functional GCAP1 in the photoreceptors. Although at their
infancy (47,48), these approaches could constitute promising
starting points for the development of effective therapies for
COD/CORD in the future.
Materials and Methods
Patients studies
This study is a retrospective case series description that does
not require ethics committee approval. Written, informed
consent was obtained from adult patients or both parents
for the minor patient, prior to their inclusion in this study
and after full explanation of the clinical and instrumental
procedures. The informed consent forms include consent for
the use of anonymized genetic results for scientific publications.
All research procedures described in this work adhered to the
tenets of the Declaration of Helsinki.
Clinical and instrumental ophthalmological
examinations
Ophthalmological characterization included visual acuity
evaluation (expressed in LogMAR), ocular motility evaluation,
dilated fundoscopy and multicolour imaging. Furthermore, in
order to complete phenotype definition, we performed spectral
domain OCT, Blue autofluorescence (Spectralis HRA+, Heidel-
berg Engineering, Heidelberg, Germany) and OCT angiography
(OptovueAngioVue System, Optovue Inc, Fremont, CA) (Imaging
not shown).
Genetic testing
Genetic testing was performed for diagnostic purposes following
genetic counselling. The DNA of all patients was extracted from
peripheral blood using a commercial kit (E.Z.N.A. Blood DNA kit
Omega Bio-tek; Norcross, GA, USA).
The proband’s DNA underwent NGS on an Illumina MiSeq
instrument (PE 2×150 bp protocol) with a custom panel designed
for a suspected diagnosis of COD. The panel comprised the
following genes: CNGA3 (OMIM ∗600053), RAB28 (OMIM ∗612994),
GUCY2D (OMIM ∗600179), C8orf37 (OMIM ∗614477), PROM1 (OMIM
∗604365), GUCA1A (OMIM ∗600364), CERKL (OMIM ∗608381),
CACNA1F (OMIM ∗300110), SEMA4A (OMIM ∗607292), CRX (OMIM
∗602225), AIPL1 (OMIM ∗604392), RPGRIP1 (OMIM ∗605446),
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ABCA4 (OMIM ∗601691), PITPNM3 (OMIM ∗608921), PRPH2 (OMIM
∗179605), CNGB3 (OMIM ∗605080), ADAM9 (OMIM ∗602713), RPGR
(OMIM ∗312610), CDHR1 (OMIM ∗609502), RIMS1 (OMIM ∗606629)
and RAX2 (OMIM ∗610362).
The sequences were mapped on the human reference se-
quenceGRCh38.The in-house bioinformatics pipeline comprises
sequence variant calling using Varscan (version v2.3), Bcftools
of SAMTools (version 0.1.19-44428cd), GATK Unified Genotyper
and filter-based annotation using Annovar software with
online databases such as dbSNP (http://www.ncbi.nlm.nih.gov/
projects/SNP), 1000 Genomes (http://www.1000genomes.org/)
and Exome Variant Server (evs.gs.washington.edu/EVS). Path-
ogenic variations were sought in HumsVar (http://omictools.
com/humsavar-tool) and Human Gene Mutation Database
(HGMD professional). In silico prediction softwares such as Muta-
tion Taster (http://www.mutationtaster.org/) and the Ensembl
Variant Effect Predictor tool (http://www.ensembl.org/Tools/VEP)
were used to assess the pathogenicity of each variant.
Sanger sequencing (CEQ8800 Sequencer, Beckman Coulter)
was used to confirm NGS variants and for target sequencing in
the family genotype–phenotype segregation study.
Materials
QuikChange II Site-Directed Mutagenesis Kit was purchased
from Agilent; Bradford reagent was purchased from Bio-
Rad. DMEM, fetal bovine serum, penicillin, streptomycin and
geneticin were purchased from Thermofisher–Life Technologies.
Chromatographic columns (Superose 12 10/300 GL, HiPrep Q HP
16/10 and HiPrep 26/60 Sephacryl S-200 HR) were purchased
from GE healthcare; HPLC column (LiChrospher 100 RP-18) was
purchased from Sigma Aldrich. Synthetic oligonucleotides were
purchased by Eurofins. All other chemicals were of the highest
commercially available purity grade and purchased from Sigma
Aldrich.
Electrophysiological recordings
Electrophysiological assessmentwas executed by Retimax appa-
ratus (CSO, Firenze, Italy).
Full-Field ERGs were obtained from both eyes, after full pupil
dilatation by 1% tropicamide eye drops. Prior to any ERG record-
ings, subjects underwent a preadaptation period to the stim-
ulus/background mean luminance (20 min of preadaptation to
a steady background of 0 cd/m2 for dark-adapted ERG and to
30 cd/m2 for light-adapted ERG).
Ganzfeld-rod and cone ERG were recorded following the
ISCEV standards (49), under the constant monitoring of an
external observer. The stimulus for dark-adapted ERG was a
dim white flash of 0.01 cd/(s m2), with a minimum interval of 2 s
between flashes. For photopic ERGs, white 50-ms stimuli with
an intensity of 3 cd/(s m2) were presented on a steady white
background of 30 cd/m2. The interstimulus interval was 1 s.
ERGs were recorded by skin electrodes. Silver chloride electrodes
(0.8mm)were taped on the skin of the lower eyelids after coating
the electrode surface with saline electroconductive gel, just
2.5 mm below the inferior lid rim, in the vertical axis passing
through the corneal apex. A similar electrode on the lower
eyelid of the contralateral patched eye was used as reference
to minimize potential artefacts due to blink and conjugate
eye movement (50). Signals were amplified (50 K), filtered
(0.3–300 Hz), digitized at 2 KHz and averaged (40 events) with
automatic artefact rejection. Two runs were typically performed
for each eye. The peak-to-peak noise level was estimated in
line with the sum of events and odd events obtained for the
averaging process.
The amplitude and implicit times of the a- and b-waves
were measured as previously described (51,52). Dark and light-
adapted ERG a-wave amplitudes were measured from prestimu-
lus baseline to first negative trough. The scotopic and photopic
ERG b-wave amplitudes were measured from the negative peak
of the a-wave to the positive peak of the b-wave.
Cloning, protein expression and purification of human
WT and E111V GCAP1
The cDNA of human GCAP1-E6S (Uniprot: P43080) was cloned
into a pET-11a using NdeI and NheI as restriction sites (Gen-
script). The E6S mutation was inserted to generate the con-
sensus sequence for posttranslational N-terminal myristoyla-
tion by Saccharomyces cerevisiae N-myristoyl transferase (yNMT)
(53). Sequence variant c.332A>T (leading to the E111V substi-
tution) was created by polymerase chain reaction site-directed
mutagenesis using QuikChange II Site-Directed Mutagenesis Kit
(Agilent), primers (forward: 5’-TGCATCGATCGCGACGTACTGCTG
ACCATTATC-3’, reverse: 5’-GATAATGGTCAGCAGTACGTCGCGAT
CGATGCA-3’) and DNA sequencing were provided by Eurofins.
Heterologous expression of GCAP1 forms was performed in
BL21 Escherichia coli cells after co-transformation with pBB131-
yNMT. Proteins were purified from the insoluble fraction by
a combination of Size Exclusion and Anionic Exchange Chro-
matography as described before (27,31,53), with the only differ-
ence of the presence of 2-mm Ca2+ in all purification buffers
for improved resolution and protein stability. Methods for the
determination of protein purity and concentration were the
same as previously reported (27,31,53). Proteins were aliquoted
in 20-mm Tris-HCl pH 7.5, 150-mm KCl, 1-mm DTT, flash-frozen
and kept at −80◦C until use. Alternatively, some aliquots of the
proteins were washed against decalcified NH4HCO3 buffer and
lyophilized for use in competition chelator assays.
Cell culture and assays of GC enzymatic activity
Recombinant human ROS-GC1 (GC) was stably expressed in HEK
flip 293 cells, and the so obtained HEK293-GC cells were cul-
tured in DMEM medium supplemented with fetal bovine serum
(10%, v/v), penicillin (100 units/ml), streptomycin (100 μg/ml) and
geneticin (500 μg/ml), as previously described (54). GC activity
wasmeasured as previously described (20,54,55) after reconstitu-
tion of cellmembranes andGCAP1 forms.Themaximal andmin-
imal GC activation of GCAP1 forms was measured by incubation
of 5-μM WT or E111V GCAP1 with either <19 nM or ∼30-μM
free Ca2+. The Ca2+ concentration at which GC activation is
half-maximal (IC50) was measured by incubation of 5-μM WT
or E111V GCAP1 at different [Ca2+] levels (<19 nM–1 mm) using
Ca2+-EGTA buffer solutions (54–56). The GCAP1 concentration
at which GC activation is half-maximal (EC50) was measured by
incubation of increasing concentrations of WT or E111V GCAP1
(0–20 μM) in the presence of <19-nM free Ca2+. X-fold activation
was expressed as (GCmax − GCmin)/GCmin, where GCmax and GCmin
are the GC activity in the presence of 1-mm Mg2+ at <19 nM
and 1-mm free Ca2+, respectively. Reported activity values are
expressed as mean ± standard deviation of at least three data
sets.
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Ca2+-binding assays
Calcium affinity of GCAP1 variants was estimated using a
method based on the competition with a chromophoric chelator
(57,58) as described in previous work (25), with the only differ-
ence consisting of the experimental decalcified buffer (20-mm
Tris-HCl pH 7.5, 150-mm KCl, 1-mm DTT initial free [Ca2+] = 0.9–
1.5 μM). Briefly, decalcified lyophilized proteins were dissolved in
the experimental buffer containing the chromophoric chelator
5,5’Br2-BAPTA (24–25 μM) at a concentration of 9.5–12 μM. The
concentration of protein stocks was determined by Bradford
assays (59) optimized for GCAP1 based on determination of
precise protein content by amino acid analysis of initial stocks
(Alphalyze).
Absorbance decrease upon Ca2+-titration was monitored at
λ = 263 nm and fitted using CaLigator (57) to estimate individual
macroscopic binding constants (log Ki, Table 2) and subsequently
apparent affinity values (Kdapp = 10–(log K1+log K2)/2, Table 2). Data
fitting to a three-independent binding sites model resulted in a
highly unreliable estimation of the lowest affinity binding site for
theWT (log Ki <<4), while for the E111V variant results were not
substantially different from data fitting to a two-independent
binding sites model.
Presented data was normalized as follows:
y = Amax − A263
Amax − Amin Normalized
[
Ca2+
]
=
[
Ca2+
]
[Q] + 3 [P]
where A263 is the absorbance at λ = 263 nm, Amax and Amin are
the maximal and the minimal absorbance values, [Ca2+] is the
total Ca2+ concentration, [Q] is the 5,5’Br2-BAPTA concentration
and [P] is the protein concentration.
CD spectroscopy and thermal denaturation profiles
CD spectra were recorded in 20-mm Tris-HCl pH 7.5, 150-mm
KCl, 1-mm DTT buffer with a Jasco J-1500 spectropolarimeter
equipped with a Peltier thermostated cell holder set at 37◦Cwith
a scan rate of 50 ns/min, 1-nm bandwidth, 4-s response time.
Each spectrum was the average of five accumulations. Far UV
CD spectra and thermal denaturation profiles were recorded in a
0.1-cm quartz cuvette with a protein concentration of ∼10 μM in
the presence of 300-μM EGTA, 300-μM EGTA and 1-mm Mg2+ or
1-mmMg2+ and 300-μM Ca2+. Near UV CD spectra were recorded
in a 1-cm quartz cuvette with a protein concentration of ∼40 μM
in the presence of 500-μM EGTA and after sequential additions
of 1-mmMg2+ and 500-μM free Ca2+. Thermal denaturation data
were collected from 20 to 96◦C at λ = 222 nm, with a scan rate
of 1.5◦C/min, data pitch 0.1◦C, response time 4 s and fitted to a
four-parameter Hill sigmoid as follows:
y = ef + |ef − eu|T
H
THm + TH
where ef is the ellipticity of the folded state, eu is the ellipticity of
the unfolded state, T is the temperature, H is the Hill coefficient
and Tm is the melting temperature.
DLS experiments
DLS measurements were performed at 25◦C with a Zetasizer
Nano-S (Malvern Instruments) with the same parameters for
hydrodynamic diameter estimation as in ref. (20). Aggregations
studies were performed at 37◦C collecting data every minute
for ∼16 h. The number of measurements for hydrodynamic
diameter estimation was at least 32, each consisting of at least
6 repetitions; data are reported as mean ± standard error. All
proteins were dissolved at a concentration of ∼40 μM in 20-mm
Tris-HCl pH 7.5, 150-mm KCl, 1-mm DTT buffer and either 500-
μM EGTA and 1-mm Mg2+ or 1-mm Mg2+ and 500-μM Ca2+, then
centrifuged at 4◦C for 15min at 18000 x g and finally filtered using
0.02-μm Anotop 10 filter (Whatman) before DLS analysis.
Analytical SEC
The MW of WT and E111V GCAP1 was determined by SEC using
a Superose 12 10/300 GL column (GE Healthcare) using the same
calibration curve as in ref. (60). The column was equilibrated
with 20-mm Tris-HCl pH 7.5, 150-mm KCl, 1-mm DTT buffer and
either 500-μM EGTA and 1-mm Mg2+ or 1-mm Mg2+ and 500-μM
Ca2+. Approximately 40-μM proteins were incubated in the same
running buffers for 5 min, then centrifuged at 4◦C for 15 min at
18000 x g before loading. Protein elution profiles were recorded
at λ = 280 nm, retention volumes Rv were determined and the
distribution coefficient Kd was calculated as follows:
Kd = Rv − V0Vt − V0
where Vt is the column volume and V0 is the void volume. MWs
were calculated from a calibration plot of log (MW) versus Kd.
Fluorescence spectroscopy
ANS fluorescence was used to monitor hydrophobicity changes
in WT and E111V GCAP1 upon Mg2+ and Ca2+ binding. Proteins
were diluted in 20-mm Tris-HCl pH 7.5, 150-mm KCl, 1-mm DTT
buffer at ∼2-μM concentration and incubated for 2 min with 30-
μM ANS and 500-μM EDTA or 1-mm Mg2+ and after addition of
1-mm Ca2+. Three accumulations of ANS fluorescence spectra
were recorded at 37◦C in the 400–650 nm range after excitation
at λ = 380 nmwith excitation and emission bandwidths of 5 nm.
Gel mobility shift assays
SDS-PAGE on a 15% acrylamide gelwas performed tomonitor the
differential mobility in denaturing conditions of WT and E111V
GCAP1 upon Mg2+ and Ca2+ binding. Proteins were diluted in
20-mm Tris-HCl pH 7.5, 150-mm KCl, 1-mm DTT buffer at 30-μM
concentration and incubated at 25◦C for 5 min with 5-mm EDTA
or 5-mm EGTA and 1.2-mm Mg2+ or 1-mm Mg2+ and 5-mm Ca2+.
MD simulation and analyses
The homology model of human GCAP1 was obtained from the
chicken GCAP1 structure template (37) using the procedure
elucidated in ref. (25). Mutation E111V was inserted by in
silico mutagenesis of WT human GCAP1 by selecting the most
probable rotamer proposed by the ‘mutate residue’ function of
the Maestro (Schrodinger) suite. MD simulations and analyses
were run on GROMACS 2016.1 simulation package (61) using
CHARMM36m all-atom force field (62), in which parameters
for myristoylated-Gly were generated manually (available upon
request). All settings for MD simulations were taken from ref. (6),
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in which details are provided. Protocols for energyminimization,
system equilibration and production phase were the same as in
ref. (42). The 200-ns trajectories were subjected to RMSF and
distance analyses, calculated on the Cα atoms with the ‘gmx
rmsf’ and ‘gmx distance’ functions of GROMACS 2016.1, respec-
tively. RMSF, representing the time-averaged root-mean square
deviation of bound ions and Cα of all n residues with respect
to the initial structure of the production, was calculated as
follows:
RMSF(Cα)n =
√√√√ 1
T
T∑
ti=1
∣∣rn (ti) − rrefn
∣∣2
where T is the 200-ns timeframe, rn (ti) and rrefn are the Cα
coordinates of residue n at time ti and in the reference structure,
respectively.
Supplementary Material
Supplementary Material is available at HMG online.
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Figure S1  
 
 
Figure S1  
Example of sequence chromatogram (A) of the GUCA1A: NM_000409: c.332A>T: p.(Glu111Val) 
variant identified in heterozygous state in the proband and in his affected daughters. Residue 
conservation of EF3 (B) Ca2+-binding loop across species of the novel GUCA1A variant showing that 
amino acid E111 of this protein is highly conserved due to its importance in Ca2+-coordination. 
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Figure S2 
 
Figure S2 
Results from Size Exclusion Chromatography and Dynamic Light Scattering experiments on WT (left 
panels) and E111V (right panels) GCAP1, performed in 20 mM Tris-HCl pH 7.5, 150 mM KCl, 1 
mM DTT at 25 °C. Chromatograms of Size Exclusion Chromatography of ~40 µM WT (A) and 
E111V (B) GCAP1 in the presence of 500 µM EGTA and 1 mM Mg2+ (blue), or 1 mM Mg2+ and 500 
µM Ca2+ (red). Hydrodynamic diameter estimation of ~20 µM WT (C) and E111V (D) GCAP1 in 
the presence of 500 µM EGTA and 1 mM Mg2+ (blue), or 1 mM Mg2+ and 500 µM Ca2+ (red). DLS 
measurements were collected approximately every minute, each measurement was an accumulation 
of 6 runs. 
 
 
 
 
 
 
 3 
Figure S3 
 
Figure S3 
Results from ANS fluorescence and far UV CD spectroscopy experiments on WT (left panels) and 
E111V (right panels) GCAP1, performed in 20 mM Tris-HCl pH 7.5, 150 mM KCl, 1 mM DTT at 37 °C. Fluorescence emission spectra from 400 to 650 nm upon excitation at λ=380 nm of ~2 µM WT 
(A) and E111V (B) GCAP1 in the presence of 30 µM ANS and 500 µM EDTA (black) and in the 
presence of 1 mM Mg2+ (blue) and after addition of 1 mM Ca2+ (red). The spectrum of ANS in the 
presence of 250 µM EDTA is shown in dashed grey. Far UV CD spectra of ~10 µM WT (C) and 
E111V (D) GCAP1 in the presence of 300 µM EGTA (black) and after additions of 1 mM Mg2+ (blue) 
and 300 µM free Ca2+ (red). 
 
 
 
 
 
B 
C D 
A 
E111V WT 
 4 
Figure S4 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S4 
Analysis of MD simulations of WT and E111V GCAP1 in their Ca2+ loaded and EF2-Mg2+ forms. 
Root-mean square fluctuation calculated over 200 ns MD simulations on Cα of WT and E111V 
GCAP1 in their (A) EF2-Mg2+ and (B) Ca2+ loaded forms. Insets show protein secondary structure, 
helices are colored according to Figure 4A. Time evolution over 200 ns of the distance between Cα 
atoms of residues V101-E/V111 of WT and E111V GCAP1 in their (C) EF2-Mg2+ and (D) Ca2+ 
loaded forms. WT is shown in blue in panels A and C and in black in panels B and D, E111V is 
represented in green in panels A and C and in red in panels B and D. 
 
 
 
 
B 
C D 
A 
 5 
Supplementary Table T1. Results from ANS measurements 
 Imax λmax Δint Δλ 
ANS      
     EDTA 42.5 517   
WT GCAP1     
     EDTA 195.7 486  31 
     Mg2+ 142.3 493 53.4 24 
     Ca2+ 148.7 493 47 24 
E111V GCAP1     
     EDTA 196.5 488  29 
     Mg2+ 121.6 494 74.9 23 
     Ca2+ 136.7 494 69.8 23 
 
Imax is the maximal intensity at λmax, Δint is the intensity variation w.r.t the protein in the presence of 
EDTA, Δλ is the variation of the maximal wavelength w.r.t. ANS alone. 
 
 
 
Supplementary Table T2. Results from CD far UV spectroscopy and thermal denaturation profiles 
 
θ222/θ208  Δθ/θ Tm (°C) 
WT GCAP1    
EGTA 0.94   
Mg
2+
 0.94 0.02 49.0 
Mg
2+
 Ca
2+
 0.96 0.06 >96 
E111V GCAP1    
EGTA 0.92   
Mg
2+
 0.93 -0.01 54.5 
Mg
2+
 Ca
2+
 0.93 0.04 >96 
 
θ222/θ208 is the intensity ratio at λ=222 and λ=208 nm, Δθ/θ is calculated as (θion-θEGTA)/ θEGTA at 
λ=222 nm, Tm is the transition temperature after fitting the signal at λ=222 nm to a 4-parameter Hill 
sigmoid 
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normal GcAps partly compensate 
for altered cGMp signaling in 
retinal dystrophies associated with 
mutations in GUCA1A
Daniele Dell’orco* & Giuditta Dal cortivo
Missense mutations in the GUCA1A gene encoding guanylate cyclase-activating protein 1 (GCAP1) are 
associated with autosomal dominant cone/cone-rod (CORD) dystrophies. The nature of the inheritance 
pattern implies that a pool of normal GcAp proteins is present in photoreceptors together with the 
mutated variant. To assess whether human GCAP1 and GCAP2 may similarly regulate the activity of 
the retinal membrane guanylate cyclase GC-1 (GC-E) in the presence of the recently discovered E111V-
GCAP1 CORD-variant, we combined biochemical and in silico assays. Surprisingly, human GCAP2 does 
not activate GC1 over the physiological range of Ca2+ whereas wild-type GCAP1 significantly attenuates 
the dysregulation of GC1 induced by E111V-GCAP1. Simulation of the phototransduction cascade in a 
well-characterized murine system, where GCAP2 is able to activate the GC1, suggests that both GCAPs 
can act in a synergic manner to mitigate the effects of the CORD-mutation. We propose the existence of 
a species-dependent compensatory mechanism. In murine photoreceptors, slight increases of wild-type 
GCAPs levels may significantly attenuate the increase in intracellular Ca2+ and cGMP induced by E111V-
GCAP1 in heterozygous conditions. In humans, however, the excess of wild-type GCAP1 may only partly 
attenuate the mutant-induced dysregulation of cGMP signaling due to the lack of GC1-regulation by 
GCAP2.
The absorption of photons by visual pigments in retinal rod and cone cells triggers a complex signaling cascade 
known as phototransduction, which results in the electrical response of the cell and generates the visual stimulus1. 
A variety of protein-protein, protein-nucleotide and protein-ion interactions finely regulates the cascade2, whose 
dynamics depend on the interplay between Ca2+ and cyclic guanosine monophosphate (cGMP), the second mes-
sengers involved in the signaling process3,4. The core of the Ca2+/cGMP signaling unit resides in the complex 
formed by the membrane retinal guanylate cyclase (GC1, also called ROS-GC1 or GC-E being the main cyclase 
in photoreceptor outer segments5) and guanylate cyclase-activating proteins (GCAPs). This supramolecular 
machinery ensures a precise control of the cGMP synthesis by GC1 as a consequence of the level of intracellular 
free Ca2+, which drops from few hundred nanomolar in the dark to below 100 nM in the light1,6. Several GCAP 
isoforms exist in various species. In mouse7 and in bovine8,9 photoreceptors both GCAP1 and GCAP2 have been 
shown to regulate the target GC1, while in humans so far only GCAP1 has been directly shown to regulate the 
activity of GC110,11.
GCAPs are neuronal calcium sensors that detect subtle changes in Ca2+ concentration and adopt specific 
conformations required for controlling the activity of the target GC1, per se unable to respond to Ca2+. At high 
[Ca2+], GCAPs adopt a Ca2+-loaded state that inhibits GC1 activity, but following the drop in intracellular [Ca2+] 
during the light activation of the cascade, they switch to a Mg2+-bound conformation12–15 that stimulates GC1 to 
rapidly restore dark-adapted cell conditions by enhancing the synthesis of cGMP3,16.
To date, 20 missense mutations have been found in the GUCA1A gene encoding GCAP1, which have been 
associated with cone (COD) or cone-rod (CORD) dystrophies, severe forms of retinal dystrophy characterized by 
central vision loss, impaired color vision and photophobia17–19. No COD/CORD mutation in the gene encoding 
GCAP2 is known to date. When studied in reconstituted in vitro systems, most of the point mutations in GUCA1A 
resulted in GCAP1 variants that constitutively activate the GC1 over the physiological range of [Ca2+]10,20–25. The 
Department of Neurosciences, Biomedicine and Movement Sciences, Section of Biological Chemistry, University of 
Verona, I-37134, Verona, Italy. *email: daniele.dellorco@univr.it
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Y99C-GCAP1 mutation was the first one to have been discovered24, moreover it was the first one to be studied in a 
transgenic mouse line26. Other transgenic mouse lines were then generated to study similar COD/CORD-related 
phenotypes associated with mutations in GCAP1, namely the E155G-GCAP127 and L151F-GCAP128 models. The 
in vivo studies showed that the COD-related mutant caused photoreceptor degeneration due to an elevated [Ca2+] 
in the rod outer segment. However, rod photoresponses from the Y99C-GCAP1 mice showed relatively little 
changes especially at bright flashes, indicating a partly preserved Ca2+-regulated cGMP synthesis. Interestingly, 
the rate of photoreceptor cell loss increased with the level of Y99C-GCAP1 expression26.
For bovine and murine photoreceptors, it is well established that GCAP1 and GCAP2 are both capable of 
activating and inhibiting the target GC1 at similar levels in the physiological range of [Ca2+], however the two 
GCAPs differ from one another in some features: (i) GCAP1 has a slightly lower affinity for Ca2+ compared to 
GCAP212; (ii) GCAP1 triggers the activation of GC1 earlier than GCAP2, that is at dimmer light conditions and/
or when intracellular Ca2+ is still relatively high3; (iii) both GCAPs are myristoylated, but the myristoylation 
seems to exert a more prominent role for GCAP1 compared to GCAP2 in GC1 activation9. Moreover, in bovine 
cells the cellular concentration of GCAP1 and GCAP2 sums to the cellular concentration of GC19. While it is clear 
that both GCAPs can regulate GC1 over the narrow physiological window of intracellular Ca2+, quite different 
mechanisms have been proposed for the regulation. Some studies support distinct binding interfaces between 
GC1 and GCAP1/GCAP2, the first GCAP being located at the juxtamembrane region and the second prevalently 
bound to the catalytic-C terminal domain29–31, thus allowing the binding of GCAP1 and GCAP2 to either the 
same or distinct GC1 molecules, but always in different interfaces On the other hand, other studies found a partly 
overlapped GC interface for GCAP1 and GCAP232,33, suggesting a competition between GCAP1 and GCAP2 for 
GC1 activation in mouse cones34 as well as in rods. Overall, GCAPs seem to operate in a “calcium-relay” mode, 
thus acting simultaneously on either the same or distinct GC1 molecules to induce gradual responses in terms 
of cGMP synthesis triggered by small changes in intracellular [Ca2+]3,35. Their slightly different GC1-regulatory 
properties and Ca2+-sensitivity would therefore be needed to achieve the complex temporal dynamics necessary 
for finely tuning the enzymatic activity of GC1 over the broad range of light stimuli typical of photoreceptors.
COD and CORD linked to mutations in GUCA1A are associated with autosomal dominant (ad) inheritance 
pattern, thus implying that one half of the GCAP1 molecules in the overall GCAP pool would carry the mutation 
in affected photoreceptors. Under the assumption that no other alteration beside the missense mutation occurs, a 
normal amount of GCAP2 molecules would be therefore still present, together with one half of normal GCAP1. 
In this work we present the results of biochemical assays of human GC1 catalytic activity performed with dif-
ferent amounts of human wild-type (WT)-GCAP1, GCAP2 and E111V-GCAP1, a recently discovered variant 
associated with a severe form of CORD10. Interestingly, we found that human GCAP2 is uncapable of activating 
GC1 and therefore does neither co-act nor compete with GCAP1. On the other hand, increasing the amount of 
WT-GCAP1 with respect to E111V-GCAP1 led to a partial restoration of the Ca2+-regulation of GC1 enzymatic 
activity, although a 3-fold excess of WT was not enough to restore a fully normal behavior. In order to predict the 
dysregulation of the Ca2+ and cGMP homeostasis in a rod cell under conditions mimicking different expression 
levels of mutated GCAP1, we transferred the quantitative results from the enzymatic assays to a comprehensive 
model of mouse phototransduction that showed capable of reproducing photoresponses under both dim and 
bright stimuli36,37. We observed a crucial role for GCAP2 in mouse in compensating the dysregulation induced 
by the disease-associated E111V-GCAP1 which cannot possibly occur in human cones due to the lack of activity 
on GC1.
Results and Discussion
Regulation of the GC1 activity by Ca2+ via GCAPs represents an exemplary case, in which an enzyme (GC1) that 
per se is not sensitive to Ca2+ can be either inhibited or activated by the same molecule (GCAP) depending on 
the subtle changes in intracellular [Ca2+]. The discovery of the highly cooperative negative feedback mechanism 
mediated by Ca2+ on the GC1 dates back to the late 80’s38, and yet the fine mechanisms of its regulation are not 
completely understood. It has been established that the GCAP1/2-mediated Ca2+ feedback on GC1 activity is the 
only one that occurs at very dim light intensities, corresponding to the single photon response39. By integrating 
quantitative information arising from assays performed with recombinant systems and numerical simulations, 
we sought to clarify some mechanisms that are apparently perturbed in cases such as the severe CORD form 
recently associated with the E111V mutation in GCAP110. To investigate the role of each GCAP variant, namely 
WT-GCAP1, E111V-GCAP1 and WT-GCAP2 in GC1 (dys)regulation, we performed biochemical assays both in 
the presence of individual GCAPs and in the co-presence of the variants, and measured quantitative parameters 
to describe the Ca2+-dependence of the cGMP synthesis by GC1 and the apparent cooperativity of the process.
Human GCAP2 does not activate human GC1. Human GCAP1 (both WT and carrying the E1111V 
mutation) and GCAP2 were heterologously expressed and purified at high purity levels. All GCAP variants 
responded to Ca2+ by switching to a different conformation that showed the typical increase in electropho-
retic mobility (Fig. 1a), as observed in other calcium sensors40. The presence of smeared or multiple bands in 
SDS-PAGE gels is usual for calcium sensor proteins, and is related to the residual capability of the protein to bind 
Ca2+ in spite of the detergent-induced denaturation and the chelator present in the buffer12. Human GC1 was 
stably expressed in HEK cells and it concentrated in the membrane milieu (Fig. S1b), thus allowing the correct in 
vitro reconstitution of the GCAP-GC1 complex for biochemical assays.
While WT-GCAP1 was able to activate GC1 at low Ca2+, as observed in previous studies10,11, GCAP2 was 
unable to exert any regulation of GC1 as in both low and high Ca2+ conditions the levels of cGMP synthesis 
were unaltered with respect to those of the control (Fig. 1b). When the enzymatic assays were performed with 
equal amounts of GCAP1 and GCAP2, at low Ca2+ a slight decrease in the GC1 activation was observed (n = 3, 
p = 0.045) with respect to the sole presence of GCAP1, thus indicating that the presence of GCAP2 only slightly 
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interferes with the activity of GCAP1, which was still capable of regulating GC1. No GCAP2-induced activation 
of GC1 was observed even when the experiments were performed at higher (12 mM) Mg2+ (Fig. S2), thus indicat-
ing that the inability is intrinsic and not due to a low amount of Mg2+-bound GCAP2 in the assay.
The finding that human GCAP2 does not activate human GC1 might seem surprising, but in fact it is in line 
with previous work indicating that in human retinas, and similarly in monkey, GCAP2 localizes in cone inner 
segments, soma and synaptic terminal and only at very low levels in inner segments41. GCAP2 is crucial for main-
taining the integrity of the photoreceptor synaptic terminal, likely mediating the effect of light on the morpho-
logical remodeling changes of synaptic ribbons42 and even a single phosphorylation of GCAP2 has been shown 
to cause the complete retention of the protein in the inner segment43. Thus, while experiments with GCAPs-/- 
transgenic mice clearly established a role for GCAP2 in regulating the GCAP1-dominated GC1 activity39,44, and 
thorough in vitro investigations confirmed such capability7, in humans GCAP2 might have not-yet clear functions 
non-related with phototransduction.
CORD-associated E111V-GCAP1 is dominant and leads to GC1-dysregulation. Since GCAP2 did 
not contribute to the activation of human GC1, we monitored the Ca2+-dependent regulation of the cyclase in 
the co-presence of different amounts of WT-GCAP1 and E111V-GCAP1, with the goal to quantitatively assess 
the effects of the two variants on the same enzymatic target. Over the relatively narrow window of physiologi-
cal variations of intracellular [Ca2+] (∼10 nM–600 nM), WT-GCAP1 correctly switched from GC1-inhibitor to 
GC1-activator (Fig. 2, black curve). The IC50 value, i.e. the [Ca2+] at which the synthesis of cGMP and therefore 
the activity of GC was half-maximal, was 251 ± 19 nM (n = 6) and the cooperativity of the process was high 
(hc = 2.60 ± 0.42; n = 6; Table 1).
Like many other COD/CORD-associated GCAP1 mutants, E111V-GCAP1 showed a dramatic shift of GC1 
regulation to very high Ca2+ levels, with IC50E111V = 10 ± 5 μM (n = 4) and a significantly lower cooperativity 
(hc = 0.83 ± 0.27, n = 4; see red curve in Fig. 2)10 compared to the WT, thus constitutively activating the GC1 tar-
get over a physiological range of [Ca2+]. Those biochemical assays, however, were performed in the sole presence 
of E111V-GCAP1. When the assay was performed by mixing equal amounts of WT and E111V-GCAP1, thus 
resembling the heterozygous WT/E111V case found in CORD patients, the situation led to a different scenario 
(Fig. 2, green curve). While no significant change in the cooperativity could be observed (Table 1), the IC50 value 
shifted down to 694 ± 75 nM (n = 6) (Fig. 2, Table 1). Although this value is still insufficient to inhibit the GC1 at 
physiologically high [Ca2+], leading to ∼55% of the maximal activity, it is definitely lower compared to the ∼90% 
activity of E111V-GCAP1 alone.
WT-GCAP1 is thus capable of partly restoring the functional switch of GC1 in the presence of a mutant that 
would otherwise block the enzyme in a constitutively active state. A similar result was previously obtained by 
Dizhoor and co-workers21, who investigated in a bovine system the Y99C-GCAP1 variant associated with COD, 
and noticed that enzymatic assays in the co-presence of WT and mutated GCAP1 still led to constitutive GC1 
activity. The authors also investigated the co-presence of Y99C-GCAP1 and WT-GCAP2, obtaining very similar 
results, and thus concluded that the mutant stimulates the cyclase in the presence of equimolar concentrations of 
Figure 1. Purity of recombinant proteins, Ca2+-induced gel shifts and GC1 enzymatic assays. (a) SDS-PAGE 
of WT/E111V GCAP1 and GCAP2 in the presence of 5 mM EDTA, 4 mM EGTA + 1.4 mM Mg2+ and 1 mM 
Mg2+ + 4 mM Ca2+. Twenty micromolar WT-GCAP1, E111V-GCAP1 and WT-GCAP2 were incubated for 
10 min at 30 °C in the presence or absence of ions and loaded in a 15% SDS-PAGE. Gel was Coomassie blue-
stained. (b) GC1 enzymatic assays in the presence of 10 μM GCAP1, 10 μM GCAP2 and equal amounts of both 
(5 μM GCAP1 + 5 μM GCAP2) in the presence of less than 19 nM Ca2+ (low Ca2+) or ~ 30 μM Ca2+ (high Ca2+). 
Each bar represents the average of three replicas ± standard deviations (n = 3). Full-length gels are reported in 
Supplementary Fig. S1.
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either WT-GCAP1 or GCAP221. However, those assays were performed in a bovine system, where GCAP2 plays 
a role in GC1 activation, at odds with our current findings referring to a human system.
Since human GCAP2 does not activate GC1, we sought to investigate whether the observed partial restoring 
capability of WT-GCAP1 to restore GC1 activity in the presence of E111V-GCAP1 could even increase in the 
presence of extra WT-GCAP1. The assays were performed with 3-fold excess of WT-GCAP1, while keeping the 
concentration of E111V unaltered with respect to the previous conditions. Interestingly, a statistically significant 
decrease of IC50 was observed (497 ± 49 compared to 694 ± 75; n = 6; one-tailed p = 0.029; Table 1). Although 
the residual activity of GC1 at physiologically high [Ca2+] was still quite high (∼45%; Fig. 1, yellow curve) the 
regulation profile became more cooperative, as shown by the increase in hc (1.49 ± 0.35 vs. 0.87 ± 0.18, n = 6). 
Therefore, although the switch was still non-optimal, the presence of 3-fold excess WT-GCAPs seems to slightly 
attenuate the dominant and detrimental effect caused by the E111V-GCAP1 mutation.
The observed results of GC1 activity in the presence of different amounts of GCAP1 and its E111V variant 
are not straightforward to interpret. Human WT-GCAP1 and E111V-GCAP1 have very similar apparent affin-
ity (EC50) for GC110, therefore it seems unlikely that the cause of the still dominant effect of the mutant in a 
situation of 3-fold excess of WT be attributed to the preferential formation of a complex with the GC1. A more 
realistic explanation could be the existence of different equilibria between the oligomeric states of WT-GCAP1 
and E111V-GCAP1, which could result in different amounts of monomeric GCAP available for GC regulation. 
GCAP1 is known to form dimers10,45 and under conditions mimicking the physiological ones E111V-GCAP1 
was also found to be dimeric10. We cannot exclude that in the conditions of our in vitro assays the tendency of 
WT-GCAP1 to form dimers enhanced at the higher concentrations corresponding to the 3-fold excess experi-
ments, de facto limiting the availability of monomers that could further improve the restoration of the GC1 reg-
ulation towards a physiological behavior.
Expression levels of normal GCAPs set the homeostasis of Ca2+ and cGMp in a computational 
model of E111V-GCAP1 mouse rod. In order to evaluate the putative cellular consequences of the Ca2+/
cGMP dysregulation brought about by the E111V-GCAP1 mutation associated with CORD and the extent of a 
potential compensation by normal GCAPs, we used the parameters experimentally measured in the human sys-
tem to predict the rate of cGMP synthesis in a mouse rod illuminated by flashes of increasing intensity. We used a 
comprehensive kinetic model of phototransduction that demonstrated very effective in reproducing experimental 
results from dim to bright light conditions37. In particular, we could directly probe the role of each GCAP, namely 
WT/E111V GCAP1 and GCAP2, in regulating the levels of second messengers by virtually tuning the contribu-
tion of each protein to GC1 regulation and simulating the dark-adapted state of the cell as well as the response to 
specific light stimuli, thus investigating the dynamic shaping of cGMP synthesis.
Figure 2. Ca2+-dependence of GC1 activity in the presence of various GCAP1 variants. The GC1 activity 
as function of [Ca2+] was measured in the presence of 10 μM WT-GCAP1 (black circles), 5 μM WT-
GCAP1 + 5 μM E111V-GCAP1 (green diamonds) and 15 μM WT-GCAP1 + 5 μM E111V-GCAP1 (yellow 
triangles). E111V-GCAP1’s activity profile is referred to the published data10. Each data set is relative to 4–6 
replicas and data are normalized according to both total protein content in membranes and maximum and 
minimum GC1 activity recorded in each replica; error bars represent s.e.m. Solid lines represent the results of 
data fitting while the grey box represents the physiological Ca2+ fluctuations in rod photoreceptors.
GCAP1WT (n = 6) GCAP1E111V b (n = 4) GCAP1WT/E111V (n = 6) 3XGCAP1WT/GCAP1E111V (n = 6)
IC50 (nM) 251 ± 19a (10 ± 5)x103 694 ± 75 497 ± 49
hc 2.60 ± 0.42 0.83 ± 0.27 0.87 ± 0.18 1.49 ± 0.35
Table 1. Results from enzymatic assays. Human GC1 activity as a function of free [Ca2+]. (a) reported data are 
mean ± s.e.m. (b) data from. ref. 10.
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The significant perturbation of the GC1 regulation induced by the E111V mutation in GCAP1 assessed in vitro 
was reflected by a substantial increase of the dark levels of Ca2+ and cGMP (Table 2).
The simulation of the rod in the dark for a heterozygous WT/E111V mouse resembles the case of adCORD 
pattern in humans, in which half of the GCAP1 pool is made of WT molecules and the other half carries the 
E111V mutation. Under these conditions, a 3.1-fold increase in the level of intracellular Ca2+ and 1.4-fold 
increase in that of cGMP was predicted by numerical simulations (Table 2). These results are substantially in 
line with the experimental measurements of intracellular [Ca2+] in Y99C-GCAP1 mice, where an increase of 1 
to 2-fold depending on the expression levels of the mutant over a background of WT-GCAP1 was observed26. To 
probe the effects of different expression levels of mutant vs. WT-GCAP1, we performed numerical simulations of 
other putative cases, first one in which the whole pool of GCAP1 carried the E111V mutation in the co-presence 
of endogenous WT-GCAP2. The simulated increase of dark levels of Ca2+ and cGMP was dramatic in this hypo-
thetical E111V/E111V homozygosis case (12.5-fold and 2.0-fold, respectively; Table 2). In line with our in vitro 
experiments with human proteins, we also simulated the effects of a 3-fold excess of WT-GCAP1 over a back-
ground of constant E111V-GCAP1, both in the presence and in the absence of endogenous GCAP2. Interestingly, 
extra-delivery of WT-GCAP1 in the presence of GCAP2 restored an almost WT-like homeostasis of dark Ca2+ 
and cGMP (1.4-fold and 1.1. fold, respectively; Table 2). However, the same delivery of WT-GCAP1 performed 
in the absence of endogenous GCAP2 did not restore a WT-like homeostasis for second messengers, and led to 
a dramatic increase of 3.0-fold dark Ca2+ and 1.4-fold cGMP, similar to what was observed in the simulated het-
erozygous WT/E111V case (Table 2). Hence, simulations suggest that GC1 activation by GCAP2 is fundamental 
in mouse photoreceptor to set the normal levels of second messengers. In its absence, the normally dominant 
WT-GCAP1 although delivered in excess cannot compensate for the detrimental dysregulation of GC1 by the 
pathogenic E111V mutation.
GCAP2 shapes cGMP synthesis in E111V-GCAP1 mouse photoresponses. Perturbation of the 
second messenger homeostasis in the dark might lead to alterations in the photoresponse of the affected cells. To 
probe such potential variations, we simulated photoresponses from mouse rods expressing the same amounts of 
GCAPs investigated in the dark following the excitation of the phototransduction cascade by flashes of increasing 
intensity, from dim to saturating. The resulting dynamics of suppression of the dark current in a rod of a WT 
mouse and the respective cases for a heterozygous WT/E111V and a homozygous E111V/E111V-GCAP1 case 
are reported in Fig. 3a,b, respectively.
For all the tested flash intensities the photoresponses of the mutant cases were prolonged compared to the WT, 
with increased time to peak. The prolongation of the photoresponse apparently depends on the relative abun-
dance of E111V-GCAP1 with respect to the WT and was in fact significantly more pronounced in the homozy-
gous (Fig. 3b) compared to the heterozygous case (Fig. 3a). Similar results were experimentally measured in 
Y99C-GCAP1 mice26, although the effect was less prominent, probably due to the milder phenotype that devel-
oped COD and not CORD as in the case of E111V-GCAP1.
Our computational implementation of the GC1 regulation by different GCAP variants allowed us to ideally 
dissect their individual contributions in shaping the rate of cGMP synthesis at different light stimuli. Figure 3c,d 
reports on the overall GCAPs contribution (black line) to the time course of cGMP synthesis as a sum of the con-
tribution by GCAP1 variants (blue line) and WT-GCAP2 (red line). Clear differences could be observed between 
WT and WT/E111V heterozygous case. For WT rods, increasing the flash intensity led to an increasing contri-
bution of GCAP2 in shaping the cGMP synthesis rate, which was less important for very dim flashes, but became 
predominant at bright intensities (Fig. 3c), in line with the Ca2+-relay mechanism3,35. In the case of WT/E111V 
heterozygous mouse, however, the unbalance in the contributions became apparent under dim light conditions, 
where GCAP1 variants dominated, while GCAP2 was still capable of shaping the rate at brighter flashes (Fig. 3d). 
It should be noticed that, in spite of the dramatic perturbation in the dark levels of Ca2+ ad cGMP (Table 2), our 
model predicts that the photoreceptor would still respond to light stimuli, with all in all minor perturbation of the 
photoresponse shape (Fig. 3a), thus fully in line with experimental observations26.
The major dysregulation of second messenger homeostasis observed in the hypothetical E111V/E111V 
homozygous case, where the whole GCAP1 pool carried the E111V mutation reflected in a dramatic perturba-
tion of the photocurrent shapes, which became significantly prolonged and did not completely shut-off even after 
5 s for brighter stimuli (Fig. 3b). Under dim flashes, GCAP2 did not contribute at all to the shaping of the cGMP 
synthesis rate, but at middle to bright light conditions, where GCAP1 was almost completely blocked in the 
GC1-constitutively activating state, GCAP2 provided most of the dynamic contribution (Fig. 3e).
Simulation of 3-fold WT-GCAP1 delivery over a background of E111V-GCAP1 variant suggested a scenario 
that strictly depends on the presence of the other endogenous GCAP2. Indeed, when endogenous GCAP2 was 
considered in the simulations, the mutant-induced prolongation of the photocurrent was reduced at all light 
intensities (Fig. 4a) and the dynamics of cGMP synthesis as well as the specific contributions of GCAPs (Fig. 4c) 
GCAP1WT/E111Va GCAP1E111V/E111V 3XGCAP1WT/GCAP1E111V + GCAP2 3XGCAP1WT/GCAP1E111V-GCAP2
X-fold [Ca2+free] 3.1 12.5 1.4 3.0
X-fold [cGMP] 1.4 2.0 1.1 1.4
Table 2. Increase in dark levels of Ca2+ and cGMP according to numerical simulations of a mouse rod outer 
segment compared to a wild-type case. acombination of individual weight factor fi to simulate each condition 
are illustrated in the Methods.
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were overall fairly similar to the WT case (Fig. 3c). This suggests that under these conditions it would be in 
principle possible to partly restore a normal shaping of both the photocurrent and cGMP synthesis profile, thus 
minimizing the perturbation of the second messengers (Table 2). However, when the same delivery of 3-fold 
WT-GCAP1 was simulated in the absence of endogenous GCAP2, the prolongation of the photocurrents became 
significant under all light regimes (Fig. 4b), resembling that of heterozygous WT/E111V (Fig. 3a). Nevertheless, 
in this case the absence of GCAP2 led to a completely GCAP1 (WT and E111V)-driven cGMP synthesis, with 
Figure 3. Simulation of flash responses and dynamics of cGMP synthesis in a mouse rod, from dim to bright 
light conditions. After equilibration of the rod outer segment in the dark, 24 ms flashes were delivered, leading 
to 1.54, 18, 87 and 500 photoisomerizations of rhodopsin; (a,b) Black traces: WT GCAPs-containing rods. 
Dash-dotted gray lines: photoresponses in a WT/E111V heterozygous case (a) and E111V/E111V homozygous 
case (b). Photocurrents represent the suppression of the dark current at each light intensity and have been 
normalized. (c–e) Simulated time course of the rate of cGMP synthesis by GC1 in the same conditions as in 
(a,b). Blue lines: contribution by WT-GCAP1 + E111V-GCAP1 (if present). Red lines: contribution by GCAP2. 
Black lines: overall GCAPs contribution obtained by adding up the former terms.
7Scientific RepoRtS |         (2019) 9:20105  | https://doi.org/10.1038/s41598-019-56606-5
www.nature.com/scientificreportswww.nature.com/scientificreports/
higher maximal levels of synthesis at each light intensity (Fig. 4d) compared to the heterozygous case (Fig. 3d). 
Hence, in spite of the dominant role of this GCAP1 isoform in the WT photoreceptor, the excess of GCAP1 alone 
is not sufficient to compensate for the absence of GCAP2 in mouse rods.
The crucial role of GCAP2 in compensating for the extreme perturbations of cGMP signaling induced by 
blocking GCAP1 into a GC1-constitutively active state was proposed by us for a bovine system based on com-
prehensive model of the phototransduction kinetics46 and was then experimentally confirmed in a mouse cone 
system34.
conclusions
In conclusion, our findings support the view that the severity of COD/CORD phenotypes associated with point 
mutations in GUCA1A correlates both with the dysregulation of the cGMP signaling induced by the point mutation 
and with the levels of mutated GCAP1 over WT-GCAPs. Increasing the levels of WT-GCAP1 on a background of 
disease-associated mutants may partly attenuate the increased dark levels of Ca2+ and cGMP, which are ultimately 
associated to cell death47,48 and reduce the perturbation of the photocurrent dynamics. Since promising strategies for 
the delivery of WT recombinant proteins to photoreceptors are under development49,50, our findings might be relevant 
for future protein therapies aimed at slowing retinal degenerations associated with GUCA1A mutants. However, our 
data also show that, while useful for the purpose, extra-WT-GCAP1 alone would probably not be sufficient to restore a 
normal regulation of GC1 in human retinas. The intricate Ca2+-relay mechanism involving GC1 and the GCAPs might 
be substantially species-dependent, and whether other regulators in human photoreceptors may mimic the synergic 
activation of GCAP1 and GCAP2 on GC1 observed in mouse and bovine retinas remains to be clarified.
Figure 4. Simulation of flash responses and dynamics of cGMP synthesis in a mouse rod, from dim to bright 
light conditions, in the presence of 3-fold WT-GCAP1 with respect to E111V-GCAP1. Panels (a,c) refer to 
simulations in which endogenous GCAP2 was present. Panels (b,d) refer to simulations in the absence of 
endogenous GCAP2. All simulated conditions and symbols are the same of Fig. 3.
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Materials and Methods
GCAPs expression and purification. Synthetic genes (Genscript) corresponding to the cDNA of human 
GCAP1 (Uniprot: P43080) and GCAP2 (Uniprot: Q9UMX6) were cloned into pET-11a(+) vectors using NdeI 
and NheI as restriction site. Mutagenesis, protein expression and purification of myristoylated proteins were per-
formed as described previously10,12. Briefly, cells were let grown at 37 °C until an OD600 value of 0.4 was reached, 
then myristic acid (100 μg/mL, in 50% EtOH, pH 7.5) was added. After the induction with 1 mM IPTG, cells were 
let grown for 4 hours at 37 °C. Both WT and E111V-GCAP1 as well as GCAP2 were purified from inclusion bod-
ies. After protein denaturation by 6 M guanidinium hydrochloride and refolding steps by dialysis, two subsequent 
chromatographic steps (size exclusion and anionic exchange chromatography) were performed. Proteins purity 
was tested by Polyacrylamide Gel Electrophoresis in the presence of Sodium-Dodecyl-Sulfate (SDS-PAGE) and 
was found to be at least 95% (see Fig. 1a). The efficiency of protein myristoylation was proven by HPLC and mass 
spectrometry. After buffer exchange (20 mM TRIS, 150 mM NaCl, 1 mM DTT), proteins were shock frozen and 
stored at −80 °C until use.
GC expression and enzymatic assays. A stable cell line expressing human guanylate cyclase isoform 
1 (GC1) was obtained as explained previously10,51 by transfecting HEK293 flp cells with pIRES-eGFP plasmid 
using Turbofect reagent. Transfected clones were selected based on the resistance to geneticin (G418). Cells were 
cultured in DMEM media containing fetal bovine serum (10% v/v), streptomycin (100 μg/mL), penicillin (100 
units/mL) and geneticin (500 μg/mL). At 90% confluence the cells were harvested, washed with sterile PBS and 
stored at −80 °C. To perform enzymatic assays on isolated membranes cells pellets were suspended in lysis buffer 
(10 mM HEPES pH 7.4, 1 mM DTT, protease inhibitor cocktail 1X) and incubated for 20 min on ice. After 15 
up-and-down cycles with a 1 mL syringe on ice, cells were centrifuged for 20 min at 10000 rpm. The obtained 
pellets were suspended in 50 mM HEPES pH 7.4, 50 mM KCl, 20 mM NaCl, 1 mM DTT.
First, GC1 activity was assessed incubating 10 μM GCAP1 or GCAP2 or a combination of both (5 μM 
GCAP1 + 5 μM GCAP2) in the absence (<19 nM) and in the presence (~30 μM) of Ca2+, obtained using 10 mM 
K2H2EGTA and K2CaEGTA buffers51 respectively (Fig. 1b). Basal GC1 activity was assessed as internal control by 
replacing GCAPs with equal amount of the buffer used for protein storing. Then, the enzymatic activity as a func-
tion of [Ca2+] was measured as in previous work10, with minor changes explained in the following. Several com-
binations of GCAPs were tested, namely: (i) 10 µM WT-GCAP1; (ii) 5 μM WT-GCAP1 + 5 μM E111V-GCAP1; 
iii) 15 μM WT-GCAP1 + 5 μM E111V-GCAP1. Data for E111V-GCAP1 alone are referred to our previous pub-
lication10. Ca2+ concentration in each assay was carefully determined by combining the same K2H2EGTA and 
K2CaEGTA buffers previously mentioned. The assay consisted in incubating for 5 min at RT the diluted proteins 
with a fixed amount of extracted membranes, then reaction buffer (30 mM MOPS pH 7.2, 20 mM KCl, 10 mM, 
4 mM NaCl, 1 mM DTT, 3.5 mM MgCl2, 1 mM GTP, 300 μM ATP, 160 μM Zaprinast) was added and the samples 
were incubated for 5 min at 30 °C. The reaction was blocked by the addition of 50 mM EDTA and incubating at 
98 °C for 5 min. After centrifugation at 13000 rpm the supernatant was loaded in a C18 reverse phase column 
(Chromolith column, Millipore) previously equilibrated with 5 mM KH2PO4. Following a previously established 
protocol10 on an HPLC apparatus (Jasco) the cGMP concentration was determined by acetonitrile gradient. Four 
to 6 repetitions of each assay were performed. Data have been normalized to the total protein content present in 
membranes used for the assay (amido black, Sigma) and on the minimum and maximum GC-activity. IC50 and 
Hill coefficient (hc) values were determined for each assay by curve fitting to a 4-parameter Hill function (Sigma 
Plot 12.5) and mean, standard deviation and standard error of the mean (s.e.m.) were determined. All data distri-
butions passed the Shapiro-Wilk normality test and the observed parameters IC50 and hc were compared with one 
another by one-tailed t-test (SigmaPlot 12.5), rejecting in all cases the null hypothesis (p < 0.05).
Numerical simulations of mouse photoresponses. A previously developed comprehensive biochem-
ical model of phototransduction in mouse rods was used for numerical simulations37. All parameters describing 
the phototransduction cascade were left unaltered, the only difference being the way the reaction describing the 
dynamic synthesis of cGMP by GC1 was implemented. In the present implementation, to account for specific 
contributions of GCAP variants to the cGMP synthesis in a mouse photoreceptor, each variant (GCAPi) was 
described to contribute by a specific fraction fi to the maximal activation (αmax) of GC1:
∑ ∑
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The value for αmax, assumed to be the same for each variant, was fixed to 120 μM/s, as in the previous model, 
while IC50 and hc for WT-GCAP1 and GCAP2 were fixed to their experimentally measured values in mouse rod 
outer segments7. IC50 and hc for E111V-GCAP1 were set to their relative values (-fold variation) compared to the 
wild type, according to the parameters experimentally measured for the human orthologs (Table 1). The use of 
different weight factors fi is a convenient way to account for the specific contribution of each GCAP variant to the 
overall regulation of GC1, with the assumption of a similar apparent affinity between GCAP variants and GC1, so 
that the variants may compete for the target based solely on their concentration/expression levels. This condition 
has been demonstrated to be realistic for E111V and WT human GCAP1, for which substantially unaltered EC50 
values for human GC1 were measured10, as well as for murine GCAP1 and GCAP2, which showed almost identi-
cal EC50 values for murine GC1 in rod outer segment membranes7.
With the above assumptions, by tuning the fi terms one can simulate a broad variety of experimental condi-
tions; for example, the situation of a heterozygous mouse E111V/WT, corresponding to the human adCORD case, 
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in which half of the GCAP1 molecules are WT and half carry the E111V mutations, in the presence of normal 
amounts of WT GCAP2 was modeled as follows:
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The case of homozygous mouse E111V/E111V in the presence of endogenous GCAP2 was simulated by set-
ting fGCAP1WT = 0; fGCAP1E111V = 0.5; fGCAP2 = 0.5. Finally, the case of 3-fold excess of WT-GCAP1 over a back-
ground of E111V-GCAP1 and endogenous GCAP2 was obtained by setting: fGCAP1WT = 0.375; fGCAP1E111V = 0.125; 
fGCAP2 = 0.5, while the same excess in the absence of endogenous GCAP2 was simulated by: fGCAP1WT = 0.75; 
fGCAP1E111V = 0.25; fGCAP2 = 0. All numerical simulations were performed in Matlab as explained in earlier 
works36,37.
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Figure S1. Purity of recombinant proteins and GC1 enzymatic assay. a) Full-length gel used for 
the preparation of Figure 1a. b) Western blot analysis of HEK293 soluble phase (Sol) and two 
different amounts (1.4 and 7 μg) of membrane proteins previously quantified by amido black. Anti-
GC1#3 antibody (Ref. 51) was used (1:1000 dilution).  
 
 
 
Figure S2: GC assay at different Mg2+ concentrations. Guanylate Cyclase activity induced by 
GCAPs was analyzed at 1 mM (left) and 12 mM Mg2+ (right), in the presence of low (< 19 nM) and 
high ( ̴ 30 µM) Ca2+ concentration. Each measurement represents the average of three replicas.  
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Luminescent and paramagnetic 
properties of nanoparticles shed 
light on their interactions with 
proteins
Giuditta Dal Cortivo1, Gabriel E. Wagner2, Paolo Cortelletti3, Krishna Mohan Padmanabha Das4, 
Klaus Zangger5, Adolfo Speghini  3, Daniele Dell’Orco  1 & N. Helge Meyer  6
Nanoparticles have been recognized as promising tools for targeted drug-delivery and protein 
therapeutics. However, the mechanisms of protein-nanoparticle interaction and the dynamics 
underlying the binding process are poorly understood. Here, we present a general methodology for 
the characterization of protein-nanoparticle interaction on a molecular level. To this end we combined 
biophysical techniques including nuclear magnetic resonance (NMR), circular dichroism (CD), resonance 
energy transfer (RET) and surface plasmon resonance (SPR). Particularly, we analyzed molecular 
mechanisms and dynamics of the interaction of CaF2 nanoparticles with the prototypical calcium 
sensor calmodulin (CaM). We observed the transient formation of an intermediate encounter complex 
involving the structural region linking the two domains. Specific interaction of CaM with CaF2 NPs is 
driven by the N-terminal EF-hands, which seem to recognize Ca2+ on the surface of the nanoparticle. We 
conclude that CaF2 NP-CaM interaction is fully compatible with potential applications in nanomedicine. 
Overall, the methods presented in this work can be extended to other systems and may be useful to 
quantitatively characterize structural and dynamic features of protein-NP interactions with important 
implications for nanomedicine and nano-biotechnology.
Nanoparticles (NPs) receive increasing attention in biomedical applications and are intensively discussed as 
promising drug delivery systems in disease treatment1–3. Due to their high degree of specificity and minimal side 
effects they are of particular interest as they can potentially be used with protein therapeutics in complex diseases. 
However, the mechanisms of protein-nanoparticle interactions are not fully understood.
Recently, it has been shown that CaF2 NPs can specifically bind calcium sensor proteins including recoverin4, 
guanylate cyclase-activating protein 1 (GCAP1)5 and calmodulin (CaM)6. In these latter cases, binding to NPs 
occurs at physiological concentrations in a fully reversible manner and most importantly, it does not alter sec-
ondary or tertiary structure of the protein6. The fact that the surface-bound protein remains structurally and 
functionally intact suggests that CaF2 NPs might be considered as specific carriers for calcium sensors including 
CaM and GCAP1, and that exploiting the high surface-to-volume ratio typical of the nanoscale could constitute a 
general strategy for protein replacement-therapy in the case of disease-associated mutant proteins5.
CaM is a prototypical calcium sensor protein, which is highly conserved and ubiquitous in eukaryotic cells. 
It comprises four EF-hands (EF1-4), each containing a functional calcium binding motif and arranged in two 
domains, termed C-terminal and N-terminal lobe. As Ca2+ ions act as important second messenger, CaM is 
involved in many physiological processes including cell motility, proliferation, apoptosis, cytoskeleton remod-
eling, metabolic homeostasis, ion transport and protein folding7,8. Focusing on CaM-dependent biochemical 
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systems could be particularly useful for targeting cell cycle dysregulation and aberrant proliferation in tumor 
cells9. Very recently, point mutations in the gene encoding CaM were found in patients suffering from arrhythmo-
genic pathologies10, moreover, a significant over-expression of CaM in Alzheimer’s disease has been found11, thus 
implying a possible involvement of CaM in protein therapeutics for a broad variety of diseases spanning from 
genetic pathologies to neurodegenerative cases.
In this work, we aim at unveiling the mechanisms of protein-NP interactions at the molecular level by focus-
ing on a biologically relevant system, namely CaF2 NP interacting with human CaM. We have used a compre-
hensive approach combining high-resolution spectroscopic techniques with lower-resolution, versatile methods. 
Specifically, we employed nuclear magnetic resonance spectroscopy (NMR) and resonance energy transfer (RET) 
by exploiting both paramagnetic and luminescence properties of lanthanide-doped CaF2 NPs and obtained fur-
ther insights in the binding process by circular dichroism spectroscopy and surface plasmon resonance (SPR). 
Our results suggest that kinetics of protein-nanoparticle interaction in this case is fully compatible with realistic 
nanomedicine applications. The methodology presented here can be extended to other protein-NP interaction 
systems of biomedical and biotechnological relevance.
Methods
Protein preparation. Calmodulin was expressed in E. coli BL21(DE3) Rosetta pLsyS over night at 25 °C 
after induction with 0.5 mM IPTG (at an OD600 of 0.8) using a modified pet24a vector (Genscript). The sequence 
contains an N-terminal 6His-tag followed by a cleavage site for tobacco etch virus (TEV) protease. Bacteria were 
grown in LB medium or M9 medium supplemented with [15N]H4Cl and 13C-Glucose for the production of unla-
beled and uniformly 15N, 13C-labeled samples, respectively.
Bacterial cells were harvested by centrifugation for 15 min. at 6000 g and resuspended in 20 mM TRIS-HCl 
pH 8, 100 mM NaCl, 10 mM imidazole, 4 mM 2-Mercaptoethanol. After addition of protease inhibitor cocktail 
(Sigma Aldrich), DNase I and Lysozyme bacterial cells were lysed by sonication. Subsequent to centrifugation for 
45 min at 48.000 g lysis supernatant was applied to a Ni-NTA-Agarose column (2 ml, 5Prime PerfectPro Ni-NTA 
Agarose, Thermofisher Scientific). The column was then washed three times each with 10 column volumes of a 
buffer containing 20 mM TRIS-HCl pH8, 100 mM NaCl, 4 mM 2-Mercaptoethanol and additionally either 10 mM 
imidazole, 500 mM NaCl or 20 mM imidazole. Protein was eluted with 400 mM imidazole in the same buffer. 
After removal of the His-Tag by cleavage TEV protease the protein sample was charged with 5 mM CaCl2 and 
applied to a Phenyl-Sepharose (PS) column (GE Healthcare). The column was washed with 20 mM TRIS-HCl 
pH 7.5, 0.5 mM CaCl2, 1 mM DTT and eluted with 20 mM TRIS-HCl, 1 mM EGTA, 1 mM DTT. After extensive 
dialysis against Ca2+-free 50 mM (NH4)2CO3 the protein was lyophilized and stored at −20 °C.
For NMR measurements uniformly labeled protein samples were washed twice with NMR buffer (20 mM 
BisTris-HCl pH 6.5, 50 mM NaCl, 500 μM CaCl2, 0.02% NaN3) by ultrafiltration (Amicon Ultra-15 Millipore) 
and concentrated to 1 mM.
Protein-fluorescent dye conjugation and luminescence titrations. The maleimide-functionalized 
fluorescent dye Alexa Fluor 532 (Thermofisher) was specifically coupled to human CaM by a thiol/disulfide 
exchange reaction. The wild type protein lacks Cys residues, therefore threonine in position 26 was mutated into 
cysteine using standard mutagenesis techniques. The conjugated dye exhibited λ = 532 nmexc
max  and 
λ = 554 nmemi
max . After dissolving 1 mg of dye in DMSO, the conjugation was performed in 50 mM TRIS-HCl pH 
7.2, 150 mM KCl buffer, in the presence of 10-fold excess of dye with respect to the protein. The dye was added to 
the protein solution dropwise in the dark, in order to prevent quenching. A buffer exchange step using a PD10 
desalting column (GE Healthcare) allowed the isolation of the unconjugated dye. Finally, the conjugation effi-
ciency was calculated using Equation 1:
ε
= ⁎ ⁎Efficiency
A MW
CaM
(%)
[ ]
100
(1)
dye
Alexa
CaM532
in which εAlexa is the dye extinction molar coefficient (78,000 M−1cm−1), MWCaM is 16,800 g mol−1 and [CaM] is 
expressed in mgmL−1. The efficiency of conjugation was 68%.
In order to study the interaction between the conjugated CaM T26C and the CaF2 NPs, titration experiments 
were performed. Twelve additions (8.05 µL each) of a fluorescently-labeled CaM stock solution (31 µM) were 
done in a dispersion of 0.5 mgmL−1 NPs, moving from a protein-free condition to a final concentration of 5.5 µM 
CaM. Solution volumes ranged between 500 µL and ~600 µL (dilution effect was considered in the final protein 
concentration calculation). For each addition, a fluorescence emission spectrum (410–750 nm) was collected 
following excitation at 980 nm.
NP preparation. Er3+, Yb3+ codoped CaF2 NPs (nominal molar ratios Ca2+:Yb3+:Er3+ = 0.78:0.20:0.02), 
Y3+,Gd3+ co-doped CaF2 NPs (nominal molar ratios Ca2+:Y3+:Gd3+ = 0.78:0.21:0.01) and Y3+ doped CaF2 NPs 
(nominal molar ratios Ca2+:Y3+ = 0.78:0.22) were prepared using a hydrothermal technique and stoichiometric 
amounts of metal chlorides12. Sodium citrate was used as a capping agent and ammonium fluoride was added as 
the fluorine precursor. The obtained solution was heat-treated in a Teflon lined autoclave at 190 °C for 6 hours. 
After the reaction, NPs were precipitated and collected by centrifugation. The NPs are easily dispersible in water 
or saline solution. Structural and optical characterizations are reported in previous papers4–6,13.
Limited proteolysis. The pattern of proteolytic digestion was first tested on CaM, in the absence or in the 
presence of Ca2+. In the experiments without NPs, 6 µg CaM in 5 mM TRIS-HCl pH 7.5, 150 mM KCl buffer 
was incubated with 0.3 µM TPCK-trypsin (trypsin:protein ratio 1:60) for a time range varying from 30 min to 
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120 min, in the presence of 2 mM Ca2+ or EGTA. Since 30 min were found to be enough to reach a complete pro-
teolysis in the presence of EGTA and a limited proteolysis pattern in the presence of Ca2+, this condition was used 
in further experiments with NPs. Mixtures of 21 μM CaM in the absence or in the presence of 3.8 mg mL−1 NPs 
(NPs:CaM = 1:139, stoichiometric ratio was estimated as described elsewhere)4 were used in these experiments. 
The protein was dissolved in 5 mM TRIS-HCl pH 7.5, 150 mM KCl buffer and incubated with 240 µM EGTA or 
Ca2+. Protein and protein-NPs mixtures were incubated with 0.35 µM TPCK-trypsin (trypsin:protein ratio 1:60) 
for 30 min at 25 °C; the reaction was stopped by adding reducing sample buffer and boiling for 5 min. For each 
experimental condition a parallel sample without trypsin was tested. Proteolytic patterns were visualized by 15% 
and 12% SDS-PAGE via Comassie blue staining.
Circular dichroism spectroscopy. Circular dichroism spectra were collected with a Jasco J-710 spectropo-
larimeter equipped with a Peltier type thermostated cell holder. Near UV spectra were recorded at 25 °C between 
250 nm and 320 nm in a 1 cm quartz cuvette, with scan rate set to 50 nm min−1, bandwidth of 1 nm and 4 s as 
integration time. Reported spectra are the mean of 5 accumulations. Spectra of buffer alone were also collected 
and considered as blank. Protein concentration was 40 μM, and the spectra were collected in the presence and in 
the absence of 5.7 mg mL−1 NPs (ratio NPs:CaM = 1:139), with 3-fold excess of Ca2+/EGTA with respect to the 
calcium binding sites.
Far UV spectra were collected between 200–250 nm in a 0.1 cm quartz cuvette in the presence and in the 
absence of 1.75 mg mL−1 of NPs (protein concentration was 12 μM). Scan rate, bandwidth, accumulations and sat-
urating conditions were the same as for near UV spectra. CaM previously incubated with NPs was tested without 
additions of Ca2+/EGTA unless differently specified.
Thermal denaturation profiles were monitored between 20 °C and 96 °C in the same conditions as for the 
far-UV experiments. The scan speed and response time were set at 1 °C/min and 4 s respectively, and the circular 
dichroism variations was followed at 222 nm.
Nuclear magnetic resonance spectroscopy. All NMR spectra were recorded on 0.1 mM uniformly 
15N-labeled or 15N,13C-labeled CaM on a Bruker Avance III 700 MHz spectrometer equipped with a cryogen-
ically cooled TCI probe-head. Spectra were processed with NMRPipe14 and analyzed with Sparky (Goddard 
and Kneller 2004) and CCPNmr15. Backbone chemical shift assignments were obtained from CBCA(CO)NH, 
CBCANH and HNCA16.
For chemical shift perturbation analysis and PRE measurements CaF2 nanoparticle or diamagnetic CaF2:Y3+ 
and paramagnetic CaF2:Y3+,Gd3+ were added to the NMR sample up to a final concentration of 1.4 mg/ml.
Surface plasmon resonance spectroscopy. Surface Plasmon Resonance (SPR) experiments were per-
formed using a SensiQ Pioneer instrument. CaM was immobilized via amine coupling on a SensiQ COOH5 sen-
sor chip coated by a carboxylated polysaccharide hydrogel spacer. Carboxyl groups were activated with sequential 
injections of 60 µL of 10 mM H3PO4, 60 µL HBS (10 mM HEPES pH 7.4, 150 mM KCl, 20 mM MgCl2, 2 mM 
CaCl2), 60 µL 10 mM NaOH and 2 × 60 µL HBS. The sensor chip surface was activated with a 7-min injection of a 
mixture of 10mM N-hydroxysuccinimide (NHS) and N-ethyl-N’-(dimethylaminopropyl)-carbodiimide (EDC) 
at a flow of 5 µL min−1. The lyophilized protein was dissolved in bidistilled water at a concentration of 1 mg mL−1. 
Subsequent injections of CaM, diluted in Na-acetate buffer and H3PO4 (pH variating between 2.7–3.1), led the 
immobilization of 2400 RU (corresponding to ~2.4 ng, 1 RU = 1 pg mm−2, flow cell volume <40 nL) in flow cell 1 
(FC1), 200 RU in FC3 (~0.2 ng) while FC2 was considered as a reference (no protein injections were performed 
and the surface was activated/deactivated). Finally, the activated carboxy-groups were blocked via injection of 
70 µL of ethanolamine hydrochloride-NaOH pH 8.5. During the immobilization steps, HBS was used as running 
buffer.
The interactions between immobilized CaM and NPs were investigated by: (a) titrating five different NPs 
concentrations ranging from 0.1 mgmL−1 to 0.5 mgmL−1 and (b) injecting the same amount of NPs both in the 
presence and in the absence of saturating CaM concentration. Interaction experiments were performed with a 
flow rate of 10 µL min−1, with 600 s association time, 1800 s dissociation time and a final 180 s injection of 10 mM 
K-citrate in order to completely remove residual NP-CaM complex before proceeding with the next injection.
Titration data were fitted to a single exponential decay model, as in Equation 2:
= ∗ − ∗RU RU e (2)k t0
off
Instrumentation for luminescence measurements. The upconversion spectra were acquired using a 
980 diode laser as excitation source. The emission was analyzed using a monochromator (HR460, Jobin Yvon) 
equipped with a 1200 g/mm grating and a CCD detector (Spectrum One, Jobin Yvon) with a spectral resolution 
of 0.15 nm.
Results and Discussion
Conformational changes and thermal stability of CaF2 NP-bound CaM. We compared confor-
mational changes of CaM upon interaction with Ca2+and/or NPs by circular dichroism (CD) spectroscopy, a 
technique particularly suitable to study proteins in solution under conditions that mimic the physiological ones. 
While far-UV spectra can reveal secondary structure rearrangements of polypeptides in solution, near-UV spec-
tra provide a fingerprint of their tertiary structure, being sensitive to the micro environment of the aromatic res-
idues. Far-UV CD spectroscopy was used to analyze the secondary structure content of apo CaM (calcium-free, 
in the presence of EGTA), holo CaM (calcium-bound, in the presence of Ca2+) and CaM bound to CaF2 NPs. As 
expected, apo CaM shows characteristics of an alpha helical protein with minima at 208 and 222 nm (Fig. 1a). 
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Decrease of these minima upon addition of Ca2+ (21.7% relative change of θ222) reflects a major conformational 
change. (Table 1). A switch in the θ222/θ208 ratio from 0.95 in the apo form to 1.00 in the holo form has been attrib-
uted to an increased alpha helical content, reorganization of the alpha helices and an overall compaction of the 
protein upon addition of Ca2+. These findings are corroborated by NMR structure analysis and SPR17,18.
Interestingly, addition of CaF2 NPs in a decalcified CaM solution evokes an alteration of the far-UV CD spec-
trum, which is very similar to the effect of free Ca2+ (17.6% relative change of θ222) and likewise shifts the θ222/θ208 
ratio to 1.00, suggesting similar rearrangements in the NP - bound form of CaM. If EGTA is added in excess to the 
CaM-NP solution, the spectral shape shifts back to the apo CaM (Table 1, Fig. 1a), being almost undistinguisha-
ble, suggesting a dissociation of the protein-NP complex. The conformational changes of CaM in the presence of 
either CaF2 NPs or free Ca2+ also result in a very similar increase in thermal stability, as probed by almost identi-
cal thermal denaturation profiles indicating incomplete unfolding at 96 °C, at odds with the complete unfolding 
observed for the apo form (Fig. 1b).
Changes of the near-UV (250–320 nm) spectra of CaM upon addition of Ca2+ or CaF2 NPs are indicative of 
reorganization of the asymmetric environment of aromatic residues which are buried in the core of the protein 
Figure 1. (a) Far- and near-UV spectra (of ~12 µM CaM or 30 µM, respectively) in the presence of equal 
amounts (400 µM) of saturating EGTA (black) or Ca2+ (red), and CaM previously incubated with 5.7 mgmL−1 
NPs (blue). (b) Thermal denaturation profiles of ~12 µM CaM previously incubated with 1.7 mgmL−1 NPs 
(blue) and in the presence of saturating (120 µM) EGTA (black) and Ca2+ (red). θ222 has been normalized to 
account for different starting values (θ222, normalized = θ222/θ222 at 20 °C).
ϴ208 ϴ222 ϴ222/ϴ208 Δϴ222/ϴ222a
CaM Ca2+ −16.34 −16.29 1.00
21.7%
CaM EGTA −14.15 −13.38 0.95
CaM + NPs −15.74 −15.75 1.00
17.6%
CaM WT + NPs EGTA −14.09 −13.39 0.95
Table 1. Far-UV CD data: spectral shapes of apo CaM incubated with CaF2 NP are very similar to those of 
Ca2+-loaded unbound protein. aRelative change in ellipticity (θ) at λ = 222 nm as obtained by the difference in θ 
in the presence of Ca2+ or in the apo conditions (EGTA), divided by θ in the apo conditions.
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(Table 1). The near-UV spectra of NP bound CaM are very similar to those of holo CaM, but significantly differ-
ent from the apo CaM spectrum (Fig. 1a).
To further investigate potential similarities between the Ca2+-bound and NP-bound forms of CaM we per-
formed limited proteolysis experiments. Results are reported in Fig. 2.
The presence of free Ca2+ clearly protects CaM from complete degradation (Fig. 2a) even after 120 min incu-
bation with trypsin. The apo CaM instead undergoes complete degradation after 30 min. We therefore decided to 
focus on 30 min incubation for assessing the effects of CaF2 NPs on the proteolytic pattern. In line with the spec-
troscopic results obtained by CD, the presence of CaF2 NPs induces a very similar proteolysis pattern compared to 
the isolated protein in the presence of Ca2+ (Fig. 2b, downwards arrows), while excess of EGTA does not prevent 
complete digestion even in the presence of NPs (Fig. 2b, upwards arrows).
Overall, we thus conclude that the NP-bound conformation of CaM resembles the Ca2+ bound state of the 
protein (Fig. 1c). Strikingly, mutational studies performed with a CaM orthologue from A. Thaliana suggested 
that binding to CaF2 NPs requires the presence of intact EF-hand motifs6.
CaM-NP interaction occurs via a two-step process. In order to characterize the interaction of CaM 
with NPs on a molecular level, we used nuclear magnetic resonance spectroscopy (Fig. 3). In particular, we 
recorded a series of 1H, 15N heteronuclear single quantum correlation (HSQC) spectra of holo CaM with increas-
ing concentrations of CaF2 NPs. This type of spectrum resolves every amide group of the protein as a single 2D 
peak.
Moreover, it is sensitive to changes in the chemical environment of individual amino acids, thus providing 
a fingerprint of the conformational state of the protein. In a titration experiment residues, which are directly or 
indirectly involved in the binding interface, typically experience a chemical shift perturbation (CSP) - a change 
in the resonance frequency of the respective nuclei. CSP has been previously utilized to characterize the bind-
ing interface of protein-NP interactions19–25. Note that the resonances of the bound state are broadened beyond 
detection, due to the high molecular weight of the complex. However, molecular details on the interaction can 
be derived under certain kinetic conditions, i.e. if the exchange between free and NP-bound CaM is fast with 
regard to the chemical shift timescale (Fig. 4a,b). In this case, a single peak with population averaged chemical 
shift is visible19. If the interaction is in the so called intermediate exchange regime CSPs can be observed as well. 
However, in this case the observed chemical shift does not represent a simple population weighted average of the 
bound and the free state. Additionally, exchange broadening of the respective peaks occurs.
In order to achieve intermediate to fast exchange condition 500 μM Ca2+ was added to the NMR sample, 
which allows a rapid exchange between Ca2+-bound and NP-bound CaM, as no conformational rearrangement 
is required. Under these conditions CaM seems to bind preferably to NP, even in the presence of high [Ca2+] as 
significant CSPs are observed upon addition of NPs (Fig. 3a,b).
This can be attributed to the high local concentration of Ca2+ on the surface of the NPs. Intriguingly, the 
strongest CSPs are observed for residues of the two N-terminal EF-hand motifs (EF1 and EF2) closely located 
near the respective calcium binding sites (Fig. 5a). EF3 and 4 in the C-terminal lobe of CaM experience only little 
Figure 2. Limited proteolysis pattern of CaM in the presence and in the absence of NPs. (a) Proteolysis 
reactions were performed at 25 °C by 30–120 min incubation with saturating (2 mM) EGTA or Ca2+, using a 
CaM:TPCK-trypsin ratio equal to 1:60. Lane M refers to the protein marker. (b) Proteolysis experiments in 
the presence of NPs were performed by 30 min incubation with saturating (240 µM) EGTA or Ca2+, using a 
CaM:TPCK-trypsin ratio equal to 1:60. Lanes 3 and 5 refer to the digested apo (lane 3) and Ca2+-bound (lane 
5) CaM. Lanes 8 and 10 refer to the digested CaM previously incubated with NPs (lane 8) and after the addition 
of EGTA (lane 10). Undigested CaM was loaded in the same conditions in lanes 2, 4, 7 and 9. The similar effect 
exerted by either free Ca2+ or NPs and excess EGTA on the proteolytic patterns is highlighted by downwards 
and upwards arrows, respectively. The figure results from two separate gels, which have been reported in full-
length in Supplementary Figure S1.
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CSP. In addition, amino acids 80–87 - the central segment of the helix, which is connecting the N- and C-terminal 
lobe of CaM – is also affected upon binding to NPs.
Assuming that the NMR signal is a population-weighted average of holo CaM and NP-bound CaM an atten-
uation of the NMR signals upon addition of NPs is expected. Indeed, we observe an overall reduction of sig-
nal intensity. The signal reduction is more pronounced in those regions that also experience CSP, namely the 
N-terminal lobe and the linker region. The C-terminal domain, however, shows slightly less pronounced signal 
reduction. We thus conclude that the C-terminal domain is not in direct contact with the NP and thus showing 
dynamical behavior which is significantly different from the NP in terms of molecular tumbling. The average 
intensity ratio INP/I0 in the N-terminal domain is 0.84 ± 0.08 with the intensity in presence and absence of NPs, 
INP and I0, respectively, thus 16% of CaM is bound to NP under these conditions. As the average CSP on CaM NP 
interaction is rather small, we conclude that the conformations of holo CaM and NP-bound CaM are very similar.
Paramagnetic relaxation enhancement (PRE) is based on a dramatic effect of unpaired electrons on NMR 
spectra and has been widely used to characterize dark states, e.g. transiently populated states or high molecular 
weight complexes, by NMR spectroscopy26,27. Recently, PRE has been used to characterize the interface of ubiq-
uitin transiently absorbed to lanthanide-doped, paramagnetic SrF2:Y3+, Gd3+ NPs24. We adapted this approach 
to study the interaction of CaM with CaF2 NPs. For our experiment we used paramagnetic CaF2:Y3+, Gd3+ NPs 
and CaF2:Y3+ NPs as the diamagnetic reference. Figure 5b shows the PRE, described as the signal intensity of the 
paramagnetic state over the intensity in the diamagnetic state (Ipara/Idia), plotted against the sequence of CaM. 
Residues which experience the highest PRE fall in a region between amino acids 77 to 87, representing the centre 
of the interconnecting helix, congruent with the region identified by CSP. However, residues involved in calcium 
binding of all four EF hands show only very little PRE. This observation is consistent with the occurrence of a 
short-lived encounter complex, which is most likely driven by an unspecific electrostatic interaction between a 
negatively charged region on CaM (the sequence of the linker stretch is very acidic 77MKDTDSEEE87) and Ca2+ 
on the surface of the nanoparticle.
PREs are population-averaged with 1/r6, where r is the distance between the paramagnetic center and the 
nucleus under investigation. Therefore, even short-lived intermediates, which bind close to the paramag-
netic center can yield significant PREs, although CSPs can be small or even unobservable for such transient 
Figure 3. (a) Overlay of 1H,15N HSQC spectra of 1 mM holo CaM (red, 500 μM Ca2+) and NP-bound CaM 
(blue, 500 μM Ca2+, 1.4 mg/mL CaF2 NP). Residues within the four EF-hands are highlighted. Down-field 
shifts of the amide protons of G25, G61, G98 and G134 are indicative of Ca2+ complexation. Mainly residues 
close to the N-terminal and not the C-terminal EF-hands experience CSP upon addition of CaF2 nanoparticles. 
(b) Close-up of residues which coordinate Ca2+ in the N-terminal EF-hand motifs (EF1 and EF2). (c) Signal 
attenuation upon addition of NPs. The ratio of intensity in the presence (INP) and absence (I0) of nanoparticles is 
plotted against the sequence of Calmodulin.
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interactions28. On the other hand, PREs can only be observed when the complex is in fast exchange with an 
exchange rate kex >102 s−1 26. This is likely the reason for the small PREs observed in EF hands 1 and 2. Thus, 
the binding event can best be described by a two-step process. A transient encounter complex in fast exchange 
Figure 4. Schematic representation of the association and dissociation equilibria between CaM and CaF2 NP as 
monitored by chemical shift perturbation (CSP) and paramagnetic relaxation enhancement (PRE).  
(a) Chemical equilibrium of CaM/CaF2 NP interaction. Exchange between free and NP-bound CaM is determined 
by the exchange rate constant (kex) which depends on the association and dissociation rate constants (kon and 
koff, respectively). (b) CSP upon CaM/NP interaction. Under slow exchange condition NP-bound CaM cannot 
be observed by NMR. However, given that chemical exchange is fast on the chemical shift timescale, one signal 
with a population-weighted chemical shift is observable. In intermediate exchange, peaks experience exchange 
broadening in addition to CSP. (c) PRE upon addition of paramagnetic NPs. Interaction with paramagnetic 
CaF2:Y3+,Gd3+ NPs causes signal broadening. PRE, measured as Ipara/Idia, is distance dependent33.
Figure 5. (a) Chemical shift perturbation (CSP) and (b) paramagnetic relaxation enhancement (PRE) upon 
CaM/NP interaction is plotted against the sequence of CaM and visualized on the protein structure. Position of 
the four EF-hands is indicated as EF1-4.
www.nature.com/scientificreports/
8SCieNtifiC REPORTS |  (2018) 8:3420  | DOI:10.1038/s41598-018-21571-y
is formed between the central helical region of CaM with the NP as indicated by PREs (Fig. 5b). This fleeting 
interaction is in equilibrium with a tighter complex between EF1 and EF2 with calcium sites on the nanoparticle 
as evidenced by CSPs (Fig. 5a).
Affinity and kinetics of CaM-NP interactions are physiologically relevant. In order to directly 
study the interaction of apo CaM and NP we utilized Resonance Energy Transfer (RET). An important feature 
of the CaF2 host is that it can be suitably doped with luminescent lanthanide ions. In particular, Er3+,Yb3+ doped 
CaF2 NPs can generate strong upconversion (UC) emission upon excitation in the near infrared (NIR) region 
by using a cheap 980 nm diode laser29,30. UC emission generated by the Er3+/Yb3+-doped CaF2 NPs upon NIR 
excitation (donor) was used to excite the suitably labelled protein (acceptor). A single point mutation in between 
the two N-terminal EF-hands, namely T26C, was introduced in CaM and used to site-specifically label the protein 
with a fluorophore (Alexa Fluor 532) that is excited at 530 nm and emits fluorescence at a maximum wavelength 
of 554 nm.
Indeed, a clear RET signal can be detected upon the interaction of CaM with NPs. Furthermore, titration 
experiments show a concentration-dependent RET phenomenon, as demonstrated by the decrease in intensity of 
emission bands at 540 and 544 nm, with conserved spectral intensity in the 650/670 nm range, compatible with 
an apparent KD of 2.5 μM for CaM-NP binding. (Fig. 6) This is in line with previous data obtained by ITC with 
orthologue CaM (KD = 2 μM) from A. Thaliana6.
The kinetics of CaM-NP interactions was monitored by SPR. Similarly to what was recently observed with 
GCAP15, CaF2 NPs interact with immobilized CaM if the surface of the particle is uncoupled to other CaM mol-
ecules. In the case of a “protein corona” formed by CaM molecules previously incubated with NPs, no association 
was indeed observed (Fig. 7). The dashed grey line in Fig. 7a reports, as an example, the case of 1.6 µM CaM 
incubated at room temperature with 0.1 mg mL−1 NPs; similar results were obtained with other amounts of NP/
protein. Several injections of NPs in a 0.1–0.5 mgmL−1 concentration range showed that, similar to the GCAP1 
case5, the association process does not follow a Langmuir adsorption model, as no specific dependency on the 
NP concentration could be detected for the SPR signal. Moreover, approximately 400 s are needed for the system 
to relax after NP injection (Fig. 7a), a phenomenon that was previously interpreted as a combination of protein 
conformational change31,32 and NP diffusion in the polysaccharide matrix on the sensor chip5 that reflects in a 
~200 s continuous increase in the SPR signal after the injection of NPs was interrupted. When real dissociation 
is concerned, however, the dissociation phase could be nicely fitted to a single exponential function, leading to a 
koff = (3.5 ± 0.4) × 10−3 s−1, compatible with a fairly faster dissociation, which appeared to be completed in 2000 s, 
Figure 6. RET analysis of CaM-NP interaction (a) Upconversion spectra of CaF2 NPs in CaM titration 
experiments. The resonance energy transfer (RET) phenomenon is evident by a strong decrease of the Er3+ 
emission in the 520–560 nm optical range. Band assignment: (i) 2H1/2→4I15/2; (ii) 4S3/2→4I15/2; (iii) 4F9/2→4I15/2. 
(b–d) Example of titration experiments of Alexa Fluor 532-conjugated CaM with a 0.5 mg/mL NPs dispersion. 
(b) Zoom of the spectral area showing the RET phenomenon. Notice the change in NPs emission at 540 (c) and 
544nm (d).
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Figure 7. SPR analysis of CaM-NP interaction. (a) Example of sensorgram obtained by flowing NPs (0.1 mg/mL) 
on a flow cell, where 2400 RU of CaM were previously immobilized via amine coupling. Injection was performed 
for 600 s (flow rate 10 µL/min) and dissociation was followed for 1800 s. The red curve refers to data fitting using 
a single exponential function. The dashed grey line refers to injection of the same amount of NPs previously 
incubated with 1.6 µM CaM. (b) Example of dissociation curves obtained by SPR overlapped to the fitting curves 
according to a single exponential in the 0.1–0.5 mg/mL NP range.
Figure 8. Schematic representation of NP-CaM interactions. Left side: when apo CaM is incubated with 
NPs, two different equilibria establish. PRE experiments suggest that the first contact between CaM and NP is 
mediated by the central linker (L) region. At this point, CaM can either return to the apo state (1) through a 
rapid dissociation by the NP surface, or be converted into a more stable NP-bound conformation (holo), via an 
interaction mostly involving the N-terminal domain (2), as suggested by CSP experiments. Right side: when an 
excess of EGTA (black blocks) is added, the chelator binds Ca2+ ions on the NP surface, thus restoring the apo-
CaM conformation (3), as suggested by near- and farUV spectra (Fig. 1a). Blue thick lines represent the areas 
mostly involved in CaM/NPs interaction.
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thus being fully compatible with potential nanomedicine applications. The fact that the complete dissociation for 
GCAP1 was observed after ~6500 s under similar conditions probably reflects the significantly higher affinity of 
GCAP1 for CaF2 NPs (12 nM)5.
Conclusions
In this study, we present a general methodology to comprehensively describe the binding of proteins to NPs by 
using a combination of biophysical techniques. As a specific example, we found that the binding of the proto-
typical calcium sensor CaM to CaF2 NPs can be described by a two-step process, involving the formation of an 
intermediate encounter complex involving the linker region. Specific interaction of CaM to CaF2 NPs is driven 
by the N-terminal EF-hands, which seem to recognize Ca2+ on the surface of the nanoparticle. If high amounts 
of chelating molecules such as EGTA are added to the system, the dissociation of CaM from the NP surface is 
favored and brings the protein back to its apo-form. Interestingly, some of us previously demonstrated that CaM 
dissociated from the CaF2 NP surface is functional and can fully activate a protein target6. We summarize the 
emerging model of interaction between CaM and CaF2 NPs in Fig. 8.
A major advantage of our comprehensive analysis is that, beside a static picture of the protein-NP system at 
the equilibrium that can be obtained by several physicochemical approaches, it offers a more dynamic description 
that provides information as to the kinetics of the association/dissociation processes. While further studies are 
needed to thoroughly decipher the complex kinetics of association, we clearly showed that once the association 
to CaF2 NPs has occurred, for instance by previous incubation, the dissociation of CaM from the NP surface is 
complete in 2000 s, thus pointing to physiological relevance of the process.
The unique feature of having a large surface-to-volume ratio confers NPs the possibility to safely carry a func-
tional protein on the surface of the device. This could be exploited in future studies for delivery purposes in the 
increasing cases in which CaM has been shown to be associated to specific disease states.
Availability of materials and data. All materials, data and protocols associated with this manuscript are 
promptly available to readers without undue qualifications in material transfer agreements.
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Full-length gels (uncropped) used to prepare panels a (left) and b (right) in Figure 2, respectively.  
